GS	SIZE	SOURCE	ES	NES	NOM p-val	FDR q-val	FWER p-val	Tag %	Gene %	Signal	FDR (median)	glob.p.val
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN	-0.63269	-1.7995	0.01006	1	0.601	0.706	0.261	0.522	1	0.576
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN	-0.67722	-1.7851	0.02947	1	0.632	0.368	0.0824	0.338	0.99323	0.5
ONO_AML1_TARGETS_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/ONO_AML1_TARGETS_DN	-0.63469	-1.7661	0.001919	1	0.675	0.538	0.203	0.43	0.8701	0.47
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	29	http://www.broadinstitute.org/gsea/msigdb/cards/BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	-0.65754	-1.7377	0.0155	1	0.732	0.517	0.185	0.422	0.97445	0.495
WILENSKY_RESPONSE_TO_DARAPLADIB	29	http://www.broadinstitute.org/gsea/msigdb/cards/WILENSKY_RESPONSE_TO_DARAPLADIB	-0.63789	-1.7244	0.009921	1	0.751	0.517	0.166	0.432	0.81471	0.449
WU_ALZHEIMER_DISEASE_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/WU_ALZHEIMER_DISEASE_DN	-0.60365	-1.7244	0.007858	1	0.751	0.529	0.274	0.385	0.97765	0.495
MCLACHLAN_DENTAL_CARIES_UP	226	http://www.broadinstitute.org/gsea/msigdb/cards/MCLACHLAN_DENTAL_CARIES_UP	-0.56491	-1.7117	0.02226	1	0.782	0.5	0.191	0.408	0.81738	0.45
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	122	http://www.broadinstitute.org/gsea/msigdb/cards/ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	-0.5342	-1.7087	0.01541	1	0.786	0.467	0.196	0.378	0.76948	0.42
BIOCARTA_COMP_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_COMP_PATHWAY	-0.63823	-1.7013	0.003731	1	0.798	0.667	0.196	0.537	0.73298	0.409
MAHADEVAN_RESPONSE_TO_MP470_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/MAHADEVAN_RESPONSE_TO_MP470_UP	-0.73349	-1.6996	0.00566	1	0.799	0.474	0.0949	0.429	0.66251	0.388
LEE_LIVER_CANCER_MYC_DN	59	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_DN	-0.469	-1.6953	0.03599	1	0.801	0.322	0.138	0.278	0.65197	0.367
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	83	http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	-0.56263	-1.6913	0.02857	1	0.806	0.53	0.235	0.407	0.62818	0.354
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN	-0.69627	-1.6907	0.02028	1	0.81	0.7	0.189	0.568	0.57986	0.331
MARKEY_RB1_CHRONIC_LOF_DN	111	http://www.broadinstitute.org/gsea/msigdb/cards/MARKEY_RB1_CHRONIC_LOF_DN	-0.44541	-1.687	0.02481	1	0.822	0.315	0.166	0.264	0.56544	0.325
VALK_AML_CLUSTER_4	28	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_4	-0.52227	-1.6763	0.01793	1	0.837	0.357	0.158	0.301	0.60211	0.332
ONO_FOXP3_TARGETS_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/ONO_FOXP3_TARGETS_DN	-0.5508	-1.6689	0.009652	1	0.851	0.366	0.129	0.319	0.59123	0.342
OLSSON_E2F3_TARGETS_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/OLSSON_E2F3_TARGETS_UP	-0.47251	-1.6653	0.01359	1	0.861	0.286	0.157	0.241	0.57404	0.337
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	56	http://www.broadinstitute.org/gsea/msigdb/cards/DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	-0.43698	-1.659	0	1	0.87	0.464	0.238	0.354	0.59972	0.338
CHEN_ETV5_TARGETS_SERTOLI	19	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_ETV5_TARGETS_SERTOLI	-0.7054	-1.6567	0.01351	1	0.872	0.579	0.153	0.491	0.58605	0.33
ZHAN_MULTIPLE_MYELOMA_SPIKED	21	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_SPIKED	-0.63014	-1.655	0.004024	1	0.874	0.619	0.281	0.445	0.56932	0.32
BIOCARTA_IL10_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL10_PATHWAY	-0.58044	-1.6534	0.01165	1	0.876	0.25	0.0876	0.228	0.54751	0.303
CONRAD_STEM_CELL	39	http://www.broadinstitute.org/gsea/msigdb/cards/CONRAD_STEM_CELL	-0.46815	-1.6511	0.02	1	0.882	0.308	0.156	0.26	0.53573	0.302
MCLACHLAN_DENTAL_CARIES_DN	220	http://www.broadinstitute.org/gsea/msigdb/cards/MCLACHLAN_DENTAL_CARIES_DN	-0.49313	-1.6496	0.03346	0.97049	0.884	0.45	0.191	0.367	0.52046	0.287
LI_WILMS_TUMOR	26	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR	-0.50597	-1.6483	0.001984	0.94273	0.889	0.346	0.159	0.291	0.50511	0.275
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	102	http://www.broadinstitute.org/gsea/msigdb/cards/ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	-0.51665	-1.6442	0.03295	0.93659	0.894	0.392	0.178	0.324	0.50756	0.272
LINDSTEDT_DENDRITIC_CELL_MATURATION_A	64	http://www.broadinstitute.org/gsea/msigdb/cards/LINDSTEDT_DENDRITIC_CELL_MATURATION_A	-0.54577	-1.636	0.02724	0.97042	0.903	0.484	0.221	0.378	0.53588	0.294
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2	55	http://www.broadinstitute.org/gsea/msigdb/cards/WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2	-0.51549	-1.6311	0.03156	0.97396	0.907	0.618	0.315	0.424	0.53143	0.296
RUAN_RESPONSE_TO_TROGLITAZONE_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TROGLITAZONE_UP	-0.44226	-1.6304	0.009652	0.94475	0.909	0.56	0.321	0.381	0.51245	0.286
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	28	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	-0.54487	-1.63	0.01536	0.91512	0.91	0.429	0.142	0.368	0.50069	0.273
PAL_PRMT5_TARGETS_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/PAL_PRMT5_TARGETS_DN	-0.58279	-1.6273	0.05437	0.90659	0.917	0.414	0.188	0.336	0.51039	0.265
GREENBAUM_E2A_TARGETS_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/GREENBAUM_E2A_TARGETS_DN	-0.58595	-1.6265	0.05336	0.88268	0.918	0.4	0.16	0.336	0.49875	0.261
WALLACE_PROSTATE_CANCER_RACE_UP	275	http://www.broadinstitute.org/gsea/msigdb/cards/WALLACE_PROSTATE_CANCER_RACE_UP	-0.52131	-1.6168	0.04688	0.9325	0.932	0.502	0.232	0.389	0.548	0.278
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	-0.52659	-1.6139	0.01536	0.92671	0.934	0.32	0.096	0.29	0.53695	0.278
GENTLES_LEUKEMIC_STEM_CELL_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/GENTLES_LEUKEMIC_STEM_CELL_DN	-0.59709	-1.6122	0.003676	0.91244	0.935	0.421	0.102	0.379	0.5353	0.272
WIELAND_UP_BY_HBV_INFECTION	95	http://www.broadinstitute.org/gsea/msigdb/cards/WIELAND_UP_BY_HBV_INFECTION	-0.55273	-1.6104	0.0699	0.90005	0.937	0.453	0.223	0.353	0.52977	0.268
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	48	http://www.broadinstitute.org/gsea/msigdb/cards/DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	-0.53882	-1.6091	0.00994	0.88401	0.94	0.667	0.328	0.449	0.52893	0.262
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	215	http://www.broadinstitute.org/gsea/msigdb/cards/JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	-0.46628	-1.6076	0.04528	0.87223	0.943	0.516	0.305	0.362	0.52186	0.258
TIAN_TNF_SIGNALING_VIA_NFKB	27	http://www.broadinstitute.org/gsea/msigdb/cards/TIAN_TNF_SIGNALING_VIA_NFKB	-0.65612	-1.6049	0.06142	0.86815	0.946	0.481	0.138	0.416	0.51615	0.257
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	-0.53402	-1.6042	0.03854	0.85192	0.948	0.518	0.248	0.39	0.51878	0.255
RADAEVA_RESPONSE_TO_IFNA1_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/RADAEVA_RESPONSE_TO_IFNA1_UP	-0.51199	-1.6021	0.04912	0.84649	0.949	0.327	0.138	0.282	0.50876	0.248
PRAMOONJAGO_SOX4_TARGETS_UP	51	http://www.broadinstitute.org/gsea/msigdb/cards/PRAMOONJAGO_SOX4_TARGETS_UP	-0.54871	-1.6004	0.05488	0.83805	0.953	0.412	0.19	0.334	0.50356	0.247
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	45	http://www.broadinstitute.org/gsea/msigdb/cards/PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	-0.53942	-1.5998	0.05469	0.82155	0.955	0.511	0.221	0.399	0.49157	0.237
PLASARI_NFIC_TARGETS_BASAL_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_NFIC_TARGETS_BASAL_DN	-0.64238	-1.5977	0.04118	0.81752	0.956	0.529	0.113	0.47	0.48793	0.239
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	-0.54101	-1.5961	0.01378	0.8099	0.957	0.448	0.163	0.376	0.48316	0.238
BAUS_TFF2_TARGETS_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/BAUS_TFF2_TARGETS_UP	-0.50521	-1.5953	0.04398	0.79706	0.958	0.387	0.209	0.307	0.47522	0.232
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	-0.51469	-1.5939	0.01341	0.78862	0.958	0.778	0.416	0.456	0.48025	0.23
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	69	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	-0.63334	-1.591	0.02734	0.79197	0.963	0.609	0.21	0.482	0.48024	0.23
LENAOUR_DENDRITIC_CELL_MATURATION_DN	125	http://www.broadinstitute.org/gsea/msigdb/cards/LENAOUR_DENDRITIC_CELL_MATURATION_DN	-0.43046	-1.5903	0.02662	0.78086	0.963	0.384	0.196	0.31	0.47957	0.229
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	97	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	-0.46075	-1.5902	0.01738	0.7654	0.963	0.505	0.24	0.385	0.46979	0.223
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	83	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	-0.49945	-1.5848	0.07087	0.78556	0.965	0.422	0.182	0.346	0.48762	0.227
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	23	http://www.broadinstitute.org/gsea/msigdb/cards/LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	-0.56714	-1.5834	0.03482	0.77904	0.966	0.478	0.189	0.388	0.48281	0.226
YAN_ESCAPE_FROM_ANOIKIS	24	http://www.broadinstitute.org/gsea/msigdb/cards/YAN_ESCAPE_FROM_ANOIKIS	-0.63537	-1.5829	0.0444	0.76774	0.966	0.458	0.169	0.381	0.47766	0.225
PID_IL23_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL23_PATHWAY	-0.47203	-1.5823	0.04546	0.75646	0.966	0.351	0.135	0.304	0.47414	0.22
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP	-0.54896	-1.5806	0.05859	0.754	0.966	0.548	0.228	0.424	0.47225	0.218
REACTOME_GLYCOSPHINGOLIPID_METABOLISM	35	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLYCOSPHINGOLIPID_METABOLISM	-0.43223	-1.5798	0.03018	0.74523	0.966	0.429	0.254	0.32	0.4669	0.216
VERHAAK_AML_WITH_NPM1_MUTATED_UP	168	http://www.broadinstitute.org/gsea/msigdb/cards/VERHAAK_AML_WITH_NPM1_MUTATED_UP	-0.45032	-1.5781	0.03599	0.74313	0.968	0.417	0.202	0.335	0.46721	0.216
LIANG_SILENCED_BY_METHYLATION_2	52	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_SILENCED_BY_METHYLATION_2	-0.62527	-1.5735	0.05182	0.75674	0.969	0.538	0.169	0.449	0.47364	0.222
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	54	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	-0.54137	-1.5725	0.02913	0.75015	0.972	0.519	0.205	0.413	0.46783	0.219
TAVOR_CEBPA_TARGETS_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/TAVOR_CEBPA_TARGETS_DN	-0.52177	-1.5722	0.07227	0.73968	0.972	0.414	0.2	0.331	0.46051	0.215
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	196	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	-0.37775	-1.5706	0.01134	0.73667	0.973	0.342	0.204	0.274	0.45993	0.217
KEGG_TYPE_I_DIABETES_MELLITUS	38	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TYPE_I_DIABETES_MELLITUS	-0.52543	-1.5688	0.02907	0.7343	0.975	0.684	0.398	0.412	0.45289	0.216
ZHAN_MULTIPLE_MYELOMA_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_DN	-0.48911	-1.5658	0.03366	0.73959	0.976	0.55	0.231	0.423	0.45951	0.213
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	137	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	-0.39325	-1.5641	0.01721	0.73856	0.976	0.409	0.232	0.316	0.46279	0.213
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	65	http://www.broadinstitute.org/gsea/msigdb/cards/SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	-0.48908	-1.5624	0.06188	0.73689	0.976	0.308	0.112	0.274	0.46109	0.215
KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	22	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	-0.53815	-1.5617	0.06312	0.7193	0.976	0.273	0.102	0.245	0.44712	0.208
MOREIRA_RESPONSE_TO_TSA_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/MOREIRA_RESPONSE_TO_TSA_DN	-0.53661	-1.5617	0.02564	0.73029	0.976	0.722	0.23	0.556	0.454	0.216
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	-0.56752	-1.5616	0.06374	0.70898	0.976	0.517	0.203	0.413	0.44215	0.203
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	-0.43015	-1.5614	0.05747	0.69964	0.976	0.448	0.269	0.328	0.43871	0.199
POOLA_INVASIVE_BREAST_CANCER_UP	267	http://www.broadinstitute.org/gsea/msigdb/cards/POOLA_INVASIVE_BREAST_CANCER_UP	-0.48862	-1.5602	0.06464	0.6959	0.978	0.416	0.2	0.336	0.43875	0.196
REACTOME_COMPLEMENT_CASCADE	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_COMPLEMENT_CASCADE	-0.51026	-1.5568	0.01897	0.70525	0.981	0.464	0.161	0.39	0.45093	0.199
NADLER_OBESITY_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/NADLER_OBESITY_UP	-0.52021	-1.5543	0.09021	0.70994	0.982	0.525	0.269	0.385	0.45113	0.199
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	26	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	-0.57271	-1.5541	0.08266	0.70116	0.982	0.423	0.157	0.357	0.44574	0.195
MAHADEVAN_RESPONSE_TO_MP470_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/MAHADEVAN_RESPONSE_TO_MP470_DN	-0.70515	-1.5537	0.05697	0.69376	0.983	0.579	0.165	0.484	0.43991	0.192
PID_IL4_2PATHWAY	61	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL4_2PATHWAY	-0.39238	-1.553	0.03495	0.6878	0.983	0.541	0.378	0.337	0.43406	0.19
YU_MYC_TARGETS_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/YU_MYC_TARGETS_DN	-0.46377	-1.5518	0.03269	0.68513	0.983	0.255	0.0889	0.233	0.43154	0.187
AMIT_EGF_RESPONSE_60_MCF10A	37	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_60_MCF10A	-0.68256	-1.5516	0.07045	0.67717	0.983	0.595	0.144	0.51	0.42872	0.187
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	64	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	-0.44053	-1.5501	0.0159	0.67644	0.988	0.344	0.148	0.293	0.42883	0.185
CADWELL_ATG16L1_TARGETS_UP	88	http://www.broadinstitute.org/gsea/msigdb/cards/CADWELL_ATG16L1_TARGETS_UP	-0.42238	-1.5497	0.01536	0.6696	0.988	0.443	0.282	0.319	0.4238	0.185
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	124	http://www.broadinstitute.org/gsea/msigdb/cards/ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	-0.51794	-1.5484	0.06783	0.66848	0.988	0.484	0.219	0.38	0.42853	0.187
HECKER_IFNB1_TARGETS	90	http://www.broadinstitute.org/gsea/msigdb/cards/HECKER_IFNB1_TARGETS	-0.53323	-1.5443	0.07386	0.68194	0.99	0.433	0.171	0.36	0.43682	0.188
BASSO_CD40_SIGNALING_UP	99	http://www.broadinstitute.org/gsea/msigdb/cards/BASSO_CD40_SIGNALING_UP	-0.46688	-1.5435	0.05114	0.67761	0.99	0.465	0.246	0.352	0.43399	0.188
LIAN_LIPA_TARGETS_3M	57	http://www.broadinstitute.org/gsea/msigdb/cards/LIAN_LIPA_TARGETS_3M	-0.51357	-1.5377	0.02434	0.70112	0.992	0.368	0.185	0.301	0.45289	0.2
BOQUEST_STEM_CELL_DN	208	http://www.broadinstitute.org/gsea/msigdb/cards/BOQUEST_STEM_CELL_DN	-0.40237	-1.5376	0.05461	0.69337	0.992	0.462	0.284	0.333	0.44765	0.195
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	-0.48994	-1.5371	0.07129	0.68775	0.992	0.444	0.204	0.354	0.44236	0.189
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	30	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	-0.55204	-1.5366	0.0159	0.68242	0.992	0.4	0.148	0.341	0.43887	0.186
NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	25	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	-0.5349	-1.5339	0.01138	0.68803	0.994	0.92	0.441	0.515	0.44575	0.19
GAURNIER_PSMD4_TARGETS	66	http://www.broadinstitute.org/gsea/msigdb/cards/GAURNIER_PSMD4_TARGETS	-0.54496	-1.5337	0.05577	0.68064	0.994	0.379	0.161	0.319	0.44062	0.187
BIOCARTA_AMI_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_AMI_PATHWAY	-0.54297	-1.5312	0.02524	0.68652	0.994	0.65	0.322	0.441	0.44383	0.19
DAUER_STAT3_TARGETS_UP	48	http://www.broadinstitute.org/gsea/msigdb/cards/DAUER_STAT3_TARGETS_UP	-0.52368	-1.5306	0.07042	0.68221	0.994	0.438	0.203	0.349	0.44607	0.186
REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS	-0.49049	-1.5292	0.005703	0.68193	0.994	0.438	0.233	0.336	0.44623	0.189
NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	38	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	-0.5095	-1.5288	0.00998	0.67628	0.994	0.816	0.434	0.463	0.44301	0.188
WESTON_VEGFA_TARGETS_3HR	72	http://www.broadinstitute.org/gsea/msigdb/cards/WESTON_VEGFA_TARGETS_3HR	-0.45832	-1.5286	0.07573	0.66977	0.994	0.431	0.24	0.328	0.4382	0.185
SU_SALIVARY_GLAND	15	http://www.broadinstitute.org/gsea/msigdb/cards/SU_SALIVARY_GLAND	-0.49589	-1.5274	0.01544	0.66847	0.994	0.333	0.134	0.289	0.43615	0.187
TSUNODA_CISPLATIN_RESISTANCE_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/TSUNODA_CISPLATIN_RESISTANCE_UP	-0.74415	-1.5265	0.05792	0.66601	0.994	0.8	0.186	0.652	0.43873	0.185
VILIMAS_NOTCH1_TARGETS_UP	51	http://www.broadinstitute.org/gsea/msigdb/cards/VILIMAS_NOTCH1_TARGETS_UP	-0.56571	-1.5241	0.03442	0.67116	0.994	0.569	0.203	0.454	0.45188	0.189
HAN_JNK_SINGALING_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/HAN_JNK_SINGALING_DN	-0.51327	-1.5233	0.03953	0.66798	0.994	0.474	0.199	0.38	0.4486	0.188
ONO_AML1_TARGETS_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/ONO_AML1_TARGETS_UP	-0.61275	-1.5216	0.05762	0.66959	0.994	0.565	0.145	0.484	0.44787	0.188
PID_IL12_2PATHWAY	61	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL12_2PATHWAY	-0.44559	-1.5209	0.06107	0.66657	0.994	0.557	0.332	0.373	0.44832	0.186
CASTELLANO_NRAS_TARGETS_UP	64	http://www.broadinstitute.org/gsea/msigdb/cards/CASTELLANO_NRAS_TARGETS_UP	-0.40876	-1.5196	0.07905	0.66631	0.994	0.312	0.178	0.258	0.45134	0.186
KLEIN_TARGETS_OF_BCR_ABL1_FUSION	44	http://www.broadinstitute.org/gsea/msigdb/cards/KLEIN_TARGETS_OF_BCR_ABL1_FUSION	-0.49014	-1.5176	0.02281	0.66968	0.994	0.523	0.297	0.368	0.45296	0.186
CHIBA_RESPONSE_TO_TSA_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/CHIBA_RESPONSE_TO_TSA_UP	-0.49046	-1.5176	0.08507	0.66324	0.994	0.367	0.176	0.303	0.44848	0.186
LOPES_METHYLATED_IN_COLON_CANCER_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/LOPES_METHYLATED_IN_COLON_CANCER_UP	-0.52097	-1.5167	0.06693	0.661	0.994	0.407	0.193	0.329	0.44506	0.185
WESTON_VEGFA_TARGETS	105	http://www.broadinstitute.org/gsea/msigdb/cards/WESTON_VEGFA_TARGETS	-0.46608	-1.5161	0.06587	0.65764	0.994	0.448	0.24	0.342	0.44177	0.185
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP	-0.54055	-1.5153	0.08721	0.65517	0.994	0.381	0.147	0.325	0.43805	0.185
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN	-0.51573	-1.5142	0.04418	0.65448	0.994	0.483	0.219	0.378	0.43449	0.184
ST_WNT_CA2_CYCLIC_GMP_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/ST_WNT_CA2_CYCLIC_GMP_PATHWAY	-0.37811	-1.513	0.04142	0.65398	0.994	0.45	0.301	0.315	0.44455	0.185
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	75	http://www.broadinstitute.org/gsea/msigdb/cards/THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	-0.48517	-1.5115	0.08383	0.65518	0.997	0.253	0.097	0.229	0.44867	0.188
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	74	http://www.broadinstitute.org/gsea/msigdb/cards/HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	-0.51995	-1.5114	0.09002	0.6494	0.997	0.473	0.204	0.378	0.44452	0.182
PID_AP1_PATHWAY	67	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AP1_PATHWAY	-0.45226	-1.5096	0.09162	0.65236	0.997	0.433	0.265	0.319	0.4442	0.182
ABE_VEGFA_TARGETS_30MIN	28	http://www.broadinstitute.org/gsea/msigdb/cards/ABE_VEGFA_TARGETS_30MIN	-0.58208	-1.5095	0.09808	0.64702	0.997	0.571	0.239	0.436	0.44116	0.181
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP	-0.49811	-1.509	0.05917	0.64333	0.997	0.667	0.353	0.432	0.43799	0.181
PIONTEK_PKD1_TARGETS_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/PIONTEK_PKD1_TARGETS_UP	-0.41206	-1.5085	0.025	0.64019	0.997	0.429	0.277	0.31	0.43987	0.181
ZHENG_RESPONSE_TO_ARSENITE_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_RESPONSE_TO_ARSENITE_DN	-0.53832	-1.5082	0.078	0.63034	0.997	0.25	0.0698	0.233	0.43215	0.18
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK	16	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK	-0.51201	-1.5082	0.07874	0.63578	0.997	0.312	0.143	0.268	0.43597	0.181
LEIN_ASTROCYTE_MARKERS	42	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_ASTROCYTE_MARKERS	-0.41738	-1.5074	0.03668	0.62893	0.999	0.667	0.413	0.392	0.43213	0.18
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	36	http://www.broadinstitute.org/gsea/msigdb/cards/UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	-0.67943	-1.5056	0.1008	0.63159	0.999	0.833	0.267	0.611	0.43565	0.18
ONO_FOXP3_TARGETS_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/ONO_FOXP3_TARGETS_UP	-0.56175	-1.5035	0.08364	0.6366	0.999	0.591	0.203	0.472	0.43604	0.18
FARMER_BREAST_CANCER_CLUSTER_1	38	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_1	-0.61791	-1.5034	0.1015	0.6319	0.999	0.526	0.123	0.462	0.43235	0.18
GAVIN_FOXP3_TARGETS_CLUSTER_P4	95	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_P4	-0.35701	-1.5033	0.06202	0.62683	0.999	0.368	0.227	0.286	0.42871	0.178
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	-0.45989	-1.5024	0.05589	0.62555	0.999	0.316	0.145	0.27	0.43148	0.177
KANG_IMMORTALIZED_BY_TERT_DN	99	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_IMMORTALIZED_BY_TERT_DN	-0.40885	-1.501	0.04941	0.62736	0.999	0.525	0.305	0.367	0.42886	0.176
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	51	http://www.broadinstitute.org/gsea/msigdb/cards/KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	-0.38917	-1.5004	0.08114	0.62526	0.999	0.353	0.202	0.282	0.42535	0.176
SMID_BREAST_CANCER_NORMAL_LIKE_UP	441	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_NORMAL_LIKE_UP	-0.41053	-1.4998	0.06963	0.62296	0.999	0.374	0.206	0.302	0.42591	0.176
HOSHIDA_LIVER_CANCER_SUBCLASS_S1	231	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_SUBCLASS_S1	-0.45866	-1.4986	0.1031	0.62357	0.999	0.338	0.167	0.284	0.42653	0.176
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	65	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	-0.51319	-1.4976	0.04633	0.62297	1	0.462	0.191	0.374	0.42548	0.176
VANHARANTA_UTERINE_FIBROID_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/VANHARANTA_UTERINE_FIBROID_DN	-0.51149	-1.4956	0.07831	0.62765	1	0.508	0.223	0.396	0.42985	0.177
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	162	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	-0.45249	-1.4953	0.08171	0.62406	1	0.284	0.0961	0.258	0.42647	0.177
BOWIE_RESPONSE_TO_TAMOXIFEN	18	http://www.broadinstitute.org/gsea/msigdb/cards/BOWIE_RESPONSE_TO_TAMOXIFEN	-0.68527	-1.4952	0.1078	0.61952	1	0.611	0.169	0.508	0.42314	0.175
WATANABE_COLON_CANCER_MSI_VS_MSS_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/WATANABE_COLON_CANCER_MSI_VS_MSS_UP	-0.44681	-1.4949	0.02959	0.6163	1	0.6	0.372	0.377	0.42638	0.171
KRIEG_HYPOXIA_VIA_KDM3A	52	http://www.broadinstitute.org/gsea/msigdb/cards/KRIEG_HYPOXIA_VIA_KDM3A	-0.40832	-1.4946	0.06757	0.61239	1	0.346	0.184	0.283	0.4232	0.169
MISSIAGLIA_REGULATED_BY_METHYLATION_UP	122	http://www.broadinstitute.org/gsea/msigdb/cards/MISSIAGLIA_REGULATED_BY_METHYLATION_UP	-0.39802	-1.4932	0.1004	0.61417	1	0.344	0.22	0.27	0.42069	0.171
LIANG_SILENCED_BY_METHYLATION_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_SILENCED_BY_METHYLATION_UP	-0.52941	-1.4931	0.05622	0.60991	1	0.355	0.114	0.315	0.4175	0.169
DEMAGALHAES_AGING_UP	50	http://www.broadinstitute.org/gsea/msigdb/cards/DEMAGALHAES_AGING_UP	-0.52274	-1.4929	0.09751	0.60609	1	0.56	0.238	0.428	0.41436	0.169
REACTOME_ZINC_TRANSPORTERS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ZINC_TRANSPORTERS	-0.46452	-1.4926	0.06731	0.60304	1	0.733	0.43	0.418	0.41171	0.165
PARK_APL_PATHOGENESIS_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_APL_PATHOGENESIS_DN	-0.51548	-1.492	0.0957	0.6013	1	0.426	0.199	0.341	0.41285	0.165
HALMOS_CEBPA_TARGETS_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/HALMOS_CEBPA_TARGETS_UP	-0.51328	-1.4917	0.09002	0.59792	1	0.388	0.166	0.324	0.4105	0.165
NAKAMURA_CANCER_MICROENVIRONMENT_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_CANCER_MICROENVIRONMENT_UP	-0.52303	-1.4909	0.06391	0.5972	1	0.571	0.235	0.437	0.40922	0.163
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	54	http://www.broadinstitute.org/gsea/msigdb/cards/WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	-0.37908	-1.4899	0.04808	0.59686	1	0.315	0.139	0.272	0.40843	0.163
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN	-0.4876	-1.4889	0.06031	0.59693	1	0.5	0.223	0.389	0.41439	0.162
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	-0.53585	-1.4879	0.06142	0.59717	1	0.444	0.209	0.352	0.41213	0.162
SANA_TNF_SIGNALING_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/SANA_TNF_SIGNALING_UP	-0.5233	-1.4875	0.1024	0.59456	1	0.372	0.158	0.314	0.41119	0.162
LINDGREN_BLADDER_CANCER_CLUSTER_2B	372	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_2B	-0.46113	-1.4871	0.08431	0.59233	1	0.384	0.185	0.318	0.41029	0.162
ALONSO_METASTASIS_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/ALONSO_METASTASIS_DN	-0.4576	-1.4856	0.0575	0.59428	1	0.333	0.15	0.284	0.41485	0.161
RODWELL_AGING_KIDNEY_UP	444	http://www.broadinstitute.org/gsea/msigdb/cards/RODWELL_AGING_KIDNEY_UP	-0.39375	-1.4855	0.0793	0.59076	1	0.327	0.206	0.264	0.41197	0.161
HOEGERKORP_CD44_TARGETS_DIRECT_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/HOEGERKORP_CD44_TARGETS_DIRECT_UP	-0.43326	-1.4847	0.06883	0.5905	1	0.385	0.161	0.323	0.41184	0.16
SCHOEN_NFKB_SIGNALING	33	http://www.broadinstitute.org/gsea/msigdb/cards/SCHOEN_NFKB_SIGNALING	-0.62882	-1.4842	0.1105	0.58863	1	0.636	0.202	0.508	0.4102	0.16
PETRETTO_HEART_MASS_QTL_CIS_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/PETRETTO_HEART_MASS_QTL_CIS_UP	-0.41639	-1.484	0.0754	0.58549	1	0.56	0.368	0.354	0.40868	0.16
WEINMANN_ADAPTATION_TO_HYPOXIA_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/WEINMANN_ADAPTATION_TO_HYPOXIA_DN	-0.49127	-1.4828	0.08103	0.58613	1	0.513	0.189	0.416	0.40771	0.161
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_TARGETS_OF_PTCH1_AND_SUFU_UP	-0.39821	-1.4824	0.09697	0.58401	1	0.265	0.161	0.223	0.40911	0.16
AMIT_SERUM_RESPONSE_40_MCF10A	31	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_SERUM_RESPONSE_40_MCF10A	-0.67167	-1.4823	0.1023	0.58058	1	0.677	0.197	0.544	0.40638	0.159
SEKI_INFLAMMATORY_RESPONSE_LPS_UP	75	http://www.broadinstitute.org/gsea/msigdb/cards/SEKI_INFLAMMATORY_RESPONSE_LPS_UP	-0.51333	-1.4808	0.1154	0.57944	1	0.387	0.157	0.327	0.40348	0.158
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN	-0.41103	-1.4808	0.04339	0.58317	1	0.426	0.217	0.334	0.40615	0.16
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	-0.54314	-1.4786	0.1036	0.58416	1	0.46	0.196	0.37	0.40741	0.159
BIOCARTA_LAIR_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_LAIR_PATHWAY	-0.53284	-1.4781	0.02128	0.58241	1	0.5	0.215	0.393	0.40824	0.157
NAKAJIMA_MAST_CELL	45	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAJIMA_MAST_CELL	-0.44725	-1.477	0.07602	0.58283	1	0.4	0.19	0.324	0.40708	0.156
MOSERLE_IFNA_RESPONSE	31	http://www.broadinstitute.org/gsea/msigdb/cards/MOSERLE_IFNA_RESPONSE	-0.75397	-1.477	0.1173	0.57938	1	0.516	0.123	0.453	0.40447	0.156
REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS	-0.65479	-1.4768	0.0867	0.57612	1	0.533	0.172	0.442	0.40317	0.156
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	-0.61629	-1.4757	0.09709	0.57715	1	0.5	0.112	0.444	0.40391	0.156
BOSCO_TH1_CYTOTOXIC_MODULE	106	http://www.broadinstitute.org/gsea/msigdb/cards/BOSCO_TH1_CYTOTOXIC_MODULE	-0.4378	-1.4744	0.03955	0.57846	1	0.396	0.211	0.314	0.40642	0.157
PID_CD8_TCR_DOWNSTREAM_PATHWAY	61	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CD8_TCR_DOWNSTREAM_PATHWAY	-0.43386	-1.472	0.064	0.58575	1	0.443	0.218	0.347	0.41282	0.157
KIM_GLIS2_TARGETS_UP	79	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_GLIS2_TARGETS_UP	-0.54327	-1.4719	0.07937	0.58273	1	0.494	0.17	0.411	0.41025	0.157
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP	-0.39824	-1.4717	0.09924	0.58005	1	0.518	0.308	0.359	0.4088	0.157
STREICHER_LSM1_TARGETS_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/STREICHER_LSM1_TARGETS_UP	-0.44298	-1.4715	0.0668	0.57723	1	0.419	0.264	0.308	0.40945	0.156
LEE_LIVER_CANCER_MYC_E2F1_DN	60	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_E2F1_DN	-0.39377	-1.4709	0.06653	0.57643	1	0.317	0.166	0.265	0.40761	0.156
WINZEN_DEGRADED_VIA_KHSRP	95	http://www.broadinstitute.org/gsea/msigdb/cards/WINZEN_DEGRADED_VIA_KHSRP	-0.41499	-1.4703	0.07692	0.57532	1	0.326	0.145	0.28	0.40805	0.156
ZHENG_IL22_SIGNALING_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_IL22_SIGNALING_UP	-0.45779	-1.4687	0.03219	0.57872	1	0.408	0.175	0.337	0.41017	0.156
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	-0.40185	-1.4686	0.06602	0.57545	1	0.35	0.186	0.286	0.40877	0.155
REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS	-0.56736	-1.4679	0.08382	0.57418	1	0.562	0.262	0.416	0.40841	0.155
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	180	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-0.40801	-1.4673	0.07185	0.57351	1	0.528	0.327	0.358	0.40718	0.155
CROONQUIST_STROMAL_STIMULATION_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_STROMAL_STIMULATION_UP	-0.61651	-1.467	0.09842	0.57133	1	0.559	0.199	0.449	0.40526	0.154
NAGASHIMA_EGF_SIGNALING_UP	57	http://www.broadinstitute.org/gsea/msigdb/cards/NAGASHIMA_EGF_SIGNALING_UP	-0.62379	-1.4665	0.1355	0.57001	1	0.544	0.127	0.476	0.40339	0.153
GOLUB_ALL_VS_AML_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/GOLUB_ALL_VS_AML_DN	-0.537	-1.4664	0.123	0.56743	1	0.591	0.328	0.398	0.40232	0.149
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	114	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	-0.42499	-1.4662	0.1034	0.56497	1	0.404	0.238	0.309	0.40142	0.148
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	17	http://www.broadinstitute.org/gsea/msigdb/cards/BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	-0.65147	-1.4656	0.1161	0.5639	1	0.588	0.209	0.466	0.40163	0.148
BECKER_TAMOXIFEN_RESISTANCE_UP	50	http://www.broadinstitute.org/gsea/msigdb/cards/BECKER_TAMOXIFEN_RESISTANCE_UP	-0.45895	-1.4653	0.092	0.56188	1	0.4	0.189	0.325	0.40018	0.146
PID_AMB2_NEUTROPHILS_PATHWAY	41	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AMB2_NEUTROPHILS_PATHWAY	-0.42517	-1.4645	0.06387	0.5617	1	0.537	0.334	0.358	0.39886	0.145
GILDEA_METASTASIS	28	http://www.broadinstitute.org/gsea/msigdb/cards/GILDEA_METASTASIS	-0.55999	-1.4644	0.1133	0.55907	1	0.393	0.114	0.348	0.39661	0.143
KRASNOSELSKAYA_ILF3_TARGETS_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/KRASNOSELSKAYA_ILF3_TARGETS_UP	-0.59727	-1.4641	0.1133	0.55713	1	0.405	0.125	0.355	0.40016	0.142
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	-0.39575	-1.4633	0.04656	0.55755	1	0.559	0.35	0.364	0.39961	0.141
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	152	http://www.broadinstitute.org/gsea/msigdb/cards/SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	-0.36496	-1.4632	0.06055	0.55471	1	0.355	0.188	0.29	0.39739	0.14
VALK_AML_CLUSTER_15	30	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_15	-0.42716	-1.4623	0.1082	0.55482	1	0.5	0.351	0.325	0.39788	0.141
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	-0.51319	-1.4603	0.05714	0.55927	1	0.481	0.207	0.382	0.40145	0.145
ZHOU_TNF_SIGNALING_30MIN	52	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_TNF_SIGNALING_30MIN	-0.44948	-1.4602	0.1482	0.55653	1	0.308	0.133	0.267	0.39938	0.145
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	116	http://www.broadinstitute.org/gsea/msigdb/cards/KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	-0.3993	-1.4573	0.07797	0.56439	1	0.319	0.189	0.26	0.40739	0.146
HELLER_SILENCED_BY_METHYLATION_UP	266	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_SILENCED_BY_METHYLATION_UP	-0.36678	-1.4572	0.06538	0.56186	1	0.523	0.376	0.329	0.40775	0.146
BROWNE_INTERFERON_RESPONSIVE_GENES	64	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_INTERFERON_RESPONSIVE_GENES	-0.50813	-1.457	0.1133	0.55944	1	0.375	0.169	0.313	0.40654	0.146
BASSO_CD40_SIGNALING_DN	64	http://www.broadinstitute.org/gsea/msigdb/cards/BASSO_CD40_SIGNALING_DN	-0.3953	-1.4565	0.05628	0.55827	1	0.438	0.251	0.329	0.40551	0.143
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	243	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	-0.399	-1.4563	0.01734	0.55611	1	0.477	0.295	0.34	0.40375	0.141
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD	19	http://www.broadinstitute.org/gsea/msigdb/cards/KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD	-0.63744	-1.4546	0.01581	0.55974	1	0.737	0.289	0.524	0.40867	0.143
WORSCHECH_TUMOR_REJECTION_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/WORSCHECH_TUMOR_REJECTION_UP	-0.47757	-1.4519	0.08696	0.56773	1	0.396	0.193	0.32	0.41416	0.145
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	41	http://www.broadinstitute.org/gsea/msigdb/cards/SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	-0.42883	-1.4507	0.0297	0.56899	1	0.634	0.387	0.389	0.41341	0.145
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	-0.48476	-1.4495	0.03661	0.57091	1	0.81	0.383	0.5	0.4171	0.144
HINATA_NFKB_TARGETS_KERATINOCYTE_UP	90	http://www.broadinstitute.org/gsea/msigdb/cards/HINATA_NFKB_TARGETS_KERATINOCYTE_UP	-0.4405	-1.4488	0.09333	0.57073	1	0.333	0.201	0.267	0.41515	0.144
LEI_HOXC8_TARGETS_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/LEI_HOXC8_TARGETS_DN	-0.54934	-1.4485	0.07946	0.56865	1	0.588	0.236	0.45	0.41573	0.143
LIAN_LIPA_TARGETS_6M	72	http://www.broadinstitute.org/gsea/msigdb/cards/LIAN_LIPA_TARGETS_6M	-0.43968	-1.4484	0.08083	0.5664	1	0.347	0.199	0.279	0.4136	0.143
ABBUD_LIF_SIGNALING_1_UP	45	http://www.broadinstitute.org/gsea/msigdb/cards/ABBUD_LIF_SIGNALING_1_UP	-0.4263	-1.448	0.1026	0.56485	1	0.778	0.378	0.485	0.41215	0.142
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	68	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	-0.42767	-1.4477	0.03876	0.56312	1	0.368	0.161	0.309	0.41005	0.143
REACTOME_INTERFERON_GAMMA_SIGNALING	52	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTERFERON_GAMMA_SIGNALING	-0.44561	-1.4475	0.1212	0.561	1	0.442	0.247	0.334	0.41229	0.141
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	-0.59897	-1.4457	0.09608	0.56459	1	0.812	0.305	0.565	0.41678	0.141
KEGG_RENIN_ANGIOTENSIN_SYSTEM	17	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RENIN_ANGIOTENSIN_SYSTEM	-0.50983	-1.4452	0.05253	0.56369	1	0.647	0.293	0.458	0.41818	0.141
SENESE_HDAC1_AND_HDAC2_TARGETS_UP	229	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC1_AND_HDAC2_TARGETS_UP	-0.34728	-1.4432	0.05697	0.5683	1	0.262	0.175	0.218	0.42138	0.143
SERVITJA_ISLET_HNF1A_TARGETS_UP	159	http://www.broadinstitute.org/gsea/msigdb/cards/SERVITJA_ISLET_HNF1A_TARGETS_UP	-0.41508	-1.4425	0.1091	0.56822	1	0.296	0.158	0.251	0.42186	0.143
LEE_LIVER_CANCER_CIPROFIBRATE_DN	65	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_CIPROFIBRATE_DN	-0.38627	-1.4418	0.0153	0.56813	1	0.385	0.225	0.299	0.42314	0.141
BIOCARTA_CTLA4_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CTLA4_PATHWAY	-0.58944	-1.4398	0.1158	0.57288	1	0.737	0.332	0.493	0.42897	0.144
PID_INTEGRIN2_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN2_PATHWAY	-0.52622	-1.4394	0.09961	0.5717	1	0.679	0.292	0.481	0.42723	0.141
MARSHALL_VIRAL_INFECTION_RESPONSE_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/MARSHALL_VIRAL_INFECTION_RESPONSE_DN	-0.41507	-1.4392	0.1105	0.56967	1	0.552	0.384	0.34	0.42575	0.141
REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	-0.47124	-1.4391	0.07708	0.56741	1	0.222	0.0483	0.212	0.42432	0.139
BIOCARTA_GATA3_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_GATA3_PATHWAY	-0.43782	-1.4387	0.04678	0.56608	1	0.25	0.0963	0.226	0.42228	0.139
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_1_DN	-0.36716	-1.4382	0.08454	0.56536	1	0.419	0.282	0.301	0.4225	0.14
ENGELMANN_CANCER_PROGENITORS_UP	45	http://www.broadinstitute.org/gsea/msigdb/cards/ENGELMANN_CANCER_PROGENITORS_UP	-0.45317	-1.4379	0.09018	0.56344	1	0.378	0.171	0.314	0.42169	0.139
JACKSON_DNMT1_TARGETS_UP	75	http://www.broadinstitute.org/gsea/msigdb/cards/JACKSON_DNMT1_TARGETS_UP	-0.41114	-1.4373	0.1296	0.56334	1	0.293	0.172	0.243	0.42113	0.139
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	-0.44902	-1.4372	0.06362	0.56081	1	0.3	0.203	0.239	0.41914	0.139
REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS	49	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS	-0.36935	-1.4364	0.02462	0.56132	1	0.469	0.299	0.33	0.41971	0.138
MARKEY_RB1_ACUTE_LOF_UP	204	http://www.broadinstitute.org/gsea/msigdb/cards/MARKEY_RB1_ACUTE_LOF_UP	-0.36145	-1.4357	0.09823	0.56143	1	0.314	0.232	0.243	0.4227	0.139
GHANDHI_DIRECT_IRRADIATION_UP	99	http://www.broadinstitute.org/gsea/msigdb/cards/GHANDHI_DIRECT_IRRADIATION_UP	-0.405	-1.4357	0.06839	0.5589	1	0.303	0.164	0.254	0.42073	0.139
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	-0.57002	-1.4352	0.07741	0.55818	1	0.429	0.102	0.385	0.41965	0.139
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	-0.55047	-1.4351	0.05148	0.55623	1	0.429	0.209	0.339	0.41771	0.138
VERNOCHET_ADIPOGENESIS	19	http://www.broadinstitute.org/gsea/msigdb/cards/VERNOCHET_ADIPOGENESIS	-0.51616	-1.4343	0.054	0.55659	1	0.474	0.188	0.385	0.41771	0.138
LEONARD_HYPOXIA	47	http://www.broadinstitute.org/gsea/msigdb/cards/LEONARD_HYPOXIA	-0.46117	-1.4339	0.164	0.55539	1	0.468	0.246	0.353	0.41712	0.138
GHANDHI_BYSTANDER_IRRADIATION_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/GHANDHI_BYSTANDER_IRRADIATION_UP	-0.46809	-1.4326	0.05577	0.5576	1	0.388	0.157	0.328	0.41929	0.138
BURTON_ADIPOGENESIS_2	70	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_2	-0.33463	-1.4321	0.1014	0.55681	1	0.343	0.235	0.263	0.41959	0.137
BIOCARTA_TH1TH2_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TH1TH2_PATHWAY	-0.54744	-1.4317	0.0972	0.55603	1	0.737	0.392	0.448	0.42215	0.136
TIAN_TNF_SIGNALING_NOT_VIA_NFKB	21	http://www.broadinstitute.org/gsea/msigdb/cards/TIAN_TNF_SIGNALING_NOT_VIA_NFKB	-0.59752	-1.4314	0.1378	0.55479	1	0.619	0.172	0.513	0.42202	0.136
AMIT_SERUM_RESPONSE_120_MCF10A	62	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_SERUM_RESPONSE_120_MCF10A	-0.44451	-1.4309	0.1163	0.55392	1	0.548	0.374	0.344	0.42014	0.136
REACTOME_INTERFERON_SIGNALING	140	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTERFERON_SIGNALING	-0.3952	-1.43	0.0994	0.55455	1	0.307	0.169	0.257	0.41993	0.136
PID_CD8_TCR_PATHWAY	52	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CD8_TCR_PATHWAY	-0.40005	-1.4297	0.09881	0.55326	1	0.577	0.369	0.365	0.41807	0.136
ZHU_CMV_8_HR_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_8_HR_UP	-0.54075	-1.4284	0.1594	0.55555	1	0.457	0.187	0.372	0.42327	0.135
SANSOM_APC_TARGETS_DN	352	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS_DN	-0.30311	-1.4271	0.05047	0.55779	1	0.486	0.364	0.313	0.42488	0.134
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN	-0.41565	-1.4269	0.08434	0.5559	1	0.542	0.393	0.329	0.42302	0.132
SANA_RESPONSE_TO_IFNG_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/SANA_RESPONSE_TO_IFNG_UP	-0.47712	-1.4259	0.1118	0.55712	1	0.31	0.158	0.262	0.4227	0.132
EINAV_INTERFERON_SIGNATURE_IN_CANCER	26	http://www.broadinstitute.org/gsea/msigdb/cards/EINAV_INTERFERON_SIGNATURE_IN_CANCER	-0.56767	-1.4243	0.1509	0.56059	1	0.385	0.122	0.338	0.4255	0.137
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	-0.34267	-1.4236	0.05253	0.56052	1	0.516	0.338	0.342	0.42377	0.135
BIOCARTA_NO2IL12_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NO2IL12_PATHWAY	-0.55161	-1.4229	0.09552	0.56101	1	0.625	0.209	0.495	0.42544	0.135
LINDSTEDT_DENDRITIC_CELL_MATURATION_B	49	http://www.broadinstitute.org/gsea/msigdb/cards/LINDSTEDT_DENDRITIC_CELL_MATURATION_B	-0.40927	-1.4221	0.1096	0.56118	1	0.265	0.138	0.229	0.42387	0.135
LIU_CDX2_TARGETS_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_CDX2_TARGETS_UP	-0.47264	-1.4215	0.05182	0.56099	1	0.806	0.48	0.42	0.42464	0.134
NAKAYAMA_FGF2_TARGETS	29	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_FGF2_TARGETS	-0.51967	-1.4213	0.1043	0.55966	1	0.414	0.218	0.324	0.42305	0.132
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	22	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	-0.48189	-1.4202	0.06061	0.56092	1	0.727	0.361	0.465	0.42366	0.134
WANG_RECURRENT_LIVER_CANCER_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RECURRENT_LIVER_CANCER_DN	-0.613	-1.4197	0.1223	0.56064	1	0.375	0.0945	0.34	0.4249	0.133
GAL_LEUKEMIC_STEM_CELL_DN	233	http://www.broadinstitute.org/gsea/msigdb/cards/GAL_LEUKEMIC_STEM_CELL_DN	-0.34572	-1.419	0.06944	0.56061	1	0.451	0.307	0.315	0.42361	0.133
REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS	-0.36835	-1.418	0.1337	0.56195	1	0.538	0.334	0.359	0.42706	0.134
KIM_HYPOXIA	25	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_HYPOXIA	-0.49432	-1.418	0.1138	0.55971	1	0.4	0.162	0.336	0.42529	0.133
VARELA_ZMPSTE24_TARGETS_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/VARELA_ZMPSTE24_TARGETS_UP	-0.38265	-1.4173	0.1714	0.55981	1	0.526	0.382	0.326	0.42593	0.135
LEE_EARLY_T_LYMPHOCYTE_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_EARLY_T_LYMPHOCYTE_DN	-0.43634	-1.4169	0.07466	0.5589	1	0.196	0.0668	0.183	0.42482	0.135
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN	-0.49257	-1.416	0.06337	0.55988	1	0.273	0.107	0.244	0.42568	0.135
KAAB_FAILED_HEART_VENTRICLE_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/KAAB_FAILED_HEART_VENTRICLE_DN	-0.39801	-1.4157	0.1437	0.55872	1	0.205	0.0831	0.188	0.42442	0.135
PLASARI_TGFB1_TARGETS_1HR_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_TARGETS_1HR_UP	-0.60167	-1.4146	0.1495	0.56023	1	0.706	0.295	0.498	0.42734	0.135
LEE_DIFFERENTIATING_T_LYMPHOCYTE	185	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_DIFFERENTIATING_T_LYMPHOCYTE	-0.34178	-1.413	0.116	0.56363	1	0.324	0.21	0.258	0.43145	0.136
KERLEY_RESPONSE_TO_CISPLATIN_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/KERLEY_RESPONSE_TO_CISPLATIN_UP	-0.42759	-1.4122	0.1107	0.5646	1	0.488	0.354	0.316	0.43365	0.136
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	73	http://www.broadinstitute.org/gsea/msigdb/cards/RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	-0.40899	-1.4093	0.1179	0.57319	1	0.315	0.165	0.264	0.43989	0.136
HAHTOLA_CTCL_PATHOGENESIS	15	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_CTCL_PATHOGENESIS	-0.68138	-1.4087	0.03839	0.57324	1	0.667	0.227	0.516	0.44272	0.135
KOBAYASHI_EGFR_SIGNALING_6HR_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/KOBAYASHI_EGFR_SIGNALING_6HR_DN	-0.49556	-1.4083	0.1165	0.57238	1	0.5	0.143	0.429	0.44096	0.135
UROSEVIC_RESPONSE_TO_IMIQUIMOD	23	http://www.broadinstitute.org/gsea/msigdb/cards/UROSEVIC_RESPONSE_TO_IMIQUIMOD	-0.58151	-1.4068	0.136	0.57597	1	0.609	0.249	0.457	0.44506	0.136
RIGGINS_TAMOXIFEN_RESISTANCE_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/RIGGINS_TAMOXIFEN_RESISTANCE_UP	-0.33969	-1.4065	0.1031	0.57472	1	0.444	0.34	0.294	0.4433	0.136
KEGG_PRIMARY_IMMUNODEFICIENCY	35	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PRIMARY_IMMUNODEFICIENCY	-0.48467	-1.4049	0.09597	0.57814	1	0.629	0.358	0.404	0.44495	0.136
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	106	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	-0.38334	-1.4044	0.0428	0.57775	1	0.349	0.219	0.274	0.44554	0.137
BURTON_ADIPOGENESIS_1	33	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_1	-0.55693	-1.4043	0.1457	0.5758	1	0.424	0.119	0.374	0.44426	0.136
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	-0.40615	-1.404	0.07905	0.57464	1	0.531	0.37	0.335	0.44302	0.136
AMIT_DELAYED_EARLY_GENES	17	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_DELAYED_EARLY_GENES	-0.63655	-1.4032	0.1689	0.57347	1	0.647	0.188	0.525	0.4432	0.136
LEE_LIVER_CANCER_MYC_E2F1_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_E2F1_UP	-0.37939	-1.4032	0.0728	0.5755	1	0.411	0.264	0.303	0.44342	0.136
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	-0.54978	-1.403	0.1203	0.57174	1	0.409	0.107	0.366	0.44157	0.136
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP	-0.3424	-1.4027	0.103	0.5708	1	0.395	0.269	0.289	0.44397	0.136
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN	-0.36804	-1.4026	0.05725	0.56886	1	0.429	0.284	0.307	0.44227	0.136
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	-0.64415	-1.4009	0.1074	0.571	1	0.471	0.115	0.417	0.44461	0.136
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	-0.47327	-1.4009	0.139	0.57303	1	0.433	0.206	0.345	0.4463	0.136
WIERENGA_STAT5A_TARGETS_GROUP2	57	http://www.broadinstitute.org/gsea/msigdb/cards/WIERENGA_STAT5A_TARGETS_GROUP2	-0.49097	-1.4008	0.09921	0.56902	1	0.333	0.145	0.286	0.44298	0.136
SHIN_B_CELL_LYMPHOMA_CLUSTER_7	27	http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_7	-0.37097	-1.4005	0.1285	0.56812	1	0.556	0.402	0.332	0.44352	0.136
THEODOROU_MAMMARY_TUMORIGENESIS	29	http://www.broadinstitute.org/gsea/msigdb/cards/THEODOROU_MAMMARY_TUMORIGENESIS	-0.4559	-1.3992	0.1002	0.57091	1	0.414	0.192	0.335	0.4457	0.136
BOYLAN_MULTIPLE_MYELOMA_C_D_DN	237	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_D_DN	-0.37167	-1.3991	0.08448	0.5671	1	0.376	0.218	0.296	0.44255	0.136
BHAT_ESR1_TARGETS_VIA_AKT1_UP	273	http://www.broadinstitute.org/gsea/msigdb/cards/BHAT_ESR1_TARGETS_VIA_AKT1_UP	-0.32587	-1.3991	0.0873	0.56907	1	0.542	0.412	0.322	0.44404	0.136
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	-0.50223	-1.3979	0.1303	0.56926	1	0.579	0.297	0.407	0.44349	0.136
KEGG_ALLOGRAFT_REJECTION	32	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ALLOGRAFT_REJECTION	-0.53911	-1.3962	0.09903	0.57315	1	0.656	0.381	0.407	0.44576	0.136
MIKKELSEN_MEF_LCP_WITH_H3K4ME3	122	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MEF_LCP_WITH_H3K4ME3	-0.35446	-1.3947	0.1175	0.57671	1	0.18	0.0951	0.164	0.45185	0.136
KANNAN_TP53_TARGETS_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/KANNAN_TP53_TARGETS_DN	-0.38242	-1.3935	0.102	0.57849	1	0.286	0.126	0.25	0.45258	0.136
BURTON_ADIPOGENESIS_PEAK_AT_2HR	50	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_2HR	-0.58613	-1.3926	0.1881	0.57982	1	0.56	0.235	0.429	0.4566	0.137
PID_FRA_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FRA_PATHWAY	-0.46459	-1.3925	0.1525	0.57789	1	0.429	0.226	0.332	0.45494	0.136
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP	-0.40987	-1.3918	0.1164	0.57887	1	0.227	0.103	0.204	0.45483	0.138
LEE_LIVER_CANCER_ACOX1_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_ACOX1_UP	-0.38404	-1.3907	0.06371	0.58052	1	0.367	0.217	0.288	0.45864	0.139
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	-0.43811	-1.3906	0.07724	0.57869	1	0.409	0.163	0.343	0.45699	0.138
SESTO_RESPONSE_TO_UV_C1	70	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C1	-0.37045	-1.3903	0.07505	0.57757	1	0.271	0.17	0.226	0.45535	0.138
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN	54	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN	-0.40641	-1.39	0.08135	0.57667	1	0.574	0.362	0.367	0.45577	0.138
PID_ARF6_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ARF6_PATHWAY	-0.38746	-1.3898	0.1198	0.57539	1	0.543	0.334	0.362	0.45483	0.137
SCHRAETS_MLL_TARGETS_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/SCHRAETS_MLL_TARGETS_DN	-0.47374	-1.3896	0.1323	0.57394	1	0.375	0.144	0.322	0.45322	0.135
ZHAN_MULTIPLE_MYELOMA_MF_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_MF_UP	-0.41198	-1.3894	0.03953	0.57269	1	0.488	0.239	0.372	0.45357	0.135
LU_TUMOR_ENDOTHELIAL_MARKERS_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/LU_TUMOR_ENDOTHELIAL_MARKERS_UP	-0.60771	-1.3891	0.1182	0.57181	1	0.591	0.17	0.491	0.45347	0.135
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	82	http://www.broadinstitute.org/gsea/msigdb/cards/GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	-0.45526	-1.3886	0.1724	0.57147	1	0.39	0.201	0.313	0.45188	0.135
HUMMERICH_BENIGN_SKIN_TUMOR_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/HUMMERICH_BENIGN_SKIN_TUMOR_DN	-0.48436	-1.3883	0.123	0.56884	1	0.5	0.293	0.354	0.45006	0.135
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	35	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	-0.49579	-1.3883	0.1047	0.57069	1	0.743	0.409	0.44	0.45164	0.135
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	-0.39752	-1.3878	0.06008	0.5685	1	0.345	0.185	0.281	0.44909	0.134
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	130	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	-0.39418	-1.3876	0.05192	0.56743	1	0.569	0.36	0.366	0.44788	0.134
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	-0.46736	-1.3874	0.1132	0.56608	1	0.292	0.13	0.254	0.44634	0.134
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	74	http://www.broadinstitute.org/gsea/msigdb/cards/BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	-0.48729	-1.3867	0.154	0.56635	1	0.446	0.247	0.337	0.44787	0.134
CORRE_MULTIPLE_MYELOMA_UP	66	http://www.broadinstitute.org/gsea/msigdb/cards/CORRE_MULTIPLE_MYELOMA_UP	-0.44001	-1.3856	0.1217	0.5687	1	0.606	0.341	0.4	0.44717	0.136
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	169	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	-0.34254	-1.3848	0.01336	0.56942	1	0.515	0.378	0.322	0.45076	0.137
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	-0.44061	-1.3844	0.137	0.56875	1	0.542	0.333	0.362	0.45097	0.136
OKAWA_NEUROBLASTOMA_1P36_31_DELETION	22	http://www.broadinstitute.org/gsea/msigdb/cards/OKAWA_NEUROBLASTOMA_1P36_31_DELETION	-0.48002	-1.3842	0.07185	0.56735	1	0.773	0.422	0.447	0.44951	0.134
CHANDRAN_METASTASIS_TOP50_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/CHANDRAN_METASTASIS_TOP50_DN	-0.3963	-1.3839	0.1082	0.56641	1	0.289	0.157	0.244	0.4492	0.134
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP	-0.49828	-1.3831	0.1448	0.56747	1	0.273	0.0684	0.254	0.45311	0.136
VERHAAK_GLIOBLASTOMA_MESENCHYMAL	207	http://www.broadinstitute.org/gsea/msigdb/cards/VERHAAK_GLIOBLASTOMA_MESENCHYMAL	-0.41669	-1.383	0.1479	0.56613	1	0.425	0.254	0.32	0.45159	0.136
ROZANOV_MMP14_TARGETS_SUBSET	33	http://www.broadinstitute.org/gsea/msigdb/cards/ROZANOV_MMP14_TARGETS_SUBSET	-0.52183	-1.3827	0.1716	0.56534	1	0.455	0.223	0.354	0.45155	0.137
GAVIN_PDE3B_TARGETS	21	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_PDE3B_TARGETS	-0.58788	-1.3803	0.159	0.57182	1	0.619	0.298	0.435	0.45748	0.138
URS_ADIPOCYTE_DIFFERENTIATION_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/URS_ADIPOCYTE_DIFFERENTIATION_DN	-0.49193	-1.3801	0.1302	0.57089	1	0.667	0.314	0.458	0.45596	0.137
WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN	-0.45565	-1.3797	0.1736	0.57023	1	0.51	0.272	0.372	0.4579	0.137
LEE_AGING_CEREBELLUM_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_AGING_CEREBELLUM_UP	-0.37246	-1.3779	0.1141	0.57452	1	0.402	0.277	0.292	0.45809	0.139
STREICHER_LSM1_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/STREICHER_LSM1_TARGETS_DN	-0.44294	-1.3774	0.1315	0.57231	1	0.684	0.399	0.411	0.45669	0.138
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION	47	http://www.broadinstitute.org/gsea/msigdb/cards/NOUSHMEHR_GBM_SILENCED_BY_METHYLATION	-0.36745	-1.3774	0.08745	0.57406	1	0.383	0.235	0.293	0.45813	0.138
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	25	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	-0.45623	-1.377	0.1193	0.57005	1	0.8	0.459	0.433	0.45463	0.137
KIM_LRRC3B_TARGETS	28	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_LRRC3B_TARGETS	-0.49743	-1.377	0.1741	0.57178	1	0.357	0.155	0.302	0.45611	0.138
TAVOR_CEBPA_TARGETS_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/TAVOR_CEBPA_TARGETS_UP	-0.47253	-1.3769	0.1483	0.56865	1	0.277	0.109	0.247	0.45406	0.137
BROWNE_HCMV_INFECTION_2HR_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_2HR_UP	-0.52604	-1.3767	0.1468	0.56741	1	0.763	0.279	0.551	0.45346	0.137
DAZARD_RESPONSE_TO_UV_NHEK_UP	231	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_RESPONSE_TO_UV_NHEK_UP	-0.32732	-1.3765	0.1141	0.56654	1	0.273	0.183	0.225	0.45326	0.137
GHO_ATF5_TARGETS_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/GHO_ATF5_TARGETS_DN	-0.50943	-1.3753	0.1853	0.56898	1	0.333	0.137	0.288	0.4569	0.137
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	53	http://www.broadinstitute.org/gsea/msigdb/cards/YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	-0.42816	-1.3741	0.09515	0.56945	1	0.434	0.255	0.324	0.45985	0.137
LI_INDUCED_T_TO_NATURAL_KILLER_UP	295	http://www.broadinstitute.org/gsea/msigdb/cards/LI_INDUCED_T_TO_NATURAL_KILLER_UP	-0.32136	-1.3741	0.1084	0.57115	1	0.292	0.203	0.235	0.46029	0.137
REACTOME_PD1_SIGNALING	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PD1_SIGNALING	-0.58624	-1.3732	0.1585	0.57069	1	0.75	0.348	0.489	0.46098	0.137
DUTTA_APOPTOSIS_VIA_NFKB	33	http://www.broadinstitute.org/gsea/msigdb/cards/DUTTA_APOPTOSIS_VIA_NFKB	-0.45243	-1.3724	0.1059	0.57181	1	0.333	0.145	0.285	0.46293	0.137
QI_PLASMACYTOMA_UP	253	http://www.broadinstitute.org/gsea/msigdb/cards/QI_PLASMACYTOMA_UP	-0.31711	-1.3719	0.104	0.57179	1	0.447	0.337	0.299	0.46496	0.137
REACTOME_BOTULINUM_NEUROTOXICITY	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BOTULINUM_NEUROTOXICITY	-0.49371	-1.3698	0.1346	0.5777	1	0.389	0.167	0.324	0.46925	0.137
WESTON_VEGFA_TARGETS_6HR	57	http://www.broadinstitute.org/gsea/msigdb/cards/WESTON_VEGFA_TARGETS_6HR	-0.50506	-1.3696	0.1409	0.57664	1	0.509	0.24	0.388	0.46854	0.137
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN	-0.55488	-1.3695	0.1335	0.5752	1	0.278	0.0654	0.26	0.46707	0.137
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	-0.63156	-1.3679	0.1339	0.57832	1	0.733	0.287	0.523	0.47113	0.138
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	21	http://www.broadinstitute.org/gsea/msigdb/cards/WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	-0.47372	-1.3676	0.08269	0.57805	1	0.762	0.422	0.441	0.47224	0.137
BAELDE_DIABETIC_NEPHROPATHY_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/BAELDE_DIABETIC_NEPHROPATHY_UP	-0.36519	-1.3672	0.05066	0.57765	1	0.5	0.366	0.318	0.47167	0.137
MA_MYELOID_DIFFERENTIATION_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/MA_MYELOID_DIFFERENTIATION_DN	-0.41585	-1.3667	0.1774	0.57737	1	0.545	0.315	0.374	0.47063	0.137
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	-0.41288	-1.3657	0.1394	0.57924	1	0.689	0.41	0.407	0.47174	0.137
NOJIMA_SFRP2_TARGETS_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/NOJIMA_SFRP2_TARGETS_UP	-0.45885	-1.3651	0.1924	0.5795	1	0.533	0.308	0.369	0.47149	0.137
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	173	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	-0.39733	-1.3644	0.1328	0.5804	1	0.399	0.238	0.306	0.47308	0.137
ZHANG_GATA6_TARGETS_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_GATA6_TARGETS_DN	-0.3314	-1.3642	0.04906	0.5796	1	0.468	0.357	0.301	0.47163	0.136
REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK	190	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK	-0.30762	-1.3624	0.01679	0.58357	1	0.479	0.378	0.3	0.4736	0.137
PHONG_TNF_TARGETS_UP	61	http://www.broadinstitute.org/gsea/msigdb/cards/PHONG_TNF_TARGETS_UP	-0.51628	-1.3617	0.221	0.5845	1	0.41	0.138	0.354	0.47511	0.137
HENDRICKS_SMARCA4_TARGETS_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/HENDRICKS_SMARCA4_TARGETS_DN	-0.37677	-1.3611	0.1134	0.5846	1	0.592	0.348	0.387	0.47525	0.137
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	-0.44028	-1.3603	0.1356	0.58568	1	0.314	0.143	0.269	0.47561	0.136
DORN_ADENOVIRUS_INFECTION_12HR_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/DORN_ADENOVIRUS_INFECTION_12HR_UP	-0.46882	-1.36	0.1891	0.58526	1	0.31	0.122	0.273	0.47542	0.136
RICKMAN_METASTASIS_DN	244	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_METASTASIS_DN	-0.31627	-1.3598	0.115	0.58425	1	0.549	0.425	0.319	0.47888	0.136
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	61	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	-0.31221	-1.3596	0.1133	0.58313	1	0.361	0.283	0.259	0.47887	0.136
CHIBA_RESPONSE_TO_TSA	45	http://www.broadinstitute.org/gsea/msigdb/cards/CHIBA_RESPONSE_TO_TSA	-0.39138	-1.3592	0.146	0.58298	1	0.244	0.124	0.215	0.47763	0.136
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	49	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	-0.48526	-1.3581	0.1628	0.58322	1	0.469	0.226	0.364	0.47685	0.136
GAJATE_RESPONSE_TO_TRABECTEDIN_UP	64	http://www.broadinstitute.org/gsea/msigdb/cards/GAJATE_RESPONSE_TO_TRABECTEDIN_UP	-0.41969	-1.3581	0.1497	0.58491	1	0.25	0.123	0.22	0.47827	0.136
OHGUCHI_LIVER_HNF4A_TARGETS_DN	143	http://www.broadinstitute.org/gsea/msigdb/cards/OHGUCHI_LIVER_HNF4A_TARGETS_DN	-0.35636	-1.358	0.03922	0.58179	1	0.538	0.423	0.312	0.47544	0.136
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA	-0.43334	-1.3579	0.125	0.58058	1	0.211	0.0483	0.201	0.47443	0.136
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	163	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	-0.35624	-1.3579	0.1257	0.5789	1	0.356	0.184	0.292	0.47303	0.136
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	144	http://www.broadinstitute.org/gsea/msigdb/cards/BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	-0.31253	-1.3575	0.1012	0.57826	1	0.306	0.209	0.243	0.47164	0.136
REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY	-0.41712	-1.3574	0.1252	0.57691	1	0.529	0.335	0.352	0.47027	0.136
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	-0.45999	-1.3569	0.0791	0.57708	1	0.438	0.201	0.35	0.47021	0.135
GOUYER_TATI_TARGETS_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/GOUYER_TATI_TARGETS_DN	-0.51906	-1.3567	0.1091	0.57613	1	0.867	0.423	0.5	0.46885	0.135
RASHI_RESPONSE_TO_IONIZING_RADIATION_6	79	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_6	-0.35964	-1.3556	0.1491	0.57843	1	0.266	0.153	0.226	0.47263	0.135
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP	-0.44854	-1.3555	0.09478	0.57693	1	0.474	0.294	0.335	0.47126	0.135
DORN_ADENOVIRUS_INFECTION_24HR_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/DORN_ADENOVIRUS_INFECTION_24HR_DN	-0.44119	-1.3552	0.1849	0.57639	1	0.279	0.122	0.245	0.47188	0.135
BROWN_MYELOID_CELL_DEVELOPMENT_UP	154	http://www.broadinstitute.org/gsea/msigdb/cards/BROWN_MYELOID_CELL_DEVELOPMENT_UP	-0.35916	-1.3537	0.1122	0.57995	1	0.448	0.303	0.314	0.47472	0.136
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_	81	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_	-0.36532	-1.353	0.1057	0.58067	1	0.444	0.295	0.314	0.47678	0.136
REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	-0.48009	-1.3523	0.1647	0.58147	1	0.462	0.19	0.374	0.47714	0.136
BIOCARTA_INFLAM_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_INFLAM_PATHWAY	-0.47356	-1.3522	0.09823	0.58015	1	0.37	0.192	0.3	0.47578	0.136
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	45	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	-0.48384	-1.3517	0.1143	0.58042	1	0.622	0.368	0.394	0.47672	0.136
KEGG_RETINOL_METABOLISM	51	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RETINOL_METABOLISM	-0.42633	-1.3516	0.07754	0.57888	1	0.549	0.362	0.351	0.47537	0.136
KEGG_LEISHMANIA_INFECTION	66	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_LEISHMANIA_INFECTION	-0.40913	-1.3514	0.1462	0.57794	1	0.303	0.183	0.248	0.47553	0.136
PID_IL27_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL27_PATHWAY	-0.42627	-1.3511	0.1379	0.57724	1	0.708	0.403	0.423	0.47419	0.136
YIH_RESPONSE_TO_ARSENITE_C3	35	http://www.broadinstitute.org/gsea/msigdb/cards/YIH_RESPONSE_TO_ARSENITE_C3	-0.36002	-1.3507	0.1033	0.57697	1	0.371	0.26	0.275	0.47374	0.136
LU_TUMOR_VASCULATURE_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/LU_TUMOR_VASCULATURE_UP	-0.57404	-1.3502	0.1525	0.57725	1	0.607	0.236	0.465	0.47528	0.136
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	-0.44946	-1.35	0.1186	0.5762	1	0.302	0.158	0.255	0.47402	0.136
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN	-0.4182	-1.3499	0.1784	0.57477	1	0.422	0.247	0.319	0.4727	0.136
KEGG_JAK_STAT_SIGNALING_PATHWAY	140	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_JAK_STAT_SIGNALING_PATHWAY	-0.30811	-1.3496	0.04478	0.57262	1	0.421	0.337	0.281	0.47117	0.135
ROY_WOUND_BLOOD_VESSEL_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/ROY_WOUND_BLOOD_VESSEL_UP	-0.50843	-1.3496	0.196	0.57417	1	0.478	0.199	0.384	0.47248	0.136
VALK_AML_CLUSTER_11	35	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_11	-0.4127	-1.3496	0.175	0.57111	1	0.657	0.431	0.375	0.46987	0.135
KEGG_AUTOIMMUNE_THYROID_DISEASE	44	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_AUTOIMMUNE_THYROID_DISEASE	-0.50839	-1.3495	0.1096	0.56991	1	0.568	0.289	0.405	0.46857	0.135
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	-0.56734	-1.3491	0.1502	0.5695	1	0.5	0.204	0.398	0.47011	0.136
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	153	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	-0.31589	-1.348	0.05792	0.57156	1	0.686	0.476	0.362	0.47396	0.135
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA	-0.38055	-1.3479	0.08782	0.57044	1	0.167	0.0483	0.159	0.47266	0.135
LI_INDUCED_T_TO_NATURAL_KILLER_DN	113	http://www.broadinstitute.org/gsea/msigdb/cards/LI_INDUCED_T_TO_NATURAL_KILLER_DN	-0.30144	-1.3478	0.1083	0.56909	1	0.23	0.162	0.194	0.47137	0.133
SU_LIVER	55	http://www.broadinstitute.org/gsea/msigdb/cards/SU_LIVER	-0.42558	-1.3476	0.1337	0.56817	1	0.545	0.321	0.371	0.47009	0.133
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	30	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	-0.32628	-1.3459	0.08637	0.57212	1	0.5	0.381	0.31	0.47127	0.136
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	109	http://www.broadinstitute.org/gsea/msigdb/cards/ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	-0.33008	-1.3454	0.08527	0.57214	1	0.422	0.341	0.279	0.47151	0.136
JIANG_TIP30_TARGETS_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_TIP30_TARGETS_DN	-0.431	-1.3444	0.1683	0.57372	1	0.478	0.375	0.299	0.47165	0.136
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	-0.45193	-1.3434	0.1245	0.57549	1	0.429	0.235	0.328	0.47163	0.136
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	-0.34174	-1.3432	0.1257	0.5746	1	0.562	0.396	0.341	0.47037	0.136
JI_METASTASIS_REPRESSED_BY_STK11	27	http://www.broadinstitute.org/gsea/msigdb/cards/JI_METASTASIS_REPRESSED_BY_STK11	-0.47774	-1.3431	0.1225	0.57331	1	0.778	0.405	0.464	0.46996	0.136
WIERENGA_STAT5A_TARGETS_UP	204	http://www.broadinstitute.org/gsea/msigdb/cards/WIERENGA_STAT5A_TARGETS_UP	-0.31736	-1.343	0.112	0.57217	1	0.48	0.35	0.315	0.46903	0.136
BIOCARTA_STATHMIN_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_STATHMIN_PATHWAY	-0.40517	-1.3427	0.1663	0.5715	1	0.316	0.123	0.277	0.47017	0.136
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF	44	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF	-0.39771	-1.3425	0.1265	0.57053	1	0.432	0.192	0.349	0.47056	0.136
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	-0.39186	-1.3415	0.1553	0.57242	1	0.5	0.303	0.349	0.47171	0.136
HANSON_HRAS_SIGNALING_VIA_NFKB	21	http://www.broadinstitute.org/gsea/msigdb/cards/HANSON_HRAS_SIGNALING_VIA_NFKB	-0.38454	-1.3414	0.1605	0.57114	1	0.476	0.331	0.319	0.47046	0.136
BIOCARTA_NKT_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NKT_PATHWAY	-0.50011	-1.3413	0.132	0.5699	1	0.429	0.195	0.346	0.46923	0.136
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	28	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	-0.46278	-1.3405	0.1268	0.57117	1	0.429	0.189	0.348	0.47163	0.136
BIOCARTA_TNFR2_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TNFR2_PATHWAY	-0.46561	-1.3392	0.1972	0.57395	1	0.556	0.398	0.335	0.47271	0.136
VALK_AML_WITH_EVI1	22	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_WITH_EVI1	-0.39489	-1.3389	0.0746	0.57358	1	0.545	0.394	0.331	0.47395	0.136
SUNG_METASTASIS_STROMA_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/SUNG_METASTASIS_STROMA_DN	-0.35558	-1.3388	0.103	0.57239	1	0.38	0.298	0.267	0.47272	0.136
FOSTER_TOLERANT_MACROPHAGE_UP	148	http://www.broadinstitute.org/gsea/msigdb/cards/FOSTER_TOLERANT_MACROPHAGE_UP	-0.32112	-1.3385	0.1356	0.57191	1	0.385	0.257	0.288	0.47228	0.136
REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	35	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	-0.51934	-1.3383	0.06576	0.57118	1	0.857	0.436	0.484	0.47106	0.136
KEEN_RESPONSE_TO_ROSIGLITAZONE_DN	104	http://www.broadinstitute.org/gsea/msigdb/cards/KEEN_RESPONSE_TO_ROSIGLITAZONE_DN	-0.44847	-1.3378	0.1699	0.5712	1	0.375	0.184	0.307	0.46984	0.136
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	144	http://www.broadinstitute.org/gsea/msigdb/cards/SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	-0.36753	-1.3369	0.1403	0.57129	1	0.292	0.163	0.246	0.47278	0.134
DASU_IL6_SIGNALING_UP	58	http://www.broadinstitute.org/gsea/msigdb/cards/DASU_IL6_SIGNALING_UP	-0.39478	-1.3369	0.1677	0.57268	1	0.466	0.283	0.334	0.474	0.136
KEGG_TRYPTOPHAN_METABOLISM	37	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TRYPTOPHAN_METABOLISM	-0.34432	-1.3365	0.128	0.57095	1	0.189	0.0939	0.172	0.472	0.134
KEGG_HEMATOPOIETIC_CELL_LINEAGE	82	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_HEMATOPOIETIC_CELL_LINEAGE	-0.3922	-1.3365	0.06579	0.56971	1	0.305	0.194	0.246	0.47101	0.134
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	159	http://www.broadinstitute.org/gsea/msigdb/cards/VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	-0.36066	-1.3363	0.1525	0.56879	1	0.314	0.193	0.255	0.47071	0.133
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	-0.34588	-1.3358	0.1507	0.56908	1	0.4	0.275	0.291	0.46985	0.133
REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE	-0.41355	-1.3352	0.1304	0.56965	1	0.208	0.0483	0.198	0.46887	0.133
VERHAAK_AML_WITH_NPM1_MUTATED_DN	238	http://www.broadinstitute.org/gsea/msigdb/cards/VERHAAK_AML_WITH_NPM1_MUTATED_DN	-0.31674	-1.3351	0.0935	0.56844	1	0.357	0.241	0.274	0.46769	0.133
MENSE_HYPOXIA_UP	97	http://www.broadinstitute.org/gsea/msigdb/cards/MENSE_HYPOXIA_UP	-0.37897	-1.3349	0.1498	0.56763	1	0.186	0.0766	0.172	0.4665	0.133
DIRMEIER_LMP1_RESPONSE_EARLY	63	http://www.broadinstitute.org/gsea/msigdb/cards/DIRMEIER_LMP1_RESPONSE_EARLY	-0.49345	-1.3341	0.1836	0.56905	1	0.413	0.169	0.344	0.46533	0.133
WIERENGA_STAT5A_TARGETS_GROUP1	127	http://www.broadinstitute.org/gsea/msigdb/cards/WIERENGA_STAT5A_TARGETS_GROUP1	-0.29035	-1.3333	0.08571	0.5699	1	0.528	0.394	0.321	0.46608	0.134
BIOCARTA_DC_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_DC_PATHWAY	-0.51533	-1.332	0.1233	0.57298	1	0.429	0.228	0.331	0.46988	0.135
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6	17	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_RESPONSE_TO_H2O2_VIA_ERCC6	-0.36313	-1.3314	0.1272	0.57336	1	0.176	0.115	0.156	0.4687	0.135
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	-0.46281	-1.3313	0.1304	0.5722	1	0.32	0.184	0.261	0.46753	0.134
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	87	http://www.broadinstitute.org/gsea/msigdb/cards/NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	-0.3946	-1.3312	0.1918	0.57102	1	0.287	0.18	0.236	0.46721	0.134
VALK_AML_CLUSTER_5	31	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_5	-0.36777	-1.3312	0.101	0.56982	1	0.484	0.301	0.339	0.46605	0.134
CROONQUIST_NRAS_SIGNALING_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_NRAS_SIGNALING_UP	-0.43061	-1.33	0.109	0.57212	1	0.55	0.238	0.42	0.46829	0.134
RUTELLA_RESPONSE_TO_HGF_DN	225	http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_HGF_DN	-0.30392	-1.3287	0.1417	0.57509	1	0.276	0.194	0.224	0.47017	0.135
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_KERATAN_SULFATE_BIOSYNTHESIS	-0.46679	-1.3285	0.1594	0.57451	1	0.24	0.0869	0.219	0.46962	0.135
MULLIGHAN_MLL_SIGNATURE_2_UP	387	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_MLL_SIGNATURE_2_UP	-0.25216	-1.326	0.1262	0.58103	1	0.465	0.399	0.284	0.47619	0.138
TENEDINI_MEGAKARYOCYTE_MARKERS	64	http://www.broadinstitute.org/gsea/msigdb/cards/TENEDINI_MEGAKARYOCYTE_MARKERS	-0.34658	-1.3239	0.1611	0.586	1	0.234	0.114	0.208	0.48023	0.138
KEGG_GRAFT_VERSUS_HOST_DISEASE	31	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GRAFT_VERSUS_HOST_DISEASE	-0.495	-1.3237	0.1737	0.58496	1	0.645	0.381	0.4	0.47906	0.138
HINATA_NFKB_TARGETS_FIBROBLAST_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/HINATA_NFKB_TARGETS_FIBROBLAST_UP	-0.37422	-1.3236	0.1499	0.58411	1	0.341	0.19	0.277	0.47808	0.138
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	118	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	-0.34682	-1.3216	0.1175	0.58921	1	0.525	0.392	0.321	0.48065	0.138
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN	-0.53707	-1.3204	0.1808	0.59175	1	0.517	0.179	0.425	0.48362	0.138
REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN	-0.54246	-1.3191	0.1676	0.59436	1	0.733	0.344	0.482	0.48633	0.138
REACTOME_ADP_SIGNALLING_THROUGH_P2RY12	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ADP_SIGNALLING_THROUGH_P2RY12	-0.4403	-1.3185	0.1141	0.59488	1	0.25	0.0483	0.238	0.48764	0.138
MALONEY_RESPONSE_TO_17AAG_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/MALONEY_RESPONSE_TO_17AAG_UP	-0.39806	-1.3177	0.1845	0.59638	1	0.325	0.183	0.266	0.49168	0.138
RAMALHO_STEMNESS_DN	71	http://www.broadinstitute.org/gsea/msigdb/cards/RAMALHO_STEMNESS_DN	-0.33266	-1.3176	0.1383	0.59513	1	0.563	0.373	0.354	0.4905	0.138
NABA_SECRETED_FACTORS	326	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_SECRETED_FACTORS	-0.36582	-1.3174	0.03295	0.59441	1	0.463	0.314	0.322	0.48933	0.138
NAKAJIMA_EOSINOPHIL	29	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAJIMA_EOSINOPHIL	-0.48581	-1.3172	0.1344	0.59376	1	0.448	0.199	0.359	0.48895	0.138
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	30	http://www.broadinstitute.org/gsea/msigdb/cards/CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	-0.43395	-1.3168	0.08171	0.59348	1	0.5	0.255	0.373	0.48905	0.138
NABA_ECM_AFFILIATED	158	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_ECM_AFFILIATED	-0.32145	-1.3168	0.02924	0.59211	1	0.532	0.41	0.316	0.48788	0.138
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	-0.38233	-1.3148	0.129	0.5974	1	0.231	0.108	0.206	0.49125	0.138
ZUCCHI_METASTASIS_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/ZUCCHI_METASTASIS_DN	-0.38105	-1.3143	0.1865	0.59779	1	0.535	0.375	0.335	0.49071	0.138
ROVERSI_GLIOMA_COPY_NUMBER_UP	96	http://www.broadinstitute.org/gsea/msigdb/cards/ROVERSI_GLIOMA_COPY_NUMBER_UP	-0.31437	-1.3138	0.07617	0.59784	1	0.354	0.287	0.254	0.49228	0.138
OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP	-0.44139	-1.3138	0.2079	0.59649	1	0.417	0.222	0.325	0.49112	0.137
POS_HISTAMINE_RESPONSE_NETWORK	32	http://www.broadinstitute.org/gsea/msigdb/cards/POS_HISTAMINE_RESPONSE_NETWORK	-0.35248	-1.3136	0.1431	0.59579	1	0.219	0.107	0.196	0.49027	0.136
REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2	-0.51335	-1.3135	0.1351	0.59337	1	0.75	0.385	0.461	0.48913	0.136
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	-0.42077	-1.3135	0.1258	0.59458	1	0.405	0.16	0.34	0.49028	0.136
SAGIV_CD24_TARGETS_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/SAGIV_CD24_TARGETS_DN	-0.43311	-1.3125	0.1549	0.59527	1	0.489	0.24	0.372	0.49016	0.136
GESERICK_TERT_TARGETS_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/GESERICK_TERT_TARGETS_DN	-0.61934	-1.3122	0.2438	0.59481	1	0.571	0.145	0.489	0.49009	0.136
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	91	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	-0.41173	-1.3119	0.1434	0.59442	1	0.363	0.166	0.304	0.48931	0.136
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	-0.41827	-1.3116	0.1587	0.5941	1	0.353	0.169	0.294	0.48843	0.136
SHIN_B_CELL_LYMPHOMA_CLUSTER_8	36	http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_8	-0.37939	-1.3115	0.1614	0.59301	1	0.361	0.157	0.305	0.4873	0.136
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN	37	http://www.broadinstitute.org/gsea/msigdb/cards/CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN	-0.35337	-1.3113	0.08511	0.59219	1	0.243	0.117	0.215	0.48617	0.136
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	197	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	-0.28899	-1.3105	0.1021	0.5934	1	0.482	0.381	0.301	0.48621	0.136
KEGG_BASAL_CELL_CARCINOMA	55	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BASAL_CELL_CARCINOMA	-0.36452	-1.3102	0.1768	0.59196	1	0.618	0.407	0.367	0.4853	0.136
REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS	-0.42234	-1.3102	0.1745	0.59318	1	0.64	0.372	0.402	0.48615	0.136
PID_TXA2PATHWAY	57	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TXA2PATHWAY	-0.31054	-1.3099	0.09811	0.59132	1	0.474	0.369	0.3	0.48419	0.136
NIELSEN_LEIOMYOSARCOMA_CNN1_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LEIOMYOSARCOMA_CNN1_UP	-0.53007	-1.3093	0.1515	0.59193	1	0.421	0.0919	0.383	0.48627	0.136
BURTON_ADIPOGENESIS_PEAK_AT_0HR	60	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_0HR	-0.42685	-1.3091	0.1772	0.59117	1	0.3	0.124	0.263	0.48516	0.136
KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	-0.48457	-1.309	0.1393	0.59021	1	0.438	0.244	0.331	0.48406	0.136
PID_TCR_PATHWAY	66	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TCR_PATHWAY	-0.35514	-1.3088	0.1741	0.58814	1	0.545	0.369	0.345	0.48253	0.135
WEBER_METHYLATED_LCP_IN_SPERM_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_LCP_IN_SPERM_UP	-0.51042	-1.3088	0.1482	0.58941	1	0.467	0.203	0.372	0.48363	0.135
MARTENS_BOUND_BY_PML_RARA_FUSION	431	http://www.broadinstitute.org/gsea/msigdb/cards/MARTENS_BOUND_BY_PML_RARA_FUSION	-0.2735	-1.3081	0.122	0.58894	1	0.506	0.412	0.302	0.48386	0.135
RIZ_ERYTHROID_DIFFERENTIATION_6HR	39	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_6HR	-0.33369	-1.3079	0.1035	0.58834	1	0.359	0.207	0.285	0.48377	0.135
TSAI_RESPONSE_TO_RADIATION_THERAPY	32	http://www.broadinstitute.org/gsea/msigdb/cards/TSAI_RESPONSE_TO_RADIATION_THERAPY	-0.48875	-1.3076	0.2056	0.5867	1	0.469	0.179	0.385	0.48241	0.135
SMIRNOV_RESPONSE_TO_IR_6HR_DN	109	http://www.broadinstitute.org/gsea/msigdb/cards/SMIRNOV_RESPONSE_TO_IR_6HR_DN	-0.38494	-1.3076	0.1654	0.58801	1	0.303	0.169	0.253	0.48349	0.135
MUNSHI_MULTIPLE_MYELOMA_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/MUNSHI_MULTIPLE_MYELOMA_UP	-0.32594	-1.3075	0.1197	0.58435	1	0.2	0.119	0.177	0.48025	0.135
ZHAN_MULTIPLE_MYELOMA_LB_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_LB_DN	-0.41996	-1.3075	0.1612	0.58563	1	0.385	0.217	0.302	0.48133	0.135
PLASARI_TGFB1_TARGETS_10HR_UP	195	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_TARGETS_10HR_UP	-0.37213	-1.3069	0.1851	0.58489	1	0.41	0.241	0.314	0.48153	0.135
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	-0.33594	-1.3062	0.1148	0.58582	1	0.449	0.291	0.319	0.48088	0.135
KANG_AR_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_AR_TARGETS_DN	-0.53651	-1.3053	0.2068	0.58737	1	0.526	0.271	0.384	0.48414	0.135
WU_HBX_TARGETS_3_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/WU_HBX_TARGETS_3_UP	-0.42742	-1.3051	0.158	0.58658	1	0.556	0.412	0.327	0.48335	0.135
WANG_TNF_TARGETS	24	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_TNF_TARGETS	-0.50551	-1.3042	0.2004	0.58808	1	1	0.495	0.505	0.48527	0.135
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP	-0.43177	-1.3041	0.1605	0.58736	1	0.579	0.27	0.423	0.4842	0.135
WEINMANN_ADAPTATION_TO_HYPOXIA_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/WEINMANN_ADAPTATION_TO_HYPOXIA_UP	-0.40408	-1.3039	0.1788	0.58659	1	0.321	0.155	0.272	0.48314	0.135
REACTOME_DOWNSTREAM_TCR_SIGNALING	34	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DOWNSTREAM_TCR_SIGNALING	-0.47583	-1.3038	0.1804	0.58553	1	0.382	0.172	0.317	0.48208	0.135
TSENG_ADIPOGENIC_POTENTIAL_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/TSENG_ADIPOGENIC_POTENTIAL_UP	-0.40464	-1.3037	0.1984	0.58468	1	0.367	0.252	0.274	0.48276	0.135
ST_TUMOR_NECROSIS_FACTOR_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/ST_TUMOR_NECROSIS_FACTOR_PATHWAY	-0.38105	-1.3035	0.1721	0.58394	1	0.448	0.336	0.298	0.48239	0.135
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	158	http://www.broadinstitute.org/gsea/msigdb/cards/PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	-0.37153	-1.3033	0.1741	0.58336	1	0.373	0.241	0.285	0.4827	0.135
LU_IL4_SIGNALING	91	http://www.broadinstitute.org/gsea/msigdb/cards/LU_IL4_SIGNALING	-0.3684	-1.3025	0.1686	0.58458	1	0.308	0.163	0.258	0.4846	0.135
DORN_ADENOVIRUS_INFECTION_48HR_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/DORN_ADENOVIRUS_INFECTION_48HR_DN	-0.41993	-1.3012	0.2271	0.58709	1	0.275	0.122	0.242	0.48653	0.135
REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	45	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	-0.32655	-1.3008	0.142	0.5871	1	0.533	0.357	0.343	0.48644	0.135
REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING	-0.34918	-1.3004	0.1235	0.58736	1	0.148	0.0483	0.141	0.48909	0.135
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1	41	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1	-0.33711	-1.3001	0.05859	0.58696	1	0.146	0.0483	0.139	0.48862	0.135
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	261	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	-0.25886	-1.2998	0.06923	0.58667	1	0.291	0.245	0.222	0.48757	0.135
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	-0.37376	-1.2993	0.1366	0.5868	1	0.254	0.109	0.227	0.48674	0.135
DAZARD_UV_RESPONSE_CLUSTER_G3	15	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G3	-0.4286	-1.2992	0.1034	0.58605	1	0.333	0.165	0.278	0.48633	0.135
REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	-0.41961	-1.2987	0.1226	0.58667	1	0.458	0.272	0.334	0.48762	0.135
GERY_CEBP_TARGETS	123	http://www.broadinstitute.org/gsea/msigdb/cards/GERY_CEBP_TARGETS	-0.35758	-1.2982	0.1833	0.58662	1	0.341	0.219	0.268	0.48933	0.135
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	-0.45843	-1.2977	0.2051	0.58692	1	0.412	0.199	0.33	0.48946	0.133
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	22	http://www.broadinstitute.org/gsea/msigdb/cards/GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	-0.4078	-1.297	0.1885	0.58804	1	0.364	0.23	0.28	0.49086	0.134
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	-0.50994	-1.2966	0.1547	0.58806	1	0.353	0.114	0.313	0.49081	0.132
PID_IL12_STAT4_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL12_STAT4_PATHWAY	-0.44129	-1.2956	0.21	0.58953	1	0.438	0.209	0.347	0.49074	0.132
RIGGI_EWING_SARCOMA_PROGENITOR_DN	177	http://www.broadinstitute.org/gsea/msigdb/cards/RIGGI_EWING_SARCOMA_PROGENITOR_DN	-0.42545	-1.2955	0.1512	0.58873	1	0.339	0.162	0.286	0.49003	0.132
CROONQUIST_IL6_DEPRIVATION_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_IL6_DEPRIVATION_UP	-0.43003	-1.2951	0.1468	0.58877	1	0.474	0.315	0.325	0.489	0.132
TOMIDA_METASTASIS_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/TOMIDA_METASTASIS_DN	-0.41897	-1.2948	0.1569	0.5884	1	0.412	0.168	0.343	0.49084	0.132
LEE_DOUBLE_POLAR_THYMOCYTE	24	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_DOUBLE_POLAR_THYMOCYTE	-0.44657	-1.2938	0.1842	0.59055	1	0.458	0.202	0.366	0.49048	0.132
STEARMAN_TUMOR_FIELD_EFFECT_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/STEARMAN_TUMOR_FIELD_EFFECT_UP	-0.4069	-1.2934	0.1624	0.59072	1	0.647	0.373	0.406	0.49109	0.132
THUM_MIR21_TARGETS_HEART_DISEASE_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/THUM_MIR21_TARGETS_HEART_DISEASE_UP	-0.69623	-1.2933	0.1823	0.58976	1	0.812	0.24	0.618	0.49052	0.132
VALK_AML_CLUSTER_12	30	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_12	-0.35503	-1.2928	0.1455	0.59006	1	0.633	0.42	0.368	0.4907	0.132
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	-0.39454	-1.2914	0.1856	0.59349	1	0.241	0.111	0.215	0.49347	0.134
HARRIS_HYPOXIA	78	http://www.broadinstitute.org/gsea/msigdb/cards/HARRIS_HYPOXIA	-0.39795	-1.2907	0.1961	0.59455	1	0.372	0.239	0.284	0.49463	0.134
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN	292	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN	-0.28024	-1.2896	0.1282	0.59702	1	0.298	0.194	0.243	0.49619	0.132
LEE_LIVER_CANCER_MYC_TGFA_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_TGFA_DN	-0.36217	-1.2895	0.1512	0.59596	1	0.306	0.172	0.254	0.49517	0.132
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	-0.44536	-1.2882	0.182	0.59897	1	0.375	0.17	0.312	0.49704	0.132
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	149	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	-0.34819	-1.2879	0.1703	0.5986	1	0.336	0.189	0.274	0.49725	0.132
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	19	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	-0.41446	-1.2877	0.1984	0.59701	1	0.316	0.145	0.27	0.49648	0.132
LIM_MAMMARY_LUMINAL_PROGENITOR_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/LIM_MAMMARY_LUMINAL_PROGENITOR_UP	-0.37028	-1.2877	0.1373	0.59811	1	0.472	0.297	0.332	0.49746	0.132
KEGG_HEDGEHOG_SIGNALING_PATHWAY	56	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_HEDGEHOG_SIGNALING_PATHWAY	-0.36001	-1.2871	0.1955	0.59764	1	0.554	0.389	0.339	0.49809	0.132
OLSSON_E2F3_TARGETS_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/OLSSON_E2F3_TARGETS_DN	-0.36764	-1.287	0.1692	0.59677	1	0.4	0.265	0.294	0.49778	0.132
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	296	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	-0.26088	-1.287	0.1969	0.59559	1	0.409	0.376	0.258	0.49694	0.132
BIOCARTA_IL12_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL12_PATHWAY	-0.40617	-1.2868	0.1663	0.59485	1	0.5	0.209	0.396	0.49593	0.132
ZHANG_TLX_TARGETS_DN	102	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_DN	-0.30059	-1.2865	0.1862	0.59483	1	0.471	0.379	0.294	0.49595	0.131
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	19	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	-0.50051	-1.2864	0.1791	0.59388	1	0.474	0.179	0.389	0.49554	0.131
REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	-0.35264	-1.2863	0.14	0.59284	1	0.163	0.0483	0.155	0.49454	0.131
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN	226	http://www.broadinstitute.org/gsea/msigdb/cards/GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN	-0.26454	-1.2858	0.1288	0.59331	1	0.465	0.388	0.287	0.49426	0.131
NAKAMURA_METASTASIS_MODEL_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_METASTASIS_MODEL_DN	-0.35683	-1.285	0.1602	0.59452	1	0.548	0.362	0.35	0.49562	0.131
PID_RHODOPSIN_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RHODOPSIN_PATHWAY	-0.49578	-1.2844	0.1641	0.59508	1	0.739	0.395	0.448	0.49786	0.131
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	84	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	-0.29758	-1.2836	0.1387	0.5965	1	0.44	0.346	0.289	0.49996	0.131
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	47	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	-0.50024	-1.2834	0.1164	0.59573	1	0.426	0.193	0.344	0.49918	0.131
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN	-0.47379	-1.2826	0.1646	0.59697	1	0.4	0.16	0.336	0.49997	0.131
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	212	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	-0.31388	-1.2823	0.1916	0.59676	1	0.302	0.211	0.24	0.49921	0.131
REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS	-0.47256	-1.2809	0.1546	0.59993	1	0.593	0.287	0.423	0.50235	0.132
REACTOME_HEMOSTASIS	439	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HEMOSTASIS	-0.26265	-1.2795	0.1206	0.60307	1	0.36	0.301	0.256	0.50393	0.133
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	363	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	-0.29185	-1.2792	0.09862	0.60298	1	0.38	0.298	0.271	0.50395	0.133
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	67	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	-0.39115	-1.2791	0.1753	0.60087	1	0.328	0.169	0.273	0.50197	0.132
BIOCARTA_IL2RB_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL2RB_PATHWAY	-0.3542	-1.2791	0.1429	0.60195	1	0.486	0.378	0.303	0.50296	0.133
HALMOS_CEBPA_TARGETS_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/HALMOS_CEBPA_TARGETS_DN	-0.39227	-1.2787	0.2361	0.60105	1	0.556	0.313	0.383	0.50334	0.132
ISSAEVA_MLL2_TARGETS	58	http://www.broadinstitute.org/gsea/msigdb/cards/ISSAEVA_MLL2_TARGETS	-0.36871	-1.2786	0.1067	0.6002	1	0.603	0.425	0.348	0.50235	0.132
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE	73	http://www.broadinstitute.org/gsea/msigdb/cards/ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE	-0.27851	-1.2785	0.1778	0.59935	1	0.219	0.197	0.176	0.50136	0.132
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/HUMMERICH_MALIGNANT_SKIN_TUMOR_DN	-0.43155	-1.2774	0.2286	0.6013	1	0.5	0.404	0.298	0.50296	0.133
BIOCARTA_CYTOKINE_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CYTOKINE_PATHWAY	-0.53089	-1.2769	0.1398	0.60181	1	0.368	0.169	0.306	0.50593	0.133
STAEGE_EWING_FAMILY_TUMOR	28	http://www.broadinstitute.org/gsea/msigdb/cards/STAEGE_EWING_FAMILY_TUMOR	-0.3459	-1.2769	0.1603	0.60072	1	0.321	0.201	0.257	0.50494	0.133
ZHANG_RESPONSE_TO_CANTHARIDIN_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_RESPONSE_TO_CANTHARIDIN_UP	-0.47181	-1.2768	0.2123	0.5998	1	0.316	0.16	0.266	0.50396	0.133
DORN_ADENOVIRUS_INFECTION_12HR_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/DORN_ADENOVIRUS_INFECTION_12HR_DN	-0.38254	-1.2766	0.198	0.59911	1	0.212	0.126	0.186	0.50298	0.133
DIRMEIER_LMP1_RESPONSE_LATE_UP	55	http://www.broadinstitute.org/gsea/msigdb/cards/DIRMEIER_LMP1_RESPONSE_LATE_UP	-0.30591	-1.2759	0.169	0.60021	1	0.418	0.309	0.29	0.50291	0.133
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	-0.40841	-1.2758	0.1876	0.59941	1	0.3	0.183	0.246	0.50304	0.133
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	299	http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	-0.30655	-1.2756	0.1629	0.59872	1	0.271	0.192	0.221	0.50254	0.131
TSUNODA_CISPLATIN_RESISTANCE_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/TSUNODA_CISPLATIN_RESISTANCE_DN	-0.397	-1.2754	0.1686	0.59827	1	0.417	0.236	0.319	0.50157	0.131
ZIRN_TRETINOIN_RESPONSE_WT1_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/ZIRN_TRETINOIN_RESPONSE_WT1_UP	-0.49556	-1.2751	0.1849	0.59817	1	0.524	0.193	0.423	0.5006	0.133
LEE_LIVER_CANCER_DENA_UP	58	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_DENA_UP	-0.36874	-1.2741	0.1615	0.60023	1	0.328	0.198	0.263	0.50275	0.133
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	201	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	-0.34411	-1.2735	0.1799	0.60098	1	0.632	0.42	0.37	0.50213	0.133
MAINA_VHL_TARGETS_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/MAINA_VHL_TARGETS_DN	-0.45819	-1.273	0.1908	0.6014	1	0.278	0.146	0.237	0.50441	0.133
KAAB_FAILED_HEART_ATRIUM_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/KAAB_FAILED_HEART_ATRIUM_UP	-0.4096	-1.2728	0.1312	0.60089	1	0.667	0.488	0.342	0.50452	0.133
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	198	http://www.broadinstitute.org/gsea/msigdb/cards/PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	-0.4587	-1.2724	0.1895	0.60126	1	0.399	0.16	0.338	0.50732	0.133
SUMI_HNF4A_TARGETS	32	http://www.broadinstitute.org/gsea/msigdb/cards/SUMI_HNF4A_TARGETS	-0.43607	-1.2721	0.182	0.60102	1	0.75	0.483	0.388	0.50796	0.133
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	47	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	-0.37462	-1.2718	0.222	0.60075	1	0.66	0.42	0.383	0.50819	0.131
GEISS_RESPONSE_TO_DSRNA_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/GEISS_RESPONSE_TO_DSRNA_UP	-0.51135	-1.2717	0.2162	0.59992	1	0.432	0.193	0.349	0.50723	0.131
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	77	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	-0.37642	-1.2715	0.1735	0.5992	1	0.468	0.306	0.326	0.50627	0.131
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	-0.50134	-1.2709	0.2004	0.60022	1	0.387	0.12	0.341	0.50702	0.131
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1	-0.41457	-1.2707	0.176	0.59968	1	0.176	0.0361	0.17	0.50664	0.13
SU_THYMUS	19	http://www.broadinstitute.org/gsea/msigdb/cards/SU_THYMUS	-0.43505	-1.2706	0.2192	0.59875	1	0.632	0.313	0.434	0.50623	0.13
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	-0.42079	-1.2702	0.1836	0.59893	1	0.493	0.256	0.368	0.50616	0.13
KEGG_NITROGEN_METABOLISM	23	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NITROGEN_METABOLISM	-0.38262	-1.2699	0.1904	0.59886	1	0.565	0.418	0.329	0.50648	0.13
BROCKE_APOPTOSIS_REVERSED_BY_IL6	141	http://www.broadinstitute.org/gsea/msigdb/cards/BROCKE_APOPTOSIS_REVERSED_BY_IL6	-0.37918	-1.2695	0.2084	0.59877	1	0.433	0.252	0.326	0.50658	0.13
REACTOME_ADP_SIGNALLING_THROUGH_P2RY1	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ADP_SIGNALLING_THROUGH_P2RY1	-0.37201	-1.2694	0.1162	0.59701	1	0.167	0.0483	0.159	0.50507	0.13
SANA_TNF_SIGNALING_DN	88	http://www.broadinstitute.org/gsea/msigdb/cards/SANA_TNF_SIGNALING_DN	-0.43985	-1.2694	0.1768	0.59806	1	0.341	0.172	0.283	0.50601	0.13
ZHANG_INTERFERON_RESPONSE	23	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_INTERFERON_RESPONSE	-0.55584	-1.2691	0.2291	0.59663	1	0.565	0.247	0.426	0.50433	0.13
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	-0.33031	-1.2686	0.175	0.59713	1	0.25	0.14	0.215	0.50503	0.13
OZANNE_AP1_TARGETS_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/OZANNE_AP1_TARGETS_UP	-0.43716	-1.2674	0.2154	0.59949	1	0.733	0.491	0.373	0.50511	0.13
LUND_SILENCED_BY_METHYLATION	15	http://www.broadinstitute.org/gsea/msigdb/cards/LUND_SILENCED_BY_METHYLATION	-0.38333	-1.2674	0.2191	0.59859	1	0.467	0.415	0.273	0.50417	0.13
HOWLIN_PUBERTAL_MAMMARY_GLAND	65	http://www.broadinstitute.org/gsea/msigdb/cards/HOWLIN_PUBERTAL_MAMMARY_GLAND	-0.3587	-1.2669	0.1562	0.59888	1	0.292	0.153	0.248	0.50607	0.13
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	-0.46478	-1.2667	0.1961	0.59833	1	0.533	0.312	0.367	0.50614	0.13
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES	90	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES	-0.28296	-1.2665	0.1032	0.59786	1	0.467	0.304	0.326	0.50521	0.13
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	-0.35307	-1.266	0.1968	0.59725	1	0.156	0.0483	0.149	0.50357	0.129
KAYO_CALORIE_RESTRICTION_MUSCLE_UP	89	http://www.broadinstitute.org/gsea/msigdb/cards/KAYO_CALORIE_RESTRICTION_MUSCLE_UP	-0.34069	-1.266	0.1766	0.59813	1	0.393	0.306	0.274	0.5045	0.13
DIRMEIER_LMP1_RESPONSE_LATE_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/DIRMEIER_LMP1_RESPONSE_LATE_DN	-0.38818	-1.2655	0.156	0.59643	1	0.567	0.468	0.302	0.5041	0.129
LENAOUR_DENDRITIC_CELL_MATURATION_UP	112	http://www.broadinstitute.org/gsea/msigdb/cards/LENAOUR_DENDRITIC_CELL_MATURATION_UP	-0.3101	-1.2655	0.1564	0.59743	1	0.286	0.18	0.235	0.50453	0.129
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	-0.38328	-1.2643	0.09811	0.59907	1	0.606	0.371	0.381	0.50629	0.13
KANNAN_TP53_TARGETS_UP	58	http://www.broadinstitute.org/gsea/msigdb/cards/KANNAN_TP53_TARGETS_UP	-0.30931	-1.264	0.2237	0.59914	1	0.5	0.425	0.288	0.50655	0.131
KHETCHOUMIAN_TRIM24_TARGETS_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/KHETCHOUMIAN_TRIM24_TARGETS_UP	-0.46083	-1.2629	0.211	0.60125	1	0.522	0.236	0.399	0.50854	0.131
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	430	http://www.broadinstitute.org/gsea/msigdb/cards/FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	-0.33009	-1.2628	0.1507	0.60052	1	0.237	0.148	0.205	0.50762	0.131
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP	-0.57615	-1.2608	0.252	0.6053	1	0.412	0.187	0.335	0.51276	0.131
MANTOVANI_NFKB_TARGETS_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/MANTOVANI_NFKB_TARGETS_UP	-0.43145	-1.2606	0.2185	0.60368	1	0.209	0.0517	0.199	0.51091	0.131
NAKAYAMA_FRA2_TARGETS	40	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_FRA2_TARGETS	-0.45967	-1.2606	0.1962	0.60476	1	0.275	0.0764	0.254	0.51184	0.131
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	-0.39154	-1.2604	0.1404	0.60307	1	0.5	0.301	0.35	0.50999	0.13
DELYS_THYROID_CANCER_UP	435	http://www.broadinstitute.org/gsea/msigdb/cards/DELYS_THYROID_CANCER_UP	-0.30936	-1.2593	0.1838	0.6055	1	0.29	0.192	0.238	0.51157	0.131
BIOCARTA_NFKB_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NFKB_PATHWAY	-0.3676	-1.2591	0.1864	0.60504	1	0.435	0.398	0.262	0.51065	0.13
REACTOME_TCR_SIGNALING	51	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TCR_SIGNALING	-0.42463	-1.2588	0.1789	0.60462	1	0.333	0.153	0.283	0.51103	0.131
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP	210	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_3_4WK_UP	-0.2821	-1.2586	0.146	0.60416	1	0.5	0.374	0.315	0.51033	0.131
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	114	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	-0.38442	-1.2581	0.1581	0.60467	1	0.333	0.206	0.266	0.51167	0.131
WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	-0.29279	-1.2578	0.1212	0.60431	1	0.471	0.345	0.31	0.51254	0.131
SHIN_B_CELL_LYMPHOMA_CLUSTER_5	17	http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_5	-0.45312	-1.2569	0.1719	0.60616	1	0.529	0.291	0.375	0.51352	0.131
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	398	http://www.broadinstitute.org/gsea/msigdb/cards/SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	-0.29641	-1.2568	0.1147	0.60532	1	0.432	0.336	0.292	0.51261	0.131
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	66	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	-0.27726	-1.2564	0.1232	0.60566	1	0.424	0.347	0.278	0.51449	0.131
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	368	http://www.broadinstitute.org/gsea/msigdb/cards/TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	-0.28519	-1.2553	0.1731	0.60791	1	0.302	0.241	0.232	0.51478	0.131
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	99	http://www.broadinstitute.org/gsea/msigdb/cards/SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	-0.35386	-1.2553	0.175	0.60694	1	0.212	0.123	0.187	0.51387	0.131
KASLER_HDAC7_TARGETS_2_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/KASLER_HDAC7_TARGETS_2_DN	-0.37201	-1.2549	0.2804	0.60688	1	0.323	0.259	0.239	0.51439	0.131
BROWNE_HCMV_INFECTION_10HR_UP	95	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_10HR_UP	-0.30864	-1.2546	0.166	0.60694	1	0.263	0.179	0.217	0.51495	0.131
KOHOUTEK_CCNT1_TARGETS	48	http://www.broadinstitute.org/gsea/msigdb/cards/KOHOUTEK_CCNT1_TARGETS	-0.30927	-1.2541	0.2091	0.60739	1	0.438	0.303	0.305	0.51473	0.131
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	233	http://www.broadinstitute.org/gsea/msigdb/cards/HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	-0.35426	-1.254	0.2072	0.60651	1	0.322	0.222	0.253	0.51383	0.131
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	177	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	-0.35866	-1.2536	0.09145	0.60672	1	0.503	0.366	0.321	0.51444	0.131
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	158	http://www.broadinstitute.org/gsea/msigdb/cards/PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	-0.39099	-1.2535	0.2277	0.60606	1	0.253	0.119	0.224	0.51477	0.131
PID_TCR_CALCIUM_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TCR_CALCIUM_PATHWAY	-0.4231	-1.2534	0.1954	0.60548	1	0.393	0.165	0.328	0.51394	0.131
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION	49	http://www.broadinstitute.org/gsea/msigdb/cards/SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION	-0.43114	-1.2531	0.251	0.6052	1	0.408	0.18	0.335	0.5143	0.131
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	-0.47609	-1.2526	0.1627	0.60561	1	0.438	0.189	0.355	0.51411	0.131
LEE_LIVER_CANCER	45	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER	-0.33782	-1.2526	0.1892	0.60462	1	0.511	0.384	0.315	0.51322	0.131
PID_INTEGRIN3_PATHWAY	42	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN3_PATHWAY	-0.45907	-1.2525	0.2401	0.60187	1	0.476	0.236	0.365	0.51142	0.13
LEE_LIVER_CANCER_CIPROFIBRATE_UP	55	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_CIPROFIBRATE_UP	-0.30555	-1.2525	0.1437	0.60372	1	0.455	0.298	0.32	0.51297	0.131
BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	-0.51019	-1.2525	0.2127	0.60284	1	0.412	0.0824	0.378	0.51208	0.131
HOSHIDA_LIVER_CANCER_SURVIVAL_UP	73	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_SURVIVAL_UP	-0.33689	-1.2521	0.1667	0.60186	1	0.329	0.246	0.249	0.51106	0.13
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	224	http://www.broadinstitute.org/gsea/msigdb/cards/OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	-0.34179	-1.252	0.167	0.60004	1	0.263	0.147	0.227	0.50931	0.13
JISON_SICKLE_CELL_DISEASE_UP	172	http://www.broadinstitute.org/gsea/msigdb/cards/JISON_SICKLE_CELL_DISEASE_UP	-0.27968	-1.252	0.1693	0.59912	1	0.291	0.215	0.23	0.50843	0.13
HAHTOLA_CTCL_CUTANEOUS	25	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_CTCL_CUTANEOUS	-0.39219	-1.252	0.2084	0.60102	1	0.36	0.185	0.294	0.51018	0.13
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	-0.48763	-1.2518	0.2342	0.59884	1	0.321	0.123	0.282	0.50848	0.13
STAMBOLSKY_BOUND_BY_MUTATED_TP53	17	http://www.broadinstitute.org/gsea/msigdb/cards/STAMBOLSKY_BOUND_BY_MUTATED_TP53	-0.36661	-1.2513	0.1868	0.59936	1	0.294	0.205	0.234	0.50908	0.128
CROMER_TUMORIGENESIS_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/CROMER_TUMORIGENESIS_UP	-0.47586	-1.2507	0.2186	0.59994	1	0.492	0.236	0.377	0.50968	0.13
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	72	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	-0.58197	-1.2501	0.2715	0.60061	1	0.431	0.124	0.378	0.51026	0.13
WANG_METHYLATED_IN_BREAST_CANCER	35	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_METHYLATED_IN_BREAST_CANCER	-0.41002	-1.2501	0.2284	0.59966	1	0.543	0.357	0.35	0.50939	0.13
LUCAS_HNF4A_TARGETS_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/LUCAS_HNF4A_TARGETS_UP	-0.28603	-1.25	0.182	0.59891	1	0.429	0.376	0.268	0.50853	0.128
BIOCARTA_CSK_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CSK_PATHWAY	-0.41182	-1.2499	0.2155	0.59815	1	0.273	0.123	0.239	0.50904	0.128
RASHI_RESPONSE_TO_IONIZING_RADIATION_1	42	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_1	-0.39904	-1.2496	0.255	0.59812	1	0.31	0.144	0.266	0.5083	0.128
DELPUECH_FOXO3_TARGETS_UP	67	http://www.broadinstitute.org/gsea/msigdb/cards/DELPUECH_FOXO3_TARGETS_UP	-0.32426	-1.249	0.1973	0.59866	1	0.299	0.202	0.239	0.5076	0.128
MULLIGHAN_MLL_SIGNATURE_1_UP	352	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_MLL_SIGNATURE_1_UP	-0.23934	-1.2485	0.1793	0.59928	1	0.423	0.372	0.269	0.50959	0.128
ZHU_CMV_24_HR_DN	87	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_24_HR_DN	-0.47356	-1.2485	0.2465	0.5983	1	0.448	0.226	0.348	0.50874	0.128
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	76	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	-0.32415	-1.2479	0.2142	0.59922	1	0.474	0.377	0.296	0.51061	0.128
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	70	http://www.broadinstitute.org/gsea/msigdb/cards/ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	-0.33093	-1.2476	0.244	0.598	1	0.286	0.183	0.234	0.51043	0.128
CAIRO_LIVER_DEVELOPMENT_DN	216	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_LIVER_DEVELOPMENT_DN	-0.26603	-1.2476	0.09108	0.59888	1	0.412	0.329	0.279	0.51128	0.128
NAKAMURA_ADIPOGENESIS_EARLY_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_ADIPOGENESIS_EARLY_DN	-0.54462	-1.2465	0.2396	0.60029	1	0.474	0.111	0.422	0.5124	0.128
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE	15	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE	-0.47464	-1.246	0.2312	0.60075	1	0.667	0.353	0.431	0.51236	0.128
DAZARD_UV_RESPONSE_CLUSTER_G24	26	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G24	-0.46451	-1.2459	0.1523	0.60015	1	0.538	0.202	0.43	0.5115	0.128
VIETOR_IFRD1_TARGETS	23	http://www.broadinstitute.org/gsea/msigdb/cards/VIETOR_IFRD1_TARGETS	-0.42258	-1.2453	0.1977	0.60098	1	0.522	0.34	0.345	0.51266	0.128
REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS	42	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS	-0.31997	-1.2451	0.167	0.60052	1	0.143	0.0483	0.136	0.51181	0.128
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	99	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	-0.35673	-1.2446	0.2061	0.60092	1	0.323	0.16	0.273	0.51246	0.128
LIU_IL13_MEMORY_MODEL_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_IL13_MEMORY_MODEL_UP	-0.40713	-1.2446	0.2031	0.59999	1	0.733	0.447	0.406	0.51282	0.128
VALK_AML_WITH_11Q23_REARRANGED	20	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_WITH_11Q23_REARRANGED	-0.37598	-1.2445	0.1956	0.59928	1	0.55	0.391	0.335	0.51197	0.128
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	260	http://www.broadinstitute.org/gsea/msigdb/cards/BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	-0.26271	-1.2442	0.1301	0.59914	1	0.381	0.316	0.263	0.51211	0.128
ABE_VEGFA_TARGETS_2HR	32	http://www.broadinstitute.org/gsea/msigdb/cards/ABE_VEGFA_TARGETS_2HR	-0.37113	-1.2434	0.2283	0.60044	1	0.438	0.306	0.304	0.51316	0.128
PEREZ_TP53_AND_TP63_TARGETS	194	http://www.broadinstitute.org/gsea/msigdb/cards/PEREZ_TP53_AND_TP63_TARGETS	-0.27687	-1.2432	0.2146	0.59991	1	0.51	0.4	0.308	0.51231	0.128
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	-0.4589	-1.2431	0.237	0.59925	1	0.308	0.125	0.27	0.51147	0.128
INGA_TP53_TARGETS	17	http://www.broadinstitute.org/gsea/msigdb/cards/INGA_TP53_TARGETS	-0.4774	-1.2427	0.2593	0.59858	1	0.588	0.328	0.395	0.5104	0.128
DAZARD_UV_RESPONSE_CLUSTER_G4	20	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G4	-0.49147	-1.2427	0.2272	0.59764	1	0.65	0.315	0.445	0.50957	0.128
FINETTI_BREAST_CANCER_KINOME_GREEN	16	http://www.broadinstitute.org/gsea/msigdb/cards/FINETTI_BREAST_CANCER_KINOME_GREEN	-0.50207	-1.2427	0.2209	0.59956	1	0.812	0.428	0.465	0.51123	0.128
PID_EPHRINB_REV_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/PID_EPHRINB_REV_PATHWAY	-0.36467	-1.2426	0.2252	0.59678	1	0.5	0.334	0.333	0.50874	0.128
MARZEC_IL2_SIGNALING_UP	109	http://www.broadinstitute.org/gsea/msigdb/cards/MARZEC_IL2_SIGNALING_UP	-0.30582	-1.2421	0.1676	0.59732	1	0.468	0.319	0.32	0.5101	0.128
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	331	http://www.broadinstitute.org/gsea/msigdb/cards/SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	-0.47482	-1.2418	0.2535	0.59703	1	0.396	0.167	0.334	0.51082	0.128
MIKKELSEN_ES_LCP_WITH_H3K4ME3	131	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_ES_LCP_WITH_H3K4ME3	-0.33725	-1.2409	0.1868	0.59868	1	0.74	0.51	0.365	0.51207	0.128
REACTOME_SHC_MEDIATED_CASCADE	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SHC_MEDIATED_CASCADE	-0.37828	-1.2407	0.1847	0.59842	1	0.607	0.39	0.371	0.51323	0.128
SESTO_RESPONSE_TO_UV_C3	19	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C3	-0.47391	-1.2403	0.2429	0.59837	1	0.263	0.0858	0.241	0.5124	0.128
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	246	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	-0.30942	-1.2398	0.1936	0.59913	1	0.232	0.161	0.196	0.51355	0.128
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	42	http://www.broadinstitute.org/gsea/msigdb/cards/KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	-0.4652	-1.2397	0.1944	0.59825	1	0.738	0.415	0.432	0.51272	0.128
ODONNELL_TFRC_TARGETS_UP	403	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_TFRC_TARGETS_UP	-0.25166	-1.2395	0.1362	0.59711	1	0.375	0.298	0.267	0.51315	0.128
AMIT_SERUM_RESPONSE_60_MCF10A	56	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_SERUM_RESPONSE_60_MCF10A	-0.52045	-1.2395	0.2792	0.59802	1	0.429	0.153	0.364	0.51398	0.128
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	105	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	-0.31872	-1.2392	0.1962	0.59693	1	0.419	0.337	0.279	0.51326	0.128
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	206	http://www.broadinstitute.org/gsea/msigdb/cards/BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	-0.28662	-1.2389	0.2106	0.59686	1	0.529	0.412	0.313	0.51279	0.128
SESTO_RESPONSE_TO_UV_C7	68	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C7	-0.30385	-1.2388	0.1804	0.59626	1	0.176	0.131	0.154	0.51197	0.127
LABBE_WNT3A_TARGETS_DN	96	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_WNT3A_TARGETS_DN	-0.28382	-1.2386	0.1079	0.59586	1	0.281	0.224	0.219	0.51115	0.126
KEGG_ASTHMA	27	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ASTHMA	-0.52405	-1.2384	0.2242	0.59557	1	0.333	0.161	0.28	0.51048	0.126
REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION	-0.45978	-1.2383	0.2351	0.59474	1	0.682	0.39	0.416	0.51033	0.126
JOHNSTONE_PARVB_TARGETS_2_UP	129	http://www.broadinstitute.org/gsea/msigdb/cards/JOHNSTONE_PARVB_TARGETS_2_UP	-0.28817	-1.2377	0.2663	0.59551	1	0.233	0.194	0.188	0.51271	0.126
NABA_ECM_REGULATORS	229	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_ECM_REGULATORS	-0.29401	-1.2376	0.1556	0.59489	1	0.415	0.305	0.291	0.5119	0.126
PID_CONE_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CONE_PATHWAY	-0.48074	-1.2374	0.2106	0.59458	1	0.318	0.129	0.277	0.51132	0.126
DORN_ADENOVIRUS_INFECTION_32HR_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/DORN_ADENOVIRUS_INFECTION_32HR_DN	-0.38996	-1.2369	0.255	0.59487	1	0.256	0.122	0.225	0.51072	0.126
REACTOME_REGULATION_OF_IFNA_SIGNALING	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_IFNA_SIGNALING	-0.5105	-1.2366	0.2093	0.59398	1	0.65	0.337	0.431	0.51037	0.126
HOEBEKE_LYMPHOID_STEM_CELL_DN	83	http://www.broadinstitute.org/gsea/msigdb/cards/HOEBEKE_LYMPHOID_STEM_CELL_DN	-0.30666	-1.2366	0.1316	0.5948	1	0.145	0.0588	0.137	0.51118	0.126
SCHLOSSER_SERUM_RESPONSE_UP	125	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_SERUM_RESPONSE_UP	-0.26793	-1.2364	0.217	0.59359	1	0.304	0.285	0.218	0.51	0.126
MAHAJAN_RESPONSE_TO_IL1A_UP	79	http://www.broadinstitute.org/gsea/msigdb/cards/MAHAJAN_RESPONSE_TO_IL1A_UP	-0.33225	-1.2352	0.1875	0.59603	1	0.38	0.235	0.291	0.51213	0.127
STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18	http://www.broadinstitute.org/gsea/msigdb/cards/STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	-0.42823	-1.2339	0.2019	0.59864	1	0.667	0.383	0.411	0.5173	0.127
GEORGANTAS_HSC_MARKERS	64	http://www.broadinstitute.org/gsea/msigdb/cards/GEORGANTAS_HSC_MARKERS	-0.38042	-1.233	0.1503	0.60038	1	0.297	0.148	0.253	0.51828	0.127
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	161	http://www.broadinstitute.org/gsea/msigdb/cards/CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	-0.27164	-1.2327	0.1551	0.60027	1	0.329	0.274	0.241	0.51818	0.127
REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION	-0.37739	-1.2324	0.1956	0.6002	1	0.15	0.0361	0.145	0.51939	0.127
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	-0.55712	-1.2319	0.2565	0.60048	1	0.312	0.0876	0.285	0.51956	0.127
KEGG_CHEMOKINE_SIGNALING_PATHWAY	179	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CHEMOKINE_SIGNALING_PATHWAY	-0.28485	-1.2311	0.1686	0.60209	1	0.408	0.327	0.277	0.52085	0.127
SHIPP_DLBCL_CURED_VS_FATAL_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/SHIPP_DLBCL_CURED_VS_FATAL_UP	-0.39598	-1.2306	0.1828	0.60167	1	0.667	0.373	0.419	0.51976	0.128
VALK_AML_WITH_CEBPA	35	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_WITH_CEBPA	-0.33614	-1.2306	0.1988	0.60248	1	0.514	0.351	0.334	0.52057	0.128
PATTERSON_DOCETAXEL_RESISTANCE	28	http://www.broadinstitute.org/gsea/msigdb/cards/PATTERSON_DOCETAXEL_RESISTANCE	-0.29887	-1.2304	0.2165	0.60028	1	0.679	0.518	0.327	0.51897	0.128
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN	-0.37953	-1.2304	0.2256	0.60112	1	0.588	0.465	0.315	0.51909	0.128
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	21	http://www.broadinstitute.org/gsea/msigdb/cards/DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	-0.40369	-1.2303	0.2345	0.59963	1	0.429	0.308	0.297	0.51839	0.128
CHYLA_CBFA2T3_TARGETS_UP	376	http://www.broadinstitute.org/gsea/msigdb/cards/CHYLA_CBFA2T3_TARGETS_UP	-0.26421	-1.2302	0.1663	0.59899	1	0.426	0.341	0.285	0.51897	0.128
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	104	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	-0.3165	-1.2299	0.2208	0.59894	1	0.356	0.263	0.263	0.51844	0.127
DER_IFN_GAMMA_RESPONSE_UP	69	http://www.broadinstitute.org/gsea/msigdb/cards/DER_IFN_GAMMA_RESPONSE_UP	-0.34149	-1.2291	0.261	0.60026	1	0.594	0.445	0.331	0.51952	0.128
DELYS_THYROID_CANCER_DN	224	http://www.broadinstitute.org/gsea/msigdb/cards/DELYS_THYROID_CANCER_DN	-0.31791	-1.2276	0.167	0.60376	1	0.308	0.202	0.248	0.52429	0.128
DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	25	http://www.broadinstitute.org/gsea/msigdb/cards/DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	-0.41175	-1.2275	0.2167	0.60309	1	0.36	0.214	0.283	0.52348	0.128
RODWELL_AGING_KIDNEY_NO_BLOOD_UP	206	http://www.broadinstitute.org/gsea/msigdb/cards/RODWELL_AGING_KIDNEY_NO_BLOOD_UP	-0.39342	-1.2274	0.2174	0.60247	1	0.257	0.116	0.229	0.52381	0.128
CROMER_METASTASIS_DN	78	http://www.broadinstitute.org/gsea/msigdb/cards/CROMER_METASTASIS_DN	-0.27848	-1.2264	0.1689	0.60421	1	0.487	0.41	0.288	0.52598	0.128
REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	-0.37964	-1.2263	0.1952	0.60367	1	0.182	0.0483	0.173	0.52616	0.128
HAN_JNK_SINGALING_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/HAN_JNK_SINGALING_UP	-0.47484	-1.226	0.2379	0.60341	1	0.371	0.141	0.32	0.52633	0.128
REACTOME_LIPOPROTEIN_METABOLISM	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LIPOPROTEIN_METABOLISM	-0.33856	-1.2258	0.2274	0.6031	1	0.607	0.357	0.391	0.52559	0.128
MIKKELSEN_IPS_LCP_WITH_H3K4ME3	160	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_IPS_LCP_WITH_H3K4ME3	-0.32222	-1.2257	0.2306	0.60251	1	0.756	0.51	0.373	0.52482	0.128
AIYAR_COBRA1_TARGETS_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/AIYAR_COBRA1_TARGETS_UP	-0.36714	-1.2254	0.2437	0.60251	1	0.184	0.072	0.171	0.5256	0.127
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	41	http://www.broadinstitute.org/gsea/msigdb/cards/MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	-0.36549	-1.2253	0.2255	0.60175	1	0.415	0.226	0.322	0.52506	0.127
GENTLES_LEUKEMIC_STEM_CELL_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/GENTLES_LEUKEMIC_STEM_CELL_UP	-0.52978	-1.2244	0.2072	0.60345	1	0.346	0.107	0.31	0.52649	0.128
FARDIN_HYPOXIA_11	31	http://www.broadinstitute.org/gsea/msigdb/cards/FARDIN_HYPOXIA_11	-0.34997	-1.2239	0.259	0.60414	1	0.194	0.119	0.171	0.5276	0.128
PID_ARF6_DOWNSTREAM_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ARF6_DOWNSTREAM_PATHWAY	-0.34879	-1.2235	0.156	0.60432	1	0.267	0.117	0.236	0.52681	0.128
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	-0.54484	-1.2231	0.2584	0.60456	1	0.609	0.186	0.496	0.52665	0.128
CHEOK_RESPONSE_TO_HD_MTX_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/CHEOK_RESPONSE_TO_HD_MTX_UP	-0.47365	-1.2226	0.2288	0.60491	1	0.421	0.185	0.344	0.52586	0.128
MIKKELSEN_ES_ICP_WITH_H3K27ME3	40	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_ES_ICP_WITH_H3K27ME3	-0.36354	-1.222	0.1632	0.6048	1	0.45	0.264	0.332	0.52697	0.128
HUANG_GATA2_TARGETS_UP	142	http://www.broadinstitute.org/gsea/msigdb/cards/HUANG_GATA2_TARGETS_UP	-0.30526	-1.222	0.2342	0.60563	1	0.218	0.144	0.188	0.52776	0.128
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	182	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	-0.3297	-1.2218	0.2116	0.60434	1	0.313	0.169	0.262	0.52736	0.128
GRADE_COLON_VS_RECTAL_CANCER_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_COLON_VS_RECTAL_CANCER_UP	-0.39985	-1.2218	0.1862	0.60355	1	0.258	0.155	0.218	0.52673	0.128
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	-0.44233	-1.2209	0.227	0.6053	1	0.347	0.154	0.294	0.52899	0.128
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C	88	http://www.broadinstitute.org/gsea/msigdb/cards/BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C	-0.25766	-1.2205	0.1629	0.60561	1	0.409	0.347	0.268	0.53016	0.128
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	71	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	-0.30638	-1.2199	0.1843	0.60626	1	0.338	0.232	0.26	0.53104	0.128
MARSON_FOXP3_TARGETS_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/MARSON_FOXP3_TARGETS_UP	-0.32366	-1.2193	0.1878	0.60686	1	0.524	0.338	0.348	0.53137	0.128
MCDOWELL_ACUTE_LUNG_INJURY_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/MCDOWELL_ACUTE_LUNG_INJURY_UP	-0.45825	-1.2189	0.2397	0.60713	1	0.545	0.258	0.405	0.53212	0.128
ZHAN_MULTIPLE_MYELOMA_CD2_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD2_UP	-0.29431	-1.2179	0.1775	0.60892	1	0.381	0.297	0.268	0.53278	0.129
INGRAM_SHH_TARGETS_UP	123	http://www.broadinstitute.org/gsea/msigdb/cards/INGRAM_SHH_TARGETS_UP	-0.30793	-1.2178	0.2021	0.60843	1	0.439	0.334	0.294	0.532	0.129
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	91	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	-0.39704	-1.2168	0.175	0.6102	1	0.319	0.165	0.267	0.53247	0.13
KEGG_TYROSINE_METABOLISM	40	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TYROSINE_METABOLISM	-0.33748	-1.2165	0.2282	0.6103	1	0.575	0.386	0.354	0.5323	0.129
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B	21	http://www.broadinstitute.org/gsea/msigdb/cards/SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B	-0.44769	-1.2161	0.2417	0.61035	1	0.524	0.235	0.401	0.53305	0.13
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	72	http://www.broadinstitute.org/gsea/msigdb/cards/PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	-0.35739	-1.2143	0.2133	0.61479	1	0.431	0.241	0.328	0.53694	0.13
WIKMAN_ASBESTOS_LUNG_CANCER_DN	26	http://www.broadinstitute.org/gsea/msigdb/cards/WIKMAN_ASBESTOS_LUNG_CANCER_DN	-0.43455	-1.2142	0.219	0.61409	1	0.269	0.0815	0.248	0.53668	0.13
WIERENGA_STAT5A_TARGETS_DN	198	http://www.broadinstitute.org/gsea/msigdb/cards/WIERENGA_STAT5A_TARGETS_DN	-0.24764	-1.2142	0.1561	0.61325	1	0.399	0.325	0.271	0.5359	0.13
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	83	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	-0.35091	-1.214	0.2236	0.61297	1	0.494	0.362	0.316	0.53621	0.13
FRIDMAN_IMMORTALIZATION_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/FRIDMAN_IMMORTALIZATION_DN	-0.44189	-1.2137	0.2584	0.61278	1	0.364	0.169	0.303	0.53543	0.13
AMIT_EGF_RESPONSE_120_HELA	66	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_120_HELA	-0.32813	-1.2135	0.2788	0.61259	1	0.273	0.194	0.22	0.53465	0.13
HILLION_HMGA1_TARGETS	86	http://www.broadinstitute.org/gsea/msigdb/cards/HILLION_HMGA1_TARGETS	-0.29721	-1.2128	0.2343	0.61354	1	0.186	0.133	0.162	0.53642	0.13
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	249	http://www.broadinstitute.org/gsea/msigdb/cards/YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	-0.25599	-1.2127	0.08818	0.61292	1	0.538	0.417	0.317	0.53617	0.13
KANG_CISPLATIN_RESISTANCE_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_CISPLATIN_RESISTANCE_UP	-0.44567	-1.2126	0.2664	0.61234	1	0.389	0.192	0.314	0.53673	0.13
BILANGES_SERUM_SENSITIVE_VIA_TSC1	23	http://www.broadinstitute.org/gsea/msigdb/cards/BILANGES_SERUM_SENSITIVE_VIA_TSC1	-0.38818	-1.2125	0.2079	0.61173	1	0.565	0.297	0.398	0.53703	0.129
GUO_HEX_TARGETS_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/GUO_HEX_TARGETS_DN	-0.30297	-1.2123	0.1699	0.61156	1	0.484	0.357	0.312	0.53667	0.129
KEGG_VIRAL_MYOCARDITIS	65	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_VIRAL_MYOCARDITIS	-0.32074	-1.212	0.2207	0.61152	1	0.538	0.401	0.323	0.53691	0.13
CERVERA_SDHB_TARGETS_2	109	http://www.broadinstitute.org/gsea/msigdb/cards/CERVERA_SDHB_TARGETS_2	-0.30618	-1.2119	0.1715	0.61099	1	0.275	0.168	0.23	0.53614	0.129
AMIT_EGF_RESPONSE_60_HELA	44	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_60_HELA	-0.46424	-1.2118	0.313	0.61017	1	0.409	0.194	0.33	0.53536	0.129
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	34	http://www.broadinstitute.org/gsea/msigdb/cards/MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	-0.35405	-1.2112	0.25	0.61112	1	0.412	0.301	0.288	0.53644	0.13
ROSS_AML_WITH_CBFB_MYH11_FUSION	51	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_AML_WITH_CBFB_MYH11_FUSION	-0.34956	-1.2111	0.2008	0.61042	1	0.294	0.168	0.245	0.53567	0.129
MUELLER_METHYLATED_IN_GLIOBLASTOMA	38	http://www.broadinstitute.org/gsea/msigdb/cards/MUELLER_METHYLATED_IN_GLIOBLASTOMA	-0.45336	-1.211	0.2525	0.60992	1	0.474	0.231	0.365	0.53545	0.129
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	124	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	-0.32942	-1.2106	0.1804	0.60996	1	0.548	0.405	0.328	0.53515	0.129
PID_NFAT_TFPATHWAY	46	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NFAT_TFPATHWAY	-0.34632	-1.21	0.2393	0.61083	1	0.348	0.218	0.272	0.53604	0.129
WILLERT_WNT_SIGNALING	22	http://www.broadinstitute.org/gsea/msigdb/cards/WILLERT_WNT_SIGNALING	-0.39479	-1.2099	0.2058	0.60951	1	0.273	0.101	0.245	0.53451	0.129
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	413	http://www.broadinstitute.org/gsea/msigdb/cards/BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	-0.35608	-1.2099	0.2048	0.61033	1	0.288	0.166	0.244	0.53527	0.129
KIM_ALL_DISORDERS_CALB1_CORR_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_ALL_DISORDERS_CALB1_CORR_DN	-0.42761	-1.2095	0.2445	0.60956	1	0.545	0.33	0.366	0.53443	0.129
SA_B_CELL_RECEPTOR_COMPLEXES	24	http://www.broadinstitute.org/gsea/msigdb/cards/SA_B_CELL_RECEPTOR_COMPLEXES	-0.32454	-1.2093	0.2612	0.60949	1	0.417	0.323	0.282	0.53433	0.129
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	133	http://www.broadinstitute.org/gsea/msigdb/cards/VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	-0.29499	-1.2083	0.2118	0.61154	1	0.489	0.325	0.332	0.53634	0.129
WONG_ENDMETRIUM_CANCER_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_ENDMETRIUM_CANCER_UP	-0.46463	-1.2082	0.2667	0.61092	1	0.417	0.171	0.346	0.53557	0.129
WALLACE_PROSTATE_CANCER_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/WALLACE_PROSTATE_CANCER_UP	-0.36773	-1.2081	0.2257	0.6102	1	0.632	0.482	0.328	0.53482	0.129
LINDVALL_IMMORTALIZED_BY_TERT_DN	79	http://www.broadinstitute.org/gsea/msigdb/cards/LINDVALL_IMMORTALIZED_BY_TERT_DN	-0.42658	-1.2073	0.2642	0.6115	1	0.342	0.131	0.298	0.538	0.128
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	109	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	-0.39581	-1.2072	0.1459	0.61102	1	0.358	0.187	0.292	0.53744	0.129
REACTOME_GPCR_LIGAND_BINDING	370	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GPCR_LIGAND_BINDING	-0.35023	-1.2071	0.2016	0.61033	1	0.584	0.404	0.353	0.53727	0.127
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_5_DN	-0.34679	-1.2068	0.2229	0.61031	1	0.256	0.123	0.225	0.53767	0.127
LIN_NPAS4_TARGETS_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_NPAS4_TARGETS_DN	-0.32794	-1.2065	0.2236	0.61033	1	0.532	0.364	0.339	0.53728	0.127
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	266	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	-0.288	-1.2063	0.2224	0.6093	1	0.38	0.314	0.263	0.53578	0.126
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	116	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	-0.32072	-1.2063	0.2139	0.61005	1	0.526	0.366	0.335	0.53653	0.127
KIM_WT1_TARGETS_8HR_UP	159	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_8HR_UP	-0.29062	-1.2062	0.1956	0.6087	1	0.333	0.234	0.257	0.53503	0.126
REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS	-0.35458	-1.2058	0.2393	0.60885	1	0.387	0.277	0.28	0.53506	0.127
RUAN_RESPONSE_TO_TNF_DN	84	http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TNF_DN	-0.25611	-1.2056	0.1981	0.60859	1	0.393	0.321	0.268	0.53522	0.126
REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS	86	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS	-0.3304	-1.2055	0.2466	0.60711	1	0.628	0.407	0.374	0.53489	0.126
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	89	http://www.broadinstitute.org/gsea/msigdb/cards/FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	-0.27999	-1.2055	0.2334	0.60787	1	0.539	0.418	0.315	0.53448	0.126
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	97	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	-0.3786	-1.2051	0.2797	0.60719	1	0.515	0.324	0.35	0.5348	0.126
WINNEPENNINCKX_MELANOMA_METASTASIS_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/WINNEPENNINCKX_MELANOMA_METASTASIS_DN	-0.37868	-1.2051	0.1884	0.60641	1	0.372	0.252	0.279	0.53406	0.125
WANG_MLL_TARGETS	279	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_MLL_TARGETS	-0.30807	-1.2041	0.2098	0.60821	1	0.362	0.241	0.278	0.53603	0.126
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	26	http://www.broadinstitute.org/gsea/msigdb/cards/MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	-0.38053	-1.2038	0.2196	0.60814	1	0.346	0.243	0.262	0.53529	0.126
KONDO_PROSTATE_CANCER_WITH_H3K27ME3	184	http://www.broadinstitute.org/gsea/msigdb/cards/KONDO_PROSTATE_CANCER_WITH_H3K27ME3	-0.31129	-1.2036	0.1782	0.60796	1	0.304	0.205	0.244	0.53564	0.126
ROZANOV_MMP14_TARGETS_UP	254	http://www.broadinstitute.org/gsea/msigdb/cards/ROZANOV_MMP14_TARGETS_UP	-0.30112	-1.203	0.248	0.60877	1	0.319	0.225	0.25	0.53604	0.126
MEISSNER_BRAIN_HCP_WITH_H3K27ME3	258	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3K27ME3	-0.40307	-1.2026	0.2959	0.60921	1	0.752	0.494	0.384	0.53706	0.125
REACTOME_HDL_MEDIATED_LIPID_TRANSPORT	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HDL_MEDIATED_LIPID_TRANSPORT	-0.37867	-1.2025	0.2533	0.6084	1	0.6	0.349	0.391	0.53632	0.125
ZIRN_TRETINOIN_RESPONSE_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/ZIRN_TRETINOIN_RESPONSE_UP	-0.54061	-1.2019	0.2829	0.60927	1	0.55	0.199	0.441	0.53772	0.126
LEI_MYB_TARGETS	314	http://www.broadinstitute.org/gsea/msigdb/cards/LEI_MYB_TARGETS	-0.2696	-1.2016	0.2191	0.60929	1	0.328	0.304	0.231	0.5376	0.126
ABE_VEGFA_TARGETS	20	http://www.broadinstitute.org/gsea/msigdb/cards/ABE_VEGFA_TARGETS	-0.50157	-1.2006	0.264	0.61111	1	0.55	0.293	0.389	0.54018	0.127
APPEL_IMATINIB_RESPONSE	31	http://www.broadinstitute.org/gsea/msigdb/cards/APPEL_IMATINIB_RESPONSE	-0.38793	-1.2005	0.234	0.61036	1	0.323	0.147	0.276	0.53963	0.123
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	116	http://www.broadinstitute.org/gsea/msigdb/cards/AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	-0.39183	-1.2003	0.2653	0.61024	1	0.336	0.195	0.272	0.54048	0.124
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6	28	http://www.broadinstitute.org/gsea/msigdb/cards/PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6	-0.38513	-1.1999	0.2016	0.61044	1	0.429	0.205	0.341	0.54078	0.124
FERRANDO_TAL1_NEIGHBORS	18	http://www.broadinstitute.org/gsea/msigdb/cards/FERRANDO_TAL1_NEIGHBORS	-0.43671	-1.1997	0.2539	0.6102	1	0.389	0.224	0.302	0.54057	0.123
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	202	http://www.broadinstitute.org/gsea/msigdb/cards/GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	-0.28102	-1.1987	0.1948	0.61234	1	0.223	0.153	0.19	0.54178	0.127
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	64	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	-0.2927	-1.1983	0.2675	0.61177	1	0.719	0.546	0.327	0.54042	0.127
LEE_LIVER_CANCER_E2F1_DN	61	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_E2F1_DN	-0.3281	-1.1983	0.2352	0.61257	1	0.279	0.166	0.233	0.54115	0.127
KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	23	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	-0.30221	-1.197	0.1856	0.61419	1	0.565	0.385	0.348	0.54333	0.127
BIOCARTA_HSP27_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_HSP27_PATHWAY	-0.34349	-1.1969	0.2207	0.61342	1	0.533	0.372	0.335	0.5426	0.127
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP	-0.50257	-1.196	0.2726	0.61536	1	0.556	0.202	0.443	0.54638	0.128
LEE_NEURAL_CREST_STEM_CELL_UP	142	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_NEURAL_CREST_STEM_CELL_UP	-0.35684	-1.1948	0.271	0.61793	1	0.373	0.241	0.285	0.54855	0.128
MURATA_VIRULENCE_OF_H_PILORI	24	http://www.broadinstitute.org/gsea/msigdb/cards/MURATA_VIRULENCE_OF_H_PILORI	-0.36792	-1.1948	0.237	0.61711	1	0.667	0.42	0.387	0.54781	0.128
REACTOME_SIGNAL_AMPLIFICATION	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNAL_AMPLIFICATION	-0.34022	-1.1944	0.2028	0.6174	1	0.167	0.0483	0.159	0.54819	0.128
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/KUNINGER_IGF1_VS_PDGFB_TARGETS_DN	-0.39761	-1.194	0.256	0.61775	1	0.286	0.0684	0.267	0.54837	0.128
DAZARD_UV_RESPONSE_CLUSTER_G28	19	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G28	-0.54165	-1.1934	0.3267	0.61837	1	0.474	0.18	0.389	0.54943	0.128
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	85	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	-0.2797	-1.1931	0.2394	0.61856	1	0.306	0.245	0.232	0.54982	0.128
AMIT_EGF_RESPONSE_40_HELA	41	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_40_HELA	-0.48285	-1.193	0.3148	0.61789	1	0.463	0.18	0.381	0.54908	0.128
PID_RHOA_REG_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RHOA_REG_PATHWAY	-0.31709	-1.1919	0.27	0.62011	1	0.467	0.323	0.316	0.55158	0.128
REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION	-0.34605	-1.1919	0.2544	0.61952	1	0.0952	0.0158	0.0938	0.55084	0.128
REACTOME_PLATELET_HOMEOSTASIS	75	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PLATELET_HOMEOSTASIS	-0.28227	-1.1911	0.1966	0.62076	1	0.373	0.286	0.267	0.55197	0.127
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP	-0.35718	-1.1899	0.2671	0.62318	1	0.286	0.187	0.233	0.5541	0.128
ZHENG_FOXP3_TARGETS_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_FOXP3_TARGETS_UP	-0.42154	-1.1898	0.2347	0.62274	1	0.462	0.173	0.382	0.55391	0.128
PEREZ_TP63_TARGETS	333	http://www.broadinstitute.org/gsea/msigdb/cards/PEREZ_TP63_TARGETS	-0.24467	-1.1894	0.2105	0.62299	1	0.441	0.367	0.283	0.55317	0.128
LEE_LIVER_CANCER_E2F1_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_E2F1_UP	-0.33992	-1.1892	0.2054	0.62248	1	0.283	0.168	0.236	0.5526	0.128
WEBER_METHYLATED_HCP_IN_SPERM_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_HCP_IN_SPERM_UP	-0.46807	-1.189	0.2339	0.62221	1	0.556	0.402	0.333	0.55449	0.127
REACTOME_BASIGIN_INTERACTIONS	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BASIGIN_INTERACTIONS	-0.33997	-1.1886	0.2548	0.62252	1	0.583	0.452	0.32	0.55476	0.124
VALK_AML_CLUSTER_2	27	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_2	-0.34747	-1.1882	0.217	0.62277	1	0.222	0.131	0.193	0.55476	0.127
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	82	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	-0.27555	-1.1873	0.2016	0.62443	1	0.244	0.176	0.202	0.55616	0.127
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	-0.38715	-1.1866	0.269	0.62559	1	0.455	0.268	0.333	0.55586	0.127
PETRETTO_HEART_MASS_QTL_CIS_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/PETRETTO_HEART_MASS_QTL_CIS_DN	-0.46459	-1.1865	0.2951	0.62497	1	0.478	0.279	0.345	0.55512	0.127
FRIDMAN_SENESCENCE_UP	77	http://www.broadinstitute.org/gsea/msigdb/cards/FRIDMAN_SENESCENCE_UP	-0.38123	-1.1854	0.3033	0.62734	1	0.364	0.194	0.294	0.5552	0.128
GRANDVAUX_IRF3_TARGETS_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/GRANDVAUX_IRF3_TARGETS_UP	-0.58706	-1.1851	0.3451	0.62725	1	0.267	0.0317	0.258	0.55626	0.127
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	263	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	-0.27666	-1.185	0.2093	0.62672	1	0.278	0.207	0.222	0.55662	0.127
HENDRICKS_SMARCA4_TARGETS_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/HENDRICKS_SMARCA4_TARGETS_UP	-0.36734	-1.1843	0.2883	0.6279	1	0.25	0.137	0.216	0.55912	0.128
RODRIGUES_NTN1_TARGETS_DN	153	http://www.broadinstitute.org/gsea/msigdb/cards/RODRIGUES_NTN1_TARGETS_DN	-0.24792	-1.1839	0.2084	0.62819	1	0.373	0.306	0.26	0.55839	0.128
WINTER_HYPOXIA_METAGENE	232	http://www.broadinstitute.org/gsea/msigdb/cards/WINTER_HYPOXIA_METAGENE	-0.30462	-1.1835	0.2564	0.62842	1	0.405	0.311	0.282	0.56017	0.128
HWANG_PROSTATE_CANCER_MARKERS	28	http://www.broadinstitute.org/gsea/msigdb/cards/HWANG_PROSTATE_CANCER_MARKERS	-0.33381	-1.1827	0.2857	0.62973	1	0.393	0.267	0.288	0.56076	0.129
LIU_IL13_PRIMING_MODEL	15	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_IL13_PRIMING_MODEL	-0.46938	-1.1822	0.2994	0.63036	1	0.533	0.298	0.375	0.56019	0.129
KANG_IMMORTALIZED_BY_TERT_UP	86	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_IMMORTALIZED_BY_TERT_UP	-0.33888	-1.182	0.2874	0.63019	1	0.221	0.112	0.197	0.56003	0.129
KOINUMA_COLON_CANCER_MSI_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/KOINUMA_COLON_CANCER_MSI_UP	-0.41075	-1.1816	0.2422	0.6304	1	0.533	0.388	0.326	0.56219	0.13
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	-0.51942	-1.1811	0.2919	0.63098	1	0.389	0.155	0.329	0.56336	0.129
ROSS_AML_WITH_MLL_FUSIONS	72	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_AML_WITH_MLL_FUSIONS	-0.27073	-1.1811	0.252	0.63017	1	0.167	0.105	0.15	0.56263	0.128
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	161	http://www.broadinstitute.org/gsea/msigdb/cards/SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	-0.2681	-1.181	0.1445	0.62952	1	0.348	0.282	0.251	0.56191	0.128
REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	400	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	-0.203	-1.1807	0.1162	0.62958	1	0.388	0.344	0.258	0.5619	0.125
HAMAI_APOPTOSIS_VIA_TRAIL_DN	169	http://www.broadinstitute.org/gsea/msigdb/cards/HAMAI_APOPTOSIS_VIA_TRAIL_DN	-0.31733	-1.1804	0.2919	0.62959	1	0.432	0.312	0.299	0.56184	0.125
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	57	http://www.broadinstitute.org/gsea/msigdb/cards/STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	-0.33427	-1.1804	0.3018	0.62884	1	0.456	0.347	0.298	0.56112	0.125
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	79	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	-0.31901	-1.18	0.2354	0.62927	1	0.506	0.385	0.312	0.56082	0.124
GOLDRATH_ANTIGEN_RESPONSE	327	http://www.broadinstitute.org/gsea/msigdb/cards/GOLDRATH_ANTIGEN_RESPONSE	-0.27553	-1.1795	0.242	0.62988	1	0.281	0.232	0.219	0.56173	0.124
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN	-0.44198	-1.1791	0.3111	0.63004	1	0.294	0.226	0.228	0.56101	0.124
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	105	http://www.broadinstitute.org/gsea/msigdb/cards/IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	-0.42255	-1.1785	0.3021	0.63079	1	0.39	0.167	0.327	0.56242	0.124
NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	15	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	-0.43041	-1.1778	0.2795	0.63203	1	0.533	0.363	0.34	0.56307	0.125
TSAI_RESPONSE_TO_IONIZING_RADIATION	144	http://www.broadinstitute.org/gsea/msigdb/cards/TSAI_RESPONSE_TO_IONIZING_RADIATION	-0.26932	-1.1773	0.23	0.6325	1	0.257	0.223	0.201	0.56425	0.125
RUAN_RESPONSE_TO_TROGLITAZONE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TROGLITAZONE_DN	-0.34877	-1.1771	0.2285	0.63238	1	0.474	0.297	0.333	0.56353	0.125
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	-0.40402	-1.1768	0.2238	0.63238	1	0.333	0.161	0.28	0.56281	0.125
WESTON_VEGFA_TARGETS_12HR	34	http://www.broadinstitute.org/gsea/msigdb/cards/WESTON_VEGFA_TARGETS_12HR	-0.47061	-1.1758	0.3146	0.6342	1	0.441	0.24	0.336	0.56579	0.125
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	261	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	-0.33525	-1.1756	0.2519	0.63384	1	0.563	0.377	0.354	0.56699	0.125
URS_ADIPOCYTE_DIFFERENTIATION_UP	74	http://www.broadinstitute.org/gsea/msigdb/cards/URS_ADIPOCYTE_DIFFERENTIATION_UP	-0.29501	-1.1753	0.2246	0.63392	1	0.351	0.27	0.257	0.56693	0.125
REACTOME_AMYLOIDS	61	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMYLOIDS	-0.38523	-1.1752	0.2436	0.63326	1	0.492	0.292	0.349	0.56621	0.125
HAHTOLA_SEZARY_SYNDROM_UP	95	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_SEZARY_SYNDROM_UP	-0.29038	-1.1745	0.1773	0.63423	1	0.358	0.256	0.267	0.56685	0.125
PEDRIOLI_MIR31_TARGETS_UP	197	http://www.broadinstitute.org/gsea/msigdb/cards/PEDRIOLI_MIR31_TARGETS_UP	-0.2418	-1.1744	0.1647	0.63374	1	0.472	0.391	0.29	0.56728	0.125
REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	88	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	-0.27941	-1.1742	0.2315	0.63346	1	0.591	0.432	0.337	0.56683	0.125
ROSS_AML_WITH_PML_RARA_FUSION	73	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_AML_WITH_PML_RARA_FUSION	-0.28181	-1.1741	0.2685	0.63287	1	0.534	0.418	0.312	0.56712	0.125
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	23	http://www.broadinstitute.org/gsea/msigdb/cards/DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	-0.48226	-1.174	0.2635	0.63248	1	0.652	0.392	0.397	0.5664	0.125
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP	-0.32009	-1.1727	0.261	0.63504	1	0.316	0.232	0.243	0.56807	0.125
LEE_LIVER_CANCER_ACOX1_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_ACOX1_DN	-0.31112	-1.1717	0.2479	0.63698	1	0.349	0.199	0.28	0.57042	0.126
NAKAMURA_ADIPOGENESIS_LATE_DN	37	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_ADIPOGENESIS_LATE_DN	-0.47917	-1.1717	0.3111	0.63631	1	0.432	0.111	0.385	0.56993	0.126
KEGG_LYSOSOME	116	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_LYSOSOME	-0.26134	-1.1716	0.2766	0.6358	1	0.293	0.26	0.218	0.57023	0.125
WU_CELL_MIGRATION	176	http://www.broadinstitute.org/gsea/msigdb/cards/WU_CELL_MIGRATION	-0.31042	-1.1714	0.2361	0.63467	1	0.244	0.16	0.207	0.56914	0.124
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN	-0.36191	-1.1714	0.2831	0.63543	1	0.184	0.072	0.171	0.56985	0.125
FOSTER_KDM1A_TARGETS_UP	249	http://www.broadinstitute.org/gsea/msigdb/cards/FOSTER_KDM1A_TARGETS_UP	-0.24785	-1.1713	0.1701	0.63419	1	0.253	0.203	0.204	0.56943	0.125
REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS	-0.33094	-1.17	0.2471	0.63682	1	0.188	0.0636	0.176	0.57212	0.126
CAMPS_COLON_CANCER_COPY_NUMBER_DN	58	http://www.broadinstitute.org/gsea/msigdb/cards/CAMPS_COLON_CANCER_COPY_NUMBER_DN	-0.34213	-1.1699	0.1633	0.63639	1	0.414	0.253	0.31	0.57224	0.125
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	-0.33118	-1.1697	0.2419	0.63619	1	0.31	0.165	0.259	0.57218	0.125
BIOCARTA_CD40_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CD40_PATHWAY	-0.42433	-1.1695	0.3004	0.63504	1	0.2	0.115	0.177	0.57216	0.125
WANG_HCP_PROSTATE_CANCER	111	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_HCP_PROSTATE_CANCER	-0.30092	-1.1695	0.2716	0.63583	1	0.378	0.251	0.285	0.57287	0.125
VALK_AML_CLUSTER_1	26	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_1	-0.36727	-1.1688	0.2196	0.6362	1	0.269	0.107	0.241	0.57261	0.125
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	71	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	-0.29881	-1.1685	0.2718	0.63609	1	0.254	0.198	0.204	0.57279	0.125
LEE_LIVER_CANCER_HEPATOBLAST	16	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_HEPATOBLAST	-0.52479	-1.1684	0.2954	0.63557	1	0.375	0.189	0.304	0.57249	0.125
WOTTON_RUNX_TARGETS_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/WOTTON_RUNX_TARGETS_DN	-0.40402	-1.1682	0.3092	0.63541	1	0.259	0.146	0.222	0.57207	0.125
REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS	69	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS	-0.29508	-1.168	0.2432	0.63439	1	0.203	0.177	0.167	0.57123	0.124
VALK_AML_WITH_FLT3_ITD	39	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_WITH_FLT3_ITD	-0.3904	-1.168	0.2213	0.63499	1	0.359	0.15	0.306	0.57136	0.125
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM	-0.40721	-1.1678	0.2579	0.63416	1	0.241	0.105	0.216	0.57101	0.124
MARKS_HDAC_TARGETS_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/MARKS_HDAC_TARGETS_DN	-0.41601	-1.1677	0.2404	0.63346	1	0.333	0.214	0.262	0.57031	0.124
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	389	http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	-0.28309	-1.1668	0.2169	0.63525	1	0.234	0.168	0.198	0.57203	0.125
PID_P38_ALPHA_BETA_PATHWAY	31	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P38_ALPHA_BETA_PATHWAY	-0.3795	-1.1662	0.2929	0.63624	1	0.581	0.334	0.387	0.57328	0.125
MCCABE_HOXC6_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/MCCABE_HOXC6_TARGETS_DN	-0.46782	-1.1661	0.2808	0.6355	1	0.316	0.0793	0.291	0.57258	0.123
VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP	-0.44597	-1.1661	0.3172	0.63493	1	0.333	0.221	0.26	0.57253	0.123
GROSS_ELK3_TARGETS_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_ELK3_TARGETS_DN	-0.38877	-1.1659	0.2563	0.63461	1	0.375	0.153	0.318	0.57183	0.123
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	26	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	-0.3574	-1.1656	0.2358	0.63463	1	0.462	0.332	0.309	0.57163	0.123
REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY	60	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY	-0.3336	-1.1651	0.2667	0.63525	1	0.55	0.378	0.343	0.57282	0.123
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	459	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	-0.22786	-1.165	0.1797	0.6345	1	0.362	0.303	0.257	0.57212	0.123
DAZARD_UV_RESPONSE_CLUSTER_G2	29	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G2	-0.43127	-1.165	0.3098	0.63389	1	0.517	0.231	0.398	0.57142	0.123
VILIMAS_NOTCH1_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/VILIMAS_NOTCH1_TARGETS_DN	-0.47289	-1.1648	0.3289	0.63363	1	0.789	0.43	0.45	0.57146	0.123
SABATES_COLORECTAL_ADENOMA_UP	125	http://www.broadinstitute.org/gsea/msigdb/cards/SABATES_COLORECTAL_ADENOMA_UP	-0.33144	-1.1645	0.2205	0.633	1	0.536	0.374	0.337	0.57044	0.123
CUI_TCF21_TARGETS_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/CUI_TCF21_TARGETS_DN	-0.32719	-1.1645	0.2353	0.63354	1	0.29	0.238	0.221	0.57113	0.123
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP	-0.24896	-1.164	0.247	0.63357	1	0.59	0.472	0.312	0.5703	0.123
KEGG_OTHER_GLYCAN_DEGRADATION	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_OTHER_GLYCAN_DEGRADATION	-0.36247	-1.1637	0.2926	0.6334	1	0.375	0.254	0.28	0.57092	0.123
GENTILE_UV_HIGH_DOSE_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_HIGH_DOSE_UP	-0.33529	-1.1636	0.2923	0.63279	1	0.625	0.401	0.375	0.57023	0.123
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	67	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	-0.36226	-1.1635	0.23	0.63232	1	0.537	0.338	0.357	0.56954	0.123
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	61	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	-0.33436	-1.1634	0.2465	0.63198	1	0.328	0.255	0.245	0.56885	0.123
LINDSTEDT_DENDRITIC_CELL_MATURATION_C	66	http://www.broadinstitute.org/gsea/msigdb/cards/LINDSTEDT_DENDRITIC_CELL_MATURATION_C	-0.32913	-1.1631	0.2913	0.63197	1	0.409	0.305	0.285	0.57089	0.123
HATADA_METHYLATED_IN_LUNG_CANCER_UP	366	http://www.broadinstitute.org/gsea/msigdb/cards/HATADA_METHYLATED_IN_LUNG_CANCER_UP	-0.22925	-1.1623	0.233	0.63319	1	0.503	0.421	0.295	0.57256	0.123
REACTOME_G_PROTEIN_ACTIVATION	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_PROTEIN_ACTIVATION	-0.35491	-1.1622	0.2592	0.63287	1	0.192	0.0483	0.183	0.57204	0.123
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	134	http://www.broadinstitute.org/gsea/msigdb/cards/ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	-0.30134	-1.1621	0.2539	0.63235	1	0.299	0.221	0.234	0.57135	0.123
OSADA_ASCL1_TARGETS_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/OSADA_ASCL1_TARGETS_UP	-0.32168	-1.1617	0.2198	0.63182	1	0.478	0.326	0.323	0.57129	0.123
NABA_CORE_MATRISOME	272	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_CORE_MATRISOME	-0.33592	-1.1617	0.3	0.63251	1	0.574	0.388	0.355	0.57197	0.123
RICKMAN_HEAD_AND_NECK_CANCER_C	106	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_HEAD_AND_NECK_CANCER_C	-0.33999	-1.1613	0.2539	0.63224	1	0.245	0.143	0.211	0.57293	0.123
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG	26	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG	-0.3579	-1.1608	0.2486	0.63269	1	0.5	0.321	0.34	0.5728	0.123
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	-0.40203	-1.1605	0.288	0.63273	1	0.338	0.172	0.281	0.5728	0.123
PID_SYNDECAN_1_PATHWAY	46	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SYNDECAN_1_PATHWAY	-0.40264	-1.1603	0.3217	0.63239	1	0.63	0.422	0.365	0.57211	0.123
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP	-0.35923	-1.1602	0.266	0.6319	1	0.444	0.241	0.338	0.57143	0.123
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3	419	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MCV6_HCP_WITH_H3K27ME3	-0.3432	-1.1595	0.3495	0.63306	1	0.613	0.43	0.355	0.57195	0.123
JEPSEN_SMRT_TARGETS	33	http://www.broadinstitute.org/gsea/msigdb/cards/JEPSEN_SMRT_TARGETS	-0.30134	-1.1593	0.2356	0.63286	1	0.455	0.368	0.288	0.57135	0.123
NEWMAN_ERCC6_TARGETS_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/NEWMAN_ERCC6_TARGETS_UP	-0.386	-1.1592	0.2305	0.63176	1	0.417	0.246	0.315	0.5707	0.122
CAIRO_HEPATOBLASTOMA_DN	257	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_HEPATOBLASTOMA_DN	-0.24966	-1.1592	0.1866	0.63235	1	0.475	0.396	0.29	0.57068	0.123
HUPER_BREAST_BASAL_VS_LUMINAL_DN	58	http://www.broadinstitute.org/gsea/msigdb/cards/HUPER_BREAST_BASAL_VS_LUMINAL_DN	-0.29722	-1.1587	0.2574	0.63225	1	0.293	0.246	0.221	0.57177	0.123
HEIDENBLAD_AMPLICON_12P11_12_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/HEIDENBLAD_AMPLICON_12P11_12_UP	-0.35579	-1.1586	0.2886	0.63183	1	0.125	0.0465	0.119	0.57174	0.123
BIOCARTA_TOB1_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TOB1_PATHWAY	-0.4663	-1.1584	0.3066	0.63075	1	0.474	0.172	0.392	0.57095	0.121
NABA_ECM_GLYCOPROTEINS	193	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_ECM_GLYCOPROTEINS	-0.31929	-1.1584	0.3035	0.63149	1	0.451	0.305	0.316	0.57163	0.122
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3	18	http://www.broadinstitute.org/gsea/msigdb/cards/PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3	-0.48057	-1.1582	0.2948	0.63045	1	0.389	0.17	0.323	0.57119	0.121
HAHTOLA_MYCOSIS_FUNGOIDES_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_MYCOSIS_FUNGOIDES_UP	-0.44562	-1.1581	0.3039	0.62987	1	0.556	0.213	0.437	0.57052	0.12
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	123	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	-0.31574	-1.1581	0.2535	0.62925	1	0.26	0.172	0.216	0.56985	0.12
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN	-0.2864	-1.1581	0.2602	0.62866	1	0.48	0.345	0.315	0.56918	0.12
MARSON_FOXP3_TARGETS_DN	52	http://www.broadinstitute.org/gsea/msigdb/cards/MARSON_FOXP3_TARGETS_DN	-0.26875	-1.1574	0.2358	0.6298	1	0.231	0.199	0.185	0.57065	0.12
DE_YY1_TARGETS_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/DE_YY1_TARGETS_UP	-0.42748	-1.1569	0.2846	0.63017	1	0.5	0.316	0.342	0.57222	0.12
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	277	http://www.broadinstitute.org/gsea/msigdb/cards/SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	-0.23074	-1.1568	0.1792	0.62965	1	0.473	0.398	0.288	0.57155	0.12
PID_IL6_7_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL6_7_PATHWAY	-0.35062	-1.1557	0.306	0.63192	1	0.489	0.326	0.33	0.57412	0.121
REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	-0.32352	-1.1548	0.2761	0.63344	1	0.632	0.447	0.349	0.5768	0.123
DASU_IL6_SIGNALING_SCAR_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/DASU_IL6_SIGNALING_SCAR_UP	-0.35465	-1.1548	0.2984	0.63271	1	0.133	0.024	0.13	0.57613	0.123
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	145	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	-0.27014	-1.1546	0.2466	0.63255	1	0.51	0.421	0.297	0.57654	0.121
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP	108	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP	-0.30443	-1.1542	0.2916	0.63282	1	0.528	0.413	0.311	0.57641	0.122
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	84	http://www.broadinstitute.org/gsea/msigdb/cards/FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	-0.29119	-1.154	0.2942	0.63269	1	0.262	0.184	0.214	0.57574	0.121
BIOCARTA_INTRINSIC_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_INTRINSIC_PATHWAY	-0.34789	-1.1538	0.2646	0.63245	1	0.565	0.322	0.384	0.57507	0.121
VALK_AML_CLUSTER_3	31	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_3	-0.34313	-1.1532	0.2469	0.633	1	0.516	0.405	0.308	0.57596	0.121
RODRIGUES_NTN1_AND_DCC_TARGETS	33	http://www.broadinstitute.org/gsea/msigdb/cards/RODRIGUES_NTN1_AND_DCC_TARGETS	-0.3811	-1.1531	0.2743	0.63254	1	0.394	0.157	0.332	0.57631	0.121
AMUNDSON_GENOTOXIC_SIGNATURE	99	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_GENOTOXIC_SIGNATURE	-0.26551	-1.153	0.2294	0.63225	1	0.364	0.299	0.256	0.57619	0.121
LINDSTEDT_DENDRITIC_CELL_MATURATION_D	65	http://www.broadinstitute.org/gsea/msigdb/cards/LINDSTEDT_DENDRITIC_CELL_MATURATION_D	-0.31123	-1.1529	0.2611	0.63173	1	0.431	0.312	0.297	0.57552	0.121
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	-0.41405	-1.1525	0.3165	0.63201	1	0.318	0.172	0.264	0.57539	0.121
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	-0.34161	-1.1524	0.2702	0.6315	1	0.2	0.0926	0.182	0.57473	0.118
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	-0.25854	-1.152	0.3149	0.63189	1	0.157	0.125	0.138	0.57507	0.12
IGLESIAS_E2F_TARGETS_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/IGLESIAS_E2F_TARGETS_DN	-0.38536	-1.1514	0.2838	0.63278	1	0.6	0.414	0.352	0.57637	0.118
LIN_APC_TARGETS	73	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_APC_TARGETS	-0.30033	-1.1512	0.3249	0.63234	1	0.548	0.431	0.313	0.57571	0.118
DELASERNA_MYOD_TARGETS_UP	85	http://www.broadinstitute.org/gsea/msigdb/cards/DELASERNA_MYOD_TARGETS_UP	-0.25218	-1.1512	0.2665	0.63172	1	0.388	0.304	0.271	0.57517	0.116
REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS	270	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS	-0.35288	-1.1502	0.2615	0.63301	1	0.407	0.282	0.296	0.57508	0.116
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	242	http://www.broadinstitute.org/gsea/msigdb/cards/KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	-0.27021	-1.1502	0.3185	0.63373	1	0.31	0.26	0.231	0.57574	0.116
STARK_HYPPOCAMPUS_22Q11_DELETION_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/STARK_HYPPOCAMPUS_22Q11_DELETION_UP	-0.29559	-1.1501	0.2396	0.63253	1	0.308	0.21	0.244	0.57442	0.116
SA_MMP_CYTOKINE_CONNECTION	15	http://www.broadinstitute.org/gsea/msigdb/cards/SA_MMP_CYTOKINE_CONNECTION	-0.44612	-1.1496	0.2974	0.63311	1	0.733	0.428	0.42	0.57634	0.116
PID_S1P_S1P3_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/PID_S1P_S1P3_PATHWAY	-0.31056	-1.1496	0.2137	0.6324	1	0.25	0.176	0.206	0.57568	0.116
PARENT_MTOR_SIGNALING_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/PARENT_MTOR_SIGNALING_DN	-0.33062	-1.1493	0.2959	0.63239	1	0.535	0.331	0.358	0.57583	0.115
PENG_RAPAMYCIN_RESPONSE_UP	191	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_RAPAMYCIN_RESPONSE_UP	-0.22895	-1.1492	0.286	0.63206	1	0.503	0.447	0.28	0.57517	0.115
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	-0.36784	-1.1491	0.2626	0.63152	1	0.229	0.166	0.191	0.57452	0.115
SEMENZA_HIF1_TARGETS	35	http://www.broadinstitute.org/gsea/msigdb/cards/SEMENZA_HIF1_TARGETS	-0.38046	-1.1487	0.294	0.63196	1	0.286	0.18	0.235	0.57491	0.115
GERHOLD_ADIPOGENESIS_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/GERHOLD_ADIPOGENESIS_DN	-0.40949	-1.1484	0.3181	0.6319	1	0.222	0.0824	0.204	0.57426	0.115
MARCHINI_TRABECTEDIN_RESISTANCE_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/MARCHINI_TRABECTEDIN_RESISTANCE_DN	-0.29708	-1.148	0.3095	0.63243	1	0.435	0.385	0.268	0.57514	0.116
LEE_AGING_NEOCORTEX_UP	87	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_AGING_NEOCORTEX_UP	-0.30107	-1.1479	0.3102	0.63181	1	0.402	0.341	0.266	0.57449	0.115
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	54	http://www.broadinstitute.org/gsea/msigdb/cards/WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	-0.43303	-1.1471	0.3281	0.63331	1	0.37	0.153	0.314	0.57515	0.116
GRUETZMANN_PANCREATIC_CANCER_UP	347	http://www.broadinstitute.org/gsea/msigdb/cards/GRUETZMANN_PANCREATIC_CANCER_UP	-0.31745	-1.147	0.3485	0.63281	1	0.239	0.166	0.202	0.57451	0.116
REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	-0.48605	-1.1466	0.3535	0.6323	1	0.588	0.287	0.42	0.57592	0.115
KOHOUTEK_CCNT2_TARGETS	56	http://www.broadinstitute.org/gsea/msigdb/cards/KOHOUTEK_CCNT2_TARGETS	-0.30549	-1.1466	0.2411	0.633	1	0.286	0.213	0.225	0.57599	0.117
ENGELMANN_CANCER_PROGENITORS_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/ENGELMANN_CANCER_PROGENITORS_DN	-0.311	-1.1461	0.2896	0.63292	1	0.683	0.495	0.346	0.57567	0.115
KUMAR_TARGETS_OF_MLL_AF9_FUSION	390	http://www.broadinstitute.org/gsea/msigdb/cards/KUMAR_TARGETS_OF_MLL_AF9_FUSION	-0.23081	-1.1456	0.2282	0.63336	1	0.372	0.334	0.252	0.57659	0.115
MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED	500	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED	-0.27574	-1.1453	0.3135	0.63366	1	0.548	0.445	0.31	0.57694	0.116
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	72	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	-0.2993	-1.1445	0.3488	0.63481	1	0.403	0.343	0.265	0.5763	0.117
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_LARGE_PRE_BII_LYMPHOCYTE_DN	-0.33443	-1.1444	0.2937	0.63435	1	0.393	0.253	0.294	0.57565	0.116
KORKOLA_TERATOMA	39	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_TERATOMA	-0.35577	-1.1441	0.2	0.63439	1	0.359	0.163	0.301	0.57577	0.116
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	41	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	-0.29995	-1.1434	0.2186	0.63537	1	0.195	0.0992	0.176	0.57737	0.117
AFFAR_YY1_TARGETS_UP	207	http://www.broadinstitute.org/gsea/msigdb/cards/AFFAR_YY1_TARGETS_UP	-0.2324	-1.1433	0.2816	0.63516	1	0.188	0.184	0.155	0.57735	0.116
ZUCCHI_METASTASIS_UP	39	http://www.broadinstitute.org/gsea/msigdb/cards/ZUCCHI_METASTASIS_UP	-0.31697	-1.1428	0.2754	0.63558	1	0.231	0.116	0.204	0.57753	0.116
REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT	-0.36819	-1.142	0.2694	0.63691	1	0.75	0.415	0.439	0.58112	0.117
AMIT_EGF_RESPONSE_480_HELA	157	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_480_HELA	-0.24005	-1.1417	0.2768	0.63702	1	0.465	0.394	0.284	0.58201	0.117
REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS	67	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS	-0.32868	-1.1413	0.2992	0.63751	1	0.388	0.255	0.29	0.58153	0.117
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	96	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	-0.29105	-1.1412	0.2328	0.63704	1	0.365	0.273	0.266	0.58088	0.117
REACTOME_GAP_JUNCTION_ASSEMBLY	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GAP_JUNCTION_ASSEMBLY	-0.44601	-1.1407	0.308	0.6369	1	0.75	0.429	0.428	0.58106	0.116
WELCH_GATA1_TARGETS	21	http://www.broadinstitute.org/gsea/msigdb/cards/WELCH_GATA1_TARGETS	-0.356	-1.1407	0.3112	0.63742	1	0.571	0.429	0.327	0.58163	0.117
MIKKELSEN_MEF_LCP_WITH_H3K27ME3	62	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MEF_LCP_WITH_H3K27ME3	-0.39692	-1.1402	0.4438	0.6374	1	0.677	0.453	0.371	0.58189	0.117
SERVITJA_LIVER_HNF1A_TARGETS_DN	157	http://www.broadinstitute.org/gsea/msigdb/cards/SERVITJA_LIVER_HNF1A_TARGETS_DN	-0.25581	-1.1402	0.1911	0.63671	1	0.395	0.319	0.271	0.58124	0.115
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	119	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	-0.40392	-1.14	0.3584	0.63657	1	0.336	0.179	0.277	0.5806	0.115
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	98	http://www.broadinstitute.org/gsea/msigdb/cards/RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	-0.28518	-1.1398	0.3074	0.63611	1	0.316	0.24	0.241	0.58074	0.115
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	-0.40128	-1.1393	0.3569	0.63684	1	0.632	0.406	0.375	0.58065	0.116
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN	-0.3499	-1.1386	0.3248	0.63777	1	0.526	0.293	0.372	0.5822	0.116
SWEET_LUNG_CANCER_KRAS_DN	423	http://www.broadinstitute.org/gsea/msigdb/cards/SWEET_LUNG_CANCER_KRAS_DN	-0.28263	-1.1385	0.2919	0.63721	1	0.277	0.192	0.227	0.58156	0.116
NIELSEN_LIPOSARCOMA_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LIPOSARCOMA_UP	-0.44241	-1.138	0.3735	0.63788	1	0.588	0.398	0.354	0.58156	0.114
HEIDENBLAD_AMPLICON_8Q24_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/HEIDENBLAD_AMPLICON_8Q24_UP	-0.27074	-1.1379	0.2764	0.6375	1	0.0882	0.027	0.086	0.58092	0.114
LY_AGING_PREMATURE_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/LY_AGING_PREMATURE_DN	-0.32485	-1.1378	0.301	0.63701	1	0.241	0.163	0.202	0.58111	0.113
BRACHAT_RESPONSE_TO_METHOTREXATE_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/BRACHAT_RESPONSE_TO_METHOTREXATE_UP	-0.35612	-1.1375	0.2692	0.63711	1	0.36	0.214	0.283	0.58122	0.114
DELACROIX_RAR_BOUND_ES	434	http://www.broadinstitute.org/gsea/msigdb/cards/DELACROIX_RAR_BOUND_ES	-0.21011	-1.1371	0.2566	0.63748	1	0.406	0.354	0.266	0.58203	0.114
BORCZUK_MALIGNANT_MESOTHELIOMA_DN	100	http://www.broadinstitute.org/gsea/msigdb/cards/BORCZUK_MALIGNANT_MESOTHELIOMA_DN	-0.25759	-1.1369	0.2601	0.63717	1	0.51	0.386	0.314	0.58246	0.113
LIU_TARGETS_OF_VMYB_VS_CMYB_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_TARGETS_OF_VMYB_VS_CMYB_DN	-0.32119	-1.1367	0.2857	0.63686	1	0.3	0.17	0.249	0.58189	0.113
KIM_WT1_TARGETS_UP	207	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_UP	-0.31425	-1.1366	0.2922	0.63662	1	0.275	0.168	0.231	0.58125	0.113
KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT	36	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT	-0.37636	-1.1365	0.2778	0.63555	1	0.361	0.235	0.277	0.58008	0.112
RADMACHER_AML_PROGNOSIS	77	http://www.broadinstitute.org/gsea/msigdb/cards/RADMACHER_AML_PROGNOSIS	-0.28352	-1.1365	0.2598	0.63624	1	0.494	0.345	0.324	0.58072	0.113
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	138	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	-0.29716	-1.1361	0.3417	0.63571	1	0.616	0.438	0.348	0.5815	0.113
DANG_REGULATED_BY_MYC_DN	240	http://www.broadinstitute.org/gsea/msigdb/cards/DANG_REGULATED_BY_MYC_DN	-0.33281	-1.1361	0.2982	0.63527	1	0.3	0.211	0.239	0.58102	0.112
KEGG_ECM_RECEPTOR_INTERACTION	83	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ECM_RECEPTOR_INTERACTION	-0.33234	-1.1357	0.341	0.63541	1	0.614	0.415	0.36	0.58154	0.113
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	154	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	-0.30774	-1.1357	0.2892	0.6348	1	0.305	0.173	0.254	0.58164	0.111
NABA_PROTEOGLYCANS	35	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_PROTEOGLYCANS	-0.43448	-1.1354	0.3236	0.63511	1	0.657	0.369	0.415	0.58131	0.111
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN	-0.26093	-1.1352	0.2656	0.63471	1	0.214	0.169	0.178	0.58178	0.111
SMID_BREAST_CANCER_ERBB2_UP	134	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_ERBB2_UP	-0.22771	-1.1345	0.1909	0.63585	1	0.418	0.372	0.264	0.58202	0.111
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	232	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	-0.21292	-1.1344	0.2209	0.6354	1	0.366	0.304	0.257	0.58207	0.111
KEGG_CALCIUM_SIGNALING_PATHWAY	171	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CALCIUM_SIGNALING_PATHWAY	-0.24532	-1.1341	0.2381	0.63549	1	0.526	0.404	0.316	0.58144	0.111
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	-0.36985	-1.1337	0.3091	0.63584	1	0.565	0.355	0.365	0.58087	0.111
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	210	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	-0.37039	-1.1335	0.3281	0.63578	1	0.319	0.191	0.26	0.58075	0.111
LEE_LIVER_CANCER_DENA_DN	73	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_DENA_DN	-0.27736	-1.1333	0.2573	0.6354	1	0.397	0.316	0.272	0.58163	0.111
CROMER_TUMORIGENESIS_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/CROMER_TUMORIGENESIS_DN	-0.37064	-1.1329	0.3359	0.63585	1	0.408	0.273	0.297	0.58196	0.111
SABATES_COLORECTAL_ADENOMA_DN	271	http://www.broadinstitute.org/gsea/msigdb/cards/SABATES_COLORECTAL_ADENOMA_DN	-0.27845	-1.1328	0.2564	0.6354	1	0.365	0.268	0.27	0.58183	0.111
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	73	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	-0.26222	-1.1323	0.3055	0.63586	1	0.384	0.361	0.246	0.58166	0.111
ZHU_CMV_ALL_DN	123	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_ALL_DN	-0.40314	-1.1322	0.332	0.63545	1	0.39	0.226	0.304	0.58104	0.111
CUI_TCF21_TARGETS_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/CUI_TCF21_TARGETS_UP	-0.41414	-1.1321	0.3699	0.63516	1	0.514	0.3	0.36	0.58042	0.111
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	166	http://www.broadinstitute.org/gsea/msigdb/cards/VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	-0.45592	-1.1316	0.3505	0.63575	1	0.458	0.204	0.367	0.58037	0.111
BROWNE_HCMV_INFECTION_1HR_UP	57	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_1HR_UP	-0.30735	-1.1313	0.2889	0.63578	1	0.211	0.12	0.186	0.58044	0.111
TSENG_IRS1_TARGETS_UP	109	http://www.broadinstitute.org/gsea/msigdb/cards/TSENG_IRS1_TARGETS_UP	-0.27451	-1.131	0.3281	0.63583	1	0.211	0.161	0.178	0.58019	0.111
NAGASHIMA_NRG1_SIGNALING_UP	171	http://www.broadinstitute.org/gsea/msigdb/cards/NAGASHIMA_NRG1_SIGNALING_UP	-0.36111	-1.1307	0.3684	0.63589	1	0.556	0.38	0.347	0.58001	0.111
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	-0.37985	-1.1306	0.3121	0.63535	1	0.365	0.183	0.299	0.57939	0.111
NGUYEN_NOTCH1_TARGETS_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/NGUYEN_NOTCH1_TARGETS_UP	-0.3754	-1.1306	0.3172	0.63467	1	0.241	0.104	0.216	0.57878	0.111
ZHAN_V2_LATE_DIFFERENTIATION_GENES	41	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_V2_LATE_DIFFERENTIATION_GENES	-0.31513	-1.1305	0.3156	0.63439	1	0.244	0.168	0.203	0.57817	0.111
ZHAN_MULTIPLE_MYELOMA_HP_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_HP_DN	-0.31918	-1.1304	0.2922	0.63391	1	0.405	0.27	0.296	0.57842	0.11
ZHAN_EARLY_DIFFERENTIATION_GENES_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_EARLY_DIFFERENTIATION_GENES_DN	-0.30311	-1.1285	0.2646	0.63796	1	0.268	0.204	0.214	0.58122	0.111
GROSS_HYPOXIA_VIA_ELK3_DN	152	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_DN	-0.34585	-1.1273	0.338	0.64031	1	0.283	0.169	0.237	0.58499	0.111
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN	-0.40726	-1.1271	0.3736	0.64028	1	0.562	0.341	0.371	0.58511	0.111
REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	49	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	-0.27716	-1.1255	0.2788	0.64347	1	0.551	0.417	0.322	0.58853	0.113
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	156	http://www.broadinstitute.org/gsea/msigdb/cards/BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	-0.28437	-1.1255	0.3693	0.64219	1	0.436	0.358	0.281	0.5873	0.112
STEGER_ADIPOGENESIS_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/STEGER_ADIPOGENESIS_UP	-0.41501	-1.1255	0.283	0.64283	1	0.381	0.17	0.317	0.58791	0.112
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	54	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	-0.26258	-1.1253	0.2593	0.64197	1	0.315	0.221	0.246	0.58785	0.112
YAMASHITA_LIVER_CANCER_STEM_CELL_DN	76	http://www.broadinstitute.org/gsea/msigdb/cards/YAMASHITA_LIVER_CANCER_STEM_CELL_DN	-0.27012	-1.1248	0.2892	0.6426	1	0.316	0.261	0.234	0.58787	0.112
NOJIMA_SFRP2_TARGETS_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/NOJIMA_SFRP2_TARGETS_DN	-0.41773	-1.1245	0.3487	0.64258	1	0.333	0.122	0.293	0.58796	0.112
MULLIGHAN_NPM1_SIGNATURE_3_DN	156	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_NPM1_SIGNATURE_3_DN	-0.23137	-1.122	0.3144	0.64805	1	0.5	0.442	0.281	0.59326	0.116
GAVIN_FOXP3_TARGETS_CLUSTER_T4	90	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_T4	-0.32294	-1.1219	0.3121	0.64773	1	0.3	0.191	0.244	0.59264	0.116
BENPORATH_ES_2	39	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_ES_2	-0.30248	-1.1218	0.2454	0.64738	1	0.513	0.367	0.325	0.59202	0.115
GENTILE_UV_RESPONSE_CLUSTER_D1	17	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D1	-0.491	-1.1216	0.3422	0.64711	1	0.235	0.0904	0.214	0.59263	0.114
MANTOVANI_VIRAL_GPCR_SIGNALING_UP	83	http://www.broadinstitute.org/gsea/msigdb/cards/MANTOVANI_VIRAL_GPCR_SIGNALING_UP	-0.28788	-1.1206	0.275	0.64815	1	0.145	0.0522	0.137	0.59372	0.115
HSIAO_LIVER_SPECIFIC_GENES	238	http://www.broadinstitute.org/gsea/msigdb/cards/HSIAO_LIVER_SPECIFIC_GENES	-0.24669	-1.1206	0.2292	0.64764	1	0.399	0.329	0.27	0.59311	0.115
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	-0.38452	-1.1206	0.3412	0.6488	1	0.59	0.407	0.35	0.59433	0.117
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	50	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	-0.24992	-1.1204	0.3051	0.64732	1	0.36	0.33	0.242	0.59385	0.115
DELACROIX_RAR_TARGETS_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/DELACROIX_RAR_TARGETS_UP	-0.33474	-1.1204	0.338	0.64676	1	0.511	0.312	0.352	0.59324	0.114
ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE	63	http://www.broadinstitute.org/gsea/msigdb/cards/ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE	-0.59433	-1.1189	0.4126	0.64975	1	0.524	0.151	0.446	0.59673	0.115
SIMBULAN_PARP1_TARGETS_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/SIMBULAN_PARP1_TARGETS_UP	-0.41901	-1.1188	0.3517	0.64939	1	0.267	0.108	0.238	0.59611	0.115
PHONG_TNF_RESPONSE_NOT_VIA_P38	326	http://www.broadinstitute.org/gsea/msigdb/cards/PHONG_TNF_RESPONSE_NOT_VIA_P38	-0.25459	-1.1186	0.3176	0.64933	1	0.414	0.341	0.277	0.59564	0.115
SENGUPTA_EBNA1_ANTICORRELATED	150	http://www.broadinstitute.org/gsea/msigdb/cards/SENGUPTA_EBNA1_ANTICORRELATED	-0.28577	-1.1173	0.4081	0.65175	1	0.62	0.448	0.344	0.59926	0.116
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	235	http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	-0.24563	-1.1166	0.3143	0.65284	1	0.289	0.246	0.22	0.59999	0.116
GUILLAUMOND_KLF10_TARGETS_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/GUILLAUMOND_KLF10_TARGETS_UP	-0.30938	-1.1165	0.275	0.65243	1	0.245	0.164	0.205	0.59937	0.116
HELLER_HDAC_TARGETS_DN	275	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_HDAC_TARGETS_DN	-0.22793	-1.1139	0.2781	0.65848	1	0.349	0.328	0.237	0.60664	0.122
LIU_COMMON_CANCER_GENES	72	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_COMMON_CANCER_GENES	-0.29416	-1.1137	0.266	0.65826	1	0.222	0.14	0.192	0.60601	0.122
KYNG_RESPONSE_TO_H2O2	70	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_RESPONSE_TO_H2O2	-0.23975	-1.1133	0.2984	0.65866	1	0.129	0.115	0.114	0.60676	0.122
SMITH_TERT_TARGETS_DN	87	http://www.broadinstitute.org/gsea/msigdb/cards/SMITH_TERT_TARGETS_DN	-0.2583	-1.1128	0.2984	0.65917	1	0.241	0.211	0.191	0.60812	0.122
REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	-0.36944	-1.1127	0.3184	0.65881	1	0.625	0.382	0.387	0.60749	0.122
SABATES_COLORECTAL_ADENOMA_SIZE_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/SABATES_COLORECTAL_ADENOMA_SIZE_UP	-0.35915	-1.1114	0.2698	0.66136	1	0.429	0.244	0.324	0.61029	0.122
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	63	http://www.broadinstitute.org/gsea/msigdb/cards/ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	-0.2682	-1.1111	0.3307	0.66141	1	0.286	0.236	0.219	0.60967	0.122
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	-0.36085	-1.111	0.3047	0.66094	1	0.362	0.209	0.287	0.61039	0.122
PID_UPA_UPAR_PATHWAY	42	http://www.broadinstitute.org/gsea/msigdb/cards/PID_UPA_UPAR_PATHWAY	-0.35067	-1.1108	0.3697	0.6608	1	0.452	0.292	0.321	0.60977	0.122
GEISS_RESPONSE_TO_DSRNA_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/GEISS_RESPONSE_TO_DSRNA_DN	-0.44367	-1.1107	0.3488	0.66044	1	0.4	0.189	0.324	0.60915	0.122
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	412	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	-0.27198	-1.1106	0.303	0.6593	1	0.218	0.161	0.186	0.6079	0.12
MORI_PRE_BI_LYMPHOCYTE_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_PRE_BI_LYMPHOCYTE_UP	-0.31172	-1.1106	0.3292	0.65984	1	0.325	0.275	0.236	0.60853	0.122
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	-0.33924	-1.1098	0.3142	0.66071	1	0.239	0.137	0.207	0.60875	0.12
GAVIN_FOXP3_TARGETS_CLUSTER_P7	84	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_P7	-0.31622	-1.1096	0.3354	0.66057	1	0.357	0.24	0.272	0.60813	0.12
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	-0.39968	-1.1095	0.3278	0.66018	1	0.483	0.308	0.334	0.60873	0.12
WEBER_METHYLATED_ICP_IN_FIBROBLAST	22	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_ICP_IN_FIBROBLAST	-0.43628	-1.1086	0.3545	0.66168	1	0.545	0.314	0.374	0.61274	0.122
BRACHAT_RESPONSE_TO_CISPLATIN	21	http://www.broadinstitute.org/gsea/msigdb/cards/BRACHAT_RESPONSE_TO_CISPLATIN	-0.37421	-1.1084	0.336	0.66174	1	0.333	0.162	0.279	0.61285	0.122
BIOCARTA_IL1R_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL1R_PATHWAY	-0.31077	-1.1078	0.3367	0.66242	1	0.25	0.183	0.205	0.61348	0.122
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE	53	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE	-0.26244	-1.1076	0.3111	0.6624	1	0.547	0.405	0.326	0.61295	0.122
REACTOME_REGULATION_OF_INSULIN_SECRETION	87	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_INSULIN_SECRETION	-0.26121	-1.1073	0.278	0.66167	1	0.115	0.0483	0.11	0.61221	0.119
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	-0.57188	-1.1073	0.3892	0.66225	1	0.471	0.146	0.403	0.61283	0.122
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	-0.32468	-1.1067	0.3479	0.66257	1	0.182	0.0684	0.17	0.61375	0.121
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	164	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	-0.35031	-1.1065	0.3874	0.6625	1	0.305	0.201	0.245	0.61436	0.121
ZHENG_RESPONSE_TO_ARSENITE_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_RESPONSE_TO_ARSENITE_UP	-0.41981	-1.1062	0.3067	0.66273	1	0.25	0.0672	0.233	0.61444	0.119
KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	20	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	-0.32507	-1.1058	0.3353	0.66286	1	0.45	0.303	0.314	0.61466	0.119
LU_TUMOR_ANGIOGENESIS_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/LU_TUMOR_ANGIOGENESIS_UP	-0.45263	-1.1058	0.3707	0.66225	1	0.417	0.26	0.309	0.61405	0.119
HUANG_GATA2_TARGETS_DN	68	http://www.broadinstitute.org/gsea/msigdb/cards/HUANG_GATA2_TARGETS_DN	-0.26733	-1.1046	0.3116	0.66466	1	0.382	0.325	0.259	0.61635	0.122
FARMER_BREAST_CANCER_CLUSTER_4	16	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_4	-0.38723	-1.1043	0.3171	0.66459	1	0.125	0.00292	0.125	0.6167	0.121
HOQUE_METHYLATED_IN_CANCER	55	http://www.broadinstitute.org/gsea/msigdb/cards/HOQUE_METHYLATED_IN_CANCER	-0.27862	-1.1042	0.3207	0.66416	1	0.473	0.331	0.317	0.61608	0.12
REACTOME_SPHINGOLIPID_METABOLISM	65	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SPHINGOLIPID_METABOLISM	-0.2502	-1.1036	0.3004	0.66506	1	0.215	0.159	0.182	0.61713	0.119
BORLAK_LIVER_CANCER_EGF_UP	57	http://www.broadinstitute.org/gsea/msigdb/cards/BORLAK_LIVER_CANCER_EGF_UP	-0.34602	-1.1035	0.3427	0.66474	1	0.316	0.167	0.264	0.61652	0.118
DER_IFN_ALPHA_RESPONSE_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/DER_IFN_ALPHA_RESPONSE_UP	-0.34293	-1.1034	0.3524	0.66425	1	0.366	0.26	0.272	0.6159	0.118
IWANAGA_CARCINOGENESIS_BY_KRAS_DN	118	http://www.broadinstitute.org/gsea/msigdb/cards/IWANAGA_CARCINOGENESIS_BY_KRAS_DN	-0.27072	-1.1032	0.3027	0.66418	1	0.305	0.227	0.237	0.61612	0.117
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	36	http://www.broadinstitute.org/gsea/msigdb/cards/SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	-0.41923	-1.1011	0.3517	0.66846	1	0.25	0.0897	0.228	0.6235	0.121
REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	-0.35325	-1.101	0.3144	0.66814	1	0.533	0.39	0.325	0.62288	0.121
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	88	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	-0.35829	-1.1002	0.3612	0.66953	1	0.25	0.137	0.216	0.62489	0.121
SERVITJA_ISLET_HNF1A_TARGETS_DN	107	http://www.broadinstitute.org/gsea/msigdb/cards/SERVITJA_ISLET_HNF1A_TARGETS_DN	-0.26767	-1.1001	0.3499	0.66906	1	0.645	0.444	0.36	0.62427	0.121
LA_MEN1_TARGETS	24	http://www.broadinstitute.org/gsea/msigdb/cards/LA_MEN1_TARGETS	-0.38646	-1.0999	0.3395	0.66879	1	0.333	0.152	0.283	0.62367	0.121
SCHEIDEREIT_IKK_INTERACTING_PROTEINS	58	http://www.broadinstitute.org/gsea/msigdb/cards/SCHEIDEREIT_IKK_INTERACTING_PROTEINS	-0.21862	-1.0997	0.3158	0.66853	1	0.379	0.361	0.243	0.62319	0.121
MEISSNER_NPC_HCP_WITH_H3K4ME2	480	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_NPC_HCP_WITH_H3K4ME2	-0.24575	-1.0997	0.3689	0.66788	1	0.592	0.464	0.323	0.62258	0.121
SIMBULAN_UV_RESPONSE_NORMAL_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/SIMBULAN_UV_RESPONSE_NORMAL_DN	-0.33768	-1.0995	0.3221	0.66787	1	0.364	0.201	0.291	0.62196	0.121
THUM_SYSTOLIC_HEART_FAILURE_UP	395	http://www.broadinstitute.org/gsea/msigdb/cards/THUM_SYSTOLIC_HEART_FAILURE_UP	-0.34045	-1.0993	0.332	0.66773	1	0.256	0.161	0.218	0.62249	0.118
DAUER_STAT3_TARGETS_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/DAUER_STAT3_TARGETS_DN	-0.395	-1.0984	0.3948	0.66912	1	0.24	0.122	0.211	0.62318	0.12
TERAMOTO_OPN_TARGETS_CLUSTER_7	16	http://www.broadinstitute.org/gsea/msigdb/cards/TERAMOTO_OPN_TARGETS_CLUSTER_7	-0.40893	-1.0971	0.3923	0.67184	1	0.812	0.524	0.387	0.6255	0.122
LEE_LIVER_CANCER_SURVIVAL_UP	180	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_SURVIVAL_UP	-0.22691	-1.0964	0.3561	0.67292	1	0.494	0.402	0.298	0.6265	0.122
REACTOME_HS_GAG_DEGRADATION	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HS_GAG_DEGRADATION	-0.36518	-1.0958	0.3541	0.67378	1	0.6	0.439	0.337	0.62792	0.123
REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING	-0.31748	-1.0954	0.3411	0.67393	1	0.1	0.0158	0.0985	0.62848	0.123
BURTON_ADIPOGENESIS_8	82	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_8	-0.37191	-1.0954	0.3875	0.67327	1	0.317	0.204	0.253	0.62787	0.122
KAMIKUBO_MYELOID_CEBPA_NETWORK	27	http://www.broadinstitute.org/gsea/msigdb/cards/KAMIKUBO_MYELOID_CEBPA_NETWORK	-0.35712	-1.0945	0.3702	0.67491	1	0.593	0.392	0.361	0.62969	0.123
SHEPARD_BMYB_MORPHOLINO_DN	192	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_BMYB_MORPHOLINO_DN	-0.2513	-1.0942	0.3327	0.67426	1	0.453	0.391	0.278	0.62862	0.122
KASLER_HDAC7_TARGETS_1_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/KASLER_HDAC7_TARGETS_1_DN	-0.39895	-1.0942	0.3664	0.6748	1	0.588	0.4	0.353	0.62924	0.122
KEGG_CELL_ADHESION_MOLECULES_CAMS	124	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CELL_ADHESION_MOLECULES_CAMS	-0.26795	-1.0936	0.323	0.67499	1	0.331	0.232	0.255	0.62941	0.122
KEGG_SPHINGOLIPID_METABOLISM	38	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_SPHINGOLIPID_METABOLISM	-0.27796	-1.0929	0.3386	0.67538	1	0.237	0.186	0.193	0.62965	0.122
FRASOR_RESPONSE_TO_ESTRADIOL_DN	79	http://www.broadinstitute.org/gsea/msigdb/cards/FRASOR_RESPONSE_TO_ESTRADIOL_DN	-0.31086	-1.0929	0.3599	0.67604	1	0.291	0.2	0.234	0.63027	0.123
MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	15	http://www.broadinstitute.org/gsea/msigdb/cards/MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	-0.42793	-1.0928	0.3678	0.67488	1	0.733	0.374	0.46	0.62904	0.121
HORTON_SREBF_TARGETS	24	http://www.broadinstitute.org/gsea/msigdb/cards/HORTON_SREBF_TARGETS	-0.31019	-1.0908	0.3385	0.67929	1	0.5	0.376	0.312	0.63351	0.125
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	-0.32648	-1.0907	0.3129	0.67881	1	0.471	0.277	0.34	0.63289	0.123
GERHOLD_ADIPOGENESIS_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/GERHOLD_ADIPOGENESIS_UP	-0.3007	-1.0887	0.3488	0.68301	1	0.449	0.308	0.311	0.63873	0.128
HUMMERICH_SKIN_CANCER_PROGRESSION_DN	99	http://www.broadinstitute.org/gsea/msigdb/cards/HUMMERICH_SKIN_CANCER_PROGRESSION_DN	-0.2708	-1.0885	0.3607	0.68283	1	0.404	0.31	0.28	0.63823	0.128
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	-0.34281	-1.0882	0.3577	0.68276	1	0.778	0.503	0.387	0.63906	0.128
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	171	http://www.broadinstitute.org/gsea/msigdb/cards/ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	-0.24795	-1.0871	0.3374	0.68507	1	0.298	0.249	0.225	0.64104	0.127
RASHI_RESPONSE_TO_IONIZING_RADIATION_2	122	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_2	-0.28146	-1.087	0.3512	0.68457	1	0.238	0.168	0.199	0.64129	0.127
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	-0.38833	-1.0868	0.3539	0.68446	1	0.303	0.165	0.253	0.64187	0.125
BOYLAN_MULTIPLE_MYELOMA_D_DN	69	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_D_DN	-0.23765	-1.0857	0.364	0.68643	1	0.246	0.268	0.181	0.64292	0.129
REACTOME_INNATE_IMMUNE_SYSTEM	237	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INNATE_IMMUNE_SYSTEM	-0.23481	-1.0854	0.3101	0.68638	1	0.257	0.218	0.203	0.64352	0.129
MAHADEVAN_IMATINIB_RESISTANCE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/MAHADEVAN_IMATINIB_RESISTANCE_DN	-0.42876	-1.0854	0.3765	0.68577	1	0.211	0.0448	0.201	0.6429	0.129
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	105	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	-0.23986	-1.0849	0.3282	0.68635	1	0.133	0.0968	0.121	0.64367	0.129
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	-0.3131	-1.0848	0.3228	0.68591	1	0.55	0.306	0.382	0.64305	0.126
DOANE_RESPONSE_TO_ANDROGEN_UP	172	http://www.broadinstitute.org/gsea/msigdb/cards/DOANE_RESPONSE_TO_ANDROGEN_UP	-0.19409	-1.0844	0.313	0.68636	1	0.419	0.376	0.263	0.64292	0.126
RASHI_NFKB1_TARGETS	19	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_NFKB1_TARGETS	-0.40726	-1.084	0.3522	0.68604	1	0.474	0.24	0.36	0.64264	0.126
MORI_MATURE_B_LYMPHOCYTE_UP	88	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_MATURE_B_LYMPHOCYTE_UP	-0.30058	-1.084	0.355	0.68659	1	0.341	0.237	0.261	0.64265	0.128
DARWICHE_SKIN_TUMOR_PROMOTER_UP	134	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_SKIN_TUMOR_PROMOTER_UP	-0.22326	-1.0817	0.3188	0.69103	1	0.187	0.161	0.157	0.64629	0.133
AMIT_SERUM_RESPONSE_240_MCF10A	56	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_SERUM_RESPONSE_240_MCF10A	-0.33246	-1.0817	0.3757	0.69037	1	0.5	0.321	0.34	0.64567	0.133
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	74	http://www.broadinstitute.org/gsea/msigdb/cards/TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	-0.29657	-1.0817	0.3487	0.68972	1	0.432	0.344	0.285	0.64505	0.13
VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN	-0.39271	-1.0816	0.358	0.6893	1	0.333	0.219	0.261	0.64518	0.13
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	387	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	-0.22422	-1.0813	0.3119	0.68926	1	0.372	0.334	0.251	0.64482	0.13
XU_AKT1_TARGETS_6HR	27	http://www.broadinstitute.org/gsea/msigdb/cards/XU_AKT1_TARGETS_6HR	-0.37507	-1.081	0.3742	0.68956	1	0.407	0.247	0.307	0.64538	0.132
NABA_COLLAGENS	44	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_COLLAGENS	-0.3897	-1.0807	0.3923	0.68958	1	0.773	0.503	0.385	0.64571	0.132
LE_NEURONAL_DIFFERENTIATION_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/LE_NEURONAL_DIFFERENTIATION_UP	-0.37469	-1.0801	0.3721	0.69044	1	0.412	0.228	0.318	0.6478	0.132
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP	254	http://www.broadinstitute.org/gsea/msigdb/cards/TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP	-0.21756	-1.0793	0.3264	0.69171	1	0.35	0.297	0.249	0.64871	0.132
FRASOR_RESPONSE_TO_ESTRADIOL_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/FRASOR_RESPONSE_TO_ESTRADIOL_UP	-0.34677	-1.0788	0.3926	0.69241	1	0.135	0.0272	0.132	0.64961	0.133
LEIN_PONS_MARKERS	85	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_PONS_MARKERS	-0.24103	-1.0783	0.3219	0.69306	1	0.553	0.458	0.301	0.6505	0.132
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	95	http://www.broadinstitute.org/gsea/msigdb/cards/REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	-0.23406	-1.0782	0.3268	0.69258	1	0.516	0.378	0.322	0.65002	0.132
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	-0.32644	-1.0776	0.3416	0.69339	1	0.484	0.378	0.301	0.6497	0.132
PID_PTP1B_PATHWAY	52	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PTP1B_PATHWAY	-0.25431	-1.0775	0.3445	0.69308	1	0.462	0.348	0.301	0.64958	0.132
WHITEHURST_PACLITAXEL_SENSITIVITY	38	http://www.broadinstitute.org/gsea/msigdb/cards/WHITEHURST_PACLITAXEL_SENSITIVITY	-0.26677	-1.0774	0.3715	0.69253	1	0.263	0.229	0.203	0.64896	0.132
RIGGI_EWING_SARCOMA_PROGENITOR_UP	406	http://www.broadinstitute.org/gsea/msigdb/cards/RIGGI_EWING_SARCOMA_PROGENITOR_UP	-0.24518	-1.0773	0.3354	0.69215	1	0.333	0.245	0.255	0.64895	0.131
LAMB_CCND1_TARGETS	19	http://www.broadinstitute.org/gsea/msigdb/cards/LAMB_CCND1_TARGETS	-0.28053	-1.077	0.3644	0.69239	1	0.526	0.418	0.307	0.64906	0.131
ZHAN_MULTIPLE_MYELOMA_LB_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_LB_UP	-0.29136	-1.0766	0.3307	0.69274	1	0.548	0.441	0.307	0.64902	0.131
BIOCARTA_UCALPAIN_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_UCALPAIN_PATHWAY	-0.31254	-1.0765	0.3918	0.69219	1	0.444	0.334	0.296	0.64858	0.131
LEE_CALORIE_RESTRICTION_MUSCLE_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_CALORIE_RESTRICTION_MUSCLE_UP	-0.2283	-1.0759	0.3333	0.69252	1	0.333	0.28	0.241	0.64912	0.129
MEISSNER_NPC_HCP_WITH_H3K27ME3	78	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_NPC_HCP_WITH_H3K27ME3	-0.37958	-1.0759	0.4722	0.69316	1	0.718	0.477	0.377	0.64974	0.132
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4	251	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4	-0.21299	-1.0757	0.3091	0.69158	1	0.394	0.34	0.263	0.64817	0.128
SMID_BREAST_CANCER_LUMINAL_A_UP	81	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_LUMINAL_A_UP	-0.3755	-1.0757	0.3887	0.69222	1	0.383	0.206	0.305	0.64878	0.129
ZHANG_TLX_TARGETS_36HR_UP	211	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_36HR_UP	-0.21957	-1.0747	0.4118	0.69343	1	0.46	0.393	0.281	0.65045	0.13
JIANG_HYPOXIA_VIA_VHL	34	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_HYPOXIA_VIA_VHL	-0.29325	-1.0741	0.3619	0.69431	1	0.235	0.198	0.189	0.65109	0.131
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	43	http://www.broadinstitute.org/gsea/msigdb/cards/SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	-0.31233	-1.0739	0.3327	0.69423	1	0.326	0.203	0.26	0.6518	0.131
MIKKELSEN_NPC_HCP_WITH_H3K27ME3	330	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_NPC_HCP_WITH_H3K27ME3	-0.3147	-1.0739	0.4291	0.69359	1	0.67	0.452	0.372	0.65119	0.13
XU_CREBBP_TARGETS_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/XU_CREBBP_TARGETS_DN	-0.27849	-1.0734	0.3682	0.69407	1	0.372	0.26	0.276	0.65323	0.131
LIU_PROSTATE_CANCER_UP	89	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_PROSTATE_CANCER_UP	-0.24668	-1.0725	0.3583	0.69575	1	0.258	0.24	0.197	0.6543	0.131
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	-0.36634	-1.0718	0.3805	0.69661	1	0.125	0.0295	0.121	0.65474	0.133
ELVIDGE_HIF1A_TARGETS_DN	88	http://www.broadinstitute.org/gsea/msigdb/cards/ELVIDGE_HIF1A_TARGETS_DN	-0.2641	-1.0717	0.381	0.69621	1	0.273	0.223	0.213	0.65456	0.133
GAVIN_FOXP3_TARGETS_CLUSTER_P3	151	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_P3	-0.24173	-1.0717	0.3366	0.69572	1	0.424	0.324	0.288	0.65395	0.13
MCCLUNG_DELTA_FOSB_TARGETS_2WK	44	http://www.broadinstitute.org/gsea/msigdb/cards/MCCLUNG_DELTA_FOSB_TARGETS_2WK	-0.31497	-1.0714	0.3527	0.69587	1	0.386	0.239	0.295	0.65482	0.13
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	72	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	-0.34686	-1.0712	0.4464	0.69554	1	0.708	0.434	0.402	0.65484	0.129
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL	-0.34669	-1.071	0.3951	0.69561	1	0.4	0.361	0.256	0.65438	0.129
KORKOLA_TERATOMA_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_TERATOMA_UP	-0.46867	-1.0701	0.3915	0.69726	1	0.312	0.0942	0.283	0.65444	0.13
PETRETTO_CARDIAC_HYPERTROPHY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PETRETTO_CARDIAC_HYPERTROPHY	-0.49896	-1.0697	0.43	0.69756	1	0.281	0.114	0.25	0.65474	0.13
REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	34	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	-0.29172	-1.0684	0.3714	0.70014	1	0.559	0.424	0.323	0.65881	0.133
BOQUEST_STEM_CELL_UP	253	http://www.broadinstitute.org/gsea/msigdb/cards/BOQUEST_STEM_CELL_UP	-0.39651	-1.0684	0.3838	0.69952	1	0.336	0.16	0.285	0.6582	0.13
ZHU_CMV_ALL_UP	119	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_ALL_UP	-0.31161	-1.0683	0.3725	0.69895	1	0.277	0.172	0.231	0.65768	0.129
MARSON_FOXP3_CORE_DIRECT_TARGETS	19	http://www.broadinstitute.org/gsea/msigdb/cards/MARSON_FOXP3_CORE_DIRECT_TARGETS	-0.35325	-1.0683	0.3567	0.6985	1	0.368	0.198	0.296	0.65707	0.129
NADLER_OBESITY_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/NADLER_OBESITY_DN	-0.24802	-1.0673	0.3571	0.70021	1	0.417	0.327	0.281	0.65883	0.133
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	63	http://www.broadinstitute.org/gsea/msigdb/cards/SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	-0.29354	-1.0665	0.3519	0.70133	1	0.19	0.102	0.172	0.65951	0.133
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP	-0.28883	-1.0658	0.3765	0.70248	1	0.381	0.4	0.229	0.66014	0.133
REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	-0.33682	-1.0648	0.4536	0.70419	1	0.5	0.364	0.318	0.66235	0.133
KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	18	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	-0.36411	-1.0633	0.4	0.70707	1	0.5	0.377	0.312	0.66529	0.133
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	291	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	-0.22718	-1.0632	0.3683	0.70692	1	0.206	0.163	0.175	0.66468	0.133
KIM_MYCN_AMPLIFICATION_TARGETS_UP	90	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_MYCN_AMPLIFICATION_TARGETS_UP	-0.24449	-1.0631	0.3897	0.70642	1	0.156	0.148	0.133	0.6647	0.133
PID_INTEGRIN_A4B1_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN_A4B1_PATHWAY	-0.38579	-1.063	0.3907	0.70589	1	0.485	0.273	0.353	0.66409	0.133
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	55	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	-0.36712	-1.0622	0.4841	0.70744	1	0.782	0.531	0.367	0.66448	0.133
RICKMAN_HEAD_AND_NECK_CANCER_D	32	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_HEAD_AND_NECK_CANCER_D	-0.35766	-1.062	0.4077	0.70711	1	0.594	0.412	0.349	0.66457	0.133
REACTOME_BIOLOGICAL_OXIDATIONS	123	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BIOLOGICAL_OXIDATIONS	-0.26029	-1.0617	0.334	0.70668	1	0.203	0.145	0.175	0.665	0.133
KYNG_DNA_DAMAGE_DN	193	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_DN	-0.28008	-1.0617	0.3752	0.7072	1	0.228	0.175	0.189	0.66518	0.133
BAKER_HEMATOPOIESIS_STAT3_TARGETS	16	http://www.broadinstitute.org/gsea/msigdb/cards/BAKER_HEMATOPOIESIS_STAT3_TARGETS	-0.39109	-1.0614	0.3683	0.70667	1	0.438	0.252	0.327	0.66482	0.133
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP	73	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP	-0.29252	-1.0612	0.3652	0.70662	1	0.384	0.228	0.297	0.66457	0.133
REACTOME_NEURONAL_SYSTEM	273	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NEURONAL_SYSTEM	-0.22043	-1.0603	0.3423	0.70819	1	0.432	0.356	0.281	0.66575	0.133
STEGER_ADIPOGENESIS_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/STEGER_ADIPOGENESIS_DN	-0.47561	-1.0603	0.4152	0.7076	1	0.435	0.175	0.359	0.66514	0.133
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	27	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	-0.32749	-1.0602	0.4344	0.7072	1	0.593	0.557	0.263	0.66453	0.133
TRACEY_RESISTANCE_TO_IFNA2_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/TRACEY_RESISTANCE_TO_IFNA2_DN	-0.27679	-1.0601	0.3513	0.70663	1	0.484	0.412	0.285	0.66393	0.133
PID_RAC1_REG_PATHWAY	38	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RAC1_REG_PATHWAY	-0.29281	-1.0595	0.3541	0.70743	1	0.421	0.26	0.312	0.66646	0.133
REACTOME_MUSCLE_CONTRACTION	47	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MUSCLE_CONTRACTION	-0.30532	-1.0593	0.3488	0.70735	1	0.553	0.38	0.344	0.66585	0.133
BRUECKNER_TARGETS_OF_MIRLET7A3_DN	71	http://www.broadinstitute.org/gsea/msigdb/cards/BRUECKNER_TARGETS_OF_MIRLET7A3_DN	-0.35078	-1.0581	0.3924	0.70976	1	0.324	0.233	0.249	0.66878	0.133
JEON_SMAD6_TARGETS_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/JEON_SMAD6_TARGETS_UP	-0.40884	-1.058	0.3735	0.70937	1	0.409	0.179	0.336	0.66817	0.133
KATSANOU_ELAVL1_TARGETS_UP	163	http://www.broadinstitute.org/gsea/msigdb/cards/KATSANOU_ELAVL1_TARGETS_UP	-0.2656	-1.058	0.3542	0.70877	1	0.239	0.171	0.2	0.66756	0.133
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3	333	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3	-0.31096	-1.0572	0.4566	0.71007	1	0.655	0.452	0.363	0.66797	0.133
CORRE_MULTIPLE_MYELOMA_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/CORRE_MULTIPLE_MYELOMA_DN	-0.37603	-1.0571	0.4118	0.7096	1	0.327	0.199	0.263	0.66737	0.133
CERVERA_SDHB_TARGETS_1_UP	110	http://www.broadinstitute.org/gsea/msigdb/cards/CERVERA_SDHB_TARGETS_1_UP	-0.24258	-1.0569	0.4064	0.70959	1	0.4	0.349	0.261	0.66758	0.133
NIELSEN_LEIOMYOSARCOMA_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LEIOMYOSARCOMA_UP	-0.37811	-1.0568	0.4213	0.7092	1	0.625	0.282	0.449	0.66701	0.133
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	-0.31393	-1.0558	0.3903	0.7111	1	0.486	0.384	0.3	0.66924	0.133
REACTOME_INTRINSIC_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTRINSIC_PATHWAY	-0.30302	-1.0555	0.3636	0.71107	1	0.706	0.412	0.415	0.66941	0.133
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	65	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	-0.27168	-1.0548	0.3794	0.71219	1	0.262	0.198	0.21	0.67007	0.133
ONDER_CDH1_TARGETS_2_DN	449	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_TARGETS_2_DN	-0.23123	-1.0547	0.3578	0.71159	1	0.459	0.374	0.293	0.66946	0.133
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	-0.26841	-1.0545	0.365	0.71147	1	0.418	0.28	0.302	0.66886	0.132
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	86	http://www.broadinstitute.org/gsea/msigdb/cards/FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	-0.22775	-1.054	0.371	0.71212	1	0.209	0.199	0.168	0.67111	0.133
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	75	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	-0.23433	-1.0538	0.3875	0.71188	1	0.493	0.429	0.283	0.67096	0.132
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	113	http://www.broadinstitute.org/gsea/msigdb/cards/DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	-0.28007	-1.0536	0.3784	0.71187	1	0.319	0.235	0.245	0.67104	0.132
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	-0.24918	-1.0533	0.3581	0.71196	1	0.298	0.273	0.217	0.67112	0.132
MURAKAMI_UV_RESPONSE_6HR_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/MURAKAMI_UV_RESPONSE_6HR_DN	-0.37265	-1.0528	0.4463	0.71261	1	0.571	0.399	0.343	0.67177	0.133
IGLESIAS_E2F_TARGETS_UP	149	http://www.broadinstitute.org/gsea/msigdb/cards/IGLESIAS_E2F_TARGETS_UP	-0.34114	-1.0524	0.4184	0.71282	1	0.295	0.184	0.242	0.67226	0.133
SMIRNOV_RESPONSE_TO_IR_2HR_UP	50	http://www.broadinstitute.org/gsea/msigdb/cards/SMIRNOV_RESPONSE_TO_IR_2HR_UP	-0.27224	-1.0522	0.4182	0.71288	1	0.42	0.328	0.283	0.67271	0.132
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	37	http://www.broadinstitute.org/gsea/msigdb/cards/SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	-0.33519	-1.0514	0.398	0.71421	1	0.216	0.134	0.187	0.67392	0.133
PID_ATF2_PATHWAY	57	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ATF2_PATHWAY	-0.3176	-1.0512	0.3883	0.71403	1	0.404	0.273	0.294	0.67356	0.133
WOTTON_RUNX_TARGETS_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/WOTTON_RUNX_TARGETS_UP	-0.35621	-1.0512	0.4016	0.71339	1	0.35	0.196	0.282	0.67296	0.133
ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN	18	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN	-0.3246	-1.0511	0.3466	0.71308	1	0.778	0.523	0.371	0.67236	0.131
MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN	16	http://www.broadinstitute.org/gsea/msigdb/cards/MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN	-0.35799	-1.0507	0.4108	0.71346	1	0.438	0.372	0.275	0.67259	0.13
WANG_BARRETTS_ESOPHAGUS_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_BARRETTS_ESOPHAGUS_UP	-0.30011	-1.0505	0.4033	0.71333	1	0.49	0.363	0.313	0.672	0.131
ZHANG_TLX_TARGETS_60HR_UP	282	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_60HR_UP	-0.20765	-1.0502	0.4283	0.71343	1	0.408	0.374	0.258	0.67181	0.13
MATZUK_SPERMATOGONIA	23	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_SPERMATOGONIA	-0.26318	-1.0498	0.3735	0.71374	1	0.478	0.402	0.286	0.67238	0.131
CAIRO_HEPATOBLASTOMA_CLASSES_DN	199	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_HEPATOBLASTOMA_CLASSES_DN	-0.26256	-1.0495	0.3812	0.71384	1	0.317	0.262	0.236	0.67257	0.131
LANDIS_BREAST_CANCER_PROGRESSION_DN	69	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_BREAST_CANCER_PROGRESSION_DN	-0.33464	-1.0494	0.396	0.71345	1	0.333	0.218	0.261	0.67197	0.13
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN	-0.35422	-1.049	0.3882	0.71382	1	0.526	0.447	0.291	0.67223	0.131
DOANE_BREAST_CANCER_ESR1_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/DOANE_BREAST_CANCER_ESR1_DN	-0.33157	-1.0488	0.4056	0.71375	1	0.277	0.163	0.232	0.67164	0.13
VALK_AML_CLUSTER_10	31	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_10	-0.2816	-1.0487	0.4049	0.71327	1	0.484	0.339	0.32	0.67117	0.13
RICKMAN_HEAD_AND_NECK_CANCER_E	88	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_HEAD_AND_NECK_CANCER_E	-0.30468	-1.0477	0.4054	0.7149	1	0.239	0.187	0.195	0.67312	0.131
BILD_HRAS_ONCOGENIC_SIGNATURE	247	http://www.broadinstitute.org/gsea/msigdb/cards/BILD_HRAS_ONCOGENIC_SIGNATURE	-0.25143	-1.0476	0.3825	0.71466	1	0.255	0.207	0.204	0.67253	0.131
LANDIS_ERBB2_BREAST_TUMORS_324_DN	146	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_TUMORS_324_DN	-0.2846	-1.0475	0.3812	0.71438	1	0.322	0.238	0.247	0.67238	0.13
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	181	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	-0.28216	-1.0474	0.3996	0.71385	1	0.32	0.229	0.249	0.67179	0.128
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	-0.32658	-1.0474	0.3906	0.7133	1	0.224	0.109	0.2	0.6712	0.128
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	85	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	-0.28407	-1.0473	0.3748	0.71275	1	0.435	0.337	0.29	0.67061	0.128
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN	60	http://www.broadinstitute.org/gsea/msigdb/cards/JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN	-0.25198	-1.0473	0.3733	0.71215	1	0.133	0.0766	0.123	0.67045	0.128
FURUKAWA_DUSP6_TARGETS_PCI35_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/FURUKAWA_DUSP6_TARGETS_PCI35_UP	-0.24991	-1.0472	0.392	0.71122	1	0.343	0.278	0.248	0.66975	0.127
SESTO_RESPONSE_TO_UV_C6	38	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C6	-0.31242	-1.0472	0.433	0.71182	1	0.316	0.179	0.26	0.67034	0.128
MURAKAMI_UV_RESPONSE_24HR	20	http://www.broadinstitute.org/gsea/msigdb/cards/MURAKAMI_UV_RESPONSE_24HR	-0.38948	-1.0471	0.482	0.7108	1	0.7	0.399	0.421	0.66919	0.127
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	128	http://www.broadinstitute.org/gsea/msigdb/cards/PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	-0.24943	-1.0465	0.3845	0.71183	1	0.453	0.334	0.303	0.67061	0.126
FERNANDEZ_BOUND_BY_MYC	179	http://www.broadinstitute.org/gsea/msigdb/cards/FERNANDEZ_BOUND_BY_MYC	-0.19414	-1.0464	0.3973	0.71074	1	0.335	0.336	0.224	0.66944	0.126
VANASSE_BCL2_TARGETS_DN	69	http://www.broadinstitute.org/gsea/msigdb/cards/VANASSE_BCL2_TARGETS_DN	-0.28297	-1.0464	0.3921	0.71133	1	0.478	0.353	0.31	0.67002	0.126
NAKAMURA_ADIPOGENESIS_EARLY_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_ADIPOGENESIS_EARLY_UP	-0.35058	-1.0461	0.4212	0.71076	1	0.19	0.0809	0.175	0.67001	0.126
RIZKI_TUMOR_INVASIVENESS_2D_DN	60	http://www.broadinstitute.org/gsea/msigdb/cards/RIZKI_TUMOR_INVASIVENESS_2D_DN	-0.24509	-1.0453	0.3772	0.7123	1	0.217	0.189	0.176	0.67098	0.126
CHANG_POU5F1_TARGETS_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_POU5F1_TARGETS_UP	-0.43925	-1.045	0.4357	0.7124	1	0.333	0.114	0.296	0.67126	0.126
CHANG_IMMORTALIZED_BY_HPV31_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_IMMORTALIZED_BY_HPV31_DN	-0.32816	-1.0441	0.4138	0.71404	1	0.302	0.187	0.246	0.67286	0.127
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	-0.2546	-1.0439	0.388	0.71386	1	0.277	0.218	0.217	0.67288	0.127
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	-0.28273	-1.0437	0.3988	0.71359	1	0.265	0.15	0.225	0.67245	0.127
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	113	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	-0.25695	-1.0436	0.4023	0.71338	1	0.363	0.313	0.25	0.67267	0.127
LEE_AGING_CEREBELLUM_DN	82	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_AGING_CEREBELLUM_DN	-0.23467	-1.0434	0.4186	0.7131	1	0.537	0.476	0.282	0.67208	0.126
KEGG_ARACHIDONIC_ACID_METABOLISM	55	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ARACHIDONIC_ACID_METABOLISM	-0.31175	-1.043	0.4418	0.71292	1	0.491	0.307	0.341	0.67185	0.127
MATTHEWS_AP1_TARGETS	17	http://www.broadinstitute.org/gsea/msigdb/cards/MATTHEWS_AP1_TARGETS	-0.3766	-1.043	0.4231	0.71349	1	0.412	0.236	0.315	0.67244	0.127
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	117	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	-0.2211	-1.0429	0.3767	0.71241	1	0.291	0.254	0.218	0.67127	0.125
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	179	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	-0.24918	-1.0426	0.3738	0.71252	1	0.263	0.176	0.218	0.6716	0.126
SHEN_SMARCA2_TARGETS_DN	330	http://www.broadinstitute.org/gsea/msigdb/cards/SHEN_SMARCA2_TARGETS_DN	-0.28034	-1.0426	0.497	0.71205	1	0.509	0.383	0.318	0.67102	0.125
RIZ_ERYTHROID_DIFFERENTIATION_HEMGN	31	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_HEMGN	-0.30427	-1.0423	0.4322	0.71218	1	0.194	0.105	0.173	0.67121	0.125
HOSHIDA_LIVER_CANCER_SUBCLASS_S3	259	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_SUBCLASS_S3	-0.21138	-1.0419	0.3843	0.71252	1	0.409	0.367	0.262	0.67222	0.126
REACTOME_COLLAGEN_FORMATION	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_COLLAGEN_FORMATION	-0.34868	-1.0415	0.4478	0.71284	1	0.589	0.422	0.341	0.67179	0.125
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	-0.39035	-1.0414	0.3968	0.71254	1	0.333	0.107	0.298	0.67121	0.125
KANG_GIST_WITH_PDGFRA_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_GIST_WITH_PDGFRA_UP	-0.32836	-1.0409	0.4107	0.71306	1	0.319	0.166	0.267	0.67196	0.126
GAVIN_FOXP3_TARGETS_CLUSTER_P2	75	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_P2	-0.26684	-1.0407	0.3877	0.71305	1	0.253	0.196	0.204	0.67291	0.126
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	125	http://www.broadinstitute.org/gsea/msigdb/cards/BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	-0.23218	-1.0403	0.4207	0.71317	1	0.432	0.381	0.269	0.67312	0.126
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	-0.36436	-1.0402	0.416	0.71295	1	0.375	0.161	0.315	0.67254	0.126
ST_GAQ_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/ST_GAQ_PATHWAY	-0.29096	-1.0399	0.41	0.71287	1	0.185	0.132	0.161	0.6729	0.126
KEEN_RESPONSE_TO_ROSIGLITAZONE_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/KEEN_RESPONSE_TO_ROSIGLITAZONE_UP	-0.23785	-1.0395	0.4115	0.71317	1	0.289	0.321	0.197	0.67306	0.127
WANG_NFKB_TARGETS	24	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_NFKB_TARGETS	-0.38902	-1.0394	0.4769	0.71277	1	0.625	0.373	0.392	0.67259	0.126
FERRANDO_LYL1_NEIGHBORS	15	http://www.broadinstitute.org/gsea/msigdb/cards/FERRANDO_LYL1_NEIGHBORS	-0.3537	-1.0393	0.4147	0.71242	1	0.2	0.0759	0.185	0.67201	0.126
ZHANG_GATA6_TARGETS_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_GATA6_TARGETS_UP	-0.36838	-1.0392	0.4084	0.71209	1	0.267	0.0839	0.244	0.67144	0.125
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	-0.34155	-1.039	0.4417	0.71195	1	0.208	0.158	0.176	0.67118	0.125
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	83	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	-0.32189	-1.0384	0.4054	0.71272	1	0.554	0.402	0.333	0.67244	0.124
HUMMERICH_SKIN_CANCER_PROGRESSION_UP	84	http://www.broadinstitute.org/gsea/msigdb/cards/HUMMERICH_SKIN_CANCER_PROGRESSION_UP	-0.30458	-1.0382	0.4071	0.71255	1	0.321	0.268	0.236	0.6724	0.124
WOOD_EBV_EBNA1_TARGETS_UP	106	http://www.broadinstitute.org/gsea/msigdb/cards/WOOD_EBV_EBNA1_TARGETS_UP	-0.25243	-1.0381	0.4096	0.71173	1	0.17	0.158	0.144	0.67126	0.124
OSADA_ASCL1_TARGETS_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/OSADA_ASCL1_TARGETS_DN	-0.4171	-1.0381	0.398	0.71227	1	0.333	0.135	0.289	0.67183	0.125
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	26	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	-0.39716	-1.0376	0.4746	0.71214	1	0.192	0.105	0.172	0.67255	0.125
PID_HES_HEY_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HES_HEY_PATHWAY	-0.2757	-1.0373	0.3873	0.71227	1	0.383	0.315	0.263	0.67283	0.124
KANG_FLUOROURACIL_RESISTANCE_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_FLUOROURACIL_RESISTANCE_DN	-0.32475	-1.0372	0.4505	0.712	1	0.625	0.479	0.326	0.67226	0.123
BROWNE_HCMV_INFECTION_16HR_DN	84	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_16HR_DN	-0.26331	-1.037	0.4144	0.71189	1	0.393	0.309	0.272	0.67169	0.123
REACTOME_RNA_POL_I_PROMOTER_OPENING	41	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_PROMOTER_OPENING	-0.39372	-1.0364	0.3777	0.71216	1	0.39	0.18	0.321	0.67202	0.121
RUTELLA_RESPONSE_TO_HGF_UP	399	http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_HGF_UP	-0.24439	-1.0364	0.3767	0.71264	1	0.261	0.223	0.206	0.67259	0.123
LIU_SMARCA4_TARGETS	59	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_SMARCA4_TARGETS	-0.29346	-1.0362	0.4004	0.7121	1	0.441	0.329	0.296	0.6722	0.121
PID_TOLL_ENDOGENOUS_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TOLL_ENDOGENOUS_PATHWAY	-0.31465	-1.0358	0.4099	0.71244	1	0.4	0.293	0.283	0.67308	0.122
PID_P53_DOWNSTREAM_PATHWAY	131	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P53_DOWNSTREAM_PATHWAY	-0.22955	-1.0354	0.375	0.71277	1	0.351	0.335	0.235	0.67338	0.121
DAZARD_UV_RESPONSE_CLUSTER_G1	64	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G1	-0.26853	-1.0342	0.4172	0.71508	1	0.266	0.212	0.21	0.67606	0.124
REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	-0.32535	-1.0341	0.4004	0.71456	1	0.44	0.269	0.322	0.6755	0.124
ST_T_CELL_SIGNAL_TRANSDUCTION	44	http://www.broadinstitute.org/gsea/msigdb/cards/ST_T_CELL_SIGNAL_TRANSDUCTION	-0.25382	-1.0336	0.3846	0.71465	1	0.477	0.348	0.312	0.6751	0.122
DELASERNA_MYOD_TARGETS_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/DELASERNA_MYOD_TARGETS_DN	-0.32736	-1.0336	0.4679	0.71523	1	0.327	0.179	0.269	0.67567	0.122
LU_EZH2_TARGETS_UP	262	http://www.broadinstitute.org/gsea/msigdb/cards/LU_EZH2_TARGETS_UP	-0.2077	-1.0335	0.4371	0.71422	1	0.469	0.422	0.274	0.67533	0.122
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	-0.33243	-1.0334	0.4121	0.71379	1	0.688	0.402	0.411	0.6752	0.122
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	-0.24708	-1.0324	0.4128	0.71555	1	0.424	0.346	0.278	0.67685	0.122
REACTOME_SIGNALLING_TO_RAS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALLING_TO_RAS	-0.24842	-1.0321	0.422	0.71564	1	0.444	0.334	0.296	0.67768	0.122
DUAN_PRDM5_TARGETS	74	http://www.broadinstitute.org/gsea/msigdb/cards/DUAN_PRDM5_TARGETS	-0.23889	-1.0318	0.4067	0.7158	1	0.378	0.297	0.267	0.67712	0.122
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	112	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	-0.34507	-1.0317	0.5294	0.71525	1	0.732	0.507	0.362	0.67655	0.122
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	95	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	-0.24116	-1.0317	0.3992	0.71479	1	0.484	0.369	0.307	0.67599	0.122
MIKKELSEN_IPS_WITH_HCP_H3K27ME3	96	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_IPS_WITH_HCP_H3K27ME3	-0.29389	-1.0315	0.4391	0.71467	1	0.448	0.331	0.301	0.67642	0.122
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	30	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	-0.27706	-1.0306	0.4254	0.71603	1	0.233	0.174	0.193	0.67812	0.122
STARK_HYPPOCAMPUS_22Q11_DELETION_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/STARK_HYPPOCAMPUS_22Q11_DELETION_DN	-0.39734	-1.0304	0.4862	0.71609	1	0.421	0.305	0.293	0.67852	0.122
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	-0.31712	-1.0295	0.4594	0.71757	1	0.588	0.539	0.272	0.67961	0.123
WONG_IFNA2_RESISTANCE_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_IFNA2_RESISTANCE_UP	-0.35541	-1.0292	0.4023	0.71757	1	0.333	0.228	0.257	0.67943	0.123
BIOCARTA_GSK3_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_GSK3_PATHWAY	-0.33682	-1.029	0.4469	0.71761	1	0.259	0.239	0.197	0.67912	0.123
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	385	http://www.broadinstitute.org/gsea/msigdb/cards/MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	-0.21391	-1.0287	0.4377	0.71761	1	0.475	0.396	0.291	0.67946	0.125
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN	-0.3805	-1.0285	0.4177	0.71758	1	0.375	0.15	0.319	0.67934	0.125
GRADE_METASTASIS_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_METASTASIS_DN	-0.22603	-1.028	0.4244	0.71811	1	0.19	0.16	0.16	0.68108	0.125
BIOCARTA_CCR5_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CCR5_PATHWAY	-0.44027	-1.0279	0.4453	0.71764	1	0.294	0.107	0.263	0.68052	0.122
PID_HIF1_TFPATHWAY	65	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HIF1_TFPATHWAY	-0.26224	-1.0279	0.4317	0.71709	1	0.246	0.221	0.192	0.67995	0.122
RICKMAN_HEAD_AND_NECK_CANCER_B	45	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_HEAD_AND_NECK_CANCER_B	-0.32971	-1.0278	0.4286	0.71666	1	0.511	0.329	0.344	0.67939	0.122
LIM_MAMMARY_LUMINAL_MATURE_UP	107	http://www.broadinstitute.org/gsea/msigdb/cards/LIM_MAMMARY_LUMINAL_MATURE_UP	-0.20993	-1.0278	0.4035	0.71607	1	0.458	0.374	0.288	0.67883	0.122
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	-0.3537	-1.0275	0.4182	0.71627	1	0.706	0.395	0.427	0.67834	0.122
HARRIS_BRAIN_CANCER_PROGENITORS	42	http://www.broadinstitute.org/gsea/msigdb/cards/HARRIS_BRAIN_CANCER_PROGENITORS	-0.27032	-1.0274	0.4338	0.71602	1	0.476	0.363	0.304	0.67778	0.122
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	-0.30802	-1.0271	0.4116	0.71622	1	0.194	0.0864	0.177	0.67768	0.12
PID_ARF6_TRAFFICKING_PATHWAY	49	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ARF6_TRAFFICKING_PATHWAY	-0.27995	-1.0239	0.4176	0.7231	1	0.306	0.217	0.24	0.68647	0.125
ST_MYOCYTE_AD_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/ST_MYOCYTE_AD_PATHWAY	-0.25321	-1.0236	0.4237	0.72316	1	0.333	0.31	0.23	0.68751	0.125
HUANG_FOXA2_TARGETS_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/HUANG_FOXA2_TARGETS_UP	-0.34918	-1.0235	0.4269	0.72232	1	0.419	0.24	0.319	0.68649	0.124
BROWNE_HCMV_INFECTION_30MIN_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_30MIN_UP	-0.29162	-1.0235	0.4092	0.72284	1	0.321	0.201	0.257	0.68706	0.125
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	148	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	-0.22567	-1.0234	0.4266	0.72183	1	0.439	0.42	0.256	0.68593	0.124
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	-0.2754	-1.0233	0.4204	0.72153	1	0.694	0.508	0.342	0.68584	0.124
SWEET_KRAS_ONCOGENIC_SIGNATURE	87	http://www.broadinstitute.org/gsea/msigdb/cards/SWEET_KRAS_ONCOGENIC_SIGNATURE	-0.23184	-1.0232	0.4008	0.72109	1	0.402	0.32	0.274	0.68527	0.122
WILLIAMS_ESR2_TARGETS_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/WILLIAMS_ESR2_TARGETS_UP	-0.30816	-1.0225	0.4024	0.72162	1	0.423	0.248	0.319	0.68702	0.122
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	79	http://www.broadinstitute.org/gsea/msigdb/cards/HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	-0.32462	-1.0225	0.4317	0.72219	1	0.278	0.16	0.235	0.68758	0.124
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	122	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	-0.19284	-1.0215	0.4137	0.72336	1	0.492	0.442	0.276	0.6883	0.126
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP	48	http://www.broadinstitute.org/gsea/msigdb/cards/STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP	-0.34342	-1.0213	0.4055	0.7232	1	0.25	0.159	0.211	0.68807	0.126
KEGG_DRUG_METABOLISM_CYTOCHROME_P450	62	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_DRUG_METABOLISM_CYTOCHROME_P450	-0.30323	-1.0197	0.4113	0.72655	1	0.355	0.261	0.263	0.69142	0.127
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	72	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	-0.27166	-1.0195	0.4291	0.72637	1	0.278	0.212	0.22	0.69182	0.127
GROSS_HYPOXIA_VIA_HIF1A_DN	106	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_HIF1A_DN	-0.28358	-1.0192	0.3933	0.72643	1	0.264	0.176	0.218	0.69173	0.127
KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	25	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	-0.39017	-1.0191	0.5039	0.72625	1	0.64	0.393	0.389	0.69191	0.127
FUKUSHIMA_TNFSF11_TARGETS	16	http://www.broadinstitute.org/gsea/msigdb/cards/FUKUSHIMA_TNFSF11_TARGETS	-0.33639	-1.0188	0.4549	0.7261	1	0.688	0.41	0.406	0.69205	0.126
REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS	-0.34051	-1.0185	0.402	0.72622	1	0.684	0.42	0.397	0.69237	0.126
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	-0.27133	-1.0183	0.4365	0.72618	1	0.294	0.233	0.226	0.69201	0.126
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	-0.27715	-1.0173	0.4139	0.72779	1	0.383	0.265	0.282	0.69337	0.127
ZHAN_MULTIPLE_MYELOMA_HP_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_HP_UP	-0.30235	-1.0168	0.4372	0.72794	1	0.14	0.0317	0.135	0.6932	0.127
SU_PANCREAS	50	http://www.broadinstitute.org/gsea/msigdb/cards/SU_PANCREAS	-0.2361	-1.0168	0.422	0.72851	1	0.3	0.252	0.225	0.69376	0.127
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	66	http://www.broadinstitute.org/gsea/msigdb/cards/JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	-0.30705	-1.0158	0.4484	0.7297	1	0.364	0.208	0.289	0.69509	0.129
MULLIGHAN_MLL_SIGNATURE_1_DN	226	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_MLL_SIGNATURE_1_DN	-0.21153	-1.0156	0.4021	0.72944	1	0.186	0.168	0.156	0.69453	0.129
BHATTACHARYA_EMBRYONIC_STEM_CELL	86	http://www.broadinstitute.org/gsea/msigdb/cards/BHATTACHARYA_EMBRYONIC_STEM_CELL	-0.26225	-1.0156	0.458	0.72907	1	0.093	0.0413	0.0895	0.69529	0.127
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	111	http://www.broadinstitute.org/gsea/msigdb/cards/BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	-0.25401	-1.0154	0.4408	0.72881	1	0.18	0.133	0.157	0.69497	0.127
REACTOME_OLFACTORY_SIGNALING_PATHWAY	281	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_OLFACTORY_SIGNALING_PATHWAY	-0.38846	-1.0153	0.4752	0.72847	1	0.327	0.182	0.271	0.69441	0.127
TOMLINS_PROSTATE_CANCER_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/TOMLINS_PROSTATE_CANCER_DN	-0.36807	-1.015	0.4385	0.72744	1	0.225	0.0635	0.211	0.69344	0.124
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	85	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	-0.30223	-1.015	0.4431	0.72801	1	0.518	0.326	0.35	0.69329	0.125
GUILLAUMOND_KLF10_TARGETS_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/GUILLAUMOND_KLF10_TARGETS_DN	-0.33747	-1.015	0.4094	0.72845	1	0.333	0.166	0.278	0.69385	0.127
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	-0.2928	-1.0144	0.3934	0.72813	1	0.182	0.109	0.162	0.69379	0.124
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	26	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	-0.28435	-1.0142	0.4058	0.72795	1	0.462	0.304	0.322	0.69404	0.124
PODAR_RESPONSE_TO_ADAPHOSTIN_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/PODAR_RESPONSE_TO_ADAPHOSTIN_DN	-0.32922	-1.014	0.4163	0.72798	1	0.278	0.221	0.217	0.69393	0.124
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	100	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	-0.23927	-1.0135	0.4644	0.72854	1	0.21	0.168	0.175	0.69472	0.124
FALVELLA_SMOKERS_WITH_LUNG_CANCER	78	http://www.broadinstitute.org/gsea/msigdb/cards/FALVELLA_SMOKERS_WITH_LUNG_CANCER	-0.30807	-1.0131	0.4193	0.72882	1	0.295	0.168	0.246	0.69597	0.124
PID_INTEGRIN1_PATHWAY	66	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN1_PATHWAY	-0.37861	-1.0122	0.4728	0.73026	1	0.591	0.383	0.365	0.69754	0.124
PID_EPHA_FWDPATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/PID_EPHA_FWDPATHWAY	-0.27415	-1.0122	0.4311	0.72977	1	0.471	0.362	0.301	0.69699	0.124
MORI_MATURE_B_LYMPHOCYTE_DN	73	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_MATURE_B_LYMPHOCYTE_DN	-0.23615	-1.0122	0.4289	0.72928	1	0.288	0.241	0.219	0.69643	0.124
BIOCARTA_TID_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TID_PATHWAY	-0.30215	-1.0115	0.4263	0.73021	1	0.211	0.132	0.183	0.69692	0.124
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	446	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	-0.21163	-1.0112	0.473	0.72977	1	0.312	0.283	0.227	0.69594	0.124
VANHARANTA_UTERINE_FIBROID_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/VANHARANTA_UTERINE_FIBROID_UP	-0.34246	-1.0112	0.4514	0.73018	1	0.273	0.179	0.224	0.6965	0.124
ONDER_CDH1_TARGETS_2_UP	247	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_TARGETS_2_UP	-0.35273	-1.0111	0.4765	0.72941	1	0.32	0.19	0.262	0.69622	0.124
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	421	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	-0.20977	-1.011	0.4794	0.72899	1	0.28	0.241	0.216	0.69601	0.124
FOSTER_TOLERANT_MACROPHAGE_DN	395	http://www.broadinstitute.org/gsea/msigdb/cards/FOSTER_TOLERANT_MACROPHAGE_DN	-0.28032	-1.0103	0.4551	0.73014	1	0.294	0.227	0.231	0.69711	0.124
REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_	-0.34828	-1.0098	0.4394	0.73054	1	0.667	0.462	0.359	0.69703	0.124
REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING	35	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING	-0.29047	-1.0097	0.4316	0.73038	1	0.543	0.39	0.331	0.69703	0.124
PID_HEDGEHOG_2PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HEDGEHOG_2PATHWAY	-0.30078	-1.0092	0.4158	0.73076	1	0.682	0.47	0.362	0.69822	0.124
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	-0.30579	-1.0092	0.4127	0.73028	1	0.375	0.302	0.262	0.69766	0.124
NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	20	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	-0.30506	-1.0089	0.4275	0.73046	1	0.4	0.37	0.252	0.69784	0.124
MANALO_HYPOXIA_UP	204	http://www.broadinstitute.org/gsea/msigdb/cards/MANALO_HYPOXIA_UP	-0.24793	-1.0088	0.4035	0.73017	1	0.26	0.192	0.212	0.69763	0.124
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	39	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	-0.28417	-1.0074	0.4288	0.73287	1	0.462	0.361	0.296	0.69986	0.126
RIZKI_TUMOR_INVASIVENESS_2D_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/RIZKI_TUMOR_INVASIVENESS_2D_UP	-0.19143	-1.0073	0.4318	0.73249	1	0.206	0.22	0.161	0.69931	0.124
BROWNE_HCMV_INFECTION_18HR_DN	172	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_18HR_DN	-0.23376	-1.0071	0.4576	0.7324	1	0.43	0.366	0.275	0.69875	0.124
ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE	17	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE	-0.33264	-1.0069	0.4239	0.73234	1	0.294	0.168	0.245	0.69962	0.124
KEGG_GAP_JUNCTION	87	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GAP_JUNCTION	-0.24845	-1.0063	0.4272	0.73315	1	0.448	0.377	0.28	0.70153	0.124
WOO_LIVER_CANCER_RECURRENCE_DN	79	http://www.broadinstitute.org/gsea/msigdb/cards/WOO_LIVER_CANCER_RECURRENCE_DN	-0.23614	-1.0061	0.4833	0.73307	1	0.392	0.357	0.253	0.70149	0.124
KONDO_EZH2_TARGETS	227	http://www.broadinstitute.org/gsea/msigdb/cards/KONDO_EZH2_TARGETS	-0.26509	-1.0056	0.4536	0.73307	1	0.256	0.204	0.205	0.70169	0.124
PASINI_SUZ12_TARGETS_UP	107	http://www.broadinstitute.org/gsea/msigdb/cards/PASINI_SUZ12_TARGETS_UP	-0.21188	-1.0056	0.4324	0.73364	1	0.383	0.314	0.264	0.70224	0.124
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	138	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	-0.20691	-1.0053	0.4624	0.73314	1	0.348	0.324	0.236	0.70152	0.126
ABE_INNER_EAR	47	http://www.broadinstitute.org/gsea/msigdb/cards/ABE_INNER_EAR	-0.25946	-1.0053	0.4163	0.73258	1	0.298	0.219	0.233	0.70097	0.124
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	74	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	-0.25316	-1.0053	0.4335	0.73211	1	0.189	0.107	0.169	0.70042	0.124
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN	78	http://www.broadinstitute.org/gsea/msigdb/cards/YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN	-0.24565	-1.0048	0.4841	0.7321	1	0.346	0.232	0.267	0.70051	0.126
YE_METASTATIC_LIVER_CANCER	26	http://www.broadinstitute.org/gsea/msigdb/cards/YE_METASTATIC_LIVER_CANCER	-0.31324	-1.0048	0.4794	0.7326	1	0.346	0.168	0.288	0.70069	0.126
LEIN_MEDULLA_MARKERS	79	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_MEDULLA_MARKERS	-0.20973	-1.0047	0.4387	0.73179	1	0.405	0.371	0.256	0.70078	0.124
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	151	http://www.broadinstitute.org/gsea/msigdb/cards/RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	-0.23728	-1.0044	0.4394	0.73192	1	0.232	0.198	0.187	0.70023	0.126
VERNELL_RETINOBLASTOMA_PATHWAY_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/VERNELL_RETINOBLASTOMA_PATHWAY_DN	-0.29217	-1.0037	0.4571	0.73282	1	0.409	0.236	0.313	0.70112	0.124
ROESSLER_LIVER_CANCER_METASTASIS_UP	102	http://www.broadinstitute.org/gsea/msigdb/cards/ROESSLER_LIVER_CANCER_METASTASIS_UP	-0.18281	-1.0036	0.463	0.73256	1	0.373	0.331	0.25	0.70057	0.123
CHEBOTAEV_GR_TARGETS_UP	72	http://www.broadinstitute.org/gsea/msigdb/cards/CHEBOTAEV_GR_TARGETS_UP	-0.27661	-1.003	0.459	0.73324	1	0.361	0.254	0.27	0.70107	0.126
SCHRAETS_MLL_TARGETS_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/SCHRAETS_MLL_TARGETS_UP	-0.33575	-1.0029	0.505	0.73296	1	0.286	0.143	0.245	0.70072	0.126
WARTERS_IR_RESPONSE_5GY	44	http://www.broadinstitute.org/gsea/msigdb/cards/WARTERS_IR_RESPONSE_5GY	-0.25576	-1.0028	0.4716	0.73254	1	0.523	0.424	0.301	0.70047	0.123
QI_PLASMACYTOMA_DN	96	http://www.broadinstitute.org/gsea/msigdb/cards/QI_PLASMACYTOMA_DN	-0.2574	-1.0027	0.4609	0.73238	1	0.354	0.292	0.252	0.70085	0.123
KEGG_OLFACTORY_TRANSDUCTION	336	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_OLFACTORY_TRANSDUCTION	-0.36647	-1.002	0.4951	0.73322	1	0.292	0.16	0.248	0.70194	0.124
DORSEY_GAB2_TARGETS	31	http://www.broadinstitute.org/gsea/msigdb/cards/DORSEY_GAB2_TARGETS	-0.35392	-1.0014	0.453	0.73424	1	0.355	0.179	0.292	0.70249	0.126
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	182	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	-0.19277	-1.001	0.4544	0.73438	1	0.429	0.356	0.278	0.70292	0.126
RIZKI_TUMOR_INVASIVENESS_3D_UP	199	http://www.broadinstitute.org/gsea/msigdb/cards/RIZKI_TUMOR_INVASIVENESS_3D_UP	-0.21377	-1.0004	0.45	0.73538	1	0.236	0.201	0.19	0.70479	0.124
SHI_SPARC_TARGETS_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/SHI_SPARC_TARGETS_UP	-0.37424	-0.99954	0.4455	0.73667	1	0.5	0.242	0.379	0.70473	0.126
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	-0.32464	-0.99933	0.4314	0.73663	1	0.432	0.271	0.316	0.70455	0.126
COATES_MACROPHAGE_M1_VS_M2_DN	74	http://www.broadinstitute.org/gsea/msigdb/cards/COATES_MACROPHAGE_M1_VS_M2_DN	-0.21544	-0.99901	0.4592	0.73674	1	0.176	0.179	0.145	0.70406	0.126
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP	-0.33076	-0.99807	0.4594	0.73836	1	0.409	0.276	0.297	0.70553	0.127
REACTOME_SMOOTH_MUSCLE_CONTRACTION	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SMOOTH_MUSCLE_CONTRACTION	-0.38384	-0.998	0.4512	0.73793	1	0.292	0.0919	0.265	0.70498	0.124
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	60	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	-0.27468	-0.99791	0.4591	0.73758	1	0.4	0.295	0.283	0.70462	0.124
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	165	http://www.broadinstitute.org/gsea/msigdb/cards/CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	-0.2667	-0.99763	0.4398	0.73762	1	0.182	0.123	0.16	0.70572	0.124
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	325	http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	-0.22498	-0.99749	0.4483	0.73737	1	0.271	0.242	0.208	0.70517	0.124
PID_CDC42_REG_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CDC42_REG_PATHWAY	-0.28264	-0.99748	0.4329	0.73683	1	0.367	0.26	0.272	0.70463	0.124
HAHTOLA_SEZARY_SYNDROM_DN	37	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_SEZARY_SYNDROM_DN	-0.30443	-0.99654	0.4883	0.73842	1	0.243	0.135	0.211	0.70513	0.124
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	63	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	-0.26842	-0.99538	0.4637	0.7405	1	0.317	0.275	0.231	0.70782	0.124
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN	26	http://www.broadinstitute.org/gsea/msigdb/cards/PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN	-0.31789	-0.99518	0.4933	0.74039	1	0.615	0.467	0.328	0.70728	0.124
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN	34	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_6_DN	-0.31014	-0.99365	0.457	0.74335	1	0.294	0.16	0.247	0.70928	0.127
ROZANOV_MMP14_TARGETS_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/ROZANOV_MMP14_TARGETS_DN	-0.31017	-0.99358	0.475	0.74293	1	0.656	0.461	0.354	0.7091	0.124
KEGG_PRION_DISEASES	35	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PRION_DISEASES	-0.28131	-0.9932	0.4579	0.74323	1	0.2	0.127	0.175	0.70902	0.126
LIU_CMYB_TARGETS_UP	157	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_CMYB_TARGETS_UP	-0.21146	-0.99316	0.4737	0.74279	1	0.28	0.235	0.216	0.70847	0.124
BURTON_ADIPOGENESIS_9	92	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_9	-0.3365	-0.99299	0.4951	0.74261	1	0.293	0.18	0.241	0.70793	0.124
REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL	133	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL	-0.19508	-0.99285	0.4534	0.74238	1	0.444	0.356	0.287	0.70871	0.124
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	105	http://www.broadinstitute.org/gsea/msigdb/cards/PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	-0.23498	-0.99208	0.5119	0.74355	1	0.39	0.32	0.267	0.71055	0.124
MOREIRA_RESPONSE_TO_TSA_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/MOREIRA_RESPONSE_TO_TSA_UP	-0.30516	-0.99135	0.4874	0.74464	1	0.393	0.399	0.236	0.7108	0.125
SENESE_HDAC2_TARGETS_UP	111	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC2_TARGETS_UP	-0.30604	-0.99095	0.4898	0.74495	1	0.261	0.192	0.212	0.71246	0.127
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	180	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	-0.3006	-0.99093	0.4785	0.74442	1	0.272	0.172	0.227	0.71192	0.127
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	-0.25669	-0.99087	0.5058	0.74397	1	0.154	0.112	0.137	0.71138	0.126
KIM_WT1_TARGETS_12HR_UP	157	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_12HR_UP	-0.2362	-0.9899	0.5129	0.74554	1	0.312	0.287	0.224	0.71308	0.127
LEE_INTRATHYMIC_T_PROGENITOR	21	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_INTRATHYMIC_T_PROGENITOR	-0.34233	-0.98964	0.5	0.74557	1	0.286	0.238	0.218	0.71326	0.126
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	360	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	-0.20211	-0.98951	0.4698	0.74529	1	0.319	0.309	0.224	0.71272	0.126
KARAKAS_TGFB1_SIGNALING	17	http://www.broadinstitute.org/gsea/msigdb/cards/KARAKAS_TGFB1_SIGNALING	-0.40341	-0.98947	0.5248	0.74478	1	0.294	0.114	0.261	0.71218	0.124
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	-0.25605	-0.98935	0.4481	0.74451	1	0.405	0.347	0.265	0.71282	0.124
KAMMINGA_SENESCENCE	37	http://www.broadinstitute.org/gsea/msigdb/cards/KAMMINGA_SENESCENCE	-0.2221	-0.98925	0.4566	0.74417	1	0.0811	0.0573	0.0765	0.71267	0.124
FINAK_BREAST_CANCER_SDPP_SIGNATURE	23	http://www.broadinstitute.org/gsea/msigdb/cards/FINAK_BREAST_CANCER_SDPP_SIGNATURE	-0.34212	-0.98903	0.4806	0.7441	1	0.565	0.261	0.418	0.71284	0.124
STOSSI_RESPONSE_TO_ESTRADIOL	46	http://www.broadinstitute.org/gsea/msigdb/cards/STOSSI_RESPONSE_TO_ESTRADIOL	-0.29041	-0.98891	0.468	0.74382	1	0.239	0.157	0.202	0.7123	0.124
KEGG_ENDOCYTOSIS	174	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ENDOCYTOSIS	-0.20234	-0.98811	0.4727	0.74511	1	0.448	0.408	0.267	0.71251	0.124
PID_S1P_S1P1_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/PID_S1P_S1P1_PATHWAY	-0.27892	-0.98804	0.499	0.74471	1	0.238	0.164	0.199	0.71232	0.124
MORI_IMMATURE_B_LYMPHOCYTE_UP	50	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_IMMATURE_B_LYMPHOCYTE_UP	-0.25756	-0.98795	0.4882	0.74437	1	0.26	0.19	0.211	0.71178	0.124
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN	-0.28179	-0.98789	0.4723	0.74395	1	0.3	0.26	0.222	0.71125	0.124
ONDER_CDH1_SIGNALING_VIA_CTNNB1	78	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_SIGNALING_VIA_CTNNB1	-0.35452	-0.98767	0.502	0.74388	1	0.269	0.142	0.232	0.71115	0.124
ZHAN_MULTIPLE_MYELOMA_CD2_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD2_DN	-0.24995	-0.98749	0.4862	0.74372	1	0.5	0.432	0.285	0.7107	0.124
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP	55	http://www.broadinstitute.org/gsea/msigdb/cards/BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP	-0.25515	-0.98745	0.4648	0.74325	1	0.345	0.28	0.249	0.71017	0.124
FERRARI_RESPONSE_TO_FENRETINIDE_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/FERRARI_RESPONSE_TO_FENRETINIDE_UP	-0.41945	-0.98741	0.4652	0.74276	1	0.364	0.162	0.305	0.70963	0.123
BRUNO_HEMATOPOIESIS	64	http://www.broadinstitute.org/gsea/msigdb/cards/BRUNO_HEMATOPOIESIS	-0.27377	-0.98702	0.473	0.74309	1	0.312	0.264	0.231	0.70971	0.124
BILBAN_B_CLL_LPL_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/BILBAN_B_CLL_LPL_DN	-0.37675	-0.98643	0.4771	0.74395	1	0.256	0.0835	0.235	0.7121	0.123
MEDINA_SMARCA4_TARGETS	40	http://www.broadinstitute.org/gsea/msigdb/cards/MEDINA_SMARCA4_TARGETS	-0.25969	-0.9864	0.4557	0.74345	1	0.4	0.308	0.277	0.71167	0.123
BIOCARTA_RELA_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_RELA_PATHWAY	-0.29514	-0.98578	0.4307	0.74433	1	0.438	0.398	0.264	0.71332	0.124
WANG_CISPLATIN_RESPONSE_AND_XPC_UP	196	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_CISPLATIN_RESPONSE_AND_XPC_UP	-0.21948	-0.98505	0.4646	0.74542	1	0.291	0.265	0.215	0.71577	0.126
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	-0.28562	-0.98496	0.4719	0.74505	1	0.151	0.0903	0.138	0.71524	0.124
REACTOME_NCAM1_INTERACTIONS	39	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NCAM1_INTERACTIONS	-0.30444	-0.98483	0.4429	0.74482	1	0.667	0.436	0.377	0.7147	0.124
YIH_RESPONSE_TO_ARSENITE_C2	18	http://www.broadinstitute.org/gsea/msigdb/cards/YIH_RESPONSE_TO_ARSENITE_C2	-0.3879	-0.9844	0.5248	0.74522	1	0.222	0.114	0.197	0.71508	0.126
PID_TRAIL_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TRAIL_PATHWAY	-0.3019	-0.98355	0.507	0.74658	1	0.107	0.0478	0.102	0.71567	0.126
NIELSEN_SYNOVIAL_SARCOMA_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_SYNOVIAL_SARCOMA_DN	-0.37542	-0.98348	0.4759	0.74618	1	0.316	0.182	0.259	0.71539	0.126
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	-0.2982	-0.98327	0.499	0.74606	1	0.2	0.145	0.171	0.71577	0.126
REACTOME_GABA_RECEPTOR_ACTIVATION	51	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GABA_RECEPTOR_ACTIVATION	-0.25387	-0.98278	0.5143	0.74664	1	0.431	0.351	0.281	0.71644	0.126
PETROVA_PROX1_TARGETS_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/PETROVA_PROX1_TARGETS_DN	-0.34595	-0.98041	0.4862	0.75136	1	0.302	0.162	0.253	0.72047	0.127
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	137	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	-0.2617	-0.98029	0.4743	0.75107	1	0.394	0.329	0.266	0.71993	0.126
BIOCARTA_PPARA_PATHWAY	57	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PPARA_PATHWAY	-0.26044	-0.9802	0.5341	0.75071	1	0.14	0.115	0.124	0.71954	0.126
REACTOME_GAP_JUNCTION_TRAFFICKING	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GAP_JUNCTION_TRAFFICKING	-0.2937	-0.97875	0.5019	0.75348	1	0.6	0.429	0.343	0.72492	0.127
PID_CXCR4_PATHWAY	102	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CXCR4_PATHWAY	-0.25531	-0.97818	0.4794	0.75415	1	0.167	0.133	0.145	0.72525	0.127
REACTOME_PLATELET_SENSITIZATION_BY_LDL	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PLATELET_SENSITIZATION_BY_LDL	-0.33846	-0.97807	0.4611	0.75384	1	0.312	0.133	0.271	0.72471	0.127
SWEET_KRAS_TARGETS_UP	79	http://www.broadinstitute.org/gsea/msigdb/cards/SWEET_KRAS_TARGETS_UP	-0.30795	-0.97784	0.4696	0.75379	1	0.304	0.159	0.256	0.72473	0.127
WENG_POR_TARGETS_LIVER_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/WENG_POR_TARGETS_LIVER_DN	-0.32649	-0.97763	0.498	0.75371	1	0.211	0.133	0.183	0.72449	0.127
PROVENZANI_METASTASIS_DN	131	http://www.broadinstitute.org/gsea/msigdb/cards/PROVENZANI_METASTASIS_DN	-0.21966	-0.97731	0.4668	0.75391	1	0.305	0.263	0.226	0.72396	0.127
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	395	http://www.broadinstitute.org/gsea/msigdb/cards/REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	-0.30897	-0.97711	0.5262	0.75383	1	0.385	0.295	0.276	0.7239	0.127
BIOCARTA_IL22BP_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL22BP_PATHWAY	-0.28122	-0.97705	0.4679	0.75339	1	0.333	0.219	0.261	0.72336	0.127
HUTTMANN_B_CLL_POOR_SURVIVAL_UP	259	http://www.broadinstitute.org/gsea/msigdb/cards/HUTTMANN_B_CLL_POOR_SURVIVAL_UP	-0.19423	-0.97665	0.502	0.75375	1	0.498	0.383	0.311	0.72413	0.127
WNT_SIGNALING	88	http://www.broadinstitute.org/gsea/msigdb/cards/WNT_SIGNALING	-0.22525	-0.97657	0.4949	0.75338	1	0.409	0.322	0.278	0.72474	0.127
DOANE_RESPONSE_TO_ANDROGEN_DN	232	http://www.broadinstitute.org/gsea/msigdb/cards/DOANE_RESPONSE_TO_ANDROGEN_DN	-0.2315	-0.97652	0.501	0.75294	1	0.224	0.198	0.181	0.72421	0.127
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP	-0.31807	-0.97592	0.4848	0.75375	1	0.467	0.329	0.313	0.72399	0.127
KEGG_NOTCH_SIGNALING_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NOTCH_SIGNALING_PATHWAY	-0.19898	-0.97553	0.4419	0.75407	1	0.511	0.421	0.296	0.72412	0.127
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS	23	http://www.broadinstitute.org/gsea/msigdb/cards/BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS	-0.25346	-0.97523	0.4932	0.75412	1	0.609	0.398	0.367	0.72402	0.127
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	210	http://www.broadinstitute.org/gsea/msigdb/cards/MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	-0.31059	-0.97434	0.4939	0.75555	1	0.305	0.189	0.249	0.727	0.129
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	-0.35263	-0.97332	0.5135	0.75725	1	0.2	0.13	0.174	0.72934	0.129
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	128	http://www.broadinstitute.org/gsea/msigdb/cards/PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	-0.23526	-0.97318	0.5031	0.75701	1	0.375	0.31	0.26	0.72881	0.127
DER_IFN_BETA_RESPONSE_UP	99	http://www.broadinstitute.org/gsea/msigdb/cards/DER_IFN_BETA_RESPONSE_UP	-0.31675	-0.97164	0.4722	0.75981	1	0.212	0.138	0.184	0.73118	0.129
MARCHINI_TRABECTEDIN_RESISTANCE_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/MARCHINI_TRABECTEDIN_RESISTANCE_UP	-0.32914	-0.97103	0.4858	0.76061	1	0.25	0.131	0.217	0.73222	0.129
SASSON_RESPONSE_TO_GONADOTROPHINS_DN	87	http://www.broadinstitute.org/gsea/msigdb/cards/SASSON_RESPONSE_TO_GONADOTROPHINS_DN	-0.31277	-0.97096	0.511	0.76019	1	0.276	0.197	0.222	0.73171	0.129
BROWNE_HCMV_INFECTION_4HR_DN	245	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_4HR_DN	-0.17385	-0.97053	0.5364	0.76057	1	0.445	0.43	0.256	0.73124	0.129
GOLDRATH_IMMUNE_MEMORY	62	http://www.broadinstitute.org/gsea/msigdb/cards/GOLDRATH_IMMUNE_MEMORY	-0.26783	-0.96987	0.5238	0.76148	1	0.548	0.394	0.333	0.73247	0.129
LEE_LIVER_CANCER_MYC_TGFA_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_TGFA_UP	-0.26543	-0.96921	0.5295	0.76237	1	0.254	0.19	0.206	0.73332	0.131
WEBER_METHYLATED_HCP_IN_SPERM_DN	26	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_HCP_IN_SPERM_DN	-0.34409	-0.96907	0.5	0.76213	1	0.423	0.274	0.307	0.73281	0.129
REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	-0.3291	-0.96897	0.5556	0.76181	1	0.567	0.412	0.334	0.73267	0.129
SANDERSON_PPARA_TARGETS	15	http://www.broadinstitute.org/gsea/msigdb/cards/SANDERSON_PPARA_TARGETS	-0.31546	-0.96894	0.4921	0.76132	1	0.267	0.183	0.218	0.73214	0.129
WEBER_METHYLATED_IN_COLON_CANCER	18	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_IN_COLON_CANCER	-0.34808	-0.96885	0.4859	0.76099	1	0.5	0.298	0.351	0.73181	0.129
INGRAM_SHH_TARGETS_DN	58	http://www.broadinstitute.org/gsea/msigdb/cards/INGRAM_SHH_TARGETS_DN	-0.27611	-0.96873	0.4912	0.76067	1	0.224	0.166	0.187	0.73131	0.129
PENG_GLUCOSE_DEPRIVATION_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_GLUCOSE_DEPRIVATION_UP	-0.26079	-0.96799	0.502	0.76174	1	0.5	0.394	0.304	0.73318	0.129
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	61	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	-0.30703	-0.96718	0.5259	0.76294	1	0.213	0.135	0.185	0.73407	0.129
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	-0.25007	-0.9657	0.4921	0.76562	1	0.191	0.159	0.161	0.7395	0.132
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	22	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	-0.33858	-0.9648	0.4932	0.76705	1	0.636	0.42	0.37	0.74149	0.132
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	36	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	-0.331	-0.964	0.5155	0.76823	1	0.194	0.0978	0.176	0.74172	0.132
WEIGEL_OXIDATIVE_STRESS_RESPONSE	34	http://www.broadinstitute.org/gsea/msigdb/cards/WEIGEL_OXIDATIVE_STRESS_RESPONSE	-0.32129	-0.96368	0.5068	0.76845	1	0.206	0.102	0.185	0.74154	0.132
REACTOME_ENDOGENOUS_STEROLS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ENDOGENOUS_STEROLS	-0.30718	-0.96352	0.4943	0.76828	1	0.2	0.108	0.179	0.7412	0.132
HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	-0.2631	-0.96347	0.512	0.7678	1	0.235	0.152	0.2	0.74066	0.132
GYORFFY_MITOXANTRONE_RESISTANCE	51	http://www.broadinstitute.org/gsea/msigdb/cards/GYORFFY_MITOXANTRONE_RESISTANCE	-0.27834	-0.96306	0.536	0.76811	1	0.294	0.216	0.231	0.74176	0.132
PID_LYMPH_ANGIOGENESIS_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/PID_LYMPH_ANGIOGENESIS_PATHWAY	-0.38314	-0.96305	0.4672	0.76758	1	0.44	0.323	0.298	0.74146	0.132
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	-0.33152	-0.96301	0.5039	0.76713	1	0.471	0.302	0.329	0.74092	0.132
KEGG_STARCH_AND_SUCROSE_METABOLISM	39	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_STARCH_AND_SUCROSE_METABOLISM	-0.26155	-0.96279	0.505	0.76704	1	0.436	0.384	0.269	0.74118	0.131
ZHU_CMV_24_HR_UP	93	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_24_HR_UP	-0.28331	-0.96203	0.5041	0.76824	1	0.226	0.15	0.193	0.74166	0.132
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	63	http://www.broadinstitute.org/gsea/msigdb/cards/BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	-0.28808	-0.962	0.5793	0.76777	1	0.524	0.374	0.329	0.74121	0.132
REACTOME_MEIOTIC_RECOMBINATION	63	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MEIOTIC_RECOMBINATION	-0.30469	-0.96188	0.505	0.76747	1	0.302	0.18	0.248	0.74099	0.132
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	-0.30688	-0.96182	0.5198	0.76705	1	0.244	0.12	0.215	0.74077	0.132
COLLER_MYC_TARGETS_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/COLLER_MYC_TARGETS_UP	-0.31377	-0.96143	0.5165	0.76733	1	0.12	0.0808	0.11	0.74065	0.132
AIYAR_COBRA1_TARGETS_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/AIYAR_COBRA1_TARGETS_DN	-0.26473	-0.96099	0.5158	0.76781	1	0.357	0.281	0.257	0.74151	0.132
SHIN_B_CELL_LYMPHOMA_CLUSTER_3	28	http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_3	-0.28188	-0.96079	0.4847	0.76768	1	0.214	0.118	0.189	0.74111	0.132
LIM_MAMMARY_STEM_CELL_UP	465	http://www.broadinstitute.org/gsea/msigdb/cards/LIM_MAMMARY_STEM_CELL_UP	-0.26175	-0.96077	0.4898	0.76717	1	0.4	0.305	0.283	0.74073	0.132
MARKS_HDAC_TARGETS_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/MARKS_HDAC_TARGETS_UP	-0.32476	-0.96067	0.4575	0.76682	1	0.261	0.193	0.211	0.7402	0.132
PID_INTEGRIN5_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN5_PATHWAY	-0.46285	-0.96061	0.5767	0.76641	1	0.412	0.186	0.336	0.73966	0.132
MOHANKUMAR_TLX1_TARGETS_DN	175	http://www.broadinstitute.org/gsea/msigdb/cards/MOHANKUMAR_TLX1_TARGETS_DN	-0.20047	-0.96033	0.5529	0.76648	1	0.423	0.371	0.268	0.73974	0.13
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN	-0.37083	-0.9601	0.504	0.76644	1	0.227	0.192	0.184	0.74024	0.13
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	-0.21395	-0.96005	0.5368	0.76603	1	0.141	0.103	0.127	0.73971	0.13
BENPORATH_ES_CORE_NINE_CORRELATED	100	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_ES_CORE_NINE_CORRELATED	-0.19969	-0.95961	0.5135	0.76653	1	0.3	0.322	0.204	0.74056	0.129
ELVIDGE_HYPOXIA_UP	164	http://www.broadinstitute.org/gsea/msigdb/cards/ELVIDGE_HYPOXIA_UP	-0.24398	-0.95941	0.4961	0.76641	1	0.293	0.233	0.226	0.74003	0.129
PID_HNF3B_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HNF3B_PATHWAY	-0.26719	-0.95909	0.5498	0.76656	1	0.511	0.393	0.311	0.7401	0.129
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	-0.27659	-0.95869	0.532	0.76695	1	0.702	0.517	0.34	0.74017	0.129
WILLIAMS_ESR1_TARGETS_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/WILLIAMS_ESR1_TARGETS_UP	-0.26858	-0.95844	0.5855	0.76694	1	0.269	0.214	0.212	0.73964	0.129
DANG_MYC_TARGETS_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/DANG_MYC_TARGETS_DN	-0.29126	-0.95803	0.498	0.76726	1	0.533	0.467	0.285	0.73912	0.129
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	60	http://www.broadinstitute.org/gsea/msigdb/cards/GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	-0.26477	-0.95795	0.5306	0.76688	1	0.467	0.399	0.281	0.73919	0.129
VERRECCHIA_RESPONSE_TO_TGFB1_C1	19	http://www.broadinstitute.org/gsea/msigdb/cards/VERRECCHIA_RESPONSE_TO_TGFB1_C1	-0.37172	-0.95786	0.5454	0.76652	1	0.579	0.292	0.41	0.73925	0.129
CHEN_ETV5_TARGETS_TESTIS	22	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_ETV5_TARGETS_TESTIS	-0.27775	-0.95776	0.5617	0.76616	1	0.227	0.188	0.185	0.73903	0.129
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	-0.3233	-0.95769	0.5625	0.76576	1	0.158	0.0391	0.152	0.7385	0.127
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN	-0.32699	-0.95766	0.5397	0.76528	1	0.326	0.211	0.257	0.73797	0.127
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4	15	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4	-0.33786	-0.9573	0.5421	0.76551	1	0.467	0.446	0.259	0.73808	0.127
WONG_ENDMETRIUM_CANCER_DN	79	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_ENDMETRIUM_CANCER_DN	-0.37987	-0.95555	0.5364	0.7687	1	0.443	0.25	0.333	0.74414	0.129
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	-0.45952	-0.9555	0.5686	0.76826	1	0.31	0.114	0.275	0.74361	0.129
KORKOLA_CORRELATED_WITH_POU5F1	33	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_CORRELATED_WITH_POU5F1	-0.30964	-0.95543	0.5758	0.76786	1	0.636	0.445	0.354	0.74308	0.129
NIELSEN_SYNOVIAL_SARCOMA_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_SYNOVIAL_SARCOMA_UP	-0.29447	-0.95522	0.5114	0.76781	1	0.5	0.349	0.326	0.74269	0.127
KEGG_MELANOMA	69	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_MELANOMA	-0.26259	-0.95516	0.5312	0.7674	1	0.188	0.148	0.161	0.74216	0.127
FAELT_B_CLL_WITH_VH3_21_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/FAELT_B_CLL_WITH_VH3_21_UP	-0.25077	-0.95497	0.5102	0.76726	1	0.476	0.442	0.266	0.7429	0.127
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	36	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	-0.33869	-0.95442	0.5302	0.76798	1	0.417	0.271	0.304	0.74325	0.127
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM	106	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLYCOSAMINOGLYCAN_METABOLISM	-0.23411	-0.95363	0.4912	0.76921	1	0.528	0.42	0.308	0.74448	0.127
PID_CIRCADIAN_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CIRCADIAN_PATHWAY	-0.28889	-0.95336	0.5215	0.76926	1	0.0667	0.00319	0.0665	0.74421	0.127
BROWNE_HCMV_INFECTION_4HR_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_4HR_UP	-0.31804	-0.95332	0.5112	0.76881	1	0.173	0.0886	0.158	0.74393	0.127
REACTOME_PI_3K_CASCADE	54	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PI_3K_CASCADE	-0.26659	-0.95198	0.506	0.77125	1	0.519	0.39	0.317	0.74595	0.127
REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT	-0.32151	-0.95196	0.5341	0.77075	1	0.429	0.298	0.301	0.74543	0.127
CHICAS_RB1_TARGETS_LOW_SERUM	89	http://www.broadinstitute.org/gsea/msigdb/cards/CHICAS_RB1_TARGETS_LOW_SERUM	-0.22961	-0.95184	0.499	0.77046	1	0.213	0.198	0.172	0.7449	0.127
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	59	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	-0.24928	-0.95139	0.5281	0.77089	1	0.288	0.217	0.226	0.74516	0.127
DURAND_STROMA_S_UP	284	http://www.broadinstitute.org/gsea/msigdb/cards/DURAND_STROMA_S_UP	-0.24481	-0.95135	0.5131	0.77045	1	0.299	0.237	0.231	0.74464	0.127
COATES_MACROPHAGE_M1_VS_M2_UP	77	http://www.broadinstitute.org/gsea/msigdb/cards/COATES_MACROPHAGE_M1_VS_M2_UP	-0.28212	-0.95119	0.5174	0.77021	1	0.26	0.157	0.22	0.74446	0.127
BIOCARTA_ERYTH_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ERYTH_PATHWAY	-0.32036	-0.95093	0.5087	0.77025	1	0.667	0.474	0.351	0.74485	0.127
KEGG_STEROID_HORMONE_BIOSYNTHESIS	44	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_STEROID_HORMONE_BIOSYNTHESIS	-0.28824	-0.95092	0.5428	0.76972	1	0.341	0.273	0.248	0.74433	0.127
ZWANG_EGF_INTERVAL_DN	199	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_EGF_INTERVAL_DN	-0.20073	-0.95083	0.6021	0.76943	1	0.201	0.166	0.169	0.74391	0.127
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	64	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	-0.22699	-0.95042	0.5157	0.76979	1	0.141	0.118	0.124	0.74459	0.127
AMIT_EGF_RESPONSE_240_MCF10A	20	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_240_MCF10A	-0.28932	-0.94982	0.5762	0.77056	1	0.5	0.32	0.34	0.74609	0.127
GRANDVAUX_IRF3_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/GRANDVAUX_IRF3_TARGETS_DN	-0.38485	-0.94955	0.5466	0.77061	1	0.211	0.0593	0.198	0.74557	0.127
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN	101	http://www.broadinstitute.org/gsea/msigdb/cards/ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN	-0.24055	-0.94954	0.5268	0.7701	1	0.238	0.189	0.193	0.74504	0.127
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	120	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	-0.25612	-0.9493	0.537	0.77006	1	0.242	0.197	0.195	0.74462	0.127
MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	24	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	-0.30841	-0.94889	0.572	0.77045	1	0.417	0.315	0.286	0.74455	0.127
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	162	http://www.broadinstitute.org/gsea/msigdb/cards/BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	-0.30741	-0.94843	0.5292	0.77094	1	0.296	0.191	0.241	0.74563	0.127
ELVIDGE_HYPOXIA_BY_DMOG_UP	125	http://www.broadinstitute.org/gsea/msigdb/cards/ELVIDGE_HYPOXIA_BY_DMOG_UP	-0.25789	-0.94834	0.5251	0.7706	1	0.344	0.264	0.255	0.74519	0.127
CAMPS_COLON_CANCER_COPY_NUMBER_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/CAMPS_COLON_CANCER_COPY_NUMBER_UP	-0.2267	-0.94826	0.5568	0.77023	1	0.524	0.443	0.293	0.74488	0.127
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	118	http://www.broadinstitute.org/gsea/msigdb/cards/IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	-0.22966	-0.94824	0.5529	0.76975	1	0.314	0.303	0.22	0.74468	0.127
MIKKELSEN_MEF_ICP_WITH_H3K27ME3	189	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MEF_ICP_WITH_H3K27ME3	-0.27164	-0.94795	0.6272	0.76986	1	0.624	0.44	0.352	0.7445	0.125
LIU_LIVER_CANCER	37	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_LIVER_CANCER	-0.22003	-0.94786	0.537	0.76952	1	0.486	0.403	0.291	0.74399	0.125
ROLEF_GLIS3_TARGETS	37	http://www.broadinstitute.org/gsea/msigdb/cards/ROLEF_GLIS3_TARGETS	-0.29003	-0.94714	0.5876	0.77058	1	0.351	0.22	0.275	0.74488	0.127
REACTOME_G_ALPHA1213_SIGNALLING_EVENTS	73	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_ALPHA1213_SIGNALLING_EVENTS	-0.22372	-0.94708	0.5394	0.77017	1	0.466	0.395	0.283	0.74436	0.125
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	-0.30025	-0.94685	0.497	0.77014	1	0.211	0.161	0.177	0.74417	0.125
DOANE_BREAST_CANCER_ESR1_UP	109	http://www.broadinstitute.org/gsea/msigdb/cards/DOANE_BREAST_CANCER_ESR1_UP	-0.19157	-0.94684	0.5931	0.76963	1	0.468	0.408	0.278	0.74366	0.124
WILCOX_RESPONSE_TO_PROGESTERONE_DN	61	http://www.broadinstitute.org/gsea/msigdb/cards/WILCOX_RESPONSE_TO_PROGESTERONE_DN	-0.32126	-0.94681	0.5423	0.76913	1	0.475	0.3	0.333	0.74314	0.123
PID_WNT_SIGNALING_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/PID_WNT_SIGNALING_PATHWAY	-0.29413	-0.94623	0.5235	0.76989	1	0.464	0.31	0.321	0.74422	0.123
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	-0.35734	-0.94622	0.5109	0.76939	1	0.346	0.191	0.28	0.7437	0.123
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	68	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	-0.22836	-0.94589	0.5198	0.76953	1	0.515	0.466	0.275	0.74353	0.123
BIOCARTA_41BB_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_41BB_PATHWAY	-0.34599	-0.94566	0.5115	0.76951	1	0.294	0.132	0.255	0.74369	0.123
ZWANG_EGF_INTERVAL_UP	90	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_EGF_INTERVAL_UP	-0.20666	-0.94566	0.6081	0.76898	1	0.322	0.267	0.237	0.74318	0.123
HOELZEL_NF1_TARGETS_UP	129	http://www.broadinstitute.org/gsea/msigdb/cards/HOELZEL_NF1_TARGETS_UP	-0.26124	-0.94543	0.5216	0.76891	1	0.271	0.197	0.219	0.74351	0.123
ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN	16	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN	-0.31136	-0.94473	0.5249	0.76986	1	0.625	0.361	0.399	0.74514	0.123
YANG_BREAST_CANCER_ESR1_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_BREAST_CANCER_ESR1_UP	-0.25258	-0.94445	0.5069	0.76993	1	0.167	0.158	0.141	0.74553	0.123
MATSUDA_NATURAL_KILLER_DIFFERENTIATION	454	http://www.broadinstitute.org/gsea/msigdb/cards/MATSUDA_NATURAL_KILLER_DIFFERENTIATION	-0.21306	-0.94433	0.5771	0.76969	1	0.233	0.204	0.189	0.74509	0.123
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	65	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	-0.2457	-0.94413	0.5513	0.76955	1	0.323	0.235	0.248	0.74469	0.123
LEE_NAIVE_T_LYMPHOCYTE	16	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_NAIVE_T_LYMPHOCYTE	-0.3177	-0.94365	0.5197	0.77	1	0.5	0.303	0.349	0.74456	0.123
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	58	http://www.broadinstitute.org/gsea/msigdb/cards/VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	-0.3578	-0.94338	0.5778	0.77004	1	0.448	0.304	0.313	0.7449	0.123
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY	35	http://www.broadinstitute.org/gsea/msigdb/cards/CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY	-0.32014	-0.94312	0.5675	0.77011	1	0.543	0.417	0.317	0.74612	0.123
FARMER_BREAST_CANCER_CLUSTER_5	19	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_5	-0.53357	-0.9422	0.5971	0.77154	1	0.368	0.0732	0.342	0.74827	0.123
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	72	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	-0.2739	-0.94137	0.5586	0.7728	1	0.222	0.143	0.191	0.74955	0.124
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	-0.26197	-0.93735	0.5431	0.7811	1	0.0625	0.0114	0.0619	0.75818	0.129
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	-0.3056	-0.93679	0.498	0.78175	1	0.393	0.325	0.265	0.75939	0.129
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP	-0.33266	-0.93617	0.5401	0.78248	1	0.462	0.283	0.331	0.75945	0.129
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP	-0.3996	-0.93594	0.5647	0.78236	1	0.333	0.164	0.279	0.75929	0.129
ROSS_AML_OF_FAB_M7_TYPE	67	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_AML_OF_FAB_M7_TYPE	-0.23189	-0.93584	0.5979	0.78204	1	0.433	0.357	0.279	0.75909	0.129
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP	-0.42958	-0.93499	0.5458	0.78332	1	0.25	0.0646	0.234	0.76023	0.129
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	172	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	-0.21717	-0.93491	0.6692	0.78294	1	0.407	0.331	0.274	0.75971	0.129
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	87	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	-0.19147	-0.93462	0.6126	0.78298	1	0.368	0.313	0.254	0.76025	0.129
NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	47	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	-0.29346	-0.93457	0.6043	0.78258	1	0.596	0.427	0.342	0.75973	0.129
ZAMORA_NOS2_TARGETS_DN	94	http://www.broadinstitute.org/gsea/msigdb/cards/ZAMORA_NOS2_TARGETS_DN	-0.22523	-0.93402	0.5179	0.78317	1	0.351	0.305	0.245	0.76006	0.129
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	100	http://www.broadinstitute.org/gsea/msigdb/cards/TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	-0.18052	-0.93373	0.6133	0.78325	1	0.22	0.234	0.169	0.76085	0.129
JAEGER_METASTASIS_DN	252	http://www.broadinstitute.org/gsea/msigdb/cards/JAEGER_METASTASIS_DN	-0.21181	-0.93365	0.6267	0.7829	1	0.413	0.366	0.264	0.76052	0.128
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES	15	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES	-0.3225	-0.93331	0.517	0.78315	1	0.6	0.383	0.371	0.76058	0.129
SHIN_B_CELL_LYMPHOMA_CLUSTER_2	29	http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_2	-0.26663	-0.93298	0.519	0.78333	1	0.414	0.335	0.276	0.76063	0.129
CHYLA_CBFA2T3_TARGETS_DN	224	http://www.broadinstitute.org/gsea/msigdb/cards/CHYLA_CBFA2T3_TARGETS_DN	-0.17192	-0.93297	0.6138	0.78283	1	0.42	0.357	0.272	0.76069	0.128
DARWICHE_PAPILLOMA_RISK_HIGH_UP	141	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_RISK_HIGH_UP	-0.17824	-0.93264	0.6413	0.78297	1	0.326	0.324	0.222	0.76074	0.128
MEISSNER_BRAIN_HCP_WITH_H3K4ME2	16	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3K4ME2	-0.32203	-0.93248	0.6211	0.78279	1	0.688	0.481	0.357	0.76038	0.128
GNATENKO_PLATELET_SIGNATURE	45	http://www.broadinstitute.org/gsea/msigdb/cards/GNATENKO_PLATELET_SIGNATURE	-0.25457	-0.93241	0.5394	0.78241	1	0.222	0.136	0.192	0.76023	0.128
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	-0.28628	-0.9321	0.5298	0.78257	1	0.341	0.172	0.283	0.7609	0.127
KOBAYASHI_EGFR_SIGNALING_24HR_UP	95	http://www.broadinstitute.org/gsea/msigdb/cards/KOBAYASHI_EGFR_SIGNALING_24HR_UP	-0.21684	-0.93146	0.54	0.78343	1	0.326	0.265	0.241	0.76259	0.128
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	76	http://www.broadinstitute.org/gsea/msigdb/cards/HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	-0.2913	-0.93054	0.5891	0.78483	1	0.197	0.0963	0.179	0.76453	0.128
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	100	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	-0.19175	-0.93017	0.5048	0.78514	1	0.49	0.458	0.267	0.76523	0.128
KEGG_TYPE_II_DIABETES_MELLITUS	46	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TYPE_II_DIABETES_MELLITUS	-0.23477	-0.92933	0.5878	0.78645	1	0.565	0.414	0.332	0.76761	0.129
PEDRIOLI_MIR31_TARGETS_DN	383	http://www.broadinstitute.org/gsea/msigdb/cards/PEDRIOLI_MIR31_TARGETS_DN	-0.1979	-0.92901	0.645	0.78663	1	0.298	0.261	0.223	0.76771	0.129
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	116	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	-0.21167	-0.92861	0.6337	0.78696	1	0.198	0.149	0.17	0.76799	0.129
KEGG_GLYCOLYSIS_GLUCONEOGENESIS	61	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOLYSIS_GLUCONEOGENESIS	-0.23804	-0.92808	0.6047	0.78759	1	0.262	0.221	0.205	0.76967	0.13
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	-0.24504	-0.92786	0.5339	0.78755	1	0.339	0.308	0.235	0.7694	0.13
TOMIDA_METASTASIS_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/TOMIDA_METASTASIS_UP	-0.22004	-0.92734	0.5825	0.78812	1	0.2	0.146	0.171	0.77015	0.129
REACTOME_REGULATION_OF_SIGNALING_BY_CBL	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_SIGNALING_BY_CBL	-0.33548	-0.92712	0.5594	0.78806	1	0.667	0.502	0.332	0.77062	0.129
BEIER_GLIOMA_STEM_CELL_DN	61	http://www.broadinstitute.org/gsea/msigdb/cards/BEIER_GLIOMA_STEM_CELL_DN	-0.26671	-0.927	0.5622	0.78778	1	0.279	0.241	0.212	0.77043	0.129
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	57	http://www.broadinstitute.org/gsea/msigdb/cards/POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	-0.31236	-0.92691	0.5708	0.78746	1	0.158	0.0465	0.151	0.76991	0.129
SA_TRKA_RECEPTOR	17	http://www.broadinstitute.org/gsea/msigdb/cards/SA_TRKA_RECEPTOR	-0.27727	-0.92685	0.5295	0.78704	1	0.353	0.323	0.239	0.76939	0.129
PID_SYNDECAN_4_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SYNDECAN_4_PATHWAY	-0.34829	-0.92651	0.5824	0.78723	1	0.406	0.293	0.288	0.76888	0.129
WOO_LIVER_CANCER_RECURRENCE_UP	102	http://www.broadinstitute.org/gsea/msigdb/cards/WOO_LIVER_CANCER_RECURRENCE_UP	-0.30264	-0.92625	0.6181	0.78728	1	0.373	0.267	0.274	0.76847	0.129
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	-0.27706	-0.92612	0.5438	0.78704	1	0.125	0.114	0.111	0.76795	0.129
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	84	http://www.broadinstitute.org/gsea/msigdb/cards/SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	-0.21737	-0.92519	0.5732	0.78854	1	0.286	0.248	0.216	0.76965	0.13
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP	-0.29335	-0.92423	0.5549	0.79006	1	0.194	0.114	0.173	0.77084	0.13
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	33	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	-0.31659	-0.92392	0.5739	0.79019	1	0.485	0.349	0.316	0.77076	0.13
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	138	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	-0.2695	-0.92366	0.5678	0.7902	1	0.232	0.151	0.198	0.77024	0.129
RIZ_ERYTHROID_DIFFERENTIATION_12HR	42	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_12HR	-0.26142	-0.92333	0.5662	0.79035	1	0.238	0.127	0.208	0.77036	0.129
BIOCARTA_CXCR4_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CXCR4_PATHWAY	-0.3355	-0.92306	0.6218	0.79042	1	0.0833	0.0272	0.0811	0.77049	0.129
KEGG_PPAR_SIGNALING_PATHWAY	68	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PPAR_SIGNALING_PATHWAY	-0.21464	-0.92278	0.6097	0.79046	1	0.25	0.224	0.195	0.77063	0.128
KEGG_GLYCEROLIPID_METABOLISM	49	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCEROLIPID_METABOLISM	-0.22736	-0.92266	0.5737	0.7902	1	0.408	0.352	0.265	0.77077	0.128
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	125	http://www.broadinstitute.org/gsea/msigdb/cards/PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	-0.3247	-0.92249	0.5492	0.79003	1	0.28	0.168	0.234	0.77043	0.128
BIOCARTA_MCALPAIN_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MCALPAIN_PATHWAY	-0.26607	-0.92239	0.5675	0.7897	1	0.12	0.0808	0.11	0.77039	0.127
OXFORD_RALA_OR_RALB_TARGETS_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/OXFORD_RALA_OR_RALB_TARGETS_DN	-0.27941	-0.92137	0.5689	0.79147	1	0.609	0.392	0.37	0.77285	0.129
CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	-0.35118	-0.92107	0.5709	0.79156	1	0.3	0.212	0.237	0.77265	0.129
JIANG_TIP30_TARGETS_UP	45	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_TIP30_TARGETS_UP	-0.34209	-0.92107	0.5277	0.79104	1	0.356	0.223	0.277	0.77214	0.129
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	22	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	-0.27132	-0.92062	0.5291	0.79148	1	0.5	0.315	0.343	0.77228	0.128
KOYAMA_SEMA3B_TARGETS_UP	266	http://www.broadinstitute.org/gsea/msigdb/cards/KOYAMA_SEMA3B_TARGETS_UP	-0.19619	-0.92013	0.626	0.79199	1	0.417	0.371	0.265	0.77296	0.128
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	17	http://www.broadinstitute.org/gsea/msigdb/cards/KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	-0.27981	-0.91961	0.6333	0.79254	1	0.235	0.142	0.202	0.77245	0.128
BILANGES_SERUM_SENSITIVE_GENES	87	http://www.broadinstitute.org/gsea/msigdb/cards/BILANGES_SERUM_SENSITIVE_GENES	-0.17761	-0.91955	0.5678	0.79215	1	0.414	0.389	0.254	0.77194	0.128
MCGOWAN_RSP6_TARGETS_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/MCGOWAN_RSP6_TARGETS_UP	-0.30944	-0.91941	0.5442	0.7919	1	0.167	0.0745	0.154	0.77142	0.128
BIOCARTA_VIP_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_VIP_PATHWAY	-0.28223	-0.91853	0.6028	0.79324	1	0.148	0.115	0.131	0.77344	0.128
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	123	http://www.broadinstitute.org/gsea/msigdb/cards/KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	-0.24511	-0.91775	0.5551	0.79441	1	0.382	0.309	0.265	0.77569	0.128
TRAYNOR_RETT_SYNDROM_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/TRAYNOR_RETT_SYNDROM_UP	-0.30787	-0.91769	0.5975	0.79401	1	0.381	0.211	0.301	0.77518	0.128
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G	94	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G	-0.26205	-0.91762	0.5482	0.79362	1	0.457	0.354	0.296	0.77503	0.128
KANG_FLUOROURACIL_RESISTANCE_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_FLUOROURACIL_RESISTANCE_UP	-0.28951	-0.91761	0.5624	0.79311	1	0.381	0.236	0.291	0.77452	0.127
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	153	http://www.broadinstitute.org/gsea/msigdb/cards/NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	-0.2075	-0.91749	0.5697	0.79285	1	0.222	0.202	0.178	0.77458	0.127
REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	-0.32451	-0.91631	0.5701	0.79489	1	0.647	0.39	0.395	0.77691	0.127
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	78	http://www.broadinstitute.org/gsea/msigdb/cards/GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	-0.20281	-0.9161	0.5824	0.79484	1	0.397	0.345	0.261	0.77783	0.127
PID_FOXM1_PATHWAY	39	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FOXM1_PATHWAY	-0.27523	-0.91569	0.527	0.7952	1	0.436	0.308	0.302	0.7781	0.127
OKUMURA_INFLAMMATORY_RESPONSE_LPS	174	http://www.broadinstitute.org/gsea/msigdb/cards/OKUMURA_INFLAMMATORY_RESPONSE_LPS	-0.20676	-0.91563	0.614	0.79481	1	0.345	0.292	0.246	0.77764	0.127
REACTOME_BETA_DEFENSINS	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BETA_DEFENSINS	-0.3951	-0.9156	0.607	0.79437	1	0.45	0.259	0.334	0.77713	0.127
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	134	http://www.broadinstitute.org/gsea/msigdb/cards/COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	-0.16812	-0.91543	0.6198	0.79421	1	0.47	0.41	0.279	0.77724	0.127
HU_GENOTOXIC_DAMAGE_24HR	32	http://www.broadinstitute.org/gsea/msigdb/cards/HU_GENOTOXIC_DAMAGE_24HR	-0.25589	-0.91537	0.5369	0.7938	1	0.219	0.178	0.18	0.77673	0.127
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	114	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	-0.19273	-0.9148	0.6227	0.79449	1	0.0877	0.0483	0.0839	0.77812	0.127
LEE_NEURAL_CREST_STEM_CELL_DN	113	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_NEURAL_CREST_STEM_CELL_DN	-0.22583	-0.91305	0.6364	0.79763	1	0.354	0.298	0.249	0.7813	0.127
REACTOME_POTASSIUM_CHANNELS	96	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_POTASSIUM_CHANNELS	-0.25308	-0.91297	0.6257	0.79729	1	0.635	0.482	0.33	0.78078	0.127
ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	486	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	-0.18179	-0.91239	0.6344	0.79793	1	0.257	0.24	0.199	0.78096	0.127
REACTOME_KINESINS	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_KINESINS	-0.26935	-0.91234	0.554	0.7975	1	0.625	0.53	0.294	0.78095	0.127
REACTOME_PYRIMIDINE_METABOLISM	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PYRIMIDINE_METABOLISM	-0.32059	-0.91178	0.5876	0.79815	1	0.591	0.442	0.33	0.78212	0.127
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	-0.29951	-0.91093	0.5424	0.79941	1	0.463	0.313	0.319	0.78335	0.128
JIANG_AGING_HYPOTHALAMUS_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_AGING_HYPOTHALAMUS_UP	-0.24824	-0.91032	0.6081	0.80018	1	0.174	0.133	0.151	0.78408	0.128
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	231	http://www.broadinstitute.org/gsea/msigdb/cards/CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	-0.20602	-0.91008	0.5686	0.80015	1	0.407	0.352	0.266	0.78373	0.127
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	-0.28162	-0.90984	0.6146	0.80012	1	0.12	0.0369	0.116	0.78396	0.127
SASSON_RESPONSE_TO_FORSKOLIN_DN	88	http://www.broadinstitute.org/gsea/msigdb/cards/SASSON_RESPONSE_TO_FORSKOLIN_DN	-0.28267	-0.90866	0.6217	0.80211	1	0.261	0.197	0.211	0.78514	0.128
HEIDENBLAD_AMPLICON_8Q24_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/HEIDENBLAD_AMPLICON_8Q24_DN	-0.28378	-0.90823	0.5799	0.80251	1	0.405	0.314	0.278	0.78593	0.129
VISALA_AGING_LYMPHOCYTE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/VISALA_AGING_LYMPHOCYTE_DN	-0.29197	-0.90762	0.622	0.80322	1	0.421	0.268	0.308	0.7861	0.131
DORSAM_HOXA9_TARGETS_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/DORSAM_HOXA9_TARGETS_DN	-0.26111	-0.9076	0.6522	0.80274	1	0.233	0.172	0.193	0.78625	0.129
SWEET_LUNG_CANCER_KRAS_UP	475	http://www.broadinstitute.org/gsea/msigdb/cards/SWEET_LUNG_CANCER_KRAS_UP	-0.17971	-0.9073	0.6419	0.80284	1	0.246	0.241	0.191	0.78587	0.128
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	197	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	-0.21464	-0.90679	0.6012	0.8034	1	0.239	0.235	0.184	0.78594	0.128
PID_PDGFRA_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PDGFRA_PATHWAY	-0.35019	-0.90636	0.5488	0.80374	1	0.526	0.401	0.315	0.78658	0.128
CHEN_LIVER_METABOLISM_QTL_CIS	89	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_LIVER_METABOLISM_QTL_CIS	-0.22004	-0.9061	0.6376	0.80371	1	0.315	0.245	0.239	0.78752	0.13
ONDER_CDH1_TARGETS_3_DN	57	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_TARGETS_3_DN	-0.28692	-0.90583	0.6149	0.80373	1	0.509	0.365	0.324	0.78763	0.128
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	67	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	-0.2205	-0.90545	0.6413	0.80407	1	0.224	0.209	0.178	0.78764	0.128
BIOCARTA_BCELLSURVIVAL_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_BCELLSURVIVAL_PATHWAY	-0.37435	-0.90434	0.5901	0.80586	1	0.188	0.0835	0.172	0.78868	0.13
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	-0.30806	-0.90409	0.5605	0.80586	1	0.367	0.244	0.278	0.78887	0.131
WANG_SMARCE1_TARGETS_UP	269	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_SMARCE1_TARGETS_UP	-0.30569	-0.90286	0.593	0.80794	1	0.286	0.19	0.234	0.79173	0.137
REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING	-0.25811	-0.90257	0.5763	0.80801	1	0.133	0.0483	0.127	0.79157	0.137
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	-0.25421	-0.90173	0.632	0.80921	1	0.576	0.376	0.36	0.79228	0.137
BIOCARTA_CDMAC_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CDMAC_PATHWAY	-0.34431	-0.90136	0.5365	0.80949	1	0.2	0.115	0.177	0.79213	0.137
HAN_SATB1_TARGETS_UP	375	http://www.broadinstitute.org/gsea/msigdb/cards/HAN_SATB1_TARGETS_UP	-0.18602	-0.90093	0.6926	0.80986	1	0.16	0.15	0.138	0.79328	0.137
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	46	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	-0.26104	-0.89999	0.5948	0.81134	1	0.304	0.235	0.233	0.79382	0.138
REACTOME_RNA_POL_I_TRANSCRIPTION	65	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_TRANSCRIPTION	-0.28731	-0.8999	0.609	0.811	1	0.277	0.18	0.228	0.79352	0.138
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	343	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	-0.18772	-0.89979	0.616	0.81073	1	0.184	0.18	0.153	0.79338	0.138
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	19	http://www.broadinstitute.org/gsea/msigdb/cards/MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	-0.32495	-0.89932	0.5959	0.81121	1	0.316	0.214	0.248	0.79535	0.138
HOWLIN_CITED1_TARGETS_2_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/HOWLIN_CITED1_TARGETS_2_DN	-0.27801	-0.89924	0.5904	0.81087	1	0.438	0.38	0.271	0.79484	0.138
ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	477	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	-0.21095	-0.89919	0.6242	0.81044	1	0.231	0.205	0.187	0.79433	0.136
SPIRA_SMOKERS_LUNG_CANCER_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/SPIRA_SMOKERS_LUNG_CANCER_UP	-0.34503	-0.89871	0.6349	0.81091	1	0.222	0.0968	0.201	0.79458	0.136
HOWLIN_CITED1_TARGETS_2_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/HOWLIN_CITED1_TARGETS_2_UP	-0.32771	-0.89845	0.549	0.81096	1	0.25	0.207	0.198	0.79483	0.136
REACTOME_SYNTHESIS_OF_PC	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_PC	-0.27075	-0.89787	0.5905	0.81162	1	0.0588	0.000389	0.0588	0.79531	0.136
KESHELAVA_MULTIPLE_DRUG_RESISTANCE	80	http://www.broadinstitute.org/gsea/msigdb/cards/KESHELAVA_MULTIPLE_DRUG_RESISTANCE	-0.19332	-0.89743	0.5865	0.81202	1	0.438	0.4	0.263	0.79592	0.136
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	36	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	-0.34501	-0.89626	0.6154	0.81396	1	0.194	0.0784	0.179	0.79748	0.137
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	175	http://www.broadinstitute.org/gsea/msigdb/cards/PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	-0.18385	-0.89605	0.634	0.81384	1	0.371	0.354	0.242	0.79741	0.137
AZARE_STAT3_TARGETS	23	http://www.broadinstitute.org/gsea/msigdb/cards/AZARE_STAT3_TARGETS	-0.37646	-0.89556	0.5666	0.8144	1	0.348	0.179	0.286	0.79768	0.137
PID_LYSOPHOSPHOLIPID_PATHWAY	65	http://www.broadinstitute.org/gsea/msigdb/cards/PID_LYSOPHOSPHOLIPID_PATHWAY	-0.21346	-0.89552	0.5698	0.81399	1	0.477	0.399	0.287	0.79717	0.136
DITTMER_PTHLH_TARGETS_DN	70	http://www.broadinstitute.org/gsea/msigdb/cards/DITTMER_PTHLH_TARGETS_DN	-0.28857	-0.89552	0.5768	0.81347	1	0.257	0.204	0.205	0.79666	0.136
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	-0.30405	-0.89534	0.5772	0.81332	1	0.31	0.191	0.251	0.79615	0.136
BROWNE_HCMV_INFECTION_48HR_DN	484	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_48HR_DN	-0.20208	-0.89428	0.6252	0.81508	1	0.314	0.291	0.227	0.79735	0.138
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP	-0.2468	-0.89286	0.6093	0.81753	1	0.37	0.313	0.255	0.80065	0.14
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	37	http://www.broadinstitute.org/gsea/msigdb/cards/QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	-0.28892	-0.89276	0.5833	0.81724	1	0.514	0.431	0.292	0.80018	0.14
REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	-0.36234	-0.89227	0.6041	0.81772	1	0.467	0.242	0.354	0.80031	0.14
KIM_ALL_DISORDERS_DURATION_CORR_DN	141	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_ALL_DISORDERS_DURATION_CORR_DN	-0.19637	-0.8921	0.5841	0.81761	1	0.624	0.536	0.291	0.79984	0.14
KEGG_MELANOGENESIS	101	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_MELANOGENESIS	-0.18878	-0.89171	0.6037	0.81787	1	0.446	0.402	0.267	0.80019	0.14
KAYO_AGING_MUSCLE_UP	236	http://www.broadinstitute.org/gsea/msigdb/cards/KAYO_AGING_MUSCLE_UP	-0.16139	-0.89159	0.749	0.81754	1	0.411	0.399	0.249	0.79968	0.139
KEGG_DRUG_METABOLISM_OTHER_ENZYMES	40	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_DRUG_METABOLISM_OTHER_ENZYMES	-0.26521	-0.89131	0.6113	0.81754	1	0.5	0.442	0.28	0.80019	0.14
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	74	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	-0.21005	-0.89079	0.6529	0.8181	1	0.5	0.406	0.298	0.80048	0.14
CHOW_RASSF1_TARGETS_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/CHOW_RASSF1_TARGETS_UP	-0.28793	-0.89017	0.6365	0.81881	1	0.296	0.201	0.237	0.80074	0.142
STEIN_ESRRA_TARGETS_DN	101	http://www.broadinstitute.org/gsea/msigdb/cards/STEIN_ESRRA_TARGETS_DN	-0.20792	-0.89015	0.6296	0.81833	1	0.208	0.196	0.168	0.80024	0.135
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	-0.28675	-0.88981	0.6441	0.81851	1	0.458	0.26	0.34	0.80147	0.14
RIZKI_TUMOR_INVASIVENESS_3D_DN	255	http://www.broadinstitute.org/gsea/msigdb/cards/RIZKI_TUMOR_INVASIVENESS_3D_DN	-0.17788	-0.88962	0.7161	0.81836	1	0.373	0.326	0.254	0.80147	0.141
BARRIER_COLON_CANCER_RECURRENCE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/BARRIER_COLON_CANCER_RECURRENCE_DN	-0.29445	-0.88902	0.569	0.81907	1	0.474	0.414	0.278	0.80228	0.141
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	65	http://www.broadinstitute.org/gsea/msigdb/cards/WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	-0.32122	-0.88879	0.5743	0.819	1	0.262	0.171	0.217	0.80217	0.141
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	36	http://www.broadinstitute.org/gsea/msigdb/cards/WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	-0.23479	-0.88823	0.5671	0.81958	1	0.333	0.303	0.233	0.80418	0.141
MITSIADES_RESPONSE_TO_APLIDIN_UP	413	http://www.broadinstitute.org/gsea/msigdb/cards/MITSIADES_RESPONSE_TO_APLIDIN_UP	-0.22243	-0.88823	0.5988	0.81908	1	0.252	0.238	0.195	0.80367	0.141
REACTOME_G_ALPHA_S_SIGNALLING_EVENTS	117	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_ALPHA_S_SIGNALLING_EVENTS	-0.22597	-0.88697	0.6956	0.82116	1	0.521	0.407	0.311	0.80582	0.144
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN	-0.22475	-0.88578	0.6533	0.82314	1	0.333	0.247	0.251	0.80818	0.147
PID_ERBB_NETWORK_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERBB_NETWORK_PATHWAY	-0.31004	-0.88541	0.613	0.8233	1	0.267	0.176	0.22	0.80792	0.147
SMID_BREAST_CANCER_LUMINAL_B_UP	164	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_LUMINAL_B_UP	-0.16586	-0.8854	0.7083	0.8228	1	0.207	0.214	0.164	0.80768	0.146
AMIT_EGF_RESPONSE_120_MCF10A	41	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_120_MCF10A	-0.27212	-0.88526	0.6145	0.82259	1	0.561	0.377	0.35	0.80717	0.145
TRAYNOR_RETT_SYNDROM_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/TRAYNOR_RETT_SYNDROM_DN	-0.28219	-0.88471	0.6457	0.82316	1	0.294	0.202	0.235	0.8085	0.143
REACTOME_FRS2_MEDIATED_CASCADE	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FRS2_MEDIATED_CASCADE	-0.22805	-0.8843	0.6201	0.82343	1	0.472	0.39	0.288	0.80903	0.143
ZHAN_MULTIPLE_MYELOMA_MF_DN	37	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_MF_DN	-0.29706	-0.88379	0.6203	0.82393	1	0.189	0.0769	0.175	0.80889	0.144
REACTOME_PACKAGING_OF_TELOMERE_ENDS	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PACKAGING_OF_TELOMERE_ENDS	-0.32288	-0.88363	0.6437	0.82373	1	0.361	0.203	0.288	0.80874	0.141
SAFFORD_T_LYMPHOCYTE_ANERGY	85	http://www.broadinstitute.org/gsea/msigdb/cards/SAFFORD_T_LYMPHOCYTE_ANERGY	-0.22086	-0.88357	0.6305	0.82332	1	0.353	0.289	0.252	0.80842	0.142
LIU_VMYB_TARGETS_UP	119	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_VMYB_TARGETS_UP	-0.25803	-0.8831	0.6506	0.82378	1	0.294	0.232	0.227	0.80907	0.143
LEE_LIVER_CANCER_MYC_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_UP	-0.20842	-0.88187	0.6773	0.82585	1	0.302	0.26	0.224	0.8113	0.146
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	66	http://www.broadinstitute.org/gsea/msigdb/cards/MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	-0.22851	-0.88041	0.6322	0.82832	1	0.409	0.328	0.276	0.81417	0.149
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	-0.26391	-0.88013	0.6305	0.82841	1	0.211	0.137	0.182	0.81366	0.149
AKL_HTLV1_INFECTION_DN	67	http://www.broadinstitute.org/gsea/msigdb/cards/AKL_HTLV1_INFECTION_DN	-0.3128	-0.87979	0.6064	0.8286	1	0.209	0.112	0.186	0.81369	0.147
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	110	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	-0.22238	-0.8796	0.683	0.82846	1	0.209	0.18	0.172	0.81373	0.147
PID_INTEGRIN_A9B1_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN_A9B1_PATHWAY	-0.33513	-0.87911	0.6113	0.82896	1	0.75	0.489	0.384	0.8143	0.147
PID_S1P_META_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/PID_S1P_META_PATHWAY	-0.25559	-0.87906	0.6236	0.82855	1	0.5	0.376	0.312	0.81379	0.147
HUPER_BREAST_BASAL_VS_LUMINAL_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/HUPER_BREAST_BASAL_VS_LUMINAL_UP	-0.23973	-0.87857	0.7505	0.82899	1	0.385	0.272	0.281	0.81506	0.147
REACTOME_PHASE_II_CONJUGATION	57	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PHASE_II_CONJUGATION	-0.25412	-0.8781	0.6966	0.8294	1	0.123	0.0686	0.115	0.81555	0.147
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	431	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	-0.26251	-0.87795	0.6343	0.82924	1	0.22	0.163	0.188	0.81554	0.147
RASHI_RESPONSE_TO_IONIZING_RADIATION_4	57	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_4	-0.20803	-0.8777	0.6426	0.82922	1	0.175	0.171	0.146	0.81532	0.147
GOLUB_ALL_VS_AML_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/GOLUB_ALL_VS_AML_UP	-0.23731	-0.87728	0.6137	0.8296	1	0.0417	0.00171	0.0416	0.81631	0.147
PID_INTEGRIN_CS_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN_CS_PATHWAY	-0.2492	-0.87681	0.6167	0.83002	1	0.308	0.258	0.228	0.81683	0.147
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	155	http://www.broadinstitute.org/gsea/msigdb/cards/MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	-0.20567	-0.87633	0.6823	0.83046	1	0.31	0.268	0.228	0.81733	0.146
SUZUKI_AMPLIFIED_IN_ORAL_CANCER	16	http://www.broadinstitute.org/gsea/msigdb/cards/SUZUKI_AMPLIFIED_IN_ORAL_CANCER	-0.32887	-0.87604	0.6012	0.83049	1	0.375	0.189	0.304	0.81849	0.146
REACTOME_ION_CHANNEL_TRANSPORT	54	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ION_CHANNEL_TRANSPORT	-0.18714	-0.87591	0.7166	0.83021	1	0.389	0.35	0.253	0.81798	0.146
OUYANG_PROSTATE_CANCER_PROGRESSION_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/OUYANG_PROSTATE_CANCER_PROGRESSION_UP	-0.28318	-0.87574	0.6685	0.83004	1	0.222	0.107	0.199	0.81748	0.146
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	112	http://www.broadinstitute.org/gsea/msigdb/cards/KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	-0.25388	-0.87487	0.6452	0.83121	1	0.188	0.132	0.163	0.81968	0.146
GHANDHI_DIRECT_IRRADIATION_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/GHANDHI_DIRECT_IRRADIATION_DN	-0.25079	-0.87487	0.6291	0.8307	1	0.625	0.406	0.372	0.81917	0.146
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN	-0.23509	-0.87464	0.6646	0.83063	1	0.286	0.26	0.212	0.81891	0.146
HORIUCHI_WTAP_TARGETS_UP	286	http://www.broadinstitute.org/gsea/msigdb/cards/HORIUCHI_WTAP_TARGETS_UP	-0.24897	-0.87445	0.6694	0.8305	1	0.171	0.111	0.154	0.81857	0.146
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	307	http://www.broadinstitute.org/gsea/msigdb/cards/KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	-0.23989	-0.87363	0.624	0.83165	1	0.257	0.2	0.208	0.81919	0.146
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	87	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	-0.18512	-0.87337	0.7177	0.83167	1	0.448	0.375	0.281	0.81923	0.146
ZHENG_GLIOBLASTOMA_PLASTICITY_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_GLIOBLASTOMA_PLASTICITY_DN	-0.21493	-0.8733	0.652	0.83132	1	0.25	0.191	0.203	0.81889	0.146
PODAR_RESPONSE_TO_ADAPHOSTIN_UP	143	http://www.broadinstitute.org/gsea/msigdb/cards/PODAR_RESPONSE_TO_ADAPHOSTIN_UP	-0.26803	-0.87316	0.5914	0.83107	1	0.238	0.172	0.198	0.81874	0.144
COLINA_TARGETS_OF_4EBP1_AND_4EBP2	349	http://www.broadinstitute.org/gsea/msigdb/cards/COLINA_TARGETS_OF_4EBP1_AND_4EBP2	-0.21046	-0.87264	0.7198	0.83152	1	0.212	0.179	0.177	0.8184	0.144
HUANG_FOXA2_TARGETS_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/HUANG_FOXA2_TARGETS_DN	-0.28056	-0.87128	0.6165	0.83375	1	0.543	0.371	0.342	0.82289	0.148
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP	-0.24968	-0.87109	0.656	0.8336	1	0.407	0.293	0.288	0.82238	0.148
VARELA_ZMPSTE24_TARGETS_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/VARELA_ZMPSTE24_TARGETS_DN	-0.2648	-0.87036	0.6323	0.83456	1	0.526	0.348	0.344	0.82368	0.148
HINATA_NFKB_TARGETS_KERATINOCYTE_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/HINATA_NFKB_TARGETS_KERATINOCYTE_DN	-0.33121	-0.8702	0.6209	0.83437	1	0.5	0.379	0.311	0.82324	0.148
GAL_LEUKEMIC_STEM_CELL_UP	128	http://www.broadinstitute.org/gsea/msigdb/cards/GAL_LEUKEMIC_STEM_CELL_UP	-0.18615	-0.86986	0.7449	0.83456	1	0.289	0.266	0.213	0.82382	0.149
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	-0.29656	-0.86975	0.6383	0.83428	1	0.348	0.245	0.263	0.82336	0.146
QI_HYPOXIA	135	http://www.broadinstitute.org/gsea/msigdb/cards/QI_HYPOXIA	-0.19899	-0.86895	0.676	0.83534	1	0.0963	0.0625	0.0908	0.82376	0.149
AMIT_EGF_RESPONSE_40_MCF10A	19	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_40_MCF10A	-0.39702	-0.86801	0.6137	0.8367	1	0.421	0.127	0.368	0.82562	0.149
KEGG_REGULATION_OF_AUTOPHAGY	30	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_REGULATION_OF_AUTOPHAGY	-0.27701	-0.86795	0.6899	0.83629	1	0.367	0.248	0.276	0.82589	0.149
BAE_BRCA1_TARGETS_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/BAE_BRCA1_TARGETS_UP	-0.21161	-0.86777	0.7348	0.83615	1	0.338	0.314	0.233	0.82596	0.146
REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	37	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	-0.18875	-0.86768	0.6354	0.83583	1	0.324	0.314	0.223	0.82555	0.146
UDAYAKUMAR_MED1_TARGETS_DN	228	http://www.broadinstitute.org/gsea/msigdb/cards/UDAYAKUMAR_MED1_TARGETS_DN	-0.2005	-0.86748	0.6331	0.83574	1	0.342	0.327	0.232	0.82517	0.144
MCCLUNG_COCAINE_REWARD_5D	79	http://www.broadinstitute.org/gsea/msigdb/cards/MCCLUNG_COCAINE_REWARD_5D	-0.17515	-0.86665	0.7563	0.83685	1	0.316	0.308	0.22	0.82489	0.144
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	61	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	-0.25294	-0.86663	0.678	0.83637	1	0.328	0.202	0.262	0.82439	0.144
KENNY_CTNNB1_TARGETS_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/KENNY_CTNNB1_TARGETS_UP	-0.24228	-0.8666	0.7209	0.83592	1	0.128	0.0625	0.12	0.82419	0.144
SENESE_HDAC2_TARGETS_DN	119	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC2_TARGETS_DN	-0.25042	-0.86592	0.6242	0.83674	1	0.235	0.157	0.199	0.82542	0.144
BIOCARTA_RHO_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_RHO_PATHWAY	-0.22906	-0.86561	0.655	0.83687	1	0.531	0.45	0.293	0.82588	0.144
LUI_THYROID_CANCER_CLUSTER_2	41	http://www.broadinstitute.org/gsea/msigdb/cards/LUI_THYROID_CANCER_CLUSTER_2	-0.21937	-0.86489	0.6322	0.83774	1	0.39	0.327	0.263	0.82648	0.145
ZHAN_LATE_DIFFERENTIATION_GENES_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_LATE_DIFFERENTIATION_GENES_DN	-0.2756	-0.8647	0.6252	0.83762	1	0.4	0.322	0.271	0.827	0.145
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	-0.29697	-0.86449	0.6248	0.83751	1	0.741	0.493	0.376	0.82665	0.144
BIOCARTA_NTHI_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NTHI_PATHWAY	-0.29257	-0.86441	0.6317	0.83717	1	0.304	0.273	0.222	0.82662	0.143
TAKAO_RESPONSE_TO_UVB_RADIATION_DN	95	http://www.broadinstitute.org/gsea/msigdb/cards/TAKAO_RESPONSE_TO_UVB_RADIATION_DN	-0.24517	-0.86375	0.7036	0.83795	1	0.158	0.123	0.139	0.82772	0.142
MULLIGHAN_MLL_SIGNATURE_2_DN	264	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_MLL_SIGNATURE_2_DN	-0.19419	-0.8637	0.7029	0.83753	1	0.242	0.23	0.189	0.82722	0.142
GENTILE_UV_RESPONSE_CLUSTER_D2	40	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D2	-0.30292	-0.86343	0.6152	0.83755	1	0.175	0.0924	0.159	0.82704	0.141
REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	-0.23709	-0.86321	0.6562	0.83751	1	0.519	0.356	0.334	0.82654	0.143
REACTOME_PI3K_CASCADE	68	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PI3K_CASCADE	-0.21706	-0.86313	0.6531	0.83714	1	0.5	0.39	0.306	0.82666	0.141
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	59	http://www.broadinstitute.org/gsea/msigdb/cards/SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	-0.2432	-0.86288	0.668	0.83708	1	0.271	0.25	0.204	0.82653	0.141
REACTOME_MEIOSIS	91	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MEIOSIS	-0.25209	-0.86278	0.674	0.83677	1	0.253	0.18	0.208	0.82603	0.14
REACTOME_MEIOTIC_SYNAPSIS	59	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MEIOTIC_SYNAPSIS	-0.26444	-0.86261	0.6752	0.83661	1	0.271	0.18	0.223	0.82619	0.14
REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS	-0.26377	-0.86256	0.6313	0.83619	1	0.125	0.0546	0.118	0.82569	0.14
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	78	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	-0.22468	-0.86235	0.625	0.83607	1	0.474	0.372	0.299	0.82565	0.14
BROWNE_HCMV_INFECTION_6HR_UP	66	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_6HR_UP	-0.20832	-0.8617	0.6242	0.83686	1	0.485	0.402	0.29	0.82719	0.14
ZHU_SKIL_TARGETS_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_SKIL_TARGETS_UP	-0.3666	-0.86127	0.682	0.83719	1	0.35	0.186	0.285	0.82741	0.14
ROME_INSULIN_TARGETS_IN_MUSCLE_DN	187	http://www.broadinstitute.org/gsea/msigdb/cards/ROME_INSULIN_TARGETS_IN_MUSCLE_DN	-0.15175	-0.8612	0.7857	0.83682	1	0.187	0.193	0.152	0.82691	0.14
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	-0.26368	-0.86089	0.5697	0.83693	1	0.353	0.309	0.244	0.82745	0.139
PENG_LEUCINE_DEPRIVATION_UP	132	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_LEUCINE_DEPRIVATION_UP	-0.17348	-0.86088	0.6373	0.83645	1	0.333	0.33	0.224	0.82695	0.139
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN	105	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN	-0.18191	-0.85997	0.7237	0.83782	1	0.133	0.111	0.119	0.82828	0.141
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	166	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	-0.23855	-0.85966	0.6502	0.83793	1	0.265	0.204	0.212	0.82796	0.141
GENTILE_UV_RESPONSE_CLUSTER_D6	34	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D6	-0.36021	-0.85954	0.6433	0.83767	1	0.176	0.0438	0.169	0.82746	0.141
AKL_HTLV1_INFECTION_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/AKL_HTLV1_INFECTION_UP	-0.2479	-0.85952	0.6163	0.8372	1	0.48	0.388	0.294	0.82696	0.139
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	50	http://www.broadinstitute.org/gsea/msigdb/cards/EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	-0.24908	-0.85908	0.6451	0.83757	1	0.22	0.176	0.182	0.82799	0.14
TSENG_IRS1_TARGETS_DN	133	http://www.broadinstitute.org/gsea/msigdb/cards/TSENG_IRS1_TARGETS_DN	-0.22931	-0.85865	0.6463	0.83785	1	0.233	0.236	0.179	0.82876	0.14
KEGG_MAPK_SIGNALING_PATHWAY	260	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_MAPK_SIGNALING_PATHWAY	-0.16876	-0.85808	0.7711	0.83843	1	0.277	0.273	0.203	0.8296	0.14
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN	34	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_3_4WK_DN	-0.22733	-0.8577	0.6734	0.83872	1	0.235	0.202	0.188	0.82939	0.141
KRIGE_AMINO_ACID_DEPRIVATION	28	http://www.broadinstitute.org/gsea/msigdb/cards/KRIGE_AMINO_ACID_DEPRIVATION	-0.23161	-0.85766	0.6318	0.83828	1	0.5	0.439	0.281	0.82931	0.14
MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	210	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	-0.21618	-0.85701	0.7424	0.83909	1	0.367	0.351	0.24	0.83019	0.141
MODY_HIPPOCAMPUS_POSTNATAL	62	http://www.broadinstitute.org/gsea/msigdb/cards/MODY_HIPPOCAMPUS_POSTNATAL	-0.20193	-0.85651	0.6322	0.83956	1	0.484	0.424	0.279	0.83164	0.141
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	115	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	-0.24801	-0.85594	0.6687	0.8402	1	0.374	0.327	0.253	0.83282	0.141
REACTOME_CD28_CO_STIMULATION	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CD28_CO_STIMULATION	-0.24806	-0.85544	0.6534	0.84069	1	0.516	0.378	0.321	0.83339	0.141
WONG_IFNA2_RESISTANCE_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_IFNA2_RESISTANCE_DN	-0.2173	-0.85523	0.688	0.84056	1	0.424	0.343	0.279	0.83326	0.141
BROWNE_HCMV_INFECTION_12HR_DN	97	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_12HR_DN	-0.27027	-0.85481	0.6214	0.8409	1	0.175	0.107	0.157	0.83365	0.141
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	-0.36944	-0.85479	0.6774	0.84045	1	0.333	0.13	0.29	0.8332	0.141
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	173	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	-0.19764	-0.85429	0.6726	0.84096	1	0.306	0.272	0.225	0.83381	0.141
CHEBOTAEV_GR_TARGETS_DN	113	http://www.broadinstitute.org/gsea/msigdb/cards/CHEBOTAEV_GR_TARGETS_DN	-0.23979	-0.85372	0.6985	0.84154	1	0.204	0.12	0.18	0.83441	0.141
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	-0.20934	-0.85369	0.662	0.84109	1	0.419	0.305	0.292	0.83391	0.14
PID_IL8_CXCR2_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL8_CXCR2_PATHWAY	-0.23007	-0.85279	0.6269	0.8424	1	0.394	0.354	0.255	0.83481	0.14
REACTOME_SIGNALING_BY_ILS	101	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_ILS	-0.21376	-0.85242	0.6693	0.84263	1	0.366	0.337	0.244	0.83524	0.139
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	200	http://www.broadinstitute.org/gsea/msigdb/cards/EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	-0.17179	-0.85205	0.7564	0.84283	1	0.27	0.256	0.202	0.83505	0.14
OHM_METHYLATED_IN_ADULT_CANCERS	27	http://www.broadinstitute.org/gsea/msigdb/cards/OHM_METHYLATED_IN_ADULT_CANCERS	-0.29001	-0.85147	0.6272	0.84341	1	0.481	0.313	0.331	0.83477	0.14
LY_AGING_OLD_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/LY_AGING_OLD_DN	-0.24063	-0.85144	0.6914	0.84295	1	0.109	0.0593	0.103	0.83427	0.139
LABBE_TGFB1_TARGETS_DN	103	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_TGFB1_TARGETS_DN	-0.19863	-0.85124	0.7365	0.84287	1	0.35	0.314	0.241	0.83429	0.139
NELSON_RESPONSE_TO_ANDROGEN_UP	84	http://www.broadinstitute.org/gsea/msigdb/cards/NELSON_RESPONSE_TO_ANDROGEN_UP	-0.25399	-0.85112	0.6872	0.84258	1	0.167	0.113	0.148	0.8338	0.138
HUANG_DASATINIB_RESISTANCE_UP	77	http://www.broadinstitute.org/gsea/msigdb/cards/HUANG_DASATINIB_RESISTANCE_UP	-0.29817	-0.85091	0.6519	0.84247	1	0.26	0.165	0.218	0.83383	0.139
MATZUK_SPERMATOZOA	112	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_SPERMATOZOA	-0.16326	-0.85036	0.8056	0.84303	1	0.321	0.316	0.221	0.83394	0.14
LI_PROSTATE_CANCER_EPIGENETIC	30	http://www.broadinstitute.org/gsea/msigdb/cards/LI_PROSTATE_CANCER_EPIGENETIC	-0.28522	-0.85014	0.6511	0.84297	1	0.267	0.196	0.215	0.83428	0.139
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	87	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	-0.22754	-0.84998	0.7577	0.84279	1	0.195	0.143	0.168	0.83386	0.139
VERRECCHIA_RESPONSE_TO_TGFB1_C2	25	http://www.broadinstitute.org/gsea/msigdb/cards/VERRECCHIA_RESPONSE_TO_TGFB1_C2	-0.34075	-0.84981	0.6342	0.84262	1	0.32	0.226	0.248	0.83397	0.139
NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	16	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	-0.33852	-0.84974	0.6955	0.84226	1	0.75	0.375	0.469	0.8338	0.138
BIDUS_METASTASIS_DN	152	http://www.broadinstitute.org/gsea/msigdb/cards/BIDUS_METASTASIS_DN	-0.20857	-0.84906	0.753	0.84305	1	0.243	0.206	0.194	0.83584	0.139
LEIN_MIDBRAIN_MARKERS	80	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_MIDBRAIN_MARKERS	-0.20801	-0.84878	0.6996	0.84309	1	0.562	0.442	0.315	0.83552	0.137
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN	116	http://www.broadinstitute.org/gsea/msigdb/cards/NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN	-0.22104	-0.84849	0.6572	0.84318	1	0.276	0.258	0.206	0.83503	0.138
REACTOME_IL1_SIGNALING	38	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_IL1_SIGNALING	-0.25032	-0.84746	0.6579	0.84471	1	0.316	0.277	0.229	0.83737	0.138
REACTOME_DIABETES_PATHWAYS	125	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DIABETES_PATHWAYS	-0.22097	-0.8473	0.6613	0.84451	1	0.344	0.314	0.237	0.83688	0.137
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	429	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	-0.16932	-0.84714	0.7078	0.84436	1	0.422	0.387	0.263	0.83771	0.137
VECCHI_GASTRIC_CANCER_EARLY_DN	336	http://www.broadinstitute.org/gsea/msigdb/cards/VECCHI_GASTRIC_CANCER_EARLY_DN	-0.22238	-0.84706	0.747	0.84403	1	0.208	0.148	0.18	0.83722	0.137
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	124	http://www.broadinstitute.org/gsea/msigdb/cards/ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	-0.19247	-0.84677	0.7216	0.84409	1	0.194	0.197	0.156	0.83692	0.137
LEE_AGING_MUSCLE_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_AGING_MUSCLE_DN	-0.23927	-0.84674	0.6667	0.84366	1	0.413	0.301	0.289	0.83697	0.135
REACTOME_SIGNALING_BY_RHO_GTPASES	110	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_RHO_GTPASES	-0.19682	-0.84667	0.6925	0.8433	1	0.391	0.339	0.26	0.83673	0.135
WANG_RESPONSE_TO_BEXAROTENE_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RESPONSE_TO_BEXAROTENE_DN	-0.26568	-0.84623	0.6398	0.8436	1	0.25	0.189	0.203	0.83684	0.135
MATZUK_EMBRYONIC_GERM_CELL	19	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_EMBRYONIC_GERM_CELL	-0.30281	-0.84622	0.6496	0.84313	1	0.263	0.109	0.235	0.83634	0.135
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI	-0.26686	-0.84615	0.6408	0.84277	1	0.444	0.398	0.268	0.83585	0.133
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	68	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	-0.19988	-0.84499	0.7671	0.8444	1	0.412	0.39	0.252	0.83748	0.133
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15	34	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15	-0.26934	-0.84408	0.7113	0.8455	1	0.176	0.0785	0.163	0.83818	0.135
DAIRKEE_TERT_TARGETS_DN	117	http://www.broadinstitute.org/gsea/msigdb/cards/DAIRKEE_TERT_TARGETS_DN	-0.20939	-0.84305	0.7304	0.84698	1	0.325	0.271	0.238	0.84029	0.137
REACTOME_REGULATION_OF_KIT_SIGNALING	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_KIT_SIGNALING	-0.26181	-0.84299	0.6721	0.84661	1	0.5	0.337	0.332	0.84002	0.137
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	184	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	-0.17201	-0.84277	0.7525	0.84651	1	0.326	0.311	0.226	0.83953	0.137
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	-0.29796	-0.84257	0.6281	0.84636	1	0.382	0.214	0.301	0.83937	0.135
BROWNE_HCMV_INFECTION_8HR_UP	100	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_8HR_UP	-0.22815	-0.84233	0.726	0.84629	1	0.31	0.279	0.225	0.83948	0.135
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12	75	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12	-0.24926	-0.84227	0.7102	0.84593	1	0.133	0.0579	0.126	0.83899	0.135
MARKEY_RB1_CHRONIC_LOF_UP	110	http://www.broadinstitute.org/gsea/msigdb/cards/MARKEY_RB1_CHRONIC_LOF_UP	-0.22236	-0.84216	0.7065	0.84564	1	0.264	0.229	0.204	0.8385	0.135
LIEN_BREAST_CARCINOMA_METAPLASTIC	34	http://www.broadinstitute.org/gsea/msigdb/cards/LIEN_BREAST_CARCINOMA_METAPLASTIC	-0.36949	-0.84167	0.6535	0.84601	1	0.235	0.0593	0.222	0.83884	0.137
BIOCARTA_IL7_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL7_PATHWAY	-0.36839	-0.84098	0.6975	0.84679	1	0.125	0.0516	0.119	0.83984	0.137
REACTOME_ACTIVATION_OF_GENES_BY_ATF4	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_GENES_BY_ATF4	-0.27583	-0.84095	0.6718	0.84636	1	0.217	0.123	0.191	0.83935	0.137
HILLION_HMGA1B_TARGETS	89	http://www.broadinstitute.org/gsea/msigdb/cards/HILLION_HMGA1B_TARGETS	-0.20011	-0.84094	0.6767	0.84589	1	0.236	0.194	0.191	0.83888	0.136
LANDIS_BREAST_CANCER_PROGRESSION_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_BREAST_CANCER_PROGRESSION_UP	-0.20769	-0.84086	0.6859	0.84553	1	0.233	0.196	0.187	0.83862	0.136
HU_ANGIOGENESIS_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/HU_ANGIOGENESIS_UP	-0.3166	-0.83926	0.6792	0.8481	1	0.65	0.416	0.38	0.84074	0.137
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A	21	http://www.broadinstitute.org/gsea/msigdb/cards/SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A	-0.28987	-0.83886	0.7794	0.84833	1	0.286	0.216	0.224	0.84066	0.137
HOUSTIS_ROS	35	http://www.broadinstitute.org/gsea/msigdb/cards/HOUSTIS_ROS	-0.22312	-0.83793	0.7549	0.84908	1	0.2	0.166	0.167	0.84121	0.137
DALESSIO_TSA_RESPONSE	21	http://www.broadinstitute.org/gsea/msigdb/cards/DALESSIO_TSA_RESPONSE	-0.3331	-0.83793	0.628	0.84957	1	0.429	0.197	0.345	0.8417	0.137
NUTT_GBM_VS_AO_GLIOMA_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/NUTT_GBM_VS_AO_GLIOMA_UP	-0.24452	-0.83707	0.6673	0.85023	1	0.295	0.219	0.231	0.84376	0.14
KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	92	http://www.broadinstitute.org/gsea/msigdb/cards/KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	-0.1929	-0.83654	0.8432	0.85076	1	0.293	0.24	0.224	0.84382	0.14
MATZUK_SPERMATID_DIFFERENTIATION	37	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_SPERMATID_DIFFERENTIATION	-0.23667	-0.83565	0.6934	0.85192	1	0.351	0.315	0.241	0.845	0.141
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	-0.18511	-0.8353	0.726	0.8516	1	0.312	0.292	0.222	0.84481	0.14
SANSOM_WNT_PATHWAY_REQUIRE_MYC	57	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_WNT_PATHWAY_REQUIRE_MYC	-0.22176	-0.8353	0.6959	0.85209	1	0.368	0.315	0.253	0.8453	0.14
BYSTROEM_CORRELATED_WITH_IL5_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/BYSTROEM_CORRELATED_WITH_IL5_UP	-0.21298	-0.83518	0.6932	0.85135	1	0.404	0.351	0.263	0.84437	0.139
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	-0.26525	-0.8351	0.6312	0.851	1	0.0588	0.00533	0.0586	0.84388	0.139
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	-0.19457	-0.83458	0.6369	0.85152	1	0.55	0.482	0.285	0.84491	0.139
KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	32	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	-0.23761	-0.83411	0.7099	0.85188	1	0.25	0.284	0.179	0.84469	0.137
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	21	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	-0.31949	-0.834	0.7131	0.85157	1	0.19	0.111	0.169	0.8442	0.135
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	-0.22842	-0.83358	0.7077	0.85189	1	0.417	0.373	0.262	0.84486	0.137
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	33	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	-0.2533	-0.83329	0.7091	0.85194	1	0.394	0.323	0.267	0.84486	0.137
GENTILE_UV_LOW_DOSE_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_LOW_DOSE_UP	-0.26625	-0.83298	0.6454	0.85202	1	0.538	0.455	0.294	0.84468	0.137
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	-0.30728	-0.83229	0.744	0.85277	1	0.208	0.145	0.178	0.84616	0.137
CUI_TCF21_TARGETS_2_UP	413	http://www.broadinstitute.org/gsea/msigdb/cards/CUI_TCF21_TARGETS_2_UP	-0.18363	-0.83195	0.707	0.85292	1	0.278	0.261	0.209	0.84642	0.138
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53	15	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_DNA_DAMAGE_RESPONSE_TP53	-0.30035	-0.83173	0.6282	0.85289	1	0.533	0.418	0.311	0.84637	0.136
LI_CYTIDINE_ANALOG_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/LI_CYTIDINE_ANALOG_PATHWAY	-0.2521	-0.82999	0.689	0.85555	1	0.25	0.199	0.2	0.84914	0.142
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	129	http://www.broadinstitute.org/gsea/msigdb/cards/VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	-0.20855	-0.82995	0.7091	0.85514	1	0.434	0.36	0.279	0.84884	0.142
NEWMAN_ERCC6_TARGETS_DN	37	http://www.broadinstitute.org/gsea/msigdb/cards/NEWMAN_ERCC6_TARGETS_DN	-0.33899	-0.82934	0.7505	0.85578	1	0.432	0.233	0.332	0.84891	0.142
LINDVALL_IMMORTALIZED_BY_TERT_UP	73	http://www.broadinstitute.org/gsea/msigdb/cards/LINDVALL_IMMORTALIZED_BY_TERT_UP	-0.25928	-0.8291	0.6954	0.85571	1	0.26	0.189	0.212	0.84847	0.142
AFFAR_YY1_TARGETS_DN	228	http://www.broadinstitute.org/gsea/msigdb/cards/AFFAR_YY1_TARGETS_DN	-0.19243	-0.82815	0.7703	0.85698	1	0.11	0.097	0.0999	0.85056	0.142
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES	36	http://www.broadinstitute.org/gsea/msigdb/cards/SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES	-0.21682	-0.82801	0.7558	0.85672	1	0.0833	0.0369	0.0804	0.85028	0.142
NIELSEN_SCHWANNOMA_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_SCHWANNOMA_UP	-0.28555	-0.82784	0.7205	0.85653	1	0.647	0.425	0.372	0.85043	0.14
CHO_NR4A1_TARGETS	31	http://www.broadinstitute.org/gsea/msigdb/cards/CHO_NR4A1_TARGETS	-0.26073	-0.82742	0.7421	0.85682	1	0.452	0.349	0.294	0.8508	0.138
LI_ADIPOGENESIS_BY_ACTIVATED_PPARG	17	http://www.broadinstitute.org/gsea/msigdb/cards/LI_ADIPOGENESIS_BY_ACTIVATED_PPARG	-0.3055	-0.82709	0.6881	0.85695	1	0.471	0.314	0.323	0.85079	0.14
KIM_GERMINAL_CENTER_T_HELPER_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_GERMINAL_CENTER_T_HELPER_DN	-0.26089	-0.82681	0.7193	0.85694	1	0.478	0.319	0.326	0.85072	0.14
REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING	-0.28873	-0.82671	0.69	0.85664	1	0.476	0.378	0.296	0.85051	0.138
RUIZ_TNC_TARGETS_UP	148	http://www.broadinstitute.org/gsea/msigdb/cards/RUIZ_TNC_TARGETS_UP	-0.28514	-0.82651	0.6789	0.85653	1	0.236	0.152	0.202	0.85003	0.136
ZEMBUTSU_SENSITIVITY_TO_CISPLATIN	18	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_CISPLATIN	-0.26842	-0.82598	0.6627	0.85704	1	0.5	0.393	0.304	0.84998	0.136
SENESE_HDAC1_AND_HDAC2_TARGETS_DN	214	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC1_AND_HDAC2_TARGETS_DN	-0.22264	-0.82544	0.7098	0.85754	1	0.168	0.112	0.151	0.85123	0.138
HOOI_ST7_TARGETS_UP	86	http://www.broadinstitute.org/gsea/msigdb/cards/HOOI_ST7_TARGETS_UP	-0.22111	-0.82533	0.7816	0.85724	1	0.209	0.148	0.179	0.85116	0.136
BIOCARTA_SPRY_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_SPRY_PATHWAY	-0.25926	-0.82472	0.7323	0.85786	1	0.471	0.369	0.297	0.852	0.139
BIOCARTA_MTA3_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MTA3_PATHWAY	-0.24899	-0.82412	0.7038	0.85845	1	0.333	0.275	0.242	0.8525	0.138
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	88	http://www.broadinstitute.org/gsea/msigdb/cards/DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	-0.26316	-0.82342	0.7392	0.85923	1	0.273	0.181	0.224	0.85412	0.141
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP	-0.23068	-0.82319	0.7692	0.8592	1	0.13	0.122	0.115	0.85449	0.14
CHIBA_RESPONSE_TO_TSA_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/CHIBA_RESPONSE_TO_TSA_DN	-0.33354	-0.82309	0.7461	0.85887	1	0.364	0.198	0.292	0.85401	0.139
WANG_CISPLATIN_RESPONSE_AND_XPC_DN	219	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_CISPLATIN_RESPONSE_AND_XPC_DN	-0.20913	-0.8221	0.7014	0.86016	1	0.155	0.142	0.134	0.85525	0.141
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	65	http://www.broadinstitute.org/gsea/msigdb/cards/MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	-0.23298	-0.82163	0.7297	0.8605	1	0.169	0.145	0.145	0.85577	0.14
SENESE_HDAC1_TARGETS_UP	434	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC1_TARGETS_UP	-0.21887	-0.82146	0.7728	0.86034	1	0.191	0.166	0.162	0.85558	0.14
BROWNE_HCMV_INFECTION_12HR_UP	103	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_12HR_UP	-0.20429	-0.82119	0.7704	0.8603	1	0.243	0.204	0.194	0.85544	0.138
TSENG_ADIPOGENIC_POTENTIAL_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/TSENG_ADIPOGENIC_POTENTIAL_DN	-0.27096	-0.82118	0.6854	0.85983	1	0.304	0.228	0.235	0.85495	0.138
REACTOME_STRIATED_MUSCLE_CONTRACTION	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_STRIATED_MUSCLE_CONTRACTION	-0.24272	-0.82032	0.7108	0.86093	1	0.519	0.372	0.326	0.85641	0.138
PID_WNT_CANONICAL_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/PID_WNT_CANONICAL_PATHWAY	-0.24793	-0.82026	0.6331	0.86056	1	0.35	0.242	0.266	0.85637	0.136
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G	167	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G	-0.18103	-0.82017	0.7919	0.86028	1	0.246	0.244	0.187	0.85639	0.136
YAGI_AML_WITH_11Q23_REARRANGED	330	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_WITH_11Q23_REARRANGED	-0.16672	-0.81952	0.7952	0.861	1	0.358	0.358	0.232	0.85705	0.138
PID_FGF_PATHWAY	54	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FGF_PATHWAY	-0.21565	-0.81946	0.7736	0.86062	1	0.407	0.334	0.272	0.85657	0.136
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP	-0.26426	-0.81904	0.7515	0.86091	1	0.45	0.238	0.343	0.8566	0.134
FRASOR_TAMOXIFEN_RESPONSE_UP	51	http://www.broadinstitute.org/gsea/msigdb/cards/FRASOR_TAMOXIFEN_RESPONSE_UP	-0.20624	-0.81895	0.7705	0.86061	1	0.549	0.46	0.297	0.85613	0.134
MACLACHLAN_BRCA1_TARGETS_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/MACLACHLAN_BRCA1_TARGETS_UP	-0.24821	-0.81892	0.6615	0.86017	1	0.25	0.308	0.173	0.85565	0.133
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	-0.20185	-0.81873	0.7076	0.86003	1	0.449	0.403	0.268	0.85516	0.132
WANG_LSD1_TARGETS_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_LSD1_TARGETS_UP	-0.29055	-0.81834	0.6529	0.86025	1	0.609	0.444	0.339	0.85568	0.134
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP	-0.24888	-0.81817	0.7715	0.86007	1	0.152	0.0654	0.142	0.85584	0.134
CHANDRAN_METASTASIS_DN	287	http://www.broadinstitute.org/gsea/msigdb/cards/CHANDRAN_METASTASIS_DN	-0.2194	-0.81657	0.7015	0.86256	1	0.303	0.236	0.234	0.85814	0.137
REACTOME_TELOMERE_MAINTENANCE	63	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TELOMERE_MAINTENANCE	-0.24181	-0.81653	0.761	0.86213	1	0.429	0.318	0.293	0.85792	0.137
REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	-0.20924	-0.81607	0.7196	0.86249	1	0.724	0.502	0.361	0.85791	0.137
LIU_TOPBP1_TARGETS	15	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_TOPBP1_TARGETS	-0.28577	-0.81607	0.7481	0.86201	1	0.667	0.367	0.422	0.85743	0.133
ZHOU_TNF_SIGNALING_4HR	54	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_TNF_SIGNALING_4HR	-0.24818	-0.81601	0.7122	0.86163	1	0.241	0.182	0.197	0.85721	0.13
PEART_HDAC_PROLIFERATION_CLUSTER_UP	55	http://www.broadinstitute.org/gsea/msigdb/cards/PEART_HDAC_PROLIFERATION_CLUSTER_UP	-0.22723	-0.81468	0.752	0.86347	1	0.145	0.12	0.128	0.85893	0.137
ZHAN_LATE_DIFFERENTIATION_GENES_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_LATE_DIFFERENTIATION_GENES_UP	-0.30113	-0.81382	0.6436	0.86449	1	0.156	0.0897	0.142	0.8593	0.135
HADDAD_B_LYMPHOCYTE_PROGENITOR	271	http://www.broadinstitute.org/gsea/msigdb/cards/HADDAD_B_LYMPHOCYTE_PROGENITOR	-0.17618	-0.81334	0.9434	0.86486	1	0.273	0.265	0.203	0.85963	0.137
PID_REG_GR_PATHWAY	80	http://www.broadinstitute.org/gsea/msigdb/cards/PID_REG_GR_PATHWAY	-0.18107	-0.81285	0.7802	0.86519	1	0.325	0.285	0.233	0.86019	0.135
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	-0.32351	-0.81283	0.6906	0.86475	1	0.22	0.0979	0.199	0.85971	0.134
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP	-0.30544	-0.81251	0.6837	0.86481	1	0.611	0.371	0.385	0.86002	0.134
CHUNG_BLISTER_CYTOTOXICITY_UP	126	http://www.broadinstitute.org/gsea/msigdb/cards/CHUNG_BLISTER_CYTOTOXICITY_UP	-0.17924	-0.81249	0.8056	0.86437	1	0.198	0.21	0.157	0.85954	0.132
SANA_RESPONSE_TO_IFNG_DN	80	http://www.broadinstitute.org/gsea/msigdb/cards/SANA_RESPONSE_TO_IFNG_DN	-0.24262	-0.81102	0.7713	0.86645	1	0.162	0.108	0.145	0.86366	0.137
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	-0.25444	-0.80979	0.737	0.86812	1	0.167	0.102	0.15	0.86466	0.139
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	280	http://www.broadinstitute.org/gsea/msigdb/cards/DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	-0.15132	-0.80951	0.7095	0.86813	1	0.307	0.324	0.21	0.86418	0.139
NAKAMURA_ADIPOGENESIS_LATE_UP	100	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_ADIPOGENESIS_LATE_UP	-0.23426	-0.8095	0.7308	0.86766	1	0.18	0.145	0.155	0.86387	0.139
LAU_APOPTOSIS_CDKN2A_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/LAU_APOPTOSIS_CDKN2A_UP	-0.19386	-0.80938	0.7495	0.86738	1	0.0566	0.0153	0.0559	0.86428	0.137
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	-0.23572	-0.8093	0.653	0.86704	1	0.321	0.26	0.238	0.86391	0.137
WU_HBX_TARGETS_2_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/WU_HBX_TARGETS_2_DN	-0.28502	-0.80917	0.6538	0.86681	1	0.467	0.399	0.28	0.86343	0.135
FUJII_YBX1_TARGETS_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/FUJII_YBX1_TARGETS_UP	-0.27108	-0.80899	0.7155	0.86666	1	0.2	0.1	0.18	0.86316	0.135
REACTOME_SIGNALLING_TO_ERKS	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALLING_TO_ERKS	-0.20437	-0.80809	0.7134	0.86772	1	0.389	0.334	0.259	0.86364	0.137
VALK_AML_CLUSTER_9	35	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_9	-0.23185	-0.80768	0.7032	0.86793	1	0.457	0.391	0.279	0.86475	0.136
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	-0.3357	-0.80763	0.7303	0.86755	1	0.3	0.102	0.27	0.86445	0.136
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	-0.23447	-0.80739	0.7041	0.86751	1	0.258	0.264	0.19	0.86423	0.135
POOLA_INVASIVE_BREAST_CANCER_DN	133	http://www.broadinstitute.org/gsea/msigdb/cards/POOLA_INVASIVE_BREAST_CANCER_DN	-0.17009	-0.8067	0.8267	0.86824	1	0.293	0.294	0.208	0.86504	0.136
BROWNE_HCMV_INFECTION_1HR_DN	215	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_1HR_DN	-0.17295	-0.80632	0.7936	0.86844	1	0.395	0.369	0.251	0.86608	0.136
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	245	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	-0.22828	-0.80615	0.7329	0.86827	1	0.241	0.186	0.198	0.8656	0.136
SHIN_B_CELL_LYMPHOMA_CLUSTER_9	19	http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_9	-0.29858	-0.80507	0.8012	0.86967	1	0.632	0.394	0.383	0.86574	0.137
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	209	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	-0.17519	-0.80404	0.7773	0.87095	1	0.407	0.38	0.254	0.86659	0.137
LABBE_TGFB1_TARGETS_UP	97	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_TGFB1_TARGETS_UP	-0.22042	-0.80397	0.7099	0.87058	1	0.33	0.308	0.229	0.86611	0.137
APRELIKOVA_BRCA1_TARGETS	49	http://www.broadinstitute.org/gsea/msigdb/cards/APRELIKOVA_BRCA1_TARGETS	-0.26023	-0.80395	0.7741	0.87015	1	0.245	0.203	0.195	0.86563	0.137
BENPORATH_MYC_TARGETS_WITH_EBOX	219	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_MYC_TARGETS_WITH_EBOX	-0.15632	-0.80252	0.7703	0.87213	1	0.306	0.318	0.211	0.86785	0.141
BIOCARTA_IL6_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL6_PATHWAY	-0.27298	-0.80195	0.7284	0.87258	1	0.5	0.358	0.321	0.86835	0.141
KEGG_ABC_TRANSPORTERS	44	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ABC_TRANSPORTERS	-0.23775	-0.80171	0.7351	0.87253	1	0.455	0.36	0.292	0.86815	0.141
YANG_BCL3_TARGETS_UP	348	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_BCL3_TARGETS_UP	-0.18659	-0.80105	0.8775	0.87317	1	0.21	0.196	0.171	0.86961	0.145
LE_EGR2_TARGETS_DN	104	http://www.broadinstitute.org/gsea/msigdb/cards/LE_EGR2_TARGETS_DN	-0.20353	-0.80054	0.749	0.87359	1	0.154	0.116	0.137	0.86996	0.143
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	180	http://www.broadinstitute.org/gsea/msigdb/cards/ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	-0.1644	-0.80035	0.8356	0.87341	1	0.244	0.242	0.187	0.86948	0.141
JOHNSTONE_PARVB_TARGETS_3_UP	403	http://www.broadinstitute.org/gsea/msigdb/cards/JOHNSTONE_PARVB_TARGETS_3_UP	-0.17176	-0.80027	0.737	0.87306	1	0.203	0.209	0.164	0.86922	0.141
TERAMOTO_OPN_TARGETS_CLUSTER_6	26	http://www.broadinstitute.org/gsea/msigdb/cards/TERAMOTO_OPN_TARGETS_CLUSTER_6	-0.27185	-0.80002	0.7089	0.87304	1	0.308	0.227	0.238	0.86953	0.141
REACTOME_DEFENSINS	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEFENSINS	-0.34545	-0.79988	0.786	0.87279	1	0.269	0.128	0.235	0.86905	0.139
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	-0.27419	-0.79926	0.7324	0.87331	1	0.422	0.342	0.278	0.87057	0.141
BIOCARTA_PGC1A_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PGC1A_PATHWAY	-0.19085	-0.79877	0.7556	0.87371	1	0.391	0.383	0.242	0.87096	0.139
KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	30	http://www.broadinstitute.org/gsea/msigdb/cards/KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	-0.26167	-0.79807	0.6898	0.8744	1	0.433	0.412	0.255	0.87083	0.141
BROWNE_HCMV_INFECTION_10HR_DN	54	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_10HR_DN	-0.25495	-0.79797	0.7606	0.87412	1	0.296	0.233	0.228	0.87075	0.139
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	87	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	-0.19388	-0.79776	0.7618	0.87397	1	0.092	0.0732	0.0855	0.8708	0.139
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	16	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	-0.28135	-0.7975	0.7271	0.87396	1	0.125	0.0579	0.118	0.87098	0.139
SHEPARD_CRUSH_AND_BURN_MUTANT_UP	187	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_CRUSH_AND_BURN_MUTANT_UP	-0.16696	-0.79708	0.7529	0.87424	1	0.31	0.297	0.22	0.87223	0.138
CHENG_RESPONSE_TO_NICKEL_ACETATE	43	http://www.broadinstitute.org/gsea/msigdb/cards/CHENG_RESPONSE_TO_NICKEL_ACETATE	-0.19512	-0.79707	0.8094	0.87379	1	0.14	0.148	0.119	0.87175	0.138
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	39	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	-0.23144	-0.79687	0.7261	0.87363	1	0.154	0.123	0.135	0.87157	0.136
HELLER_SILENCED_BY_METHYLATION_DN	101	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_SILENCED_BY_METHYLATION_DN	-0.2048	-0.79647	0.7992	0.87383	1	0.228	0.198	0.183	0.87148	0.138
DASU_IL6_SIGNALING_SCAR_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/DASU_IL6_SIGNALING_SCAR_DN	-0.40527	-0.79629	0.7002	0.87365	1	0.467	0.215	0.366	0.87116	0.136
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	107	http://www.broadinstitute.org/gsea/msigdb/cards/LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	-0.1989	-0.79611	0.798	0.87347	1	0.467	0.388	0.287	0.87093	0.138
DOANE_BREAST_CANCER_CLASSES_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/DOANE_BREAST_CANCER_CLASSES_UP	-0.20725	-0.79605	0.7623	0.87311	1	0.443	0.356	0.286	0.87069	0.133
SA_PTEN_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/SA_PTEN_PATHWAY	-0.29074	-0.79411	0.7444	0.876	1	0.118	0.0652	0.11	0.87333	0.14
ONDER_CDH1_TARGETS_1_UP	134	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_TARGETS_1_UP	-0.16306	-0.79371	0.8028	0.87621	1	0.433	0.418	0.253	0.87444	0.138
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	18	http://www.broadinstitute.org/gsea/msigdb/cards/MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	-0.28529	-0.7936	0.7854	0.87593	1	0.111	0.0917	0.101	0.87396	0.138
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	308	http://www.broadinstitute.org/gsea/msigdb/cards/DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	-0.26649	-0.79245	0.7753	0.87734	1	0.231	0.165	0.195	0.87537	0.14
YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	-0.3266	-0.7912	0.7495	0.87897	1	0.533	0.365	0.339	0.87785	0.141
REACTOME_ADAPTIVE_IMMUNE_SYSTEM	498	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ADAPTIVE_IMMUNE_SYSTEM	-0.16919	-0.79052	0.8059	0.87966	1	0.195	0.21	0.157	0.87881	0.141
PID_IFNG_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IFNG_PATHWAY	-0.2419	-0.79039	0.7405	0.87943	1	0.459	0.463	0.247	0.87834	0.14
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	-0.21285	-0.78807	0.7728	0.88298	1	0.293	0.266	0.215	0.88139	0.146
PID_HIF2PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HIF2PATHWAY	-0.24825	-0.78787	0.7787	0.88282	1	0.265	0.204	0.211	0.88146	0.145
REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	-0.2732	-0.78772	0.7575	0.88258	1	0.628	0.429	0.359	0.88098	0.143
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE	84	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE	-0.17687	-0.78766	0.8059	0.8822	1	0.452	0.39	0.277	0.8805	0.142
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	65	http://www.broadinstitute.org/gsea/msigdb/cards/FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	-0.21422	-0.78646	0.9222	0.8837	1	0.277	0.219	0.217	0.88229	0.145
LANDIS_ERBB2_BREAST_TUMORS_65_DN	36	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_TUMORS_65_DN	-0.29118	-0.78456	0.7667	0.88642	1	0.222	0.0811	0.204	0.88551	0.148
PID_TCPTP_PATHWAY	41	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TCPTP_PATHWAY	-0.25284	-0.78423	0.7068	0.88649	1	0.146	0.0876	0.134	0.88592	0.148
PID_GLYPICAN_1PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/PID_GLYPICAN_1PATHWAY	-0.25049	-0.78406	0.7696	0.88632	1	0.148	0.0617	0.139	0.88577	0.147
PID_PI3KCI_PATHWAY	49	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PI3KCI_PATHWAY	-0.1843	-0.7837	0.8421	0.88649	1	0.367	0.334	0.245	0.88638	0.148
REACTOME_OPIOID_SIGNALLING	76	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_OPIOID_SIGNALLING	-0.17719	-0.78329	0.8618	0.88673	1	0.355	0.327	0.24	0.8859	0.148
JIANG_VHL_TARGETS	130	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_VHL_TARGETS	-0.17777	-0.7831	0.7944	0.8866	1	0.277	0.28	0.2	0.88586	0.145
LOPES_METHYLATED_IN_COLON_CANCER_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/LOPES_METHYLATED_IN_COLON_CANCER_DN	-0.19194	-0.78299	0.755	0.88629	1	0.5	0.398	0.301	0.88545	0.144
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	180	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	-0.22616	-0.78297	0.7984	0.88585	1	0.156	0.0981	0.141	0.88497	0.144
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	86	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	-0.25116	-0.78284	0.7252	0.88559	1	0.244	0.163	0.205	0.88485	0.144
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	157	http://www.broadinstitute.org/gsea/msigdb/cards/PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	-0.16048	-0.78272	0.8737	0.88533	1	0.229	0.226	0.179	0.88468	0.144
BRUECKNER_TARGETS_OF_MIRLET7A3_UP	103	http://www.broadinstitute.org/gsea/msigdb/cards/BRUECKNER_TARGETS_OF_MIRLET7A3_UP	-0.203	-0.78269	0.795	0.88489	1	0.194	0.166	0.163	0.88432	0.143
MAYBURD_RESPONSE_TO_L663536_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/MAYBURD_RESPONSE_TO_L663536_UP	-0.21158	-0.78233	0.787	0.88499	1	0.276	0.186	0.225	0.8847	0.143
BERENJENO_TRANSFORMED_BY_RHOA_DN	378	http://www.broadinstitute.org/gsea/msigdb/cards/BERENJENO_TRANSFORMED_BY_RHOA_DN	-0.21676	-0.78059	0.7433	0.88748	1	0.156	0.119	0.139	0.88696	0.144
REACTOME_GABA_B_RECEPTOR_ACTIVATION	37	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GABA_B_RECEPTOR_ACTIVATION	-0.21857	-0.78027	0.6973	0.88748	1	0.108	0.0546	0.102	0.88715	0.144
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP	88	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP	-0.20385	-0.78015	0.802	0.8872	1	0.193	0.207	0.154	0.88749	0.144
HAN_SATB1_TARGETS_DN	425	http://www.broadinstitute.org/gsea/msigdb/cards/HAN_SATB1_TARGETS_DN	-0.18812	-0.78014	0.845	0.88673	1	0.252	0.264	0.188	0.88701	0.144
WANG_LSD1_TARGETS_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_LSD1_TARGETS_DN	-0.24101	-0.77915	0.7853	0.88787	1	0.526	0.386	0.323	0.88807	0.144
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	-0.23551	-0.77787	0.7587	0.8895	1	0.393	0.31	0.271	0.89062	0.145
REACTOME_SEMAPHORIN_INTERACTIONS	66	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SEMAPHORIN_INTERACTIONS	-0.21222	-0.77461	0.7329	0.89435	1	0.318	0.278	0.23	0.89555	0.156
BIOCARTA_SHH_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_SHH_PATHWAY	-0.24127	-0.77459	0.8206	0.89391	1	0.188	0.131	0.163	0.89506	0.15
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	247	http://www.broadinstitute.org/gsea/msigdb/cards/MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	-0.17018	-0.77422	0.8052	0.894	1	0.352	0.338	0.235	0.89509	0.15
REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	-0.21617	-0.77342	0.8016	0.89484	1	0.63	0.502	0.314	0.89603	0.154
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	-0.20936	-0.77315	0.7953	0.89478	1	0.588	0.495	0.297	0.89581	0.158
VERRECCHIA_RESPONSE_TO_TGFB1_C5	21	http://www.broadinstitute.org/gsea/msigdb/cards/VERRECCHIA_RESPONSE_TO_TGFB1_C5	-0.26177	-0.77271	0.7572	0.89504	1	0.381	0.35	0.248	0.89599	0.159
ZHU_CMV_8_HR_DN	52	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_8_HR_DN	-0.25891	-0.77181	0.7635	0.89609	1	0.462	0.357	0.297	0.89718	0.159
HUNSBERGER_EXERCISE_REGULATED_GENES	31	http://www.broadinstitute.org/gsea/msigdb/cards/HUNSBERGER_EXERCISE_REGULATED_GENES	-0.26089	-0.77127	0.7196	0.89646	1	0.452	0.323	0.306	0.89781	0.159
CUI_GLUCOSE_DEPRIVATION	57	http://www.broadinstitute.org/gsea/msigdb/cards/CUI_GLUCOSE_DEPRIVATION	-0.17457	-0.76753	0.8252	0.90187	1	0.368	0.392	0.224	0.9025	0.17
MIKKELSEN_IPS_ICP_WITH_H3K27ME3	52	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_IPS_ICP_WITH_H3K27ME3	-0.21693	-0.76697	0.8786	0.90227	1	0.25	0.222	0.195	0.90331	0.171
APPIERTO_RESPONSE_TO_FENRETINIDE_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/APPIERTO_RESPONSE_TO_FENRETINIDE_DN	-0.21011	-0.76649	0.8457	0.90256	1	0.2	0.156	0.169	0.90305	0.171
VANTVEER_BREAST_CANCER_ESR1_DN	223	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_ESR1_DN	-0.17316	-0.76624	0.8337	0.90249	1	0.161	0.165	0.136	0.9028	0.171
BIOCARTA_IL2_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL2_PATHWAY	-0.22139	-0.76592	0.8061	0.90254	1	0.5	0.358	0.321	0.90297	0.171
YAGI_AML_WITH_T_8_21_TRANSLOCATION	350	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_WITH_T_8_21_TRANSLOCATION	-0.16821	-0.76579	0.8262	0.90225	1	0.38	0.358	0.247	0.90249	0.171
MALONEY_RESPONSE_TO_17AAG_DN	78	http://www.broadinstitute.org/gsea/msigdb/cards/MALONEY_RESPONSE_TO_17AAG_DN	-0.22535	-0.76574	0.8075	0.90185	1	0.218	0.162	0.183	0.90201	0.171
HASLINGER_B_CLL_WITH_13Q14_DELETION	23	http://www.broadinstitute.org/gsea/msigdb/cards/HASLINGER_B_CLL_WITH_13Q14_DELETION	-0.24716	-0.76562	0.7521	0.90156	1	0.261	0.175	0.215	0.90152	0.171
BIOCARTA_ALK_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ALK_PATHWAY	-0.23721	-0.76535	0.7297	0.90147	1	0.459	0.315	0.315	0.90104	0.168
TOMLINS_PROSTATE_CANCER_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/TOMLINS_PROSTATE_CANCER_UP	-0.25709	-0.76513	0.8484	0.90133	1	0.132	0.0855	0.121	0.90125	0.166
BURTON_ADIPOGENESIS_7	47	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_7	-0.25611	-0.76499	0.8148	0.90105	1	0.213	0.123	0.187	0.90102	0.166
DARWICHE_PAPILLOMA_PROGRESSION_RISK	69	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_PROGRESSION_RISK	-0.19131	-0.76469	0.8337	0.90106	1	0.551	0.467	0.294	0.90122	0.166
CHICAS_RB1_TARGETS_GROWING	233	http://www.broadinstitute.org/gsea/msigdb/cards/CHICAS_RB1_TARGETS_GROWING	-0.22874	-0.76446	0.8364	0.90092	1	0.219	0.163	0.185	0.90125	0.165
HOLLMANN_APOPTOSIS_VIA_CD40_DN	246	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLMANN_APOPTOSIS_VIA_CD40_DN	-0.18149	-0.76428	0.8518	0.90074	1	0.24	0.242	0.183	0.90098	0.164
REACTOME_METAL_ION_SLC_TRANSPORTERS	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METAL_ION_SLC_TRANSPORTERS	-0.24785	-0.76402	0.8211	0.90064	1	0.545	0.43	0.311	0.90116	0.164
BIOCARTA_EDG1_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_EDG1_PATHWAY	-0.21762	-0.76384	0.7866	0.90045	1	0.654	0.532	0.306	0.90073	0.16
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	262	http://www.broadinstitute.org/gsea/msigdb/cards/KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	-0.15107	-0.76253	0.8889	0.90198	1	0.26	0.263	0.193	0.90227	0.164
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR	97	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR	-0.16898	-0.7624	0.8698	0.90172	1	0.464	0.408	0.276	0.90183	0.164
WINTER_HYPOXIA_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/WINTER_HYPOXIA_DN	-0.29202	-0.76216	0.7732	0.90161	1	0.24	0.124	0.211	0.90135	0.164
MASSARWEH_RESPONSE_TO_ESTRADIOL	60	http://www.broadinstitute.org/gsea/msigdb/cards/MASSARWEH_RESPONSE_TO_ESTRADIOL	-0.21067	-0.76167	0.8805	0.90189	1	0.167	0.145	0.143	0.90227	0.165
REACTOME_PERK_REGULATED_GENE_EXPRESSION	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PERK_REGULATED_GENE_EXPRESSION	-0.25408	-0.76142	0.7704	0.9018	1	0.192	0.123	0.169	0.9025	0.165
KEGG_APOPTOSIS	85	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_APOPTOSIS	-0.18515	-0.7614	0.8563	0.90135	1	0.0706	0.0478	0.0674	0.90202	0.164
PID_SHP2_PATHWAY	57	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SHP2_PATHWAY	-0.21661	-0.76116	0.8285	0.90127	1	0.193	0.15	0.164	0.9023	0.162
LI_DCP2_BOUND_MRNA	88	http://www.broadinstitute.org/gsea/msigdb/cards/LI_DCP2_BOUND_MRNA	-0.16564	-0.761	0.767	0.90103	1	0.398	0.379	0.248	0.90182	0.161
ROSS_LEUKEMIA_WITH_MLL_FUSIONS	73	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_LEUKEMIA_WITH_MLL_FUSIONS	-0.24269	-0.76096	0.8013	0.9006	1	0.219	0.148	0.187	0.90156	0.161
PID_LIS1_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/PID_LIS1_PATHWAY	-0.20134	-0.75956	0.8694	0.90238	1	0.259	0.256	0.193	0.90267	0.163
PID_P38_MK2_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P38_MK2_PATHWAY	-0.24442	-0.75941	0.7715	0.90216	1	0.619	0.438	0.348	0.90262	0.162
SEKI_INFLAMMATORY_RESPONSE_LPS_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/SEKI_INFLAMMATORY_RESPONSE_LPS_DN	-0.25829	-0.75936	0.7754	0.90175	1	0.227	0.109	0.203	0.90214	0.162
SERVITJA_LIVER_HNF1A_TARGETS_UP	131	http://www.broadinstitute.org/gsea/msigdb/cards/SERVITJA_LIVER_HNF1A_TARGETS_UP	-0.17358	-0.75768	0.9049	0.90384	1	0.473	0.418	0.277	0.9047	0.162
HE_PTEN_TARGETS_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/HE_PTEN_TARGETS_UP	-0.25688	-0.75751	0.7988	0.9036	1	0.0625	0.0178	0.0614	0.90464	0.163
ST_G_ALPHA_I_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/ST_G_ALPHA_I_PATHWAY	-0.20306	-0.75744	0.827	0.90324	1	0.0857	0.0478	0.0817	0.90416	0.162
REACTOME_CELL_CELL_COMMUNICATION	116	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CELL_COMMUNICATION	-0.1733	-0.75663	0.8725	0.90402	1	0.44	0.378	0.275	0.906	0.165
JACKSON_DNMT1_TARGETS_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/JACKSON_DNMT1_TARGETS_DN	-0.23826	-0.75646	0.7867	0.9038	1	0.12	0.034	0.116	0.90569	0.164
MELLMAN_TUT1_TARGETS_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/MELLMAN_TUT1_TARGETS_DN	-0.19934	-0.75615	0.8152	0.90379	1	0.152	0.125	0.133	0.9063	0.163
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	-0.30407	-0.75384	0.7134	0.90683	1	0.3	0.191	0.243	0.9095	0.165
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	147	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	-0.16274	-0.75299	0.8394	0.90761	1	0.395	0.379	0.247	0.91066	0.165
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	61	http://www.broadinstitute.org/gsea/msigdb/cards/FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	-0.18553	-0.75263	0.8878	0.90772	1	0.246	0.236	0.188	0.9103	0.166
BURTON_ADIPOGENESIS_5	115	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_5	-0.17262	-0.75229	0.8732	0.90776	1	0.33	0.33	0.222	0.91013	0.166
REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION	-0.25883	-0.7522	0.814	0.90743	1	0.467	0.356	0.301	0.90969	0.164
PLASARI_NFIC_TARGETS_BASAL_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_NFIC_TARGETS_BASAL_UP	-0.21953	-0.75133	0.7943	0.90828	1	0.185	0.149	0.158	0.91083	0.167
REACTOME_METABOLISM_OF_CARBOHYDRATES	227	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_CARBOHYDRATES	-0.14564	-0.75116	0.8855	0.90811	1	0.145	0.163	0.123	0.91116	0.167
PID_ALK1_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ALK1_PATHWAY	-0.27244	-0.75105	0.8209	0.90778	1	0.308	0.207	0.244	0.91097	0.166
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM	290	http://www.broadinstitute.org/gsea/msigdb/cards/IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM	-0.16401	-0.75092	0.9286	0.90751	1	0.314	0.308	0.22	0.91072	0.165
ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY	-0.20107	-0.74963	0.8326	0.90894	1	0.27	0.242	0.205	0.91194	0.167
RAMASWAMY_METASTASIS_DN	60	http://www.broadinstitute.org/gsea/msigdb/cards/RAMASWAMY_METASTASIS_DN	-0.20022	-0.74929	0.8472	0.90896	1	0.317	0.287	0.226	0.9123	0.167
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS	-0.21632	-0.74854	0.7697	0.90962	1	0.353	0.311	0.243	0.91274	0.165
WANG_TARGETS_OF_MLL_CBP_FUSION_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_TARGETS_OF_MLL_CBP_FUSION_UP	-0.1809	-0.74853	0.8211	0.90916	1	0.349	0.332	0.233	0.91227	0.164
NUMATA_CSF3_SIGNALING_VIA_STAT3	19	http://www.broadinstitute.org/gsea/msigdb/cards/NUMATA_CSF3_SIGNALING_VIA_STAT3	-0.25914	-0.74783	0.786	0.90971	1	0.211	0.205	0.167	0.91253	0.163
RIZ_ERYTHROID_DIFFERENTIATION_HBZ	41	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_HBZ	-0.20332	-0.74756	0.8337	0.90963	1	0.61	0.518	0.294	0.91244	0.162
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	-0.26481	-0.74711	0.8491	0.90983	1	0.143	0.0513	0.136	0.91279	0.162
LEIN_CEREBELLUM_MARKERS	79	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_CEREBELLUM_MARKERS	-0.16886	-0.74534	0.8685	0.91198	1	0.443	0.403	0.266	0.9152	0.165
VANLOO_SP3_TARGETS_DN	82	http://www.broadinstitute.org/gsea/msigdb/cards/VANLOO_SP3_TARGETS_DN	-0.1679	-0.74503	0.8407	0.91196	1	0.28	0.314	0.193	0.91499	0.165
YANG_MUC2_TARGETS_DUODENUM_6MO_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_MUC2_TARGETS_DUODENUM_6MO_DN	-0.25707	-0.74495	0.8525	0.9116	1	0.25	0.241	0.19	0.91544	0.165
REACTOME_BASE_EXCISION_REPAIR	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BASE_EXCISION_REPAIR	-0.24182	-0.74365	0.7543	0.91293	1	0.333	0.309	0.23	0.91576	0.165
REACTOME_PI3K_AKT_ACTIVATION	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PI3K_AKT_ACTIVATION	-0.23874	-0.74278	0.762	0.91375	1	0.167	0.112	0.148	0.91725	0.168
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	-0.19196	-0.74085	0.7969	0.91608	1	0.259	0.252	0.194	0.91961	0.172
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	-0.23636	-0.73993	0.7731	0.91691	1	0.391	0.443	0.218	0.91964	0.175
HOEBEKE_LYMPHOID_STEM_CELL_UP	90	http://www.broadinstitute.org/gsea/msigdb/cards/HOEBEKE_LYMPHOID_STEM_CELL_UP	-0.15984	-0.73967	0.9118	0.91682	1	0.289	0.281	0.208	0.9207	0.176
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY	37	http://www.broadinstitute.org/gsea/msigdb/cards/CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY	-0.19441	-0.73937	0.8408	0.9168	1	0.514	0.389	0.314	0.92062	0.172
ZHENG_BOUND_BY_FOXP3	471	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_BOUND_BY_FOXP3	-0.22594	-0.73917	0.8586	0.91659	1	0.214	0.167	0.182	0.92025	0.168
PASINI_SUZ12_TARGETS_DN	310	http://www.broadinstitute.org/gsea/msigdb/cards/PASINI_SUZ12_TARGETS_DN	-0.25356	-0.7391	0.7762	0.91622	1	0.297	0.236	0.229	0.91977	0.166
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	-0.18093	-0.73907	0.9	0.91579	1	0.5	0.403	0.299	0.91938	0.166
NGUYEN_NOTCH1_TARGETS_DN	85	http://www.broadinstitute.org/gsea/msigdb/cards/NGUYEN_NOTCH1_TARGETS_DN	-0.21981	-0.7385	0.7972	0.91609	1	0.153	0.097	0.139	0.91986	0.166
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	180	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	-0.2128	-0.73792	0.8271	0.91649	1	0.328	0.308	0.228	0.92053	0.166
KEGG_HISTIDINE_METABOLISM	28	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_HISTIDINE_METABOLISM	-0.217	-0.73642	0.7791	0.91828	1	0.571	0.416	0.334	0.92301	0.17
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	30	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	-0.2376	-0.73634	0.8437	0.91791	1	0.2	0.17	0.166	0.92284	0.17
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR	105	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_INSULIN_RECEPTOR	-0.15869	-0.7359	0.896	0.91807	1	0.438	0.4	0.264	0.92292	0.167
LEE_CALORIE_RESTRICTION_MUSCLE_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_CALORIE_RESTRICTION_MUSCLE_DN	-0.18161	-0.73589	0.8158	0.91761	1	0.18	0.18	0.148	0.92244	0.165
KANG_AR_TARGETS_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_AR_TARGETS_UP	-0.29304	-0.73587	0.7895	0.91716	1	0.471	0.228	0.364	0.92197	0.163
REACTOME_AMINE_DERIVED_HORMONES	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMINE_DERIVED_HORMONES	-0.32202	-0.7351	0.8151	0.91777	1	0.667	0.436	0.376	0.92244	0.165
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	69	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	-0.19329	-0.73423	0.833	0.91852	1	0.217	0.226	0.169	0.92378	0.169
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	334	http://www.broadinstitute.org/gsea/msigdb/cards/IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	-0.16902	-0.73351	0.9452	0.91904	1	0.189	0.191	0.155	0.92437	0.17
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	39	http://www.broadinstitute.org/gsea/msigdb/cards/WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	-0.2395	-0.73314	0.7964	0.91907	1	0.154	0.125	0.135	0.92454	0.165
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	-0.27415	-0.73205	0.7552	0.92013	1	0.25	0.16	0.21	0.92587	0.17
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	37	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	-0.19572	-0.73195	0.8078	0.9198	1	0.459	0.363	0.293	0.92555	0.17
PID_TAP63_PATHWAY	53	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TAP63_PATHWAY	-0.16919	-0.7314	0.8558	0.92015	1	0.528	0.435	0.299	0.92542	0.169
GENTILE_UV_HIGH_DOSE_DN	299	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_HIGH_DOSE_DN	-0.21854	-0.73124	0.833	0.9199	1	0.154	0.119	0.137	0.92497	0.169
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	75	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	-0.25097	-0.73104	0.8289	0.91969	1	0.36	0.282	0.259	0.92473	0.168
LI_CISPLATIN_RESISTANCE_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/LI_CISPLATIN_RESISTANCE_DN	-0.25704	-0.73087	0.8299	0.91948	1	0.258	0.156	0.218	0.92425	0.165
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	-0.19946	-0.73045	0.7663	0.9196	1	0.444	0.409	0.263	0.92446	0.168
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	24	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	-0.24793	-0.73028	0.8608	0.91935	1	0.208	0.17	0.173	0.92413	0.167
SUNG_METASTASIS_STROMA_UP	107	http://www.broadinstitute.org/gsea/msigdb/cards/SUNG_METASTASIS_STROMA_UP	-0.25259	-0.73024	0.7692	0.91894	1	0.364	0.301	0.256	0.92366	0.165
SUBTIL_PROGESTIN_TARGETS	35	http://www.broadinstitute.org/gsea/msigdb/cards/SUBTIL_PROGESTIN_TARGETS	-0.21912	-0.72986	0.804	0.919	1	0.486	0.37	0.306	0.92381	0.164
CHANG_CORE_SERUM_RESPONSE_DN	195	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_CORE_SERUM_RESPONSE_DN	-0.19346	-0.72931	0.8392	0.91929	1	0.277	0.273	0.203	0.92454	0.165
SYED_ESTRADIOL_RESPONSE	19	http://www.broadinstitute.org/gsea/msigdb/cards/SYED_ESTRADIOL_RESPONSE	-0.25753	-0.72901	0.807	0.9192	1	0.526	0.467	0.281	0.92446	0.163
SANSOM_APC_TARGETS_REQUIRE_MYC	195	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS_REQUIRE_MYC	-0.13843	-0.72757	0.9022	0.92077	1	0.256	0.301	0.181	0.92633	0.166
NIELSEN_LEIOMYOSARCOMA_CNN1_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LEIOMYOSARCOMA_CNN1_DN	-0.29958	-0.72678	0.7505	0.92136	1	0.25	0.135	0.216	0.92622	0.168
WANG_RECURRENT_LIVER_CANCER_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RECURRENT_LIVER_CANCER_UP	-0.28402	-0.72665	0.8218	0.92106	1	0.15	0.123	0.132	0.92622	0.165
PID_FCER1_PATHWAY	60	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FCER1_PATHWAY	-0.2076	-0.72646	0.8722	0.92086	1	0.217	0.2	0.174	0.92593	0.165
REACTOME_NOD1_2_SIGNALING_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NOD1_2_SIGNALING_PATHWAY	-0.22071	-0.72563	0.8613	0.92153	1	0.296	0.277	0.214	0.92714	0.166
REACTOME_TIGHT_JUNCTION_INTERACTIONS	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TIGHT_JUNCTION_INTERACTIONS	-0.21577	-0.72549	0.8814	0.92124	1	0.429	0.324	0.29	0.92701	0.166
ST_B_CELL_ANTIGEN_RECEPTOR	40	http://www.broadinstitute.org/gsea/msigdb/cards/ST_B_CELL_ANTIGEN_RECEPTOR	-0.16156	-0.72486	0.8372	0.92166	1	0.625	0.515	0.304	0.92711	0.166
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	159	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	-0.23639	-0.7247	0.8474	0.9214	1	0.245	0.216	0.193	0.92664	0.162
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	73	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	-0.16703	-0.7237	0.8668	0.9223	1	0.548	0.502	0.274	0.92773	0.166
BIOCARTA_PAR1_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PAR1_PATHWAY	-0.20525	-0.72353	0.8583	0.92205	1	0.595	0.478	0.311	0.92746	0.165
KEGG_PATHWAYS_IN_CANCER	318	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PATHWAYS_IN_CANCER	-0.14881	-0.72335	0.9246	0.92181	1	0.415	0.402	0.251	0.92698	0.164
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	38	http://www.broadinstitute.org/gsea/msigdb/cards/VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	-0.2485	-0.72277	0.7846	0.92217	1	0.447	0.35	0.291	0.92704	0.163
BIOCARTA_CCR3_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CCR3_PATHWAY	-0.22401	-0.72256	0.813	0.92198	1	0.13	0.148	0.111	0.92665	0.16
BIOCARTA_MYOSIN_PATHWAY	31	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MYOSIN_PATHWAY	-0.18835	-0.72244	0.8432	0.92169	1	0.0645	0.0178	0.0634	0.92721	0.159
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	49	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	-0.22742	-0.7221	0.8377	0.92167	1	0.265	0.252	0.199	0.9273	0.159
BIOCARTA_DEATH_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_DEATH_PATHWAY	-0.20999	-0.72171	0.8657	0.92176	1	0.0625	0.0119	0.0618	0.92777	0.159
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	25	http://www.broadinstitute.org/gsea/msigdb/cards/KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	-0.20274	-0.72163	0.8316	0.9214	1	0.04	0.000467	0.04	0.9273	0.154
PID_A6B1_A6B4_INTEGRIN_PATHWAY	46	http://www.broadinstitute.org/gsea/msigdb/cards/PID_A6B1_A6B4_INTEGRIN_PATHWAY	-0.19627	-0.72113	0.8859	0.92163	1	0.239	0.203	0.191	0.92771	0.155
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	-0.21524	-0.7202	0.8962	0.92246	1	0.17	0.118	0.15	0.92911	0.156
KEGG_GALACTOSE_METABOLISM	25	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GALACTOSE_METABOLISM	-0.22456	-0.7195	0.8192	0.9229	1	0.6	0.439	0.337	0.92906	0.16
KEGG_AXON_GUIDANCE	128	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_AXON_GUIDANCE	-0.17039	-0.71911	0.9324	0.92294	1	0.305	0.286	0.219	0.92892	0.16
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	94	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	-0.14748	-0.71903	0.8922	0.92258	1	0.511	0.463	0.275	0.92845	0.157
LIU_PROSTATE_CANCER_DN	459	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_PROSTATE_CANCER_DN	-0.186	-0.71797	0.8212	0.92348	1	0.261	0.243	0.202	0.92986	0.158
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI	-0.27193	-0.71788	0.8604	0.9231	1	0.222	0.12	0.196	0.92943	0.155
BROWNE_HCMV_INFECTION_14HR_DN	283	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_14HR_DN	-0.17044	-0.71763	0.9418	0.92296	1	0.127	0.124	0.113	0.92936	0.154
STEIN_ESR1_TARGETS	83	http://www.broadinstitute.org/gsea/msigdb/cards/STEIN_ESR1_TARGETS	-0.17344	-0.71728	0.8663	0.92297	1	0.205	0.202	0.164	0.92973	0.154
KEGG_GLIOMA	64	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLIOMA	-0.17023	-0.71575	0.9022	0.92449	1	0.109	0.111	0.0975	0.93146	0.158
RAGHAVACHARI_PLATELET_SPECIFIC_GENES	68	http://www.broadinstitute.org/gsea/msigdb/cards/RAGHAVACHARI_PLATELET_SPECIFIC_GENES	-0.19907	-0.71564	0.8619	0.92416	1	0.25	0.226	0.194	0.93099	0.154
REACTOME_SIGNALING_BY_PDGF	117	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_PDGF	-0.18596	-0.71562	0.8392	0.92372	1	0.12	0.0876	0.11	0.93054	0.154
BROWNE_HCMV_INFECTION_24HR_DN	143	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_24HR_DN	-0.23112	-0.71556	0.8191	0.92332	1	0.238	0.216	0.187	0.93007	0.154
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	-0.25081	-0.7152	0.8278	0.92334	1	0.6	0.462	0.323	0.9298	0.153
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	19	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	-0.24119	-0.71481	0.7933	0.92339	1	0.316	0.324	0.214	0.93046	0.151
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	111	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	-0.15829	-0.7134	0.9177	0.92471	1	0.396	0.366	0.252	0.93195	0.153
BURTON_ADIPOGENESIS_3	99	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_3	-0.19313	-0.71235	0.7495	0.92565	1	0.253	0.26	0.188	0.9326	0.154
LIU_BREAST_CANCER	28	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_BREAST_CANCER	-0.17624	-0.71161	0.7765	0.92612	1	0.536	0.459	0.29	0.93397	0.154
ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE	17	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE	-0.22931	-0.70892	0.8984	0.92915	1	0.765	0.554	0.341	0.93712	0.162
BROWNE_HCMV_INFECTION_20HR_DN	98	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_20HR_DN	-0.24361	-0.70764	0.8283	0.93027	1	0.337	0.299	0.237	0.93776	0.166
LIM_MAMMARY_LUMINAL_MATURE_DN	96	http://www.broadinstitute.org/gsea/msigdb/cards/LIM_MAMMARY_LUMINAL_MATURE_DN	-0.2109	-0.70639	0.8227	0.93135	1	0.312	0.268	0.23	0.93854	0.171
KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	-0.21643	-0.70627	0.8998	0.93105	1	0.146	0.116	0.13	0.9382	0.17
SU_PLACENTA	30	http://www.broadinstitute.org/gsea/msigdb/cards/SU_PLACENTA	-0.20431	-0.70459	0.8765	0.93264	1	0.7	0.502	0.349	0.93984	0.172
BOCHKIS_FOXA2_TARGETS	408	http://www.broadinstitute.org/gsea/msigdb/cards/BOCHKIS_FOXA2_TARGETS	-0.13534	-0.70429	0.9731	0.93255	1	0.282	0.303	0.2	0.93974	0.172
DAZARD_RESPONSE_TO_UV_SCC_DN	116	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_RESPONSE_TO_UV_SCC_DN	-0.20758	-0.70349	0.8953	0.9331	1	0.155	0.115	0.138	0.94019	0.173
WANG_RESPONSE_TO_BEXAROTENE_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RESPONSE_TO_BEXAROTENE_UP	-0.21096	-0.70333	0.879	0.93283	1	0.531	0.443	0.296	0.93995	0.173
BIOCARTA_G2_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_G2_PATHWAY	-0.1816	-0.70288	0.8849	0.93291	1	0.375	0.308	0.26	0.9405	0.171
WANG_SMARCE1_TARGETS_DN	353	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_SMARCE1_TARGETS_DN	-0.17975	-0.7025	0.9603	0.93293	1	0.167	0.151	0.144	0.94048	0.169
BIOCARTA_NO1_PATHWAY	31	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NO1_PATHWAY	-0.17719	-0.70198	0.8975	0.93309	1	0.387	0.324	0.262	0.94075	0.171
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	54	http://www.broadinstitute.org/gsea/msigdb/cards/GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	-0.19129	-0.70179	0.8713	0.93286	1	0.315	0.275	0.229	0.94044	0.17
JI_RESPONSE_TO_FSH_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/JI_RESPONSE_TO_FSH_DN	-0.25529	-0.70105	0.8828	0.93327	1	0.286	0.221	0.223	0.94072	0.17
YOKOE_CANCER_TESTIS_ANTIGENS	33	http://www.broadinstitute.org/gsea/msigdb/cards/YOKOE_CANCER_TESTIS_ANTIGENS	-0.20403	-0.70096	0.8762	0.9329	1	0.455	0.399	0.273	0.94025	0.169
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	221	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	-0.13762	-0.69895	0.9659	0.93481	1	0.29	0.309	0.202	0.94217	0.173
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	-0.26024	-0.69875	0.8745	0.93462	1	0.273	0.165	0.228	0.94177	0.173
PID_AVB3_INTEGRIN_PATHWAY	74	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AVB3_INTEGRIN_PATHWAY	-0.23313	-0.69845	0.8283	0.93455	1	0.527	0.43	0.301	0.94174	0.173
REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	49	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	-0.24308	-0.69797	0.9175	0.93464	1	0.429	0.286	0.307	0.94167	0.173
ASTIER_INTEGRIN_SIGNALING	55	http://www.broadinstitute.org/gsea/msigdb/cards/ASTIER_INTEGRIN_SIGNALING	-0.15747	-0.69703	0.8652	0.9353	1	0.364	0.358	0.234	0.94245	0.173
KAAB_FAILED_HEART_ATRIUM_DN	137	http://www.broadinstitute.org/gsea/msigdb/cards/KAAB_FAILED_HEART_ATRIUM_DN	-0.18846	-0.69693	0.8772	0.93496	1	0.131	0.104	0.118	0.94212	0.172
RODRIGUES_THYROID_CARCINOMA_DN	72	http://www.broadinstitute.org/gsea/msigdb/cards/RODRIGUES_THYROID_CARCINOMA_DN	-0.28298	-0.69568	0.8586	0.93594	1	0.111	0.0323	0.108	0.94315	0.172
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	-0.20053	-0.69558	0.8213	0.9356	1	0.579	0.474	0.305	0.94281	0.172
MANTOVANI_VIRAL_GPCR_SIGNALING_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/MANTOVANI_VIRAL_GPCR_SIGNALING_DN	-0.16907	-0.69476	0.8802	0.93614	1	0.111	0.0982	0.1	0.94387	0.172
PID_IL2_STAT5_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL2_STAT5_PATHWAY	-0.19317	-0.69336	0.9198	0.93729	1	0.448	0.378	0.279	0.94553	0.174
ST_GRANULE_CELL_SURVIVAL_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/ST_GRANULE_CELL_SURVIVAL_PATHWAY	-0.228	-0.69125	0.8395	0.93943	1	0.192	0.135	0.167	0.94742	0.175
BURTON_ADIPOGENESIS_PEAK_AT_16HR	40	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_16HR	-0.1952	-0.69027	0.8755	0.94014	1	0.2	0.178	0.165	0.94814	0.179
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	186	http://www.broadinstitute.org/gsea/msigdb/cards/STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	-0.17749	-0.68969	0.9222	0.94037	1	0.269	0.269	0.198	0.94829	0.18
LEE_AGING_NEOCORTEX_DN	76	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_AGING_NEOCORTEX_DN	-0.14595	-0.68804	0.9598	0.94186	1	0.329	0.37	0.208	0.94928	0.182
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	155	http://www.broadinstitute.org/gsea/msigdb/cards/ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	-0.16472	-0.68788	0.8824	0.94158	1	0.194	0.195	0.157	0.94887	0.181
WANG_BARRETTS_ESOPHAGUS_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_BARRETTS_ESOPHAGUS_DN	-0.20358	-0.68745	0.9176	0.94161	1	0.16	0.131	0.139	0.94905	0.181
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	91	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	-0.13674	-0.68685	0.9553	0.94186	1	0.527	0.473	0.279	0.9497	0.181
PID_EPHA2_FWD_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/PID_EPHA2_FWD_PATHWAY	-0.23594	-0.686	0.8889	0.94238	1	0.474	0.334	0.316	0.9502	0.183
WENG_POR_DOSAGE	19	http://www.broadinstitute.org/gsea/msigdb/cards/WENG_POR_DOSAGE	-0.20395	-0.684	0.8641	0.9442	1	0.105	0.145	0.0901	0.95226	0.187
MCCLUNG_CREB1_TARGETS_UP	94	http://www.broadinstitute.org/gsea/msigdb/cards/MCCLUNG_CREB1_TARGETS_UP	-0.1745	-0.68337	0.9014	0.94438	1	0.426	0.354	0.276	0.95286	0.186
WU_HBX_TARGETS_2_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/WU_HBX_TARGETS_2_UP	-0.22039	-0.68331	0.9207	0.94399	1	0.217	0.179	0.179	0.95239	0.185
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	271	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	-0.18226	-0.68259	0.9129	0.94431	1	0.218	0.204	0.175	0.95243	0.185
PID_IL2_1PATHWAY	54	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL2_1PATHWAY	-0.17947	-0.6822	0.9226	0.94425	1	0.167	0.135	0.144	0.95227	0.185
GAVIN_FOXP3_TARGETS_CLUSTER_P6	89	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_P6	-0.18439	-0.68061	0.8787	0.94554	1	0.607	0.475	0.32	0.95431	0.187
PENG_GLUTAMINE_DEPRIVATION_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_GLUTAMINE_DEPRIVATION_UP	-0.19063	-0.67783	0.9212	0.94814	1	0.0833	0.0521	0.0791	0.95638	0.193
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	-0.26319	-0.67648	0.8313	0.94917	1	0.0938	0.0271	0.0913	0.95785	0.196
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP	-0.29902	-0.67547	0.786	0.94977	1	0.333	0.251	0.25	0.95794	0.199
LI_AMPLIFIED_IN_LUNG_CANCER	172	http://www.broadinstitute.org/gsea/msigdb/cards/LI_AMPLIFIED_IN_LUNG_CANCER	-0.15537	-0.675	0.8715	0.94981	1	0.279	0.299	0.197	0.95803	0.196
ROY_WOUND_BLOOD_VESSEL_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/ROY_WOUND_BLOOD_VESSEL_DN	-0.22568	-0.67365	0.862	0.95086	1	0.182	0.178	0.15	0.95922	0.198
WU_HBX_TARGETS_1_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/WU_HBX_TARGETS_1_DN	-0.23482	-0.67274	0.8718	0.95135	1	0.217	0.191	0.176	0.95986	0.196
WU_HBX_TARGETS_1_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/WU_HBX_TARGETS_1_UP	-0.22568	-0.67267	0.8478	0.95096	1	0.733	0.538	0.339	0.9596	0.195
UEDA_CENTRAL_CLOCK	87	http://www.broadinstitute.org/gsea/msigdb/cards/UEDA_CENTRAL_CLOCK	-0.19719	-0.67255	0.9122	0.95061	1	0.092	0.0688	0.0859	0.95913	0.194
DORMOY_ELAVL1_TARGETS	16	http://www.broadinstitute.org/gsea/msigdb/cards/DORMOY_ELAVL1_TARGETS	-0.24669	-0.67242	0.8907	0.95029	1	0.438	0.303	0.305	0.95914	0.192
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	189	http://www.broadinstitute.org/gsea/msigdb/cards/SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	-0.13517	-0.672	0.9597	0.95028	1	0.434	0.434	0.247	0.95867	0.192
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	177	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	-0.16387	-0.67169	0.8682	0.95015	1	0.209	0.214	0.165	0.95844	0.192
IVANOVSKA_MIR106B_TARGETS	86	http://www.broadinstitute.org/gsea/msigdb/cards/IVANOVSKA_MIR106B_TARGETS	-0.17215	-0.67109	0.8952	0.95034	1	0.209	0.196	0.169	0.9588	0.192
GROSS_HYPOXIA_VIA_ELK3_UP	197	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_UP	-0.13861	-0.67079	0.9447	0.95018	1	0.228	0.261	0.17	0.95875	0.19
BIOCARTA_ARAP_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ARAP_PATHWAY	-0.23059	-0.67013	0.7899	0.9504	1	0.118	0.102	0.106	0.95872	0.191
LIN_MELANOMA_COPY_NUMBER_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_MELANOMA_COPY_NUMBER_UP	-0.14262	-0.66912	0.8996	0.95099	1	0.25	0.305	0.174	0.95936	0.192
GROSS_ELK3_TARGETS_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_ELK3_TARGETS_UP	-0.22278	-0.66868	0.8864	0.95097	1	0.115	0.0509	0.11	0.95941	0.192
JI_RESPONSE_TO_FSH_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/JI_RESPONSE_TO_FSH_UP	-0.19357	-0.66802	0.877	0.95117	1	0.114	0.116	0.101	0.95907	0.19
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	42	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	-0.19236	-0.66714	0.8903	0.9516	1	0.262	0.277	0.19	0.95977	0.192
JIANG_HYPOXIA_CANCER	78	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_HYPOXIA_CANCER	-0.16958	-0.66673	0.9337	0.95153	1	0.269	0.258	0.2	0.9594	0.192
PIONTEK_PKD1_TARGETS_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/PIONTEK_PKD1_TARGETS_DN	-0.22961	-0.66667	0.9175	0.95113	1	0.375	0.295	0.264	0.95893	0.189
DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	488	http://www.broadinstitute.org/gsea/msigdb/cards/DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	-0.20231	-0.66603	0.9145	0.95127	1	0.309	0.265	0.232	0.95981	0.19
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	42	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	-0.17987	-0.66538	0.9454	0.95149	1	0.405	0.385	0.249	0.95978	0.19
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	64	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	-0.15267	-0.66297	0.8923	0.9534	1	0.531	0.447	0.295	0.96108	0.194
ST_GA13_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/ST_GA13_PATHWAY	-0.19353	-0.66275	0.9163	0.95313	1	0.162	0.155	0.137	0.96065	0.192
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	444	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	-0.21989	-0.66194	0.8216	0.9535	1	0.286	0.252	0.218	0.96135	0.192
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	176	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	-0.16896	-0.6615	0.9002	0.9535	1	0.392	0.365	0.251	0.9614	0.19
ALONSO_METASTASIS_EMT_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/ALONSO_METASTASIS_EMT_UP	-0.25459	-0.66075	0.853	0.95377	1	0.143	0.0942	0.13	0.96138	0.192
LE_EGR2_TARGETS_UP	106	http://www.broadinstitute.org/gsea/msigdb/cards/LE_EGR2_TARGETS_UP	-0.18173	-0.66069	0.8716	0.95336	1	0.283	0.273	0.207	0.96091	0.19
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS	-0.23552	-0.66021	0.8613	0.95335	1	0.5	0.393	0.304	0.96072	0.19
LOPEZ_EPITHELIOID_MESOTHELIOMA	17	http://www.broadinstitute.org/gsea/msigdb/cards/LOPEZ_EPITHELIOID_MESOTHELIOMA	-0.28248	-0.65973	0.8735	0.95332	1	0.647	0.36	0.415	0.9607	0.186
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	74	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	-0.17304	-0.65951	0.8743	0.95307	1	0.446	0.406	0.266	0.96023	0.187
PID_NECTIN_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NECTIN_PATHWAY	-0.21763	-0.6595	0.9206	0.95262	1	0.552	0.462	0.297	0.95976	0.185
RIZ_ERYTHROID_DIFFERENTIATION	72	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION	-0.14585	-0.65901	0.882	0.95265	1	0.347	0.376	0.217	0.95995	0.183
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	82	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	-0.13859	-0.65803	0.9509	0.95317	1	0.207	0.235	0.159	0.96054	0.183
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	-0.18051	-0.6567	0.8938	0.954	1	0.538	0.474	0.283	0.9617	0.185
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	-0.24609	-0.65647	0.8998	0.95376	1	0.368	0.31	0.254	0.96123	0.185
BIOCARTA_AGR_PATHWAY	36	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_AGR_PATHWAY	-0.18716	-0.65613	0.9113	0.95366	1	0.361	0.304	0.252	0.96133	0.18
BIOCARTA_TCR_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TCR_PATHWAY	-0.19935	-0.6558	0.8898	0.95351	1	0.356	0.323	0.241	0.96149	0.178
RUIZ_TNC_TARGETS_DN	137	http://www.broadinstitute.org/gsea/msigdb/cards/RUIZ_TNC_TARGETS_DN	-0.15784	-0.65571	0.9578	0.95314	1	0.314	0.339	0.209	0.96107	0.176
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	75	http://www.broadinstitute.org/gsea/msigdb/cards/SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	-0.16867	-0.65549	0.9691	0.95289	1	0.16	0.161	0.135	0.96082	0.169
MIKKELSEN_NPC_LCP_WITH_H3K4ME3	55	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_NPC_LCP_WITH_H3K4ME3	-0.15213	-0.65531	0.9463	0.95261	1	0.6	0.502	0.299	0.96044	0.167
ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL	15	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL	-0.25603	-0.65512	0.874	0.95233	1	0.133	0.0478	0.127	0.96013	0.165
CHEN_HOXA5_TARGETS_9HR_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_HOXA5_TARGETS_9HR_DN	-0.15928	-0.65379	0.936	0.9531	1	0.385	0.359	0.247	0.9608	0.167
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	61	http://www.broadinstitute.org/gsea/msigdb/cards/HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	-0.17072	-0.65263	0.9847	0.95373	1	0.23	0.235	0.176	0.96162	0.168
REACTOME_SIGNALING_BY_FGFR	107	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_FGFR	-0.15247	-0.64758	0.9782	0.9579	1	0.449	0.408	0.267	0.96609	0.193
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	-0.28502	-0.64667	0.8182	0.95826	1	0.229	0.138	0.197	0.96632	0.192
NAGASHIMA_NRG1_SIGNALING_DN	54	http://www.broadinstitute.org/gsea/msigdb/cards/NAGASHIMA_NRG1_SIGNALING_DN	-0.20592	-0.64584	0.9408	0.95852	1	0.0926	0.0666	0.0866	0.96648	0.194
KEGG_FOCAL_ADHESION	197	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_FOCAL_ADHESION	-0.16143	-0.64325	0.9586	0.96026	1	0.416	0.383	0.259	0.96893	0.2
KEGG_BASE_EXCISION_REPAIR	32	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BASE_EXCISION_REPAIR	-0.16916	-0.64294	0.8745	0.96005	1	0.312	0.309	0.216	0.96855	0.199
REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS	-0.14897	-0.6414	0.9625	0.96096	1	0.226	0.26	0.167	0.96925	0.2
REACTOME_CTLA4_INHIBITORY_SIGNALING	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CTLA4_INHIBITORY_SIGNALING	-0.20691	-0.64131	0.937	0.96058	1	0.238	0.187	0.194	0.96891	0.198
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	311	http://www.broadinstitute.org/gsea/msigdb/cards/GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	-0.13027	-0.63883	0.8399	0.96228	1	0.514	0.505	0.258	0.97034	0.207
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	51	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	-0.14137	-0.63834	0.9722	0.96224	1	0.431	0.449	0.238	0.97003	0.206
REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	55	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	-0.16694	-0.63746	0.9415	0.96255	1	0.4	0.331	0.268	0.97026	0.212
MADAN_DPPA4_TARGETS	41	http://www.broadinstitute.org/gsea/msigdb/cards/MADAN_DPPA4_TARGETS	-0.17423	-0.63604	0.9453	0.96333	1	0.415	0.434	0.235	0.97147	0.213
STONER_ESOPHAGEAL_CARCINOGENESIS_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/STONER_ESOPHAGEAL_CARCINOGENESIS_UP	-0.17703	-0.63569	0.8828	0.96315	1	0.263	0.269	0.193	0.97108	0.208
HU_GENOTOXIC_DAMAGE_4HR	34	http://www.broadinstitute.org/gsea/msigdb/cards/HU_GENOTOXIC_DAMAGE_4HR	-0.18386	-0.63469	0.9167	0.96353	1	0.559	0.541	0.257	0.97164	0.214
SCIBETTA_KDM5B_TARGETS_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/SCIBETTA_KDM5B_TARGETS_UP	-0.19456	-0.63353	0.898	0.96402	1	0.471	0.403	0.281	0.97223	0.213
SIG_BCR_SIGNALING_PATHWAY	46	http://www.broadinstitute.org/gsea/msigdb/cards/SIG_BCR_SIGNALING_PATHWAY	-0.16378	-0.63249	0.9231	0.96443	1	0.0435	0.0095	0.0431	0.97277	0.216
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	113	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	-0.17269	-0.6315	0.8802	0.9648	1	0.513	0.465	0.276	0.97313	0.216
CHOW_RASSF1_TARGETS_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/CHOW_RASSF1_TARGETS_DN	-0.15542	-0.63124	0.9469	0.96453	1	0.464	0.421	0.269	0.97275	0.21
SMIRNOV_RESPONSE_TO_IR_6HR_UP	157	http://www.broadinstitute.org/gsea/msigdb/cards/SMIRNOV_RESPONSE_TO_IR_6HR_UP	-0.1576	-0.63084	0.9638	0.96436	1	0.223	0.231	0.172	0.97258	0.209
YIH_RESPONSE_TO_ARSENITE_C1	23	http://www.broadinstitute.org/gsea/msigdb/cards/YIH_RESPONSE_TO_ARSENITE_C1	-0.24956	-0.63065	0.9063	0.96405	1	0.13	0.0712	0.121	0.97214	0.203
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	448	http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	-0.17141	-0.63052	0.9398	0.96368	1	0.263	0.269	0.196	0.97185	0.196
ZHANG_PROLIFERATING_VS_QUIESCENT	50	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_PROLIFERATING_VS_QUIESCENT	-0.15466	-0.63025	0.9157	0.96346	1	0.28	0.323	0.19	0.97172	0.191
BIOCARTA_CARDIACEGF_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CARDIACEGF_PATHWAY	-0.23796	-0.63	0.8893	0.96321	1	0.167	0.118	0.147	0.97151	0.187
CHEOK_RESPONSE_TO_HD_MTX_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/CHEOK_RESPONSE_TO_HD_MTX_DN	-0.21876	-0.6296	0.9485	0.96306	1	0.304	0.222	0.237	0.97123	0.187
NIELSEN_SCHWANNOMA_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_SCHWANNOMA_DN	-0.24393	-0.62811	0.8742	0.96379	1	0.312	0.231	0.24	0.97202	0.187
CHANGOLKAR_H2AFY_TARGETS_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/CHANGOLKAR_H2AFY_TARGETS_UP	-0.14456	-0.62803	0.9496	0.9634	1	0.0217	0.000389	0.0218	0.97156	0.183
BIOCARTA_MTOR_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MTOR_PATHWAY	-0.22269	-0.62582	0.9367	0.96465	1	0.136	0.0914	0.124	0.97232	0.19
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	145	http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	-0.17003	-0.62507	0.9234	0.96481	1	0.11	0.091	0.101	0.97278	0.191
YAGI_AML_FAB_MARKERS	184	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_FAB_MARKERS	-0.16479	-0.62449	0.9937	0.96477	1	0.326	0.305	0.228	0.97246	0.186
BIOCARTA_ERK5_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ERK5_PATHWAY	-0.21842	-0.62421	0.8968	0.96453	1	0.353	0.378	0.22	0.97231	0.184
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES	50	http://www.broadinstitute.org/gsea/msigdb/cards/SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES	-0.16856	-0.62235	0.9501	0.96553	1	0.34	0.331	0.228	0.97337	0.193
BIOCARTA_NDKDYNAMIN_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NDKDYNAMIN_PATHWAY	-0.19638	-0.62178	0.8791	0.96547	1	0.526	0.389	0.322	0.97362	0.187
KEGG_RENAL_CELL_CARCINOMA	70	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RENAL_CELL_CARCINOMA	-0.17872	-0.62065	0.8918	0.96591	1	0.129	0.119	0.114	0.97406	0.19
YU_MYC_TARGETS_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/YU_MYC_TARGETS_UP	-0.20262	-0.62038	0.8965	0.96565	1	0.075	0.0209	0.0735	0.97389	0.188
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	50	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	-0.1765	-0.62021	0.891	0.96531	1	0.44	0.348	0.287	0.97348	0.181
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	183	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	-0.23722	-0.61779	0.9234	0.9666	1	0.202	0.148	0.173	0.97457	0.189
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	-0.20239	-0.61712	0.9202	0.96665	1	0.432	0.387	0.265	0.97437	0.188
REACTOME_GAB1_SIGNALOSOME	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GAB1_SIGNALOSOME	-0.18431	-0.61551	0.9259	0.96729	1	0.444	0.378	0.277	0.97502	0.191
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	-0.17699	-0.61534	0.9406	0.96696	1	0.524	0.464	0.281	0.97468	0.188
ODONNELL_METASTASIS_UP	76	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_METASTASIS_UP	-0.1464	-0.61499	0.9884	0.96676	1	0.329	0.329	0.222	0.97465	0.18
GRATIAS_RETINOBLASTOMA_16Q24	15	http://www.broadinstitute.org/gsea/msigdb/cards/GRATIAS_RETINOBLASTOMA_16Q24	-0.18442	-0.61308	0.927	0.96757	1	0.6	0.49	0.306	0.97499	0.188
YAGI_AML_RELAPSE_PROGNOSIS	34	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_RELAPSE_PROGNOSIS	-0.16346	-0.61178	0.9141	0.96798	1	0.265	0.281	0.191	0.9759	0.188
REACTOME_CELL_JUNCTION_ORGANIZATION	75	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_JUNCTION_ORGANIZATION	-0.15384	-0.61052	0.9919	0.96843	1	0.387	0.341	0.255	0.97659	0.188
PLASARI_TGFB1_TARGETS_10HR_DN	239	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_TARGETS_10HR_DN	-0.21305	-0.60958	0.969	0.96865	1	0.205	0.166	0.173	0.97689	0.186
WALLACE_JAK2_TARGETS_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/WALLACE_JAK2_TARGETS_UP	-0.1727	-0.60822	0.9546	0.9691	1	0.346	0.37	0.218	0.97718	0.186
REACTOME_PIP3_ACTIVATES_AKT_SIGNALING	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PIP3_ACTIVATES_AKT_SIGNALING	-0.17959	-0.6073	0.9372	0.96929	1	0.148	0.112	0.132	0.9774	0.187
BIOCARTA_KERATINOCYTE_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_KERATINOCYTE_PATHWAY	-0.14953	-0.60283	0.9681	0.97178	1	0.511	0.473	0.27	0.98026	0.207
BIOCARTA_SPPA_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_SPPA_PATHWAY	-0.20622	-0.60228	0.9189	0.9717	1	0.636	0.502	0.317	0.97983	0.205
NABA_BASEMENT_MEMBRANES	40	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_BASEMENT_MEMBRANES	-0.174	-0.6021	0.8988	0.97135	1	0.5	0.418	0.291	0.97945	0.204
CHUNG_BLISTER_CYTOTOXICITY_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/CHUNG_BLISTER_CYTOTOXICITY_DN	-0.18992	-0.60165	0.9505	0.97117	1	0.286	0.226	0.222	0.97907	0.195
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	90	http://www.broadinstitute.org/gsea/msigdb/cards/WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	-0.19158	-0.60079	0.9374	0.97128	1	0.111	0.0919	0.101	0.97942	0.193
BIOCARTA_GCR_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_GCR_PATHWAY	-0.17743	-0.59989	0.9405	0.97139	1	0.65	0.51	0.319	0.9796	0.191
SHEPARD_BMYB_TARGETS	67	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_BMYB_TARGETS	-0.16196	-0.59407	0.9175	0.97448	1	0.507	0.433	0.288	0.98283	0.204
RHODES_UNDIFFERENTIATED_CANCER	68	http://www.broadinstitute.org/gsea/msigdb/cards/RHODES_UNDIFFERENTIATED_CANCER	-0.1493	-0.59273	0.9508	0.97481	1	0.265	0.308	0.184	0.98287	0.206
WHITFIELD_CELL_CYCLE_G2	172	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G2	-0.15284	-0.59141	0.9856	0.97515	1	0.244	0.28	0.177	0.98284	0.208
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S	-0.17395	-0.58684	0.901	0.97741	1	0.302	0.303	0.211	0.98508	0.219
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE	-0.1886	-0.58641	0.9225	0.97719	1	0.4	0.395	0.242	0.98471	0.213
LEE_AGING_MUSCLE_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_AGING_MUSCLE_UP	-0.19388	-0.58484	0.9269	0.97758	1	0.19	0.138	0.164	0.98518	0.223
REACTOME_GLUCONEOGENESIS	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLUCONEOGENESIS	-0.16686	-0.58437	0.9551	0.97737	1	0.156	0.146	0.134	0.9848	0.216
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	-0.18783	-0.58328	0.9719	0.97755	1	0.179	0.168	0.149	0.9848	0.214
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN	-0.23729	-0.58317	0.9771	0.97717	1	0.222	0.118	0.196	0.98436	0.212
PID_IL1_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL1_PATHWAY	-0.20068	-0.58303	0.938	0.97678	1	0.188	0.183	0.153	0.9839	0.208
TANG_SENESCENCE_TP53_TARGETS_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/TANG_SENESCENCE_TP53_TARGETS_DN	-0.17401	-0.58144	0.9212	0.97722	1	0.286	0.285	0.205	0.98414	0.209
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP	-0.16504	-0.58117	0.9264	0.9769	1	0.267	0.286	0.191	0.98372	0.203
REACTOME_EGFR_DOWNREGULATION	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_EGFR_DOWNREGULATION	-0.1567	-0.57845	0.9356	0.97785	1	0.375	0.369	0.237	0.98463	0.209
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	171	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	-0.15958	-0.57481	0.896	0.97935	1	0.333	0.308	0.232	0.98603	0.216
BIOCARTA_NGF_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NGF_PATHWAY	-0.22533	-0.57429	0.9716	0.97917	1	0.176	0.107	0.158	0.98575	0.209
REACTOME_NEPHRIN_INTERACTIONS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NEPHRIN_INTERACTIONS	-0.21441	-0.57359	0.986	0.97905	1	0.105	0.0478	0.1	0.98564	0.203
CAFFAREL_RESPONSE_TO_THC_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/CAFFAREL_RESPONSE_TO_THC_DN	-0.15759	-0.57121	0.9521	0.9798	1	0.367	0.391	0.224	0.98639	0.211
YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	-0.1227	-0.5698	1	0.98004	1	0.351	0.366	0.223	0.98656	0.207
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	132	http://www.broadinstitute.org/gsea/msigdb/cards/WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	-0.15278	-0.56739	0.9881	0.98077	1	0.295	0.317	0.203	0.9873	0.215
LE_NEURONAL_DIFFERENTIATION_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/LE_NEURONAL_DIFFERENTIATION_DN	-0.19853	-0.56536	0.9542	0.98127	1	0.579	0.426	0.333	0.98782	0.216
BIOCARTA_ARF_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ARF_PATHWAY	-0.21497	-0.56179	0.9232	0.9825	1	0.412	0.378	0.256	0.98892	0.231
BURTON_ADIPOGENESIS_PEAK_AT_24HR	42	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_24HR	-0.16841	-0.56061	0.9405	0.98258	1	0.262	0.265	0.193	0.98878	0.223
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE	-0.16109	-0.55748	0.9632	0.98354	1	0.577	0.51	0.283	0.98961	0.24
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	-0.19716	-0.5573	0.9419	0.98314	1	0.333	0.347	0.218	0.98926	0.217
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	42	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	-0.15312	-0.55223	0.9758	0.98489	1	0.405	0.378	0.252	0.99072	0.247
SEIDEN_MET_SIGNALING	19	http://www.broadinstitute.org/gsea/msigdb/cards/SEIDEN_MET_SIGNALING	-0.26688	-0.55052	0.9268	0.98508	1	0.158	0.175	0.13	0.99063	0.254
REACTOME_INFLAMMASOMES	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INFLAMMASOMES	-0.18736	-0.54953	0.9596	0.98502	1	0.0667	0.0312	0.0646	0.99048	0.243
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	44	http://www.broadinstitute.org/gsea/msigdb/cards/SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	-0.15482	-0.54715	0.9941	0.98551	1	0.523	0.457	0.285	0.99066	0.252
REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING	-0.15991	-0.54027	0.978	0.98764	1	0.139	0.112	0.124	0.993	0.278
GU_PDEF_TARGETS_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/GU_PDEF_TARGETS_UP	-0.18998	-0.53908	0.9663	0.98759	1	0.38	0.308	0.264	0.99282	0.271
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	187	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	-0.14081	-0.53738	0.9979	0.9877	1	0.0963	0.096	0.0877	0.99292	0.275
BIOCARTA_ERK_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ERK_PATHWAY	-0.13549	-0.53322	0.9894	0.98867	1	0.462	0.478	0.241	0.99387	0.275
KEGG_SMALL_CELL_LUNG_CANCER	82	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_SMALL_CELL_LUNG_CANCER	-0.14019	-0.53197	0.9854	0.98867	1	0.354	0.398	0.214	0.99367	0.265
PID_AVB3_OPN_PATHWAY	31	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AVB3_OPN_PATHWAY	-0.18602	-0.53184	0.9803	0.98824	1	0.258	0.254	0.193	0.99328	0.25
PID_NFKAPPAB_ATYPICAL_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NFKAPPAB_ATYPICAL_PATHWAY	-0.1628	-0.52862	0.9896	0.98881	1	0.562	0.502	0.28	0.99404	0.252
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	-0.1515	-0.52597	0.9915	0.98916	1	0.261	0.277	0.189	0.99418	0.251
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	-0.17515	-0.52549	0.9438	0.98883	1	0.391	0.333	0.261	0.99401	0.24
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES	26	http://www.broadinstitute.org/gsea/msigdb/cards/SIG_IL4RECEPTOR_IN_B_LYPHOCYTES	-0.17561	-0.51774	0.9719	0.99068	1	0.0385	0.00374	0.0384	0.99505	0.276
PID_MAPK_TRK_PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/PID_MAPK_TRK_PATHWAY	-0.14724	-0.51558	0.998	0.99083	1	0.353	0.399	0.212	0.99505	0.278
CHEN_LUNG_CANCER_SURVIVAL	26	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_LUNG_CANCER_SURVIVAL	-0.1409	-0.51411	0.9878	0.99076	1	0.385	0.467	0.205	0.99515	0.269
REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	-0.22047	-0.49878	0.9544	0.99399	1	0.5	0.395	0.303	0.99766	0.37
YANG_MUC2_TARGETS_DUODENUM_3MO_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_MUC2_TARGETS_DUODENUM_3MO_DN	-0.17804	-0.49847	0.9942	0.99361	1	0.227	0.241	0.173	0.99724	0.351
AMUNDSON_GAMMA_RADIATION_RESISTANCE	17	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_GAMMA_RADIATION_RESISTANCE	-0.1518	-0.49607	1	0.99367	1	0.0588	0.0237	0.0575	0.99711	0.343
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	134	http://www.broadinstitute.org/gsea/msigdb/cards/CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	-0.12755	-0.4905	0.988	0.99437	1	0.313	0.334	0.21	0.99766	0.345
CHANG_CYCLING_GENES	143	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_CYCLING_GENES	-0.13484	-0.47227	0.992	0.99715	1	0.294	0.315	0.202	0.99972	0.483
MURAKAMI_UV_RESPONSE_6HR_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/MURAKAMI_UV_RESPONSE_6HR_UP	-0.12984	-0.4694	0.9905	0.99712	1	0.389	0.425	0.224	0.9997	0.48
LAIHO_COLORECTAL_CANCER_SERRATED_UP	108	http://www.broadinstitute.org/gsea/msigdb/cards/LAIHO_COLORECTAL_CANCER_SERRATED_UP	-0.17451	-0.46857	0.9958	0.99677	1	0.12	0.108	0.108	0.99934	0.426
PID_ERBB1_INTERNALIZATION_PATHWAY	41	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERBB1_INTERNALIZATION_PATHWAY	-0.14368	-0.46456	0.998	0.99686	1	0.39	0.389	0.239	0.9992	0.424
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP	-0.14627	-0.46412	0.9923	0.99645	1	0.37	0.36	0.237	0.99876	0.391
JAEGER_METASTASIS_UP	39	http://www.broadinstitute.org/gsea/msigdb/cards/JAEGER_METASTASIS_UP	-0.188	-0.45654	0.9941	0.99702	1	0.256	0.236	0.196	0.99932	0.425
MORI_PLASMA_CELL_UP	48	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_PLASMA_CELL_UP	-0.14445	-0.4364	0.9939	0.99872	1	0.167	0.218	0.131	1	0.559
BIOCARTA_ECM_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ECM_PATHWAY	-0.157	-0.43596	0.994	0.9983	1	0.0833	0.0808	0.0767	1	0.509
PID_THROMBIN_PAR1_PATHWAY	43	http://www.broadinstitute.org/gsea/msigdb/cards/PID_THROMBIN_PAR1_PATHWAY	-0.11898	-0.42033	1	0.99908	1	0.0465	0.0278	0.0453	1	0.569
KANG_DOXORUBICIN_RESISTANCE_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_DOXORUBICIN_RESISTANCE_UP	-0.14885	-0.40252	0.9805	0.99972	1	0.173	0.179	0.142	1	0.634
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	-0.15976	-0.38578	0.9777	0.99998	1	0.294	0.4	0.176	1	0.691
EGUCHI_CELL_CYCLE_RB1_TARGETS	23	http://www.broadinstitute.org/gsea/msigdb/cards/EGUCHI_CELL_CYCLE_RB1_TARGETS	-0.14427	-0.35636	0.9903	1	1	0.261	0.304	0.182	1	0.783
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	136	http://www.broadinstitute.org/gsea/msigdb/cards/ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	-0.11405	-0.35215	0.9841	0.99987	1	0.404	0.438	0.228	1	0.646
BIOCARTA_HER2_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_HER2_PATHWAY	-0.10113	-0.32346	1	0.99976	1	1	0.899	0.101	1	0.763
